sampleID	_EVENT	_INTEGRATION	_OS	_OS_IND	_PANCAN_CNA_PANCAN_K8	_PANCAN_Cluster_Cluster_PANCAN	_PANCAN_DNAMethyl_PANCAN	_PANCAN_RPPA_PANCAN_K8	_PANCAN_UNC_RNAseq_PANCAN_K16	_PANCAN_miRNA_PANCAN	_PANCAN_mirna_OV	_PANCAN_mutation_PANCAN	_PATIENT	_TIME_TO_EVENT	_anatomical_origin	_cohort	_primary_disease	additional_pharmaceutical_therapy	additional_radiation_therapy	age_at_initial_pathologic_diagnosis	anatomic_neoplasm_subdivision	bcr_followup_barcode	clinical_stage	days_to_birth	days_to_collection	days_to_death	days_to_initial_pathologic_diagnosis	days_to_last_followup	days_to_new_tumor_event_additional_surgery_procedure	days_to_new_tumor_event_after_initial_treatment	eastern_cancer_oncology_group	followup_case_report_form_submission_reason	followup_treatment_success	form_completion_date	gender	histological_type	history_of_neoadjuvant_treatment	icd_10	icd_o_3_histology	icd_o_3_site	informed_consent_verified	initial_pathologic_diagnosis_method	initial_weight	intermediate_dimension	is_ffpe	karnofsky_performance_score	longest_dimension	lost_follow_up	lymphatic_invasion	neoplasm_histologic_grade	new_neoplasm_event_type	new_tumor_event_additional_surgery_procedure	new_tumor_event_after_initial_treatment	oct_embedded	pathology_report_file_name	percent_lymphocyte_infiltration_BOTTOM	percent_lymphocyte_infiltration_TOP	percent_monocyte_infiltration_BOTTOM	percent_monocyte_infiltration_TOP	percent_necrosis_BOTTOM	percent_necrosis_TOP	percent_neutrophil_infiltration_BOTTOM	percent_neutrophil_infiltration_TOP	percent_normal_cells_BOTTOM	percent_normal_cells_TOP	percent_stromal_cells_BOTTOM	percent_stromal_cells_TOP	percent_tumor_cells_BOTTOM	percent_tumor_cells_TOP	percent_tumor_nuclei_BOTTOM	percent_tumor_nuclei_TOP	performance_status_scale_timing	person_neoplasm_cancer_status	postoperative_rx_tx	primary_therapy_outcome_success	prior_dx	progression_determined_by	radiation_therapy	residual_tumor	sample_type	sample_type_id	shortest_dimension	tissue_prospective_collection_indicator	tissue_retrospective_collection_indicator	tissue_source_site	tumor_residual_disease	tumor_tissue_site	venous_invasion	vial_number	vital_status	year_of_initial_pathologic_diagnosis	_GENOMIC_ID_TCGA_OV_mutation_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_PDMarrayCNV	_GENOMIC_ID_TCGA_OV_mutation_curated_bcm_solid_gene	_GENOMIC_ID_TCGA_OV_mutation	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_percentile	_GENOMIC_ID_TCGA_OV_RPPA	_GENOMIC_ID_TCGA_OV_G4502A_07_2	_GENOMIC_ID_TCGA_OV_miRNA_HiSeq	_GENOMIC_ID_TCGA_OV_hMethyl27	_GENOMIC_ID_TCGA_OV_PDMRNAseqCNV	_GENOMIC_ID_TCGA_OV_PDMRNAseq	_GENOMIC_ID_TCGA_OV_gistic2	_GENOMIC_ID_TCGA_OV_PDMarray	_GENOMIC_ID_TCGA_OV_gistic2thd	_GENOMIC_ID_TCGA_OV_GSNP6raw	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_PANCAN	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2_exon	_GENOMIC_ID_TCGA_OV_GSNP6noCNV	_GENOMIC_ID_TCGA_OV_RPPA_RBN	_GENOMIC_ID_TCGA_OV_exp_HiSeq	_GENOMIC_ID_TCGA_OV_G4502A_07_3	_GENOMIC_ID_TCGA_OV_hMethyl450	_GENOMIC_ID_TCGA_OV_exp_u133a	_GENOMIC_ID_TCGA_OV_exp_HiSeqV2	_GENOMIC_ID_TCGA_OV_exp_HiSeq_exon	_GENOMIC_ID_TCGA_OV_mutation_broad_gene	_GENOMIC_ID_TCGA_OV_mutation_wustl_gene
TCGA-01-0628-11		TCGA-01-0628-11											TCGA-01-0628		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.4	NO		0.4																																	Solid Tissue Normal	11	0.4							A											TCGA-01-0628-11A-01D-0383-05												TCGA-01-0628-11A-01R-0363-07		78fc9d0c-7cb2-475b-bd98-e36f04d16358				
TCGA-01-0629-11		TCGA-01-0629-11											TCGA-01-0629		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																																																																																			TCGA-01-0629-11A-01D-0383-05												TCGA-01-0629-11A-01R-0363-07						
TCGA-01-0630-11		TCGA-01-0630-11											TCGA-01-0630		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.4	NO		1																																	Solid Tissue Normal	11	0.4							A									TCGA-01-0630-11A-01R-0363-07		TCGA-01-0630-11A-01D-0383-05														a87c0a4d-bb41-412c-abd4-7fa010fb18d8				
TCGA-01-0631-11		TCGA-01-0631-11											TCGA-01-0631		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.8	NO		1																																	Solid Tissue Normal	11	0.8							A									TCGA-01-0631-11A-01R-0363-07		TCGA-01-0631-11A-01D-0383-05														0c490ce9-9178-4dfe-8384-208d3d2d46c5				
TCGA-01-0633-11		TCGA-01-0633-11											TCGA-01-0633		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.4	NO		0.8																																	Solid Tissue Normal	11	0.3							A									TCGA-01-0633-11A-01R-0363-07		TCGA-01-0633-11A-01D-0383-05														eb14ef88-0adc-424d-b0a7-dd449f0907c6				
TCGA-01-0636-11		TCGA-01-0636-11											TCGA-01-0636		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.8	NO		1.1																																	Solid Tissue Normal	11	0.8							A									TCGA-01-0636-11A-01R-0363-07		TCGA-01-0636-11A-01D-0383-05														f17680d1-12eb-45ad-83bc-ba3d14485d10				
TCGA-01-0637-11		TCGA-01-0637-11											TCGA-01-0637		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.7	NO		0.7																																	Solid Tissue Normal	11	0.3							A									TCGA-01-0637-11A-01R-0363-07		TCGA-01-0637-11A-01D-0383-05														c22da589-1714-4d0c-aa00-e16b466e8a64				
TCGA-01-0638-11		TCGA-01-0638-11											TCGA-01-0638		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																																																																																	TCGA-01-0638-11A-02R-0363-07		TCGA-01-0638-11A-02D-0383-05																		
TCGA-01-0639-11		TCGA-01-0639-11											TCGA-01-0639		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.8	NO		0.9																																	Solid Tissue Normal	11	0.5							A											TCGA-01-0639-11A-01D-0383-05												TCGA-01-0639-11A-01R-0363-07		c417e63f-8714-4777-af37-5b39e34492c9				
TCGA-01-0642-11		TCGA-01-0642-11											TCGA-01-0642		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.8	NO		0.8																																	Solid Tissue Normal	11	0.4							A											TCGA-01-0642-11A-02D-0383-05												TCGA-01-0642-11A-02R-0363-07		4a42ad28-e3d0-4ec8-9c54-40179a2e2953				
TCGA-04-1331-01	1	TCGA-04-1331-01	1336	1	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1331	1336	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	78	Bilateral	TCGA-04-1331-F23906	Stage IIIC	-28848		1336	0	1224		459				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.5		YES	G3	Recurrence				TCGA-04-1331.2CF541C5-B56A-4946-A5C4-DBB4D71D7908.pdf					5	2			0	0	65	20	30	78	88	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary	NO	A	DECEASED	2004		TCGA-04-1331-01		TCGA-04-1331-01A-01W-0486-08				TCGA-04-1331-01A-01R-1569-13	TCGA-04-1331-01A-01D-0432-05			TCGA-04-1331-01A-01D-0428-01	TCGA-04-1331-01	TCGA-04-1331-01A-01D-0428-01	eb2cd85e-61a9-4180-b953-a8ad5fd9bef0			eb2cd85e-61a9-4180-b953-a8ad5fd9bef0		TCGA-04-1331-01A-01R-1569-13	TCGA-04-1331-01A-01R-0436-07		96db4ec8-524f-4a9a-a23c-30fade0992b7		TCGA-04-1331-01A-01R-1569-13	TCGA-04-1331-01A-01W-0486-08	
TCGA-04-1332-01	1	TCGA-04-1332-01	1247	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1332	1247	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Bilateral	TCGA-04-1332-F23911	Stage IIIC	-25786		1247	0	1247		393	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence				TCGA-04-1332.97ED2B5D-4349-40FE-A612-949EBBF108C4.pdf					8	3			0	0	52	89	40	8	89	90	Pre-Operative	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.5			04	1-10 mm	Ovary		A	DECEASED	2002		TCGA-04-1332-01		TCGA-04-1332-01A-01W-0488-09				TCGA-04-1332-01A-01R-1564-13	TCGA-04-1332-01A-01D-0432-05			TCGA-04-1332-01A-01D-0428-01	TCGA-04-1332-01	TCGA-04-1332-01A-01D-0428-01	79e63073-7d6d-456b-92c7-a3a7f0216ee7			79e63073-7d6d-456b-92c7-a3a7f0216ee7		TCGA-04-1332-01A-01R-1564-13	TCGA-04-1332-01A-01R-0436-07		e984c174-f724-49b0-84bf-788ff370d89f		TCGA-04-1332-01A-01R-1564-13		TCGA-04-1332-01A-01W-0488-09
TCGA-04-1335-01	1	TCGA-04-1335-01	55	1	Squamous		OV-like c1	OV-like c4					TCGA-04-1335	55	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Bilateral	TCGA-04-1335-F23924	Stage IB	-21963		55	0	55						2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		NO	G2					TCGA-04-1335.A3CEAB60-287E-41D1-A0BD-12B6626BA574.pdf					18	15			0	0	20	15	62	70	90	90	Pre-Operative	WITH TUMOR	NO				NO		Primary Tumor	01	0.4			04		Ovary	NO	A	DECEASED	2005		TCGA-04-1335-01				b1473202-11db-484b-8896-56abe5a3296e			TCGA-04-1335-01A-01D-0432-05			TCGA-04-1335-01A-01D-0428-01	TCGA-04-1335-01	TCGA-04-1335-01A-01D-0428-01	272b1120-4662-4049-b46a-ef68b8497a60			272b1120-4662-4049-b46a-ef68b8497a60	TCGA-04-1335-01A-21-20		TCGA-04-1335-01A-01R-0436-07		51038814-3401-4377-a815-92b9ce678f3d				
TCGA-04-1336-01	0	TCGA-04-1336-01	1495	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1336	1495	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Bilateral	TCGA-04-1336-F23926	Stage IIIB	-20271			0	1495						2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3					TCGA-04-1336.D66DA590-83E1-4607-8806-6402DF3F3385.pdf					0	4			17	0	0	4	83	92	91	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-04-1336-01		TCGA-04-1336-01A-01W-0488-09		7892f3fd-fdb3-43a0-8fd9-390927061f7a		TCGA-04-1336-01A-01R-1564-13	TCGA-04-1336-01A-01D-0432-05			TCGA-04-1336-01A-01D-0428-01	TCGA-04-1336-01	TCGA-04-1336-01A-01D-0428-01	f523d8fe-3bc7-4bcf-b5c1-6210c642442b			f523d8fe-3bc7-4bcf-b5c1-6210c642442b	TCGA-04-1336-01A-21-20		TCGA-04-1336-01A-01R-0436-07		e53eba00-2869-4168-98aa-a6c491b69fc6				TCGA-04-1336-01A-01W-0488-09
TCGA-04-1337-01	1	TCGA-04-1337-01	61	1	BRCA-LUAD+		UCEC Serous c4			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1337	61	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Bilateral	TCGA-04-1337-F23931	Stage IIIC	-28626		61	0				1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2		NO	G2					TCGA-04-1337.BA3A3AFD-9687-4FD3-B43A-2A5E623E3B31.pdf					0	0			0	0	50	21	50	79	84	82	Pre-Operative	WITH TUMOR	NO				NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	DECEASED	2005	TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01	TCGA-04-1337-01A-01W-0484-10	TCGA-04-1337-01A-01W-0484-10				TCGA-04-1337-01A-01R-1564-13	TCGA-04-1337-01A-01D-0432-05			TCGA-04-1337-01A-01D-0428-01	TCGA-04-1337-01	TCGA-04-1337-01A-01D-0428-01	e9050a41-d803-4991-b9b6-0aafbfa90480			e9050a41-d803-4991-b9b6-0aafbfa90480		TCGA-04-1337-01A-01R-1564-13	TCGA-04-1337-01A-01R-0436-07		543cc1e4-76ee-4e0a-80fa-7ad8477d8d40		TCGA-04-1337-01A-01R-1564-13		
TCGA-04-1338-01	0	TCGA-04-1338-01	1418	0	High	C9-OV	OV-like c1	OV-like c4				mutation cluster 5	TCGA-04-1338	1418	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	78	Bilateral	TCGA-04-1338-F23933	Stage IIIC	-28789			0	1418		380	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-04-1338.889AF2DB-7FF9-45B1-8FD4-28D57CF870A7.pdf					15	15					40	30	45	55	85	85	Pre-Operative	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary		A	LIVING	2005	TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01	TCGA-04-1338-01A-01W-0484-10	TCGA-04-1338-01A-01W-0484-10		ee14145d-2ec8-4323-804e-c0a15371559b			TCGA-04-1338-01A-01D-0432-05			TCGA-04-1338-01A-01D-0428-01	TCGA-04-1338-01	TCGA-04-1338-01A-01D-0428-01	8fee54d4-4bfb-487a-94b3-be40b1e5f416			8fee54d4-4bfb-487a-94b3-be40b1e5f416	TCGA-04-1338-01A-21-20	TCGA-04-1338-01A-01R-1564-13	TCGA-04-1338-01A-01R-0436-07		17aa44c9-3071-4184-9692-4c04fabb5a4b		TCGA-04-1338-01A-01R-1564-13		
TCGA-04-1341-01	0	TCGA-04-1341-01	33	0	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-04-1341	33	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			85		TCGA-04-1341-F23940		-31215			0	33				Scheduled Follow-up Submission		2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			1	NO		1.5			G3					TCGA-04-1341.9DB095E5-19F0-4ECE-9E54-2F030190FDB5.pdf					17	3					28	22	55	75	80	80		WITH TUMOR		Complete Remission/Response			NO		Primary Tumor	01	0.4	NO	YES	04		Ovary		A	LIVING	2006		TCGA-04-1341-01				9e5cf025-e667-4a73-94a3-e45255194ec3		TCGA-04-1341-01A-01R-1564-13	TCGA-04-1341-01A-01D-0432-05			TCGA-04-1341-01A-01D-0428-01	TCGA-04-1341-01	TCGA-04-1341-01A-01D-0428-01	504eb58f-bb8f-4171-b8e2-41f3d6dd8f88			504eb58f-bb8f-4171-b8e2-41f3d6dd8f88	TCGA-04-1341-01A-21-20	TCGA-04-1341-01A-01R-1564-13	TCGA-04-1341-01A-01R-0436-07		a9e75af6-31c2-4d32-8c4e-ee9538e77b0e		TCGA-04-1341-01A-01R-1564-13		
TCGA-04-1342-01	1	TCGA-04-1342-01	563	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1342	563	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			80	Bilateral	TCGA-04-1342-F23942	Stage IV	-29501		563	0				2			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2			G2					TCGA-04-1342.B296EAFA-9EE4-4611-888A-FA0B58EC2A88.pdf					1	4			0	0	9	11	90	85	91	95	Pre-Operative	WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.2			04	>20 mm	Ovary		A	DECEASED	2006		TCGA-04-1342-01		TCGA-04-1342-01A-01W-0486-08		e79f6986-9f15-4826-901b-1a97c2b8ae42		TCGA-04-1342-01A-01R-1564-13	TCGA-04-1342-01A-01D-0432-05			TCGA-04-1342-01A-01D-0428-01	TCGA-04-1342-01	TCGA-04-1342-01A-01D-0428-01	d5aabe0b-7274-49da-9d1a-558f1ef71877			d5aabe0b-7274-49da-9d1a-558f1ef71877	TCGA-04-1342-01A-21-20		TCGA-04-1342-01A-01R-0436-07		3cfa7f01-3d75-4c1a-8e7f-ac849f5fde70			TCGA-04-1342-01A-01W-0486-08	
TCGA-04-1343-01	1	TCGA-04-1343-01	361	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1343	361	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			72	Bilateral	TCGA-04-1343-F23949	Stage IV	-26428		361	0				3			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3					TCGA-04-1343.E62828D9-A46C-498F-9976-CC430D16057E.pdf					4	1			0	0	16	4	80	95	88	93	Pre-Operative	WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2002		TCGA-04-1343-01		TCGA-04-1343-01A-01W-0488-09		58f649ec-b1cd-4775-8c03-4ebdfe0ad072		TCGA-04-1343-01A-01R-1564-13	TCGA-04-1343-01A-01D-0432-05			TCGA-04-1343-01A-01D-0428-01	TCGA-04-1343-01	TCGA-04-1343-01A-01D-0428-01	2ea95bbb-00cd-491e-814e-25360d715683			2ea95bbb-00cd-491e-814e-25360d715683	TCGA-04-1343-01A-21-20	TCGA-04-1343-01A-01R-1564-13	TCGA-04-1343-01A-01R-0436-07		ecfe5ba4-b146-4757-894e-ee6e44f4ba5c		TCGA-04-1343-01A-01R-1564-13		TCGA-04-1343-01A-01W-0488-09
TCGA-04-1346-01	0	TCGA-04-1346-01	1993	0	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1346	1993	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-04-1346-F23959	Stage IIIC	-26865			0	1993						2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO	100	2		YES	G2					TCGA-04-1346.40C05C93-8968-4FF0-855F-09E2F7FAAB68.pdf					1	2			0	0	30	30	69	68	80	90		TUMOR FREE	NO	Complete Remission/Response			NO		Primary Tumor	01	0.3			04		Ovary		A	LIVING	2003		TCGA-04-1346-01		TCGA-04-1346-01A-01W-0488-09				TCGA-04-1346-01A-01R-1569-13	TCGA-04-1346-01A-01D-0432-05			TCGA-04-1346-01A-01D-0428-01	TCGA-04-1346-01	TCGA-04-1346-01A-01D-0428-01	29c06801-2cc2-4f52-847a-2a31ec7d776b			29c06801-2cc2-4f52-847a-2a31ec7d776b			TCGA-04-1346-01A-01R-0436-07		3b372510-9632-40d8-a82b-d58e0a0c0ba6				TCGA-04-1346-01A-01W-0488-09
TCGA-04-1347-01	0	TCGA-04-1347-01	1919	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1347	1919	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			81	Bilateral	TCGA-04-1347-F23961	Stage IV	-29695			0	1919			0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	100	1.1		NO	G3					TCGA-04-1347.18BFB10C-5EDC-4253-A2A8-93533CB4B471.pdf					5	2			0	0	40	5	55	93	70	99	Pre-Operative	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.1			04	No Macroscopic disease	Ovary	NO	A	LIVING	2004		TCGA-04-1347-01		TCGA-04-1347-01A-01W-0488-09				TCGA-04-1347-01A-01R-1564-13	TCGA-04-1347-01A-01D-0432-05			TCGA-04-1347-01A-01D-0428-01	TCGA-04-1347-01	TCGA-04-1347-01A-01D-0428-01	41386f0c-6c92-4ae3-9b7a-fc2b98108e4f			41386f0c-6c92-4ae3-9b7a-fc2b98108e4f		TCGA-04-1347-01A-01R-1564-13	TCGA-04-1347-01A-01R-0436-07		886f150b-23d2-4000-b550-e0fda444ca61		TCGA-04-1347-01A-01R-1564-13		TCGA-04-1347-01A-01W-0488-09
TCGA-04-1348-01	1	TCGA-04-1348-01	1483	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1348	1483	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-04-1348-F23967	Stage IIIB	-16236		1483	0			575				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3	Recurrence				TCGA-04-1348.51B558EF-C11B-41A7-A7BF-15D201506006.pdf					8	4			0	0	2	1	90	95	99	99		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary		A	DECEASED	2004		TCGA-04-1348-01		TCGA-04-1348-01A-01W-0494-09	1465139e-d1b2-4026-a532-08513fe0ad4d	21a891e7-6da2-4d9e-a1e3-e760605d9dee		TCGA-04-1348-01A-01R-1565-13	TCGA-04-1348-01A-01D-0460-05	TCGA-04-1348-01	TCGA-04-1348-01	TCGA-04-1348-01A-01D-0452-01	TCGA-04-1348-01	TCGA-04-1348-01A-01D-0452-01	86b353ef-ba2c-4dd0-91f6-ef700eb3c5d6	1465139e-d1b2-4026-a532-08513fe0ad4d	1465139e-d1b2-4026-a532-08513fe0ad4d	86b353ef-ba2c-4dd0-91f6-ef700eb3c5d6	TCGA-04-1348-01A-21-20	TCGA-04-1348-01A-01R-1565-13	TCGA-04-1348-01A-01R-0456-07		6b5e9411-a6df-45a9-8281-75228283c4f4	1465139e-d1b2-4026-a532-08513fe0ad4d	TCGA-04-1348-01A-01R-1565-13		TCGA-04-1348-01A-01W-0494-09
TCGA-04-1349-01	1	TCGA-04-1349-01	656	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1349	656	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	69	Bilateral	TCGA-04-1349-F23977	Stage IV	-25213		656	0			428				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1		YES	G3	Recurrence				TCGA-04-1349.8D470D24-17DD-4180-987E-F33FA31535AE.pdf					1	0			0	0	20	10	79	90	90	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			04		Ovary		A	DECEASED	2004		TCGA-04-1349-01		TCGA-04-1349-01A-01W-0494-09		2a143727-7310-4103-beec-3522534165fe		TCGA-04-1349-01A-01R-1565-13	TCGA-04-1349-01A-01D-0460-05			TCGA-04-1349-01A-01D-0452-01	TCGA-04-1349-01	TCGA-04-1349-01A-01D-0452-01	736806c4-db62-4e8f-8f4c-ec723295ea84			736806c4-db62-4e8f-8f4c-ec723295ea84	TCGA-04-1349-01A-21-20		TCGA-04-1349-01A-01R-0456-07		83332db9-57b5-40ce-ad30-cf81d48a7cd6				TCGA-04-1349-01A-01W-0494-09
TCGA-04-1350-01	1	TCGA-04-1350-01	1946	1	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1350	1946	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	46	Bilateral	TCGA-04-1350-F23988	Stage IIIC	-16942		1946	0			111	0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-04-1350.C4BB615C-ABBA-4136-AAB4-52EA1FE88D14.pdf					1	1			0	0	5	5	94	94	99	99	Pre-Operative	WITH TUMOR	NO	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2003	TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01	TCGA-04-1350-01A-01W-0490-10	TCGA-04-1350-01A-01W-0490-10				TCGA-04-1350-01A-01R-1565-13	TCGA-04-1350-01A-01D-0460-05			TCGA-04-1350-01A-01D-0452-01	TCGA-04-1350-01	TCGA-04-1350-01A-01D-0452-01	9ee784ec-de14-4b73-b0eb-94f4ff4defcf			9ee784ec-de14-4b73-b0eb-94f4ff4defcf		TCGA-04-1350-01A-01R-1565-13	TCGA-04-1350-01A-01R-0456-07		339c6cc0-96b2-4225-b3bc-6cac497c7b92		TCGA-04-1350-01A-01R-1565-13		
TCGA-04-1351-01	0	TCGA-04-1351-01	1991	0	High		OV-like c1						TCGA-04-1351	1991	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76		TCGA-04-1351-F24001	Stage IIIC	-28045			0	1991		1658				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.4	NO	100	2			G2	Recurrence				TCGA-04-1351.E52A52E0-5A81-4CD6-A78F-B721E5CE039B.pdf					20	15			0	0	40	30	40	55	80	90		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			04		Ovary		A	LIVING	2004	TCGA-04-1351-01A-01W-0490-10	TCGA-04-1351-01	TCGA-04-1351-01A-01W-0490-10						TCGA-04-1351-01A-01D-0460-05			TCGA-04-1351-01A-01D-0452-01	TCGA-04-1351-01	TCGA-04-1351-01A-01D-0452-01	3b948e06-a6e7-439a-9a49-63e921749f39			3b948e06-a6e7-439a-9a49-63e921749f39			TCGA-04-1351-01A-01R-0456-07		a8c3bbb4-24aa-4975-916a-50c6ba1f7eac				
TCGA-04-1353-01	0	TCGA-04-1353-01	16	0	High		OV-like c1						TCGA-04-1353	16	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64		TCGA-04-1353-F65201	Stage IIIC	-23611			0	16				Scheduled Follow-up Submission		2014-9-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.5	NO		1	NO							TCGA-04-1353.AF052ECD-D583-45B1-A5C9-B8735C15F799.pdf					5	1			0	0	30	40	65	59	90	75					No				Primary Tumor	01	0.2	NO	YES	04		Ovary		A	LIVING	2003		TCGA-04-1353-01							TCGA-04-1353-01A-01D-1047-05			TCGA-04-1353-01A-01D-1043-01	TCGA-04-1353-01	TCGA-04-1353-01A-01D-1043-01	0836cb2f-6a21-463c-9774-4892587f1e84			0836cb2f-6a21-463c-9774-4892587f1e84			TCGA-04-1353-01A-01R-1050-07		b4d1d595-41fa-4b9d-9f01-e820fdace4f6				TCGA-04-1353-01A-01D-1526-09
TCGA-04-1353-11	0	TCGA-04-1353-11	16	0									TCGA-04-1353	16	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64		TCGA-04-1353-F65201	Stage IIIC	-23611			0	16				Scheduled Follow-up Submission		2014-9-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.4	NO		1.5	NO																												No				Solid Tissue Normal	11	0.2	NO	YES	04		Ovary		B	LIVING	2003									TCGA-04-1353-11B-01D-1047-05																		
TCGA-04-1356-01	1	TCGA-04-1356-01	1499	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1356	1499	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62	Bilateral	TCGA-04-1356-F24005	Stage IIC	-22855		1499	0			156				2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	80	1.2		YES	G3	Recurrence				TCGA-04-1356.7D26B212-1DE7-43CC-A0DC-A9071C3A534F.pdf					5	10			0	0	10	5	85	85	95	99	Pre-Operative	WITH TUMOR	NO	Progressive Disease		Physical Examination	NO		Primary Tumor	01	0.4			04		Ovary	YES	A	DECEASED	2004		TCGA-04-1356-01		TCGA-04-1356-01A-01W-0492-08		6b9482bd-967a-447e-8f6f-324c7ec41b4d		TCGA-04-1356-01A-01R-1569-13	TCGA-04-1356-01A-01D-0460-05			TCGA-04-1356-01A-01D-0452-01	TCGA-04-1356-01	TCGA-04-1356-01A-01D-0452-01	72a0595a-c9a2-4424-bbfc-1b63c7c21489			72a0595a-c9a2-4424-bbfc-1b63c7c21489	TCGA-04-1356-01A-21-20	TCGA-04-1356-01A-01R-1569-13	TCGA-04-1356-01A-01R-0456-07		9e919b59-a80e-4165-ba65-02ae5c35e910		TCGA-04-1356-01A-01R-1569-13	TCGA-04-1356-01A-01W-0492-08	
TCGA-04-1357-01		TCGA-04-1357-01			High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1357		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52		TCGA-04-1357-F24009	Stage IIIB	-18999			0							2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.6	NO		1.5			G3					TCGA-04-1357.D1D902A3-DF76-4623-B2E7-88FFA9E1542F.pdf	50				1	0			0	0	20	50	79	50	90	70			YES				NO		Primary Tumor	01	0.6			04		Ovary		A	LIVING	2005		TCGA-04-1357-01		TCGA-04-1357-01A-01W-0492-08	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	fcbf9267-5e2a-4a94-8851-9f7151aee4a0		TCGA-04-1357-01A-01R-1565-13	TCGA-04-1357-01A-01D-0460-05	TCGA-04-1357-01	TCGA-04-1357-01	TCGA-04-1357-01A-01D-0452-01	TCGA-04-1357-01	TCGA-04-1357-01A-01D-0452-01	934ee741-d185-47f2-860c-74e90af24b4e	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	934ee741-d185-47f2-860c-74e90af24b4e	TCGA-04-1357-01A-21-20	TCGA-04-1357-01A-01R-1565-13	TCGA-04-1357-01A-01R-0456-07		ab3d12c9-29b5-41b0-98dd-56670fe303d9	ec1fc406-d1c4-4eba-ab6b-6cfb460f0862	TCGA-04-1357-01A-01R-1565-13	TCGA-04-1357-01A-01W-0492-08	
TCGA-04-1360-01		TCGA-04-1360-01			High		OV-like c1	OV-like c4					TCGA-04-1360		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			65		TCGA-04-1360-F24011	Stage IA	-23993			0							2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.8	NO		1			G3					TCGA-04-1360.D215D37F-D04B-44BC-AF17-D3B8C804A3E9.pdf					1	1			0	0	40	20	59	79	70	90			YES				NO		Primary Tumor	01	0.4			04		Ovary		A	LIVING	2005		TCGA-04-1360-01				e470041a-5d0c-4818-8246-bd4530cc81e0			TCGA-04-1360-01A-01D-0460-05			TCGA-04-1360-01A-01D-0452-01	TCGA-04-1360-01	TCGA-04-1360-01A-01D-0452-01	64f9f41e-43ea-4193-a30d-3dd6b7863800			64f9f41e-43ea-4193-a30d-3dd6b7863800	TCGA-04-1360-01A-21-20		TCGA-04-1360-01A-01R-0456-07		09afddf6-c527-4561-b476-cbc9bcc7ca24				
TCGA-04-1361-01	0	TCGA-04-1361-01	989	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1361	989	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-04-1361-F24013	Stage IIIB	-20860			0	989		927	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3	Recurrence				TCGA-04-1361.5116FD62-7A2C-425A-A99E-D47C1B456961.pdf					1	1			0	0	30	30	69	69	80	80			YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-04-1361-01		TCGA-04-1361-01A-01W-0494-09		62d06e8a-aed1-4904-8651-c9912e5b1eae		TCGA-04-1361-01A-01R-1565-13	TCGA-04-1361-01A-01D-0460-05			TCGA-04-1361-01A-01D-0452-01	TCGA-04-1361-01	TCGA-04-1361-01A-01D-0452-01	49aff11e-7532-4ca6-9192-b6d8e8b806c1			49aff11e-7532-4ca6-9192-b6d8e8b806c1	TCGA-04-1361-01A-21-20	TCGA-04-1361-01A-01R-1565-13	TCGA-04-1361-01A-01R-0456-07		874772d1-76e5-4480-9fb5-0130d66f1b3a		TCGA-04-1361-01A-01R-1565-13		TCGA-04-1361-01A-01W-0494-09
TCGA-04-1362-01	1	TCGA-04-1362-01	1348	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-04-1362	1348	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-04-1362-F24020	Stage IIC	-21745		1348	0			223	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence				TCGA-04-1362.D3757F96-E669-4D0E-BBCB-41696AB72004.pdf					1	1			0	0	10	15	89	84	99	99	Pre-Adjuvant Therapy	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.6			04	1-10 mm	Ovary		A	DECEASED	2002		TCGA-04-1362-01		TCGA-04-1362-01A-01W-0494-09	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	e6a03e2b-8fcf-4ad5-9b40-be38c0b08786		TCGA-04-1362-01A-01R-1565-13	TCGA-04-1362-01A-01D-0460-05	TCGA-04-1362-01	TCGA-04-1362-01	TCGA-04-1362-01A-01D-0452-01	TCGA-04-1362-01	TCGA-04-1362-01A-01D-0452-01	8fcdd3d0-8a62-49aa-b7e2-5b06cb390d40	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	8fcdd3d0-8a62-49aa-b7e2-5b06cb390d40	TCGA-04-1362-01A-21-20	TCGA-04-1362-01A-01R-1565-13	TCGA-04-1362-01A-01R-0456-07		9dcb2e40-d569-439e-8359-4178124447b5	802ea3c6-e07f-49a1-a1c2-8f90e3197e62	TCGA-04-1362-01A-01R-1565-13		TCGA-04-1362-01A-01W-0494-09
TCGA-04-1364-01	1	TCGA-04-1364-01	1024	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1364	1024	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-04-1364-F24028	Stage IIIC	-22294		1024	0			288	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2		NO	G3	Recurrence				TCGA-04-1364.CA87C9DF-D4ED-41BD-AEC9-B41C4FEC54A4.pdf					2	2			0	0	5	5	93	93	99	99	Pre-Operative	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2003	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01	TCGA-04-1364-01A-01W-0490-10	TCGA-04-1364-01A-01W-0490-10	2fadaf5a-402b-483d-bc26-08feb3dc162d			TCGA-04-1364-01A-01R-1565-13	TCGA-04-1364-01A-01D-0460-05	TCGA-04-1364-01	TCGA-04-1364-01	TCGA-04-1364-01A-01D-0452-01	TCGA-04-1364-01	TCGA-04-1364-01A-01D-0452-01	e73359b7-f33f-4a24-b93a-f93196d5719a	2fadaf5a-402b-483d-bc26-08feb3dc162d	2fadaf5a-402b-483d-bc26-08feb3dc162d	e73359b7-f33f-4a24-b93a-f93196d5719a		TCGA-04-1364-01A-01R-1565-13	TCGA-04-1364-01A-01R-0456-07		0e23070a-25c9-49b4-8c4a-a9994de3a312	2fadaf5a-402b-483d-bc26-08feb3dc162d	TCGA-04-1364-01A-01R-1565-13		
TCGA-04-1365-01	0	TCGA-04-1365-01	2329	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-04-1365	2329	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	87	Left	TCGA-04-1365-F24044	Stage IIIB	-31925			0	2329		1328	1			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.2		NO	G3	Recurrence				TCGA-04-1365.049FC54E-4D17-4B68-9E41-268529C9F18F.pdf					1	1			0	0	5	5	94	94	99	95	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.6			04		Ovary		A	LIVING	2003	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01	TCGA-04-1365-01A-01W-0490-10	TCGA-04-1365-01A-01W-0490-10	2535da6b-39f0-41de-afd3-82cb37916b95			TCGA-04-1365-01A-01R-1565-13	TCGA-04-1365-01A-01D-0460-05	TCGA-04-1365-01	TCGA-04-1365-01	TCGA-04-1365-01A-01D-0452-01	TCGA-04-1365-01	TCGA-04-1365-01A-01D-0452-01	1461657f-a324-4423-8eea-8d284dde4139	2535da6b-39f0-41de-afd3-82cb37916b95	2535da6b-39f0-41de-afd3-82cb37916b95	1461657f-a324-4423-8eea-8d284dde4139		TCGA-04-1365-01A-01R-1565-13	TCGA-04-1365-01A-01R-0456-07		a64bec02-eddf-4723-90a8-6742267b4f51	2535da6b-39f0-41de-afd3-82cb37916b95	TCGA-04-1365-01A-01R-1565-13		
TCGA-04-1367-01	0	TCGA-04-1367-01	2174	0	High		OV-like c1			miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1367	2174	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-04-1367-F62486	Stage IIIC	-18577			0	2174		2997	0	Scheduled Follow-up Submission		2009-10-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	100	0.7		NO	G3	Progression of Disease				TCGA-04-1367.78E00062-0996-45A9-80FC-125409EE370A.pdf					5	2			0	0	5	10	90	88	99	95	Pre-Operative	TUMOR FREE	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.5	NO	YES	04	No Macroscopic disease	Ovary	NO	A	LIVING	2003		TCGA-04-1367-01		TCGA-04-1367-01A-01W-0492-08				TCGA-04-1367-01A-01R-1565-13	TCGA-04-1367-01A-01D-0460-05			TCGA-04-1367-01A-01D-0452-01	TCGA-04-1367-01	TCGA-04-1367-01A-01D-0452-01	6b7cbe78-6513-49e6-b623-dd6ae19a0298			6b7cbe78-6513-49e6-b623-dd6ae19a0298			TCGA-04-1367-01A-01R-0456-07		69b2dded-5eff-448b-8220-8163c264e63b			TCGA-04-1367-01A-01W-0492-08	
TCGA-04-1369-01	1	TCGA-04-1369-01	642	1			OV-like c1	OV-like c4					TCGA-04-1369	642	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-04-1369-F24056	Stage IIIC	-19571		642	0			315	0			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G2	Progression of Disease				TCGA-04-1369.5C54C779-C561-4625-B8F0-029BE2D3C91B.pdf					5	5				0	5	10	90	85	99	90	Pre-Adjuvant Therapy	WITH TUMOR	YES			Imaging Study	NO	R1	Primary Tumor	01	0.2			04	1-10 mm	Ovary		A	DECEASED	2004						40f6f0ca-e0e0-4c0b-96b1-3d305aa93f95			TCGA-04-1369-01A-02D-1047-05				TCGA-04-1369-01		2aa36c4f-8057-498b-832c-127ecff9cb03			2aa36c4f-8057-498b-832c-127ecff9cb03	TCGA-04-1369-01A-11-1562-20		TCGA-04-1369-01A-02R-1050-07		940c48c2-f75f-498a-9c40-a33d65dfbce1				TCGA-04-1369-01A-02D-1526-09
TCGA-04-1369-11	1	TCGA-04-1369-11	642	1									TCGA-04-1369	642	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-04-1369-F24056	Stage IIIC	-19571		642	0			315	0			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G2	Progression of Disease																					Pre-Adjuvant Therapy	WITH TUMOR	YES			Imaging Study	NO	R1	Solid Tissue Normal	11	0.3			04	1-10 mm	Ovary		A	DECEASED	2004									TCGA-04-1369-11A-01D-1047-05																		
TCGA-04-1370-01	0	TCGA-04-1370-01	1824	0				OV-like c4					TCGA-04-1370	1824	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-04-1370-F24062	Stage IIIC	-19329			0	1824			1			2010-8-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2			G3					TCGA-04-1370.6E990DE9-ED0A-4152-A862-866FBF8A41DE.pdf					0	5			0	0	10	15	90	80	95	90	Pre-Adjuvant Therapy		YES				NO	R1	Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	LIVING	2004						4234f147-09cf-480f-bfca-5ae6c5d338f9													TCGA-04-1370-01A-21-1562-20								
TCGA-04-1371-01	0	TCGA-04-1371-01	2506	0	High		OV-like c1						TCGA-04-1371	2506	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-04-1371-F24066	Stage IIIC	-21243			0	2506			0			2009-3-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2			G3					TCGA-04-1371.06C70ACA-8222-43CF-9E68-FCDF8D1A9C21.pdf					1	5			0	0	25	15	74	80	75	90	Pre-Adjuvant Therapy	TUMOR FREE	YES				NO		Primary Tumor	01	0.1			04	1-10 mm	Ovary		A	LIVING	2001		TCGA-04-1371-01							TCGA-04-1371-01A-01D-0460-05			TCGA-04-1371-01A-01D-0452-01	TCGA-04-1371-01	TCGA-04-1371-01A-01D-0452-01	7adacb86-5d5b-4894-a2d1-0eaa93a6fd5d			7adacb86-5d5b-4894-a2d1-0eaa93a6fd5d			TCGA-04-1371-01A-01R-0456-07		bf67f8d7-e33c-4b18-9801-4b78ce0b41bb				
TCGA-04-1514-01	1	TCGA-04-1514-01	1720	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1514	1720	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Bilateral	TCGA-04-1514-F24071	Stage IIIA	-16725		1720	0			1221	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1		NO	G2	Recurrence				TCGA-04-1514.A0487B93-029F-48EB-AF5C-06A2F5A3FAAA.pdf					5	5			0	0	10	10	85	85	95	95	Pre-Operative	TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			04	No Macroscopic disease	Ovary		A	DECEASED	2004	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01	TCGA-04-1514-01A-01W-0552-10	TCGA-04-1514-01A-01W-0552-10	cc5e2498-a9e6-48be-bbda-9aa101546ca4	8fcd1179-3170-4ca1-b961-dbaa7a391ea4		TCGA-04-1514-01A-01R-1566-13	TCGA-04-1514-01A-01D-0501-05	TCGA-04-1514-01	TCGA-04-1514-01	TCGA-04-1514-01A-01D-0497-01	TCGA-04-1514-01	TCGA-04-1514-01A-01D-0497-01	a059d969-2eb2-44d5-93cd-ed88f5b61719	cc5e2498-a9e6-48be-bbda-9aa101546ca4	cc5e2498-a9e6-48be-bbda-9aa101546ca4	a059d969-2eb2-44d5-93cd-ed88f5b61719	TCGA-04-1514-01A-21-1558-20	TCGA-04-1514-01A-01R-1566-13	TCGA-04-1514-01A-01R-0504-07		c7e3fccc-4e03-4914-874c-e5034bcc6941	cc5e2498-a9e6-48be-bbda-9aa101546ca4	TCGA-04-1514-01A-01R-1566-13		
TCGA-04-1516-01	0	TCGA-04-1516-01	1265	0	High		OV-like c1	OV-like c4					TCGA-04-1516	1265	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Left	TCGA-04-1516-F24087	Stage IA	-17768			0	1265			0			2010-6-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3					TCGA-04-1516.434BDC72-1BE6-4235-AFBA-10ADE94C8901.pdf					0	0			0	0	2	15	98	85	99	95	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO	R0	Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-04-1516-01				556a186c-d6ab-4f84-9cac-2b237c3bb4fc			TCGA-04-1516-01A-01D-1047-05			TCGA-04-1516-01A-01D-1043-01	TCGA-04-1516-01	TCGA-04-1516-01A-01D-1043-01	9cc09b82-8dd1-4e93-a49e-fef483c29709			9cc09b82-8dd1-4e93-a49e-fef483c29709	TCGA-04-1516-01A-21-1558-20		TCGA-04-1516-01A-01R-1050-07		0c2520a9-0937-40b7-a09f-9f21a4726876				TCGA-04-1516-01A-01D-1526-09
TCGA-04-1516-11	0	TCGA-04-1516-11	1265	0									TCGA-04-1516	1265	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Left	TCGA-04-1516-F24087	Stage IA	-17768			0	1265			0			2010-6-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3																						Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO	R0	Solid Tissue Normal	11	0.5			04	No Macroscopic disease	Ovary		B	LIVING	2006									TCGA-04-1516-11B-01D-1047-05																		
TCGA-04-1517-01	1	TCGA-04-1517-01	608	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-04-1517	608	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	79	Bilateral	TCGA-04-1517-F24092	Stage IIIC	-29045		608	0			349				2009-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5		NO	G3	Recurrence				TCGA-04-1517.ED992763-74E1-466F-A71A-AC0455AD40F6.pdf					0	10			0	0	5	5	95	85	99	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			04	>20 mm	Ovary	NO	A	DECEASED	2006	TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01	TCGA-04-1517-01A-01W-0615-10	TCGA-04-1517-01A-01W-0615-10		9e4ae9f4-e1ef-40a6-af24-7ea99c9beccd		TCGA-04-1517-01A-01R-1565-13	TCGA-04-1517-01A-01D-0536-05			TCGA-04-1517-01A-01D-0533-01	TCGA-04-1517-01	TCGA-04-1517-01A-01D-0533-01	5e521fd3-5489-4e99-92db-70c6bb30d44f			5e521fd3-5489-4e99-92db-70c6bb30d44f	TCGA-04-1517-01A-21-1558-20	TCGA-04-1517-01A-01R-1565-13	TCGA-04-1517-01A-01R-0540-07		663aa6bd-30d1-47fb-8aec-2baece0cbb87		TCGA-04-1517-01A-01R-1565-13		
TCGA-04-1519-01	0	TCGA-04-1519-01	24	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-04-1519	24	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48		TCGA-04-1519-F58470	Stage IIIC	-17671			0	24				Scheduled Follow-up Submission		2014-4-10	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.4	NO		1.3	YES		G3					TCGA-04-1519.53840C6E-E1AA-415E-BB85-8E1B8976F45C.pdf					0	0			0	0	10	10	90	90	95	95									Primary Tumor	01	0.4			04		Ovary		A	LIVING	2007	TCGA-04-1519-01A-01W-0615-10	TCGA-04-1519-01	TCGA-04-1519-01A-01W-0615-10		193d3e7f-ec7f-453a-9c2a-77b240c4ba19	0ed2d853-f94d-49d0-856b-85d54e4817f5		TCGA-04-1519-01A-01R-1565-13	TCGA-04-1519-01A-01D-0536-05	TCGA-04-1519-01	TCGA-04-1519-01	TCGA-04-1519-01A-01D-0533-01	TCGA-04-1519-01	TCGA-04-1519-01A-01D-0533-01	74c4f7e9-6f7e-41b7-8f57-f4cd0a5312d0	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	74c4f7e9-6f7e-41b7-8f57-f4cd0a5312d0	TCGA-04-1519-01A-21-1558-20	TCGA-04-1519-01A-01R-1565-13	TCGA-04-1519-01A-01R-0540-07		87caa261-28f0-4d9d-bec5-3842c715d23a	193d3e7f-ec7f-453a-9c2a-77b240c4ba19	TCGA-04-1519-01A-01R-1565-13		
TCGA-04-1525-01	1	TCGA-04-1525-01	1167	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-04-1525	1167	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-04-1525-F24099	Stage IIIC	-17469		1167	0	1167		213				2009-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		2		NO	G3	Recurrence				TCGA-04-1525.B84E0C8B-B383-453F-9099-92B5445691D6.pdf					0	0			0	0	50	25	50	75	70	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			04	1-10 mm	Ovary	NO	A	DECEASED	2005	TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01	TCGA-04-1525-01A-01W-0615-10	TCGA-04-1525-01A-01W-0615-10		1ea5f6bb-950e-4383-b76b-f3918c0a0366		TCGA-04-1525-01A-01R-1565-13	TCGA-04-1525-01A-01D-0536-05			TCGA-04-1525-01A-01D-0533-01	TCGA-04-1525-01	TCGA-04-1525-01A-01D-0533-01	d204c18a-05e0-46d3-a340-51ba48ea31a7			d204c18a-05e0-46d3-a340-51ba48ea31a7	TCGA-04-1525-01A-21-1558-20		TCGA-04-1525-01A-01R-0540-07		9fffbdac-8e68-4ea7-ba2f-b2f6156e9f15				
TCGA-04-1530-01	1	TCGA-04-1530-01	3622	1	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-04-1530	3622	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	68	Bilateral	TCGA-04-1530-F24104	Stage IIIC	-25013		3622	0			350				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3	Recurrence				TCGA-04-1530.6CB3AECE-ADBB-4AED-A036-2E2D28D68369.pdf					15	10			45	15	0	0	40	75	70	70		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary	NO	A	DECEASED	1995	TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01	TCGA-04-1530-01A-02W-0552-10	TCGA-04-1530-01A-02W-0552-10				TCGA-04-1530-01A-02R-1569-13	TCGA-04-1530-01A-02D-0501-05			TCGA-04-1530-01A-02D-0497-01	TCGA-04-1530-01	TCGA-04-1530-01A-02D-0497-01	bed7524f-5148-430a-8c10-deeefa3f408e			bed7524f-5148-430a-8c10-deeefa3f408e		TCGA-04-1530-01A-02R-1569-13	TCGA-04-1530-01A-02R-0504-07		4271a8fa-e416-4274-8a37-49673f212605		TCGA-04-1530-01A-02R-1569-13		
TCGA-04-1536-01	1	TCGA-04-1536-01	885	1	High		OV-like c1			miRNA cluster 1	cluster 4		TCGA-04-1536	885	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-04-1536-F24110	Stage IV	-21939		885	0			498	0			2009-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence																						WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01				04	1-10 mm	Ovary			DECEASED	2001		TCGA-04-1536-01						TCGA-04-1536-01A-01R-1566-13	TCGA-04-1536-01A-01D-0536-05			TCGA-04-1536-01A-01D-0533-01	TCGA-04-1536-01	TCGA-04-1536-01A-01D-0533-01	c65769ca-85bb-4730-a7d7-4fb0776baed8			c65769ca-85bb-4730-a7d7-4fb0776baed8		TCGA-04-1536-01A-01R-1566-13	TCGA-04-1536-01A-01R-0540-07		f2c0342a-1302-47ff-8615-8d3eb700e3a5		TCGA-04-1536-01A-01R-1566-13		
TCGA-04-1542-01	1	TCGA-04-1542-01	2561	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-04-1542	2561	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	52	Bilateral	TCGA-04-1542-F24118	Stage IIIB	-19263		2561	0			1020	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G2	Recurrence				TCGA-04-1542.E3103C8A-50CB-43FE-9670-2BFB5D1DC318.pdf					5	1			42	0	0	20	63	79	80	80	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2001		TCGA-04-1542-01		TCGA-04-1542-01A-01W-0553-09		abafb551-fa90-465c-8122-6a8c2793c2d8		TCGA-04-1542-01A-01R-1566-13	TCGA-04-1542-01A-01D-0501-05			TCGA-04-1542-01A-01D-0497-01	TCGA-04-1542-01	TCGA-04-1542-01A-01D-0497-01	d346cd40-dcdc-4a57-8a9d-b20544c87d5f			d346cd40-dcdc-4a57-8a9d-b20544c87d5f	TCGA-04-1542-01A-21-1558-20	TCGA-04-1542-01A-01R-1566-13	TCGA-04-1542-01A-01R-0504-07		7a29ab3a-5d05-47e9-bd87-2cf0285fc8a6		TCGA-04-1542-01A-01R-1566-13		TCGA-04-1542-01A-01W-0553-09
TCGA-04-1638-01	1	TCGA-04-1638-01	1686	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-04-1638	1686	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	57		TCGA-04-1638-F24136	Stage IV	-20987		1686	0			298	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence				TCGA-04-1638.5CA47F76-8E99-4594-B84C-FAC31BB42269.pdf					5	3			0	0	5	2	90	95	99	99	Pre-Adjuvant Therapy	TUMOR FREE	YES			Other Method: Specify In Notes	NO		Primary Tumor	01	0.3			04	No Macroscopic disease	Ovary		A	DECEASED	2002		TCGA-04-1638-01				66049405-6d0c-4409-a9be-166eda4f96b6		TCGA-04-1638-01A-01R-1567-13	TCGA-04-1638-01A-01D-0581-05			TCGA-04-1638-01A-01D-0577-01	TCGA-04-1638-01	TCGA-04-1638-01A-01D-0577-01	e6262f58-9f82-48e5-958a-5762789f35e6			e6262f58-9f82-48e5-958a-5762789f35e6	TCGA-04-1638-01A-21-1558-20		TCGA-04-1638-01A-01R-0584-07		11e368d8-9506-45d7-90e6-3ddf23c9e903				TCGA-04-1638-01A-01W-0639-09
TCGA-04-1644-01	1	TCGA-04-1644-01	1487	1	Squamous		OV-like c1	OV-like c4					TCGA-04-1644	1487	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-04-1644-F24145	Stage IIIC	-17725		1487	0			634	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Progression of Disease				TCGA-04-1644.7AA7FF0A-C1C4-42A1-A340-A1E03CED8DEB.pdf																	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.4			04	>20 mm	Ovary		A	DECEASED	2002		TCGA-04-1644-01				3fa1c199-830d-486c-859f-2179bb86e5bf			TCGA-04-1644-01B-01D-1047-05			TCGA-04-1644-01B-01D-1043-01	TCGA-04-1644-01	TCGA-04-1644-01B-01D-1043-01	992da2f8-f307-4a6c-8cfd-97b1129621fe			992da2f8-f307-4a6c-8cfd-97b1129621fe	TCGA-04-1644-01A-11-1562-20		TCGA-04-1644-01B-01R-1050-07		5c14dcb5-1dd3-4eaa-a71a-e7b62d4698ee				TCGA-04-1644-01B-01D-1526-09
TCGA-04-1644-11	1	TCGA-04-1644-11	1487	1									TCGA-04-1644	1487	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-04-1644-F24145	Stage IIIC	-17725		1487	0			634	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1			G3	Progression of Disease																					Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Solid Tissue Normal	11	0.4			04	>20 mm	Ovary		A	DECEASED	2002									TCGA-04-1644-11A-01D-1047-05																		
TCGA-04-1646-01	1	TCGA-04-1646-01	848	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1646	848	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-04-1646-F24152	Stage IIIC	-22207		848	0			508	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1			G3	Recurrence				TCGA-04-1646.DA9C3D15-50A7-4606-BE1B-6D7C3303B48F.pdf					0	0			0	0	2	0	98	100	80	80	Pre-Adjuvant Therapy	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2003		TCGA-04-1646-01				c278e930-af50-4be7-a706-48a80e58b24f		TCGA-04-1646-01A-01R-1567-13	TCGA-04-1646-01A-01D-0581-05			TCGA-04-1646-01A-01D-0577-01	TCGA-04-1646-01	TCGA-04-1646-01A-01D-0577-01	89ba5753-d63d-4a87-9f18-078d2dd315ee			89ba5753-d63d-4a87-9f18-078d2dd315ee	TCGA-04-1646-01A-21-1558-20		TCGA-04-1646-01A-01R-0584-07		d6a1fffb-cecf-4137-865c-95d7d95fae2d				TCGA-04-1646-01A-01W-0639-09
TCGA-04-1648-01	1	TCGA-04-1648-01	871	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1648	871	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57		TCGA-04-1648-F24159	Stage IIIC	-21113		871	0			412	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.4	NO		1.2			G2	Recurrence				TCGA-04-1648.B35F03FC-84CB-4468-9289-3DB91A6F913E.pdf					15	15			0	0	10	0	75	85	80	90	Pre-Adjuvant Therapy		YES			Molecular Marker(S)	NO		Primary Tumor	01	0.4			04	1-10 mm	Ovary		A	DECEASED	2003		TCGA-04-1648-01				f904c338-e425-42f1-a15e-b5eb2dcfe829		TCGA-04-1648-01A-01R-1567-13	TCGA-04-1648-01A-01D-0581-05			TCGA-04-1648-01A-01D-0577-01	TCGA-04-1648-01	TCGA-04-1648-01A-01D-0577-01	634da42b-ae78-42e0-8115-37a735e4e057			634da42b-ae78-42e0-8115-37a735e4e057	TCGA-04-1648-01A-21-1558-20	TCGA-04-1648-01A-01R-1567-13	TCGA-04-1648-01A-01R-0584-07		b145279e-8242-4087-9584-0519d4639d31		TCGA-04-1648-01A-01R-1567-13		TCGA-04-1648-01A-01W-0639-09
TCGA-04-1649-01	0	TCGA-04-1649-01	1966	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-04-1649	1966	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-04-1649-F24168	Stage IIIC	-27165			0	1966		1672	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.7			G3	Recurrence				TCGA-04-1649.C0A1166D-7233-4843-A007-DDF16A45A5E8.pdf			3	3	0	0			0	0	15	15	85	85	75	75	Pre-Operative		NO			Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	LIVING	2003		TCGA-04-1649-01				fd9ff078-e2fe-4ab6-9e62-445caba9e611		TCGA-04-1649-01A-01R-1567-13	TCGA-04-1649-01A-01D-0581-05			TCGA-04-1649-01A-01D-0577-01	TCGA-04-1649-01	TCGA-04-1649-01A-01D-0577-01	2a358871-990f-478b-ab36-a50f66506f0e			2a358871-990f-478b-ab36-a50f66506f0e	TCGA-04-1649-01A-21-1558-20		TCGA-04-1649-01A-01R-0584-07		3ae3b762-3f04-450d-86db-44daec23ca9f				TCGA-04-1649-01A-01W-0639-09
TCGA-04-1651-01	1	TCGA-04-1651-01	1102	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-04-1651	1102	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-04-1651-F24172	Stage IIIC	-19628		1102	0			990	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.4	NO		1.5			G3	Recurrence				TCGA-04-1651.703BEFE1-07E0-48AE-826E-133A59F97068.pdf					2	2			0	0	10	8	88	90	85	90	Pre-Adjuvant Therapy		YES			Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	2004		TCGA-04-1651-01				5c0f2819-0ecd-43de-aa9b-6073e34779e5		TCGA-04-1651-01A-01R-1567-13	TCGA-04-1651-01A-01D-0581-05			TCGA-04-1651-01A-01D-0577-01	TCGA-04-1651-01	TCGA-04-1651-01A-01D-0577-01	5ce5aabb-61c2-484f-9fd2-be3da4e1242f			5ce5aabb-61c2-484f-9fd2-be3da4e1242f	TCGA-04-1651-01A-21-1558-20	TCGA-04-1651-01A-01R-1567-13	TCGA-04-1651-01A-01R-0584-07		797b7d36-42e2-4f9d-9f8f-7d3fb52219ff		TCGA-04-1651-01A-01R-1567-13		TCGA-04-1651-01A-01W-0639-09
TCGA-04-1652-01	1	TCGA-04-1652-01	969	1	High		OV-like c1			miRNA cluster 1	cluster 2		TCGA-04-1652	969	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76	Right	TCGA-04-1652-F24179	Stage IIIC	-28101		969	0			880				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5		NO	G2	Recurrence				TCGA-04-1652.115E4406-75E8-401F-8D2F-401AD61356AD.pdf					0	0			0	0	25	35	75	65	90	85		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.2			04		Ovary	NO	A	DECEASED	2004		TCGA-04-1652-01						TCGA-04-1652-01A-01R-1567-13	TCGA-04-1652-01A-01D-0581-05			TCGA-04-1652-01A-01D-0577-01	TCGA-04-1652-01	TCGA-04-1652-01A-01D-0577-01	18004841-99c3-4b9d-910e-63a47d4287d9			18004841-99c3-4b9d-910e-63a47d4287d9			TCGA-04-1652-01A-01R-0584-07		dd1addbf-ba25-418f-98d9-efe155026fdd				TCGA-04-1652-01A-01W-0639-09
TCGA-04-1654-01	1	TCGA-04-1654-01	1451	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-04-1654	1451	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	69	Bilateral	TCGA-04-1654-F24185	Stage IIIC	-25387		1451	0			808	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2			G2	Recurrence				TCGA-04-1654.E6F4CDD1-DD1B-4C69-8A9F-0DCA88F8C539.pdf					0	5			0	0	5	5	95	90	99	99	Pre-Adjuvant Therapy		YES			Imaging Study	NO		Primary Tumor	01	0.3			04	1-10 mm	Ovary		A	DECEASED	1999		TCGA-04-1654-01				2b44138a-955e-46f3-bf8e-c8ace62e6389		TCGA-04-1654-01A-02R-1567-13	TCGA-04-1654-01A-02D-0652-05			TCGA-04-1654-01A-02D-0648-01	TCGA-04-1654-01	TCGA-04-1654-01A-02D-0648-01	7f9a9102-1105-4cbf-8381-a7f45cb26878			7f9a9102-1105-4cbf-8381-a7f45cb26878	TCGA-04-1654-01A-11-1562-20		TCGA-04-1654-01A-02R-0655-07		bf9a9a62-9471-41f7-b10f-35a1316f63c3				
TCGA-04-1655-01	1	TCGA-04-1655-01	1380	1	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-04-1655	1380	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-04-1655-F24191	Stage IIIB	-17988		1380	0			819	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		1.1			G2	Recurrence				TCGA-04-1655.D808763E-D67C-460C-B5D6-85CC5C1C05BC.pdf					0	3			0	0	10	2	90	95	95	99	Pre-Adjuvant Therapy		YES			Physical Examination	NO		Primary Tumor	01	0.4			04	No Macroscopic disease	Ovary		A	DECEASED	1999		TCGA-04-1655-01						TCGA-04-1655-01A-01R-1566-13	TCGA-04-1655-01A-01D-0563-05			TCGA-04-1655-01A-01D-0559-01	TCGA-04-1655-01	TCGA-04-1655-01A-01D-0559-01	496e4773-961e-4a65-8f28-8997bde6290c			496e4773-961e-4a65-8f28-8997bde6290c		TCGA-04-1655-01A-01R-1566-13	TCGA-04-1655-01A-01R-0566-07		461a33bb-1055-403e-b7e0-7f16d1c10f7b		TCGA-04-1655-01A-01R-1566-13		TCGA-04-1655-01A-01W-0633-09
TCGA-09-0364-01	1	TCGA-09-0364-01	887	1	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-0364	887	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	80	Right	TCGA-09-0364-F24198	Stage IIC	-29262		887	0			395				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO				NO	G3	Recurrence				TCGA-09-0364.27b9efd3-7748-4deb-96a2-3869a19bfa6f.pdf					0	0			0	0	10	10	90	90	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				09	11-20 mm	Ovary	NO	A	DECEASED	1998	TCGA-09-0364-01A-02W-0370-10	TCGA-09-0364-01	TCGA-09-0364-01A-02W-0370-10		2d0702a8-bf85-458e-879c-ebc03a2aa3d1		TCGA-09-0364-01A-02R-0363-07	TCGA-09-0364-01A-02R-1564-13	TCGA-09-0364-01A-02D-0359-05	TCGA-09-0364-01	TCGA-09-0364-01	TCGA-09-0364-01A-02D-0356-01	TCGA-09-0364-01	TCGA-09-0364-01A-02D-0356-01	3ad89fc4-fa3f-4090-a41c-a46b6aa68cd5	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	3ad89fc4-fa3f-4090-a41c-a46b6aa68cd5		TCGA-09-0364-01A-02R-1564-13			0ba4e8de-0013-421a-8605-efb4f3ebfc0a	2d0702a8-bf85-458e-879c-ebc03a2aa3d1	TCGA-09-0364-01A-02R-1564-13		
TCGA-09-0365-01	1	TCGA-09-0365-01	288	1	GBM		OV-like c1						TCGA-09-0365	288	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Left	TCGA-09-0365-F24203	Stage IIIC	-25703		288	0			251				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)			NO				NO	G3	Recurrence				TCGA-09-0365.459f8df7-b386-47c6-bf17-73af831441d4.pdf					0	0			0	0	5	5	95	95	98	98		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				09	No Macroscopic disease	Ovary	NO	A	DECEASED	1999		TCGA-09-0365-01					TCGA-09-0365-01A-02R-0363-07		TCGA-09-0365-01A-02D-0359-05			TCGA-09-0365-01A-02D-0356-01	TCGA-09-0365-01	TCGA-09-0365-01A-02D-0356-01	a176e8f9-e8b2-4133-bed2-2a7d63e5d2e6			a176e8f9-e8b2-4133-bed2-2a7d63e5d2e6					16f6b497-da7d-4156-9b83-dda375a1c04f				
TCGA-09-0366-01	1	TCGA-09-0366-01	1757	1	BRCA-LUAD+	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-09-0366	1757	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-09-0366-F24207	Stage IIIC	-20440		1757	0			190				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C48.1	YES	Tumor resection			NO				NO	G3	Recurrence				TCGA-09-0366.6C254448-2CF7-4283-9026-988273C712A1.pdf					0	0			0	0	5	0	95	100	98	98		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01				09	1-10 mm	Ovary	NO	A	DECEASED	1999		TCGA-09-0366-01		TCGA-09-0366-01A-01W-0372-09	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7		TCGA-09-0366-01A-01R-0363-07	TCGA-09-0366-01A-01R-1564-13,TCGA-09-0366-01A-01R-1986-13	TCGA-09-0366-01A-01D-0359-05	TCGA-09-0366-01	TCGA-09-0366-01	TCGA-09-0366-01A-01D-0356-01	TCGA-09-0366-01	TCGA-09-0366-01A-01D-0356-01	00014f01-24a5-4226-9ed6-4b9cabacd074	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	00014f01-24a5-4226-9ed6-4b9cabacd074		TCGA-09-0366-01A-01R-1564-13			e091ea57-ec3e-4357-8929-b4e149dfa3f5	cfb1a6e0-f2d8-48bd-9303-fe7be5276ab7	TCGA-09-0366-01A-01R-1564-13		TCGA-09-0366-01A-01W-0372-09
TCGA-09-0367-01	1	TCGA-09-0367-01	547	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-0367	547	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-09-0367-F24212	Stage IIIC	-24473		547	0							2009-3-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO				YES	G3					TCGA-09-0367.8a24fe8a-9f7f-4fbf-86c7-704427ccaf89.pdf					0	0			0	1	5	9	95	90	98	95		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01				09	1-10 mm	Ovary	YES	A	DECEASED	2001		TCGA-09-0367-01			047e04aa-6a91-4535-b279-50430098e638		TCGA-09-0367-01A-01R-0363-07	TCGA-09-0367-01A-01R-1564-13	TCGA-09-0367-01A-01D-0359-05	TCGA-09-0367-01	TCGA-09-0367-01	TCGA-09-0367-01A-01D-0356-01	TCGA-09-0367-01	TCGA-09-0367-01A-01D-0356-01	41399846-fdce-43f6-80fa-25f214c43933	047e04aa-6a91-4535-b279-50430098e638	047e04aa-6a91-4535-b279-50430098e638	41399846-fdce-43f6-80fa-25f214c43933		TCGA-09-0367-01A-01R-1564-13			129c93c0-eb2f-47c5-acdc-4fd083e9dc8a	047e04aa-6a91-4535-b279-50430098e638	TCGA-09-0367-01A-01R-1564-13		
TCGA-09-0369-01	1	TCGA-09-0369-01	1082	1	High	C9-OV	OV-like c1		OV-like c16			mutation cluster 5	TCGA-09-0369	1082	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Left	TCGA-09-0369-F24217	Stage IIIC	-20705		1082	0			274				2009-3-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO				YES	G3	Recurrence				TCGA-09-0369.c052e190-b5c2-44bf-b5b0-2b37cde18cee.pdf					0	0			0	0	5	5	95	95	98	98		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				09	No Macroscopic disease	Ovary	YES	A	DECEASED	2003		TCGA-09-0369-01		TCGA-09-0369-01A-01W-0372-09	1f972766-2f58-4d41-b84c-3493ef2dd0c4		TCGA-09-0369-01A-01R-0363-07		TCGA-09-0369-01A-01D-0359-05	TCGA-09-0369-01	TCGA-09-0369-01	TCGA-09-0369-01A-01D-0356-01	TCGA-09-0369-01	TCGA-09-0369-01A-01D-0356-01	0ae9f973-4f93-48f0-a214-35d671d46fef	1f972766-2f58-4d41-b84c-3493ef2dd0c4	1f972766-2f58-4d41-b84c-3493ef2dd0c4	0ae9f973-4f93-48f0-a214-35d671d46fef		TCGA-09-0369-01A-01R-1564-13			11197914-6f55-4542-9138-ad6b451c3350	1f972766-2f58-4d41-b84c-3493ef2dd0c4	TCGA-09-0369-01A-01R-1564-13		TCGA-09-0369-01A-01W-0372-09
TCGA-09-1659-01	1	TCGA-09-1659-01	304	1	High		OV-like c1					mutation cluster 5	TCGA-09-1659	304	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-09-1659-F24226	Stage IIIC	-18733		304	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3										3	10			17	5	0	0	80	85	85	85		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.4			09	>20 mm	Ovary	NO	B	DECEASED	1997	TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01	TCGA-09-1659-01B-01W-0615-10	TCGA-09-1659-01B-01W-0615-10					TCGA-09-1659-01B-01D-0536-05			TCGA-09-1659-01B-01D-0533-01	TCGA-09-1659-01	TCGA-09-1659-01B-01D-0533-01	a3ec404c-0806-48eb-b3ac-2a5e759748b1			a3ec404c-0806-48eb-b3ac-2a5e759748b1		TCGA-09-1659-01B-01R-1564-13	TCGA-09-1659-01B-01R-0540-07		5203ba2e-518a-4492-8f15-25182bff1dec		TCGA-09-1659-01B-01R-1564-13		
TCGA-09-1661-01	1	TCGA-09-1661-01	1169	1	High		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1661	1169	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			75	Right	TCGA-09-1661-F24233	Stage IIIC	-27486		1169	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		NO	G3										2	5			28	20	0	0	70	75	80	80		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.1			09	1-10 mm	Ovary	NO	B	DECEASED	2000	TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01	TCGA-09-1661-01B-01W-0615-10	TCGA-09-1661-01B-01W-0615-10				TCGA-09-1661-01B-01R-1566-13	TCGA-09-1661-01B-01D-0536-05			TCGA-09-1661-01B-01D-0533-01	TCGA-09-1661-01	TCGA-09-1661-01B-01D-0533-01	57bcc405-f49e-4201-afff-dcd766946ce0			57bcc405-f49e-4201-afff-dcd766946ce0		TCGA-09-1661-01B-01R-1566-13	TCGA-09-1661-01B-01R-0540-07		956ee2ec-8a47-417a-a82b-dc4c91f9cf46		TCGA-09-1661-01B-01R-1566-13		
TCGA-09-1662-01	1	TCGA-09-1662-01	2717	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-09-1662	2717	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Left	TCGA-09-1662-F24243	Stage IV	-21246		2717	0			1046				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3	Recurrence				TCGA-09-1662.8e2676a4-2ac3-42af-be7d-cf74b6d82f2f.pdf					3	5			10	8	0	0	87	87	95	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			09	1-10 mm	Ovary	YES	A	DECEASED	2001	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01	TCGA-09-1662-01A-01W-0615-10	TCGA-09-1662-01A-01W-0615-10	759060d9-af2e-4098-b4ee-7aa2214acba8	253b785e-f10b-4d0e-88cb-4db4a3610c7c		TCGA-09-1662-01A-01R-1566-13	TCGA-09-1662-01A-01D-0536-05	TCGA-09-1662-01	TCGA-09-1662-01	TCGA-09-1662-01A-01D-0533-01	TCGA-09-1662-01	TCGA-09-1662-01A-01D-0533-01	e9bba0c4-8491-438b-838b-d52ef50cfdf7	759060d9-af2e-4098-b4ee-7aa2214acba8	759060d9-af2e-4098-b4ee-7aa2214acba8	e9bba0c4-8491-438b-838b-d52ef50cfdf7	TCGA-09-1662-01A-21-1558-20	TCGA-09-1662-01A-01R-1566-13	TCGA-09-1662-01A-01R-0540-07		0fc0fc51-c5b7-428e-92c6-d55c8514b689	759060d9-af2e-4098-b4ee-7aa2214acba8	TCGA-09-1662-01A-01R-1566-13		
TCGA-09-1664-01	1	TCGA-09-1664-01	2279	1	Squamous		OV-like c1	OV-like c4					TCGA-09-1664	2279	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			37	Bilateral	TCGA-09-1664-F24268	Stage IIIC	-13739		2279	0							2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		2		NO	G1					TCGA-09-1664.1e80516c-0cc5-4a3b-abae-054c57ca7b3c.pdf					2	2			18	5	5	8	75	85	90	90			YES	Complete Remission/Response			NO		Primary Tumor	01	0.7			09	1-10 mm	Ovary	NO	A	DECEASED	2002		TCGA-09-1664-01				e2007adb-55b1-4b8b-99c0-4e6a61a2da29			TCGA-09-1664-01A-01D-0581-05			TCGA-09-1664-01A-01D-0577-01	TCGA-09-1664-01	TCGA-09-1664-01A-01D-0577-01	55c015ce-ed2e-4a91-bc96-18e7da55447f			55c015ce-ed2e-4a91-bc96-18e7da55447f	TCGA-09-1664-01A-21-1558-20		TCGA-09-1664-01A-01R-0584-07		ab246047-1519-4cd8-b1c5-abb4ef58697a				TCGA-09-1664-01A-01W-0639-09
TCGA-09-1665-01	1	TCGA-09-1665-01	1266	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1665	1266	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	73	Left	TCGA-09-1665-F24272	Stage IIIC	-27010		1266	0			468				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G2	Recurrence									2	5			25	10	5	0	68	85	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			09	No Macroscopic disease	Ovary	YES	B	DECEASED	2002	TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01	TCGA-09-1665-01B-01W-0615-10	TCGA-09-1665-01B-01W-0615-10		a565c52a-a226-47db-b68c-d579055e4c06		TCGA-09-1665-01B-01R-1566-13	TCGA-09-1665-01B-01D-0536-05			TCGA-09-1665-01B-01D-0533-01	TCGA-09-1665-01	TCGA-09-1665-01B-01D-0533-01	7fa92667-c84b-4b05-ab4f-4813e5a2e956			7fa92667-c84b-4b05-ab4f-4813e5a2e956	TCGA-09-1665-01B-21-1558-20	TCGA-09-1665-01B-01R-1566-13	TCGA-09-1665-01B-01R-0540-07		5b880786-e40d-41ff-9fee-f542f1b5a27c		TCGA-09-1665-01B-01R-1566-13		
TCGA-09-1666-01	0	TCGA-09-1666-01	1752	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-1666	1752	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-09-1666-F24279	Stage IIIC	-21066			0	1752		480				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		NO	G3	Recurrence				TCGA-09-1666.2de50dd9-b607-4a87-baae-468c4bf43205.pdf					2	2			0	0	5	5	93	93	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			09	No Macroscopic disease	Ovary	NO	A	LIVING	2003	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01	TCGA-09-1666-01A-01W-0615-10	TCGA-09-1666-01A-01W-0615-10	529b7dd2-075c-4e93-b8c8-6990d3297c30	aa4fad88-9a21-4085-9ac7-21b349113168		TCGA-09-1666-01A-01R-1566-13	TCGA-09-1666-01A-01D-0536-05	TCGA-09-1666-01	TCGA-09-1666-01	TCGA-09-1666-01A-01D-0533-01	TCGA-09-1666-01	TCGA-09-1666-01A-01D-0533-01	6fda2b13-621a-4bd6-8a0b-38b140751163	529b7dd2-075c-4e93-b8c8-6990d3297c30	529b7dd2-075c-4e93-b8c8-6990d3297c30	6fda2b13-621a-4bd6-8a0b-38b140751163	TCGA-09-1666-01A-21-1558-20	TCGA-09-1666-01A-01R-1566-13	TCGA-09-1666-01A-01R-0540-07		fc1d50d5-b097-41f0-a9b2-0efd207d6ebd	529b7dd2-075c-4e93-b8c8-6990d3297c30	TCGA-09-1666-01A-01R-1566-13		
TCGA-09-1667-01	0	TCGA-09-1667-01	1882	0	High		OV-like c1		OV-like c16	miRNA cluster 2	cluster 1		TCGA-09-1667	1882	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	61	Bilateral	TCGA-09-1667-F24292	Stage IIC	-22306			0	1882		460				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1		NO	G2	Recurrence									3	5			0	5	7	7	90	83	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	C	LIVING	2004		TCGA-09-1667-01			9b7a1eb0-014f-4cd6-bde8-fd96131fac3e			TCGA-09-1667-01C-01R-1566-13	TCGA-09-1667-01C-01D-0536-05	TCGA-09-1667-01	TCGA-09-1667-01	TCGA-09-1667-01C-01D-0533-01	TCGA-09-1667-01	TCGA-09-1667-01C-01D-0533-01	700b28ed-9160-4ab7-be99-2202ac1ca694	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	700b28ed-9160-4ab7-be99-2202ac1ca694		TCGA-09-1667-01C-01R-1566-13	TCGA-09-1667-01C-01R-0540-07		64fbf0df-6693-4ea5-a868-925636d9d20f	9b7a1eb0-014f-4cd6-bde8-fd96131fac3e	TCGA-09-1667-01C-01R-1566-13		
TCGA-09-1668-01	0	TCGA-09-1668-01	1684	0	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-1668	1684	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Right	TCGA-09-1668-F24300	Stage IIIC	-20972			0	1684						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.7		NO	G3										5	5			0	0	5	10	90	85	95	95		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			09		Ovary	NO	B	LIVING	2004		TCGA-09-1668-01			66894abe-8af5-4fd9-9a59-cf24e57fc07f			TCGA-09-1668-01B-01R-1566-13	TCGA-09-1668-01B-01D-0536-05	TCGA-09-1668-01	TCGA-09-1668-01	TCGA-09-1668-01B-01D-0533-01	TCGA-09-1668-01	TCGA-09-1668-01B-01D-0533-01	2dd5f72c-3f5e-4cf5-85c1-7a550e69578f	66894abe-8af5-4fd9-9a59-cf24e57fc07f	66894abe-8af5-4fd9-9a59-cf24e57fc07f	2dd5f72c-3f5e-4cf5-85c1-7a550e69578f		TCGA-09-1668-01B-01R-1566-13	TCGA-09-1668-01B-01R-0540-07		fe849a8b-cfb0-44a3-a264-75ccef069be3	66894abe-8af5-4fd9-9a59-cf24e57fc07f	TCGA-09-1668-01B-01R-1566-13		
TCGA-09-1669-01	0	TCGA-09-1669-01	928	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-1669	928	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54	Right	TCGA-09-1669-F24305	Stage IIIA	-20052			0	928						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.9		NO	G3					TCGA-09-1669.7870b5a7-a96c-4e55-b56f-8eca45918251.pdf					5	5			0	0	40	30	55	65	70	80		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	A	LIVING	2004	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01	TCGA-09-1669-01A-01W-0615-10	TCGA-09-1669-01A-01W-0615-10	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8			TCGA-09-1669-01A-01R-1566-13	TCGA-09-1669-01A-01D-0536-05	TCGA-09-1669-01	TCGA-09-1669-01	TCGA-09-1669-01A-01D-0533-01	TCGA-09-1669-01	TCGA-09-1669-01A-01D-0533-01	0fa8feb6-7f0c-4f3e-8f45-efa5baa423bd	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	0fa8feb6-7f0c-4f3e-8f45-efa5baa423bd		TCGA-09-1669-01A-01R-1566-13	TCGA-09-1669-01A-01R-0540-07		01119e56-c4b0-4d4f-876c-fd34e4185af3	a56ccd4c-1959-44a9-968d-57e6c5bc0cf8	TCGA-09-1669-01A-01R-1566-13		
TCGA-09-1670-01	0	TCGA-09-1670-01	547	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-09-1670	547	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-09-1670-F24309	Stage IIIA	-21147			0	547		547				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.6		NO	G3	Recurrence				TCGA-09-1670.5cc85cd9-99c4-4087-bdc5-8039b0369538.pdf					0	0			0	0	5	5	95	95	99	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	A	LIVING	2005		TCGA-09-1670-01			eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	950ea36f-87d6-4730-b11d-e8eae3e0fe79		TCGA-09-1670-01A-01R-1566-13	TCGA-09-1670-01A-01D-0563-05	TCGA-09-1670-01	TCGA-09-1670-01	TCGA-09-1670-01A-01D-0559-01	TCGA-09-1670-01	TCGA-09-1670-01A-01D-0559-01	e7b08df1-ec95-4c9e-93a8-b3d5a4b1bc74	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	e7b08df1-ec95-4c9e-93a8-b3d5a4b1bc74	TCGA-09-1670-01A-21-1558-20	TCGA-09-1670-01A-01R-1566-13	TCGA-09-1670-01A-01R-0566-07		99b305e7-c4d7-4174-955d-7618d91f84d0	eb2322dd-5a7f-41c0-9be2-7e1f7dc485b4	TCGA-09-1670-01A-01R-1566-13		TCGA-09-1670-01A-01W-0633-09
TCGA-09-1672-01	0	TCGA-09-1672-01	178	0	BRCA-LUAD+		OV-like c1						TCGA-09-1672	178	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Right	TCGA-09-1672-F24314	Stage IIIC	-28556			0	178						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G1					TCGA-09-1672.103ad514-77dc-42fd-8cf2-31e9de128a74.pdf					0	0			0	0	50	15	50	85	70	90		TUMOR FREE	YES				NO		Primary Tumor	01	0.3			09		Ovary	YES	A	LIVING	2008		TCGA-09-1672-01							TCGA-09-1672-01A-01D-0563-05			TCGA-09-1672-01A-01D-0559-01	TCGA-09-1672-01	TCGA-09-1672-01A-01D-0559-01	4bb77e15-5968-45a8-ba4d-4be38a34661b			4bb77e15-5968-45a8-ba4d-4be38a34661b			TCGA-09-1672-01A-01R-0566-07		67029a85-41d6-41a6-844e-cecf63941f3e				TCGA-09-1672-01A-01W-0633-09
TCGA-09-1673-01	0	TCGA-09-1673-01	92	0	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-09-1673	92	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Bilateral	TCGA-09-1673-F24318	Stage IV	-18599			0	92						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		3		YES	G3					TCGA-09-1673.d4f7aa96-11e8-4d66-a1be-595ec22de450.pdf					8	10			0	0	5	5	87	85	99	99		WITH TUMOR	YES				NO		Primary Tumor	01	0.6			09	>20 mm	Ovary	YES	A	LIVING	2008		TCGA-09-1673-01			37037dcf-fa69-4cd3-b83d-e474d69059b4	ca0ee85f-6e38-447b-b232-49812c6e2a97		TCGA-09-1673-01A-01R-1566-13	TCGA-09-1673-01A-01D-0563-05	TCGA-09-1673-01	TCGA-09-1673-01	TCGA-09-1673-01A-01D-0559-01	TCGA-09-1673-01	TCGA-09-1673-01A-01D-0559-01	f7833173-18ff-44f8-97cb-148e73842517	37037dcf-fa69-4cd3-b83d-e474d69059b4	37037dcf-fa69-4cd3-b83d-e474d69059b4	f7833173-18ff-44f8-97cb-148e73842517	TCGA-09-1673-01A-21-1558-20	TCGA-09-1673-01A-01R-1566-13	TCGA-09-1673-01A-01R-0566-07		f45664bd-409f-4819-bb3f-b16ce74e7d9c	37037dcf-fa69-4cd3-b83d-e474d69059b4	TCGA-09-1673-01A-01R-1566-13		TCGA-09-1673-01A-01W-0633-09
TCGA-09-1674-01	0	TCGA-09-1674-01	260	0	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 2	cluster 1		TCGA-09-1674	260	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			79	Bilateral	TCGA-09-1674-F24322	Stage IIIC	-28878			0	260						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2.1		NO	G3					TCGA-09-1674.d8e0ddd2-304d-4f5e-9225-2cd88ae9984e.pdf					5	5			0	0	5	5	90	90	99	99		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.7			09	1-10 mm	Ovary	NO	A	LIVING	2008		TCGA-09-1674-01			3a81f083-56dc-48a5-be8d-b69a146db93b	872b7aec-febf-4104-8269-bfb0c72fbeec		TCGA-09-1674-01A-01R-1566-13	TCGA-09-1674-01A-01D-0563-05	TCGA-09-1674-01	TCGA-09-1674-01	TCGA-09-1674-01A-01D-0559-01	TCGA-09-1674-01	TCGA-09-1674-01A-01D-0559-01	e33a75e9-bfad-4575-8b7f-46c7bdef6df2	3a81f083-56dc-48a5-be8d-b69a146db93b	3a81f083-56dc-48a5-be8d-b69a146db93b	e33a75e9-bfad-4575-8b7f-46c7bdef6df2	TCGA-09-1674-01A-21-1558-20	TCGA-09-1674-01A-01R-1566-13	TCGA-09-1674-01A-01R-0566-07		995f3a5f-4e3d-4e69-a473-4b53da943923	3a81f083-56dc-48a5-be8d-b69a146db93b	TCGA-09-1674-01A-01R-1566-13		TCGA-09-1674-01A-01W-0633-09
TCGA-09-1675-01	0	TCGA-09-1675-01	2967	0	Squamous		OV-like c1						TCGA-09-1675	2967	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Left	TCGA-09-1675-F24326	Stage IC	-18596			0	2967						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1.1		NO	G2										0	0			0	0	30	30	70	70	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.1			09	No Macroscopic disease	Ovary	NO	B	LIVING	2001		TCGA-09-1675-01							TCGA-09-1675-01B-01D-0563-05			TCGA-09-1675-01B-01D-0559-01	TCGA-09-1675-01	TCGA-09-1675-01B-01D-0559-01	17a8210b-98fd-4bca-9c8a-059b573a5911			17a8210b-98fd-4bca-9c8a-059b573a5911			TCGA-09-1675-01B-01R-0566-07		690beb52-7ca9-448a-a134-7317be4f8289				TCGA-09-1675-01B-01W-0633-09
TCGA-09-2043-01	0	TCGA-09-2043-01	188	0	High		OV-like c1	OV-like c4					TCGA-09-2043	188	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			69	Left	TCGA-09-2043-F24332	Stage IC	-25480			0	188						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2		NO	G3					TCGA-09-2043.1fa4e0b8-344f-4ebb-b150-c3ace0ec4a00.pdf					0	0			0	0	10	10	90	90	90	90		TUMOR FREE	NO	Complete Remission/Response			NO		Primary Tumor	01	0.1			09	No Macroscopic disease	Ovary	NO	A	LIVING	2009		TCGA-09-2043-01				066f35fb-d0a8-4968-acf1-1da9ec81748e			TCGA-09-2043-01A-01D-0708-05			TCGA-09-2043-01A-01D-0704-01	TCGA-09-2043-01	TCGA-09-2043-01A-01D-0704-01	90a5754c-687f-4aeb-b600-b4dcc28c870c			90a5754c-687f-4aeb-b600-b4dcc28c870c	TCGA-09-2043-01A-21-1560-20		TCGA-09-2043-01A-01R-0711-07		dec0d15f-9489-4987-83ff-3613cf21c379				
TCGA-09-2044-01	0	TCGA-09-2044-01	186	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-09-2044	186	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			77	Right	TCGA-09-2044-F24334	Stage IIB	-28231			0	186						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		1.8		NO	G3										1	0			0	1	5	9	94	90	95	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	B	LIVING	2009		TCGA-09-2044-01		TCGA-09-2044-01B-01W-0799-08	658b4847-33bc-414c-a2bb-ce9379ef57bd	32c1a264-b1dd-4307-ab4d-f710ea9692cc		TCGA-09-2044-01B-01R-1568-13	TCGA-09-2044-01B-01D-0708-05	TCGA-09-2044-01	TCGA-09-2044-01	TCGA-09-2044-01B-01D-0704-01	TCGA-09-2044-01	TCGA-09-2044-01B-01D-0704-01	a399002a-41d4-4159-b13b-a3d13a44617e	658b4847-33bc-414c-a2bb-ce9379ef57bd	658b4847-33bc-414c-a2bb-ce9379ef57bd	a399002a-41d4-4159-b13b-a3d13a44617e	TCGA-09-2044-01B-21-1560-20	TCGA-09-2044-01B-01R-1568-13	TCGA-09-2044-01B-01R-0711-07		0b4c7448-2729-45db-b1b2-0fba79016c76	658b4847-33bc-414c-a2bb-ce9379ef57bd	TCGA-09-2044-01B-01R-1568-13	TCGA-09-2044-01B-01W-0799-08	
TCGA-09-2045-01	1	TCGA-09-2045-01	1069	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-09-2045	1069	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-09-2045-F24338	Stage IV	-18285		1069	0			631				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G2	Recurrence				TCGA-09-2045.6c826e9d-b1aa-4c84-b294-c8fb41818da1.pdf					1	0			0	0	5	10	94	90	95	90		WITH TUMOR	YES	Stable Disease		Physical Examination	NO		Primary Tumor	01	0.4			09	1-10 mm	Ovary	YES	A	DECEASED	1996		TCGA-09-2045-01		TCGA-09-2045-01A-01W-0799-08	7b412fd9-4414-440f-b768-70666037c768	51c5bf06-26be-471c-927c-1cb07bf10a2b		TCGA-09-2045-01A-01R-1568-13	TCGA-09-2045-01A-01D-0708-05	TCGA-09-2045-01	TCGA-09-2045-01	TCGA-09-2045-01A-01D-0704-01	TCGA-09-2045-01	TCGA-09-2045-01A-01D-0704-01	c7485ff7-5733-441c-8496-c28f0056e5b3	7b412fd9-4414-440f-b768-70666037c768	7b412fd9-4414-440f-b768-70666037c768	c7485ff7-5733-441c-8496-c28f0056e5b3	TCGA-09-2045-01A-21-1560-20	TCGA-09-2045-01A-01R-1568-13	TCGA-09-2045-01A-01R-0711-07		4456d296-bac1-461d-bda9-d3c52aba590c	7b412fd9-4414-440f-b768-70666037c768	TCGA-09-2045-01A-01R-1568-13	TCGA-09-2045-01A-01W-0799-08	
TCGA-09-2048-01	1	TCGA-09-2048-01	138	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-09-2048	138	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-09-2048-F24351	Stage IIIC	-23043		138	0							2009-11-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1		YES	G3					TCGA-09-2048.0755D708-ADF5-4219-ABC6-BCD9C2BCA089.pdf					1	5			0	0	5	5	94	90	95	95		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.2			09	1-10 mm	Ovary	YES	A	DECEASED	1999		TCGA-09-2048-01			d3220bce-1bf3-47c4-951f-937dac7581be			TCGA-09-2048-01A-01R-1568-13	TCGA-09-2048-01A-01D-0708-05	TCGA-09-2048-01	TCGA-09-2048-01	TCGA-09-2048-01A-01D-0704-01	TCGA-09-2048-01	TCGA-09-2048-01A-01D-0704-01	c01b7017-c6c2-40d5-8e87-59d44c67459f	d3220bce-1bf3-47c4-951f-937dac7581be	d3220bce-1bf3-47c4-951f-937dac7581be	c01b7017-c6c2-40d5-8e87-59d44c67459f		TCGA-09-2048-01A-01R-1568-13	TCGA-09-2048-01A-01R-0711-07		8d5f3a67-69eb-49b0-a1bc-f626eb70c76f	d3220bce-1bf3-47c4-951f-937dac7581be	TCGA-09-2048-01A-01R-1568-13		
TCGA-09-2049-01	0	TCGA-09-2049-01	3419	0	High	C9-OV	OV-like c1	OV-like c4				mutation cluster 8	TCGA-09-2049	3419	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	64	Left	TCGA-09-2049-F24354	Stage IIIC	-23410			0	3419		953				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1		NO	G3	Recurrence									0	0			0	0	20	5	80	95	98	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			09	>20 mm	Ovary	NO	D	LIVING	1999		TCGA-09-2049-01		TCGA-09-2049-01D-01W-0799-08		ccaa932c-805b-4a2c-825f-d742a9fddb2c			TCGA-09-2049-01D-01D-0708-05			TCGA-09-2049-01D-01D-0704-01	TCGA-09-2049-01	TCGA-09-2049-01D-01D-0704-01	50416b2c-b491-47c0-995e-9236e27c2c3d			50416b2c-b491-47c0-995e-9236e27c2c3d	TCGA-09-2049-01D-21-1560-20		TCGA-09-2049-01D-01R-0711-07		870e7182-fd31-4863-b19b-001fb9a2a11d			TCGA-09-2049-01D-01W-0799-08	
TCGA-09-2050-01	0	TCGA-09-2050-01	2163	0	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2050	2163	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			65	Bilateral	TCGA-09-2050-F24367	Stage IIA	-23987			0	2163						2009-11-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6		NO	G2					TCGA-09-2050.fb343129-010d-430b-aae4-f7beb7122279.pdf					0	0			0	0	40	10	60	90	96	98		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	A	LIVING	2003		TCGA-09-2050-01		TCGA-09-2050-01A-01W-0799-08				TCGA-09-2050-01A-01R-1568-13	TCGA-09-2050-01A-01D-0708-05			TCGA-09-2050-01A-01D-0704-01	TCGA-09-2050-01	TCGA-09-2050-01A-01D-0704-01	2fcf54e4-1099-4323-b5f1-246aa2cc5aaf			2fcf54e4-1099-4323-b5f1-246aa2cc5aaf			TCGA-09-2050-01A-01R-0711-07		968defb5-7701-4ec8-9c4f-7b73a13b0411			TCGA-09-2050-01A-01W-0799-08	
TCGA-09-2051-01	0	TCGA-09-2051-01	1919	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-09-2051	1919	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	42	Bilateral	TCGA-09-2051-F24373	Stage IIIC	-15650			0	1919		583				2009-11-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3	Recurrence				TCGA-09-2051.242a1ff3-05ad-4623-b5aa-9bb556e2cfa9.pdf					0	0			0	0	5	10	95	90	99	98		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	YES	A	LIVING	2004		TCGA-09-2051-01		TCGA-09-2051-01A-01W-0799-08	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	5bcc9755-b429-47c1-9a00-af84edd803aa		TCGA-09-2051-01A-01R-1568-13	TCGA-09-2051-01A-01D-0708-05	TCGA-09-2051-01	TCGA-09-2051-01	TCGA-09-2051-01A-01D-0704-01	TCGA-09-2051-01	TCGA-09-2051-01A-01D-0704-01	3c96b2d3-8778-4c9c-8bf9-dc7559292fa9	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	3c96b2d3-8778-4c9c-8bf9-dc7559292fa9	TCGA-09-2051-01A-21-1560-20	TCGA-09-2051-01A-01R-1568-13	TCGA-09-2051-01A-01R-0711-07		34b0a38d-33f0-436f-a30b-4c730a37e27c	6bc296b8-ac74-4ff9-872d-5f7e4a3d011a	TCGA-09-2051-01A-01R-1568-13	TCGA-09-2051-01A-01W-0799-08	
TCGA-09-2053-01	0	TCGA-09-2053-01	1209	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-09-2053	1209	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			72	Left	TCGA-09-2053-F24384	Stage IIIC	-26433			0	1209						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.7		NO	G3										0	0			0	0	10	10	90	90	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			09	No Macroscopic disease	Ovary	NO	C	LIVING	2005		TCGA-09-2053-01		TCGA-09-2053-01C-01W-0722-08				TCGA-09-2053-01C-01R-1568-13	TCGA-09-2053-01C-01D-0667-05			TCGA-09-2053-01C-01D-0663-01	TCGA-09-2053-01	TCGA-09-2053-01C-01D-0663-01	95cdd81f-7ef1-4d35-b210-da86727a610a			95cdd81f-7ef1-4d35-b210-da86727a610a		TCGA-09-2053-01C-01R-1568-13	TCGA-09-2053-01C-01R-0670-07		00fdb098-d819-43f1-995d-a43f2499afe7		TCGA-09-2053-01C-01R-1568-13	TCGA-09-2053-01C-01W-0722-08	
TCGA-09-2054-01	1	TCGA-09-2054-01	637	1	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3		TCGA-09-2054	637	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-09-2054-F24388	Stage IIIC	-21285		637	0	637						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		2		YES	G3					TCGA-09-2054.4f0eb2a1-996c-4816-a956-835ce5085438.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	90	90		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.4			09	1-10 mm	Ovary	YES	A	DECEASED	2005		TCGA-09-2054-01			5cd7faa0-323a-4ea3-a658-859d0336e0ac	3b31fec3-6dd6-4ef7-bcb4-8c67007f6937		TCGA-09-2054-01A-01R-1568-13	TCGA-09-2054-01A-01D-0667-05	TCGA-09-2054-01	TCGA-09-2054-01	TCGA-09-2054-01A-01D-0663-01	TCGA-09-2054-01	TCGA-09-2054-01A-01D-0663-01	47e0a74c-6d83-40ba-8d6d-f04add97433b	5cd7faa0-323a-4ea3-a658-859d0336e0ac	5cd7faa0-323a-4ea3-a658-859d0336e0ac	47e0a74c-6d83-40ba-8d6d-f04add97433b	TCGA-09-2054-01A-21-1560-20	TCGA-09-2054-01A-01R-1568-13	TCGA-09-2054-01A-01R-0670-07		f6aa28c5-b1f6-4552-82a7-a6a170814534	5cd7faa0-323a-4ea3-a658-859d0336e0ac	TCGA-09-2054-01A-01R-1568-13		
TCGA-09-2055-01	0	TCGA-09-2055-01	819	0	Squamous		OV-like c1	OV-like c4					TCGA-09-2055	819	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Left	TCGA-09-2055-F24395	Stage IC	-17545			0	819						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.8		NO	G3										15	0			1	1	10	10	74	89	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			09	No Macroscopic disease	Ovary	NO	B	LIVING	2007		TCGA-09-2055-01				b02ef957-7893-4222-983a-3784ee59dfdd			TCGA-09-2055-01B-01D-0708-05			TCGA-09-2055-01B-01D-0704-01	TCGA-09-2055-01	TCGA-09-2055-01B-01D-0704-01	7c508788-0de6-4512-991b-06ee5b1bd847			7c508788-0de6-4512-991b-06ee5b1bd847	TCGA-09-2055-01A-11-1563-20		TCGA-09-2055-01B-01R-0711-07		7c240854-d066-4ecd-905d-1f6dea67d509				
TCGA-09-2056-01	0	TCGA-09-2056-01	379	0	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-09-2056	379	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Bilateral	TCGA-09-2056-F24399	Stage IIIC	-22864			0	379						2009-11-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.6		NO	G3						0	0	0	0	0	0	0	0	0	0	20	20	80	80	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			09	No Macroscopic disease	Ovary	NO	B	LIVING	2008		TCGA-09-2056-01		TCGA-09-2056-01B-01W-0722-08	67670628-ad07-41ef-8977-890080616900	568718ea-3d9d-4d09-b155-0b8467a10bbe		TCGA-09-2056-01B-01R-1568-13	TCGA-09-2056-01B-01D-0667-05	TCGA-09-2056-01	TCGA-09-2056-01	TCGA-09-2056-01B-01D-0663-01	TCGA-09-2056-01	TCGA-09-2056-01B-01D-0663-01	794b6a48-f610-4711-8b1a-4736252c8bea	67670628-ad07-41ef-8977-890080616900	67670628-ad07-41ef-8977-890080616900	794b6a48-f610-4711-8b1a-4736252c8bea	TCGA-09-2056-01B-21-1560-20	TCGA-09-2056-01B-01R-1568-13	TCGA-09-2056-01B-01R-0670-07		6c194f10-5bf3-4331-b035-f50e93536dda	67670628-ad07-41ef-8977-890080616900	TCGA-09-2056-01B-01R-1568-13	TCGA-09-2056-01B-01W-0722-08	
TCGA-10-0925-01	1	TCGA-10-0925-01	1652	1	BRCA-LUAD+		OV-like c1	OV-like c4					TCGA-10-0925	1652	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-10-0925-F24403	Stage IIIB	-21498		1652	0	1652		558				2010-2-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.1	YES	Tumor resection		0.7	NO	80	0.7			G1	Recurrence									0	0			0	0	30	30	70	70	75	75	Pre-Operative	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			10	1-10 mm	Ovary		B	DECEASED	2000		TCGA-10-0925-01				ee2bb61b-4b7c-4cb4-b9e8-381285ad51f7			TCGA-10-0925-01B-01D-0652-05			TCGA-10-0925-01B-01D-0648-01	TCGA-10-0925-01	TCGA-10-0925-01B-01D-0648-01	1f062476-2401-45e5-955a-c98a5c418d98			1f062476-2401-45e5-955a-c98a5c418d98	TCGA-10-0925-01A-11-20		TCGA-10-0925-01B-01R-0655-07		54016305-6747-489d-b09b-8db5be8409dc				
TCGA-10-0926-01	1	TCGA-10-0926-01	788	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0926	788	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Bilateral	TCGA-10-0926-F24413	Stage IIIC	-23307		788	0	788		287				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1		NO	G3	Recurrence				TCGA-10-0926.b940b1b3-8278-400e-b43a-e7897e0361b7.pdf					0	0			2	5	0	0	98	95	99	99	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	YES		Primary Tumor	01	0.6			10	11-20 mm	Ovary	NO	A	DECEASED	2000		TCGA-10-0926-01		TCGA-10-0926-01A-01W-0420-08		fb5e42c3-de28-4dc9-8e33-c56685b72e5e		TCGA-10-0926-01A-01R-1564-13	TCGA-10-0926-01A-01D-0402-05			TCGA-10-0926-01A-01D-0399-01	TCGA-10-0926-01	TCGA-10-0926-01A-01D-0399-01	7f20859a-904e-4a7b-b57b-20ad49c3eeae			7f20859a-904e-4a7b-b57b-20ad49c3eeae	TCGA-10-0926-01A-21-20	TCGA-10-0926-01A-01R-1564-13	TCGA-10-0926-01A-01R-0406-07		892ce3d6-a97f-480f-85fb-5491e5ab9afa		TCGA-10-0926-01A-01R-1564-13	TCGA-10-0926-01A-01W-0420-08	
TCGA-10-0927-01	1	TCGA-10-0927-01	2490	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-10-0927	2490	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-10-0927-F24420	Stage IIIC	-23982		2490	0	2478		1001				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1			G2	Recurrence				TCGA-10-0927.3d93f935-2a93-4987-99c6-0b75e2e59cd3.pdf					0	0			10	5	30	5	60	90	75	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			10	1-10 mm	Ovary		A	DECEASED	2000	TCGA-10-0927-01A-02W-0419-10	TCGA-10-0927-01	TCGA-10-0927-01A-02W-0419-10	TCGA-10-0927-01				TCGA-10-0927-01A-02R-1564-13	TCGA-10-0927-01A-02D-0402-05			TCGA-10-0927-01A-02D-0399-01	TCGA-10-0927-01	TCGA-10-0927-01A-02D-0399-01	0afd6963-4ee0-474d-89b9-4fa151d8f1b4			0afd6963-4ee0-474d-89b9-4fa151d8f1b4		TCGA-10-0927-01A-02R-1564-13	TCGA-10-0927-01A-02R-0406-07		c4ec4774-a95e-4097-bd99-7b0862020450		TCGA-10-0927-01A-02R-1564-13		
TCGA-10-0928-01	1	TCGA-10-0928-01	563	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-10-0928	563	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Bilateral	TCGA-10-0928-F24430	Stage IIIC	-26066		563	0	563			0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G3					TCGA-10-0928.859b2662-493a-4ead-9ac7-0aa8d0a7a3d8.pdf					0	0			5	5	5	5	90	90	95	95		WITH TUMOR	YES				NO		Primary Tumor	01	0.4			10	1-10 mm	Ovary	NO	A	DECEASED	2000	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01	TCGA-10-0928-01A-02W-0419-10	TCGA-10-0928-01A-02W-0419-10	9aa3ae15-1033-46f1-a304-993f5d41cd50			TCGA-10-0928-01A-02R-1564-13	TCGA-10-0928-01A-02D-0402-05	TCGA-10-0928-01	TCGA-10-0928-01	TCGA-10-0928-01A-02D-0399-01	TCGA-10-0928-01	TCGA-10-0928-01A-02D-0399-01	53d6550d-4d80-4e28-accb-fd3a46abcdd5	9aa3ae15-1033-46f1-a304-993f5d41cd50	9aa3ae15-1033-46f1-a304-993f5d41cd50	53d6550d-4d80-4e28-accb-fd3a46abcdd5		TCGA-10-0928-01A-02R-1564-13	TCGA-10-0928-01A-02R-0406-07		3534ce20-56e1-409a-a438-50513c622602	9aa3ae15-1033-46f1-a304-993f5d41cd50	TCGA-10-0928-01A-02R-1564-13		
TCGA-10-0930-01	1	TCGA-10-0930-01	1040	1	High		OV-like c1			miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0930	1040	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Left	TCGA-10-0930-F24432	Stage IIIC	-25737		1040	0	1011		680				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8			G3	Recurrence				TCGA-10-0930.89034658-e10d-47d3-9ad8-d79aa51cf234.pdf					0	0			5	0	5	5	90	95	95	98		WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.3			10	1-10 mm	Ovary		A	DECEASED	2002		TCGA-10-0930-01		TCGA-10-0930-01A-02W-0421-09				TCGA-10-0930-01A-02R-1564-13	TCGA-10-0930-01A-02D-0402-05			TCGA-10-0930-01A-02D-0399-01	TCGA-10-0930-01	TCGA-10-0930-01A-02D-0399-01	7ae59829-3d0f-44df-819b-0b9bf21a2e9e			7ae59829-3d0f-44df-819b-0b9bf21a2e9e			TCGA-10-0930-01A-02R-0406-07		36457b1f-1ee7-4bdc-82f4-75f3fccceb66				TCGA-10-0930-01A-02W-0421-09
TCGA-10-0931-01	1	TCGA-10-0931-01	1000	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-10-0931	1000	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-10-0931-F24440	Stage IIIC	-16262		1000	0	982		300	1			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G3	Recurrence				TCGA-10-0931.45d8f828-6dfb-4e68-8282-f2ee74671461.pdf					0	0			0	5	5	10	95	85	98	85	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			10	1-10 mm	Ovary	NO	A	DECEASED	2002		TCGA-10-0931-01		TCGA-10-0931-01A-01W-0420-08		25a69746-6f70-41eb-9805-6299ea0a4728		TCGA-10-0931-01A-01R-1564-13	TCGA-10-0931-01A-01D-0402-05			TCGA-10-0931-01A-01D-0399-01	TCGA-10-0931-01	TCGA-10-0931-01A-01D-0399-01	fa0c4583-eb33-4be7-9d29-a9587b4eeefe			fa0c4583-eb33-4be7-9d29-a9587b4eeefe	TCGA-10-0931-01A-21-20	TCGA-10-0931-01A-01R-1564-13	TCGA-10-0931-01A-01R-0406-07		3d021366-16ec-4c18-8ce6-17beebce1e9c		TCGA-10-0931-01A-01R-1564-13	TCGA-10-0931-01A-01W-0420-08	
TCGA-10-0933-01	1	TCGA-10-0933-01	446	1	High	C9-OV	UCEC Serous c4	OV-like c4		miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-10-0933	446	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	77	Bilateral	TCGA-10-0933-F24454	Stage IIIC	-28433		446	0	356		356	1			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence				TCGA-10-0933.f973309d-55dd-489b-a7ca-9348666a9129.pdf		0			0	0		0	5	5	10	5	85	90	90	90	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			10	No Macroscopic disease	Ovary		A	DECEASED	2003		TCGA-10-0933-01		TCGA-10-0933-01A-01W-0421-09		7c7459b2-2a24-4866-a4fc-e960ef606d39		TCGA-10-0933-01A-01R-1569-13	TCGA-10-0933-01A-01D-0402-05			TCGA-10-0933-01A-01D-0399-01	TCGA-10-0933-01	TCGA-10-0933-01A-01D-0399-01	e601f5e7-56ad-440a-873e-34e99749e92b			e601f5e7-56ad-440a-873e-34e99749e92b	TCGA-10-0933-01A-21-20	TCGA-10-0933-01A-01R-1569-13	TCGA-10-0933-01A-01R-0406-07		99221367-1f21-45c5-944f-f734178e1468		TCGA-10-0933-01A-01R-1569-13		TCGA-10-0933-01A-01W-0421-09
TCGA-10-0934-01	1	TCGA-10-0934-01	204	1	High		UCEC non-CIMP c3			miRNA cluster 6	cluster 4	mutation cluster 5	TCGA-10-0934	204	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-10-0934-F24458	Stage IIIC	-18602		204	0	119		111				2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							NO	G3	Recurrence																						WITH TUMOR	YES	Progressive Disease		First Seen At Further Surgery	NO		Primary Tumor	01				10	1-10 mm	Ovary			DECEASED	2003		TCGA-10-0934-01		TCGA-10-0934-01A-02W-0420-08				TCGA-10-0934-01A-02R-1564-13	TCGA-10-0934-01A-02D-0402-05			TCGA-10-0934-01A-02D-0399-01	TCGA-10-0934-01	TCGA-10-0934-01A-02D-0399-01	afd657cb-1c27-4a3c-a8a6-9f5ccd3bb3d7			afd657cb-1c27-4a3c-a8a6-9f5ccd3bb3d7		TCGA-10-0934-01A-02R-1564-13	TCGA-10-0934-01A-02R-0406-07		cb990c79-c1bf-45d1-88ff-04a916bf3a16		TCGA-10-0934-01A-02R-1564-13	TCGA-10-0934-01A-02W-0420-08	
TCGA-10-0935-01	1	TCGA-10-0935-01	1078	1	BRCA-LUAD+		OV-like c1					mutation cluster 5	TCGA-10-0935	1078	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			68	Bilateral	TCGA-10-0935-F24462	Stage IIIC	-25098		1078	0	1078						2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							YES	G3																							WITH TUMOR	YES				NO		Primary Tumor	01				10	1-10 mm	Ovary	YES		DECEASED	2003		TCGA-10-0935-01		TCGA-10-0935-01A-03W-0421-09					TCGA-10-0935-01A-03D-0402-05			TCGA-10-0935-01A-03D-0399-01	TCGA-10-0935-01	TCGA-10-0935-01A-03D-0399-01	a3a9276a-e5be-4e59-8a9c-ffea435ccdc8			a3a9276a-e5be-4e59-8a9c-ffea435ccdc8			TCGA-10-0935-01A-02R-0406-07		da4b7cf0-830b-42de-9bd5-fa065c331362				TCGA-10-0935-01A-03W-0421-09
TCGA-10-0936-01	1	TCGA-10-0936-01	1123	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 2		TCGA-10-0936	1123	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			69	Bilateral	TCGA-10-0936-F24466	Stage IIIC	-25454		1123	0	1089			0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3					TCGA-10-0936.6b9a13e4-760e-476f-a0a7-fb42ab7c63c5.pdf					0	0			5	5	5	5	90	90	90	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.5			10	>20 mm	Ovary		A	DECEASED	2005		TCGA-10-0936-01			04112b9c-6ef4-49cd-bed8-43151b5bbe1f	5e8ac787-50cc-45ea-9fc4-efe67b6d05ff		TCGA-10-0936-01A-01R-1564-13	TCGA-10-0936-01A-01D-0402-05	TCGA-10-0936-01	TCGA-10-0936-01	TCGA-10-0936-01A-01D-0399-01	TCGA-10-0936-01	TCGA-10-0936-01A-01D-0399-01	0eb9976b-f75f-4763-8954-bdba8c9047a1	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	0eb9976b-f75f-4763-8954-bdba8c9047a1	TCGA-10-0936-01A-21-20	TCGA-10-0936-01A-01R-1564-13	TCGA-10-0936-01A-01R-0406-07		8492ae5a-2139-4159-8b99-133e01b12568	04112b9c-6ef4-49cd-bed8-43151b5bbe1f	TCGA-10-0936-01A-01R-1564-13		
TCGA-10-0937-01	1	TCGA-10-0937-01	608	1	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0937	608	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-10-0937-F24476	Stage IIIC	-16222		608	0	460		235	0			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6			G3	Recurrence				TCGA-10-0937.2a86dcb5-1af7-447d-b20f-eef4972048a0.pdf					0	0			5	5	15	20	80	75	85	80	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			10	1-10 mm	Ovary		A	DECEASED	2005	TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01	TCGA-10-0937-01A-02W-0419-10	TCGA-10-0937-01A-02W-0419-10				TCGA-10-0937-01A-02R-1564-13	TCGA-10-0937-01A-02D-0402-05			TCGA-10-0937-01A-02D-0399-01	TCGA-10-0937-01	TCGA-10-0937-01A-02D-0399-01	265af9ca-8abd-4c8a-b657-88ae76237368			265af9ca-8abd-4c8a-b657-88ae76237368		TCGA-10-0937-01A-02R-1564-13	TCGA-10-0937-01A-02R-0406-07		a104dfcb-8b29-4ab3-99ad-9ccbac4b2d4d		TCGA-10-0937-01A-02R-1564-13		
TCGA-10-0938-01	1	TCGA-10-0938-01	636	1	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-10-0938	636	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			80	Bilateral	TCGA-10-0938-F24483	Stage IIIC	-29558		636	0	604		362	2			2009-3-6	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.6	NO		1			G3	Progression of Disease				TCGA-10-0938.faa8920a-3b4a-4767-bdb1-5d086e51fe92.pdf					0	0			5	10	15	20	80	70	80	85		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.6			10	>20 mm	Ovary		A	DECEASED	2002	TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01	TCGA-10-0938-01A-02W-0419-10	TCGA-10-0938-01A-02W-0419-10				TCGA-10-0938-01A-02R-1564-13	TCGA-10-0938-01A-02D-0402-05			TCGA-10-0938-01A-02D-0399-01	TCGA-10-0938-01	TCGA-10-0938-01A-02D-0399-01	b2a05747-aa38-4968-8fb8-1f27a40a4181			b2a05747-aa38-4968-8fb8-1f27a40a4181		TCGA-10-0938-01A-02R-1564-13	TCGA-10-0938-01A-02R-0406-07		02e1cf40-826f-451a-bb3c-a3c7c94e8104		TCGA-10-0938-01A-02R-1564-13		
TCGA-13-0714-01	1	TCGA-13-0714-01	189	1	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0714	189	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-13-0714-F24489	Stage IV	-20109		189	0	189		110				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.2			G3	Progression of Disease				TCGA-13-0714.96EB4BD1-CE3B-44D8-8095-076712A3E082.pdf					1	1			9	19			90	80	91	81	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2000	TCGA-13-0714-01A-01W-0370-10	TCGA-13-0714-01	TCGA-13-0714-01A-01W-0370-10	TCGA-13-0714-01A-01W-0370-10			TCGA-13-0714-01A-01R-0363-07	TCGA-13-0714-01A-01R-1564-13	TCGA-13-0714-01A-01D-0359-05			TCGA-13-0714-01A-01D-0356-01	TCGA-13-0714-01	TCGA-13-0714-01A-01D-0356-01	e4f66c8d-3cf1-4e33-b49e-98b6ee4b98f2			e4f66c8d-3cf1-4e33-b49e-98b6ee4b98f2		TCGA-13-0714-01A-01R-1564-13			408156df-a8fa-4068-9b87-f92bd60ca873		TCGA-13-0714-01A-01R-1564-13		
TCGA-13-0717-01	1	TCGA-13-0717-01	748	1	High		OV-like c1					mutation cluster 8	TCGA-13-0717	748	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-13-0717-F24494	Stage IIIC	-20042		748	0	748		294				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01				13	>20 mm	Ovary			DECEASED	2000	TCGA-13-0717-01A-01W-0370-10	TCGA-13-0717-01	TCGA-13-0717-01A-01W-0370-10	TCGA-13-0717-01A-01W-0370-10			TCGA-13-0717-01A-01R-0363-07		TCGA-13-0717-01A-01D-0359-05			TCGA-13-0717-01A-01D-0356-01	TCGA-13-0717-01	TCGA-13-0717-01A-01D-0356-01	a741d476-65cd-4424-9612-3118190d7bba			a741d476-65cd-4424-9612-3118190d7bba					d6012831-3668-402e-8be1-849c011767a6				
TCGA-13-0720-01	1	TCGA-13-0720-01	1355	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-13-0720	1355	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-13-0720-F24498	Stage IIIC	-17799		1355	0	1355		292				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO	80	8			G3	Recurrence				TCGA-13-0720.0A196866-A083-40AC-90E3-5ECA3B141645.pdf		80			1	3		20	5	10	1	2	93	85	94	88	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2001	TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01	TCGA-13-0720-01A-01W-0370-10	TCGA-13-0720-01A-01W-0370-10		5864cd1e-a0da-4553-b12b-75f8941ecbab		TCGA-13-0720-01A-01R-1564-13	TCGA-13-0720-01A-01D-0359-05			TCGA-13-0720-01A-01D-0356-01	TCGA-13-0720-01	TCGA-13-0720-01A-01D-0356-01	a1704a37-9809-4d75-97f0-97ecb2e298c6			a1704a37-9809-4d75-97f0-97ecb2e298c6	TCGA-13-0720-01A-21-20	TCGA-13-0720-01A-01R-1564-13	TCGA-13-0720-01A-01R-0363-07		595dacaa-2763-4482-998c-eb748907f146		TCGA-13-0720-01A-01R-1564-13		
TCGA-13-0723-01	1	TCGA-13-0723-01	1204	1	High		OV-like c1			miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-0723	1204	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	63	Bilateral	TCGA-13-0723-F24503	Stage IIIC	-23094		1204	0	1204		210				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G3	Progression of Disease				TCGA-13-0723.0A628FDD-EDDF-48BA-A083-8E2676DD9B5C.pdf	70				3	5	30		18	10	2		77	75	80	80		WITH TUMOR	YES	Progressive Disease		Molecular Marker(S)	NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2002		TCGA-13-0723-01		TCGA-13-0723-01A-02W-0372-09			TCGA-13-0723-01A-02R-0363-07	TCGA-13-0723-01A-02R-1564-13	TCGA-13-0723-01A-02D-0359-05			TCGA-13-0723-01A-02D-0356-01	TCGA-13-0723-01	TCGA-13-0723-01A-02D-0356-01	e4726939-32a7-4ecf-bcee-420817d9d234			e4726939-32a7-4ecf-bcee-420817d9d234					95906f3c-8c5d-4eb9-8183-a444efde2a18				TCGA-13-0723-01A-02W-0372-09
TCGA-13-0724-01	1	TCGA-13-0724-01	83	1	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0724	83	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	72	Right	TCGA-13-0724-F24507	Stage IV	-26342		83	0	83		83				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Excisional Biopsy				80				G3	Progression of Disease																					Pre-Operative	WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2002		TCGA-13-0724-01		TCGA-13-0724-01A-01W-0372-09			TCGA-13-0724-01A-01R-0363-07	TCGA-13-0724-01A-01R-1564-13	TCGA-13-0724-01A-01D-0359-05			TCGA-13-0724-01A-01D-0356-01	TCGA-13-0724-01	TCGA-13-0724-01A-01D-0356-01	f609b580-4ab3-4dc5-9636-f5562f2324e5			f609b580-4ab3-4dc5-9636-f5562f2324e5		TCGA-13-0724-01A-01R-1564-13			fb6ffde7-3b9f-4f28-845c-e2bb245db90b		TCGA-13-0724-01A-01R-1564-13		TCGA-13-0724-01A-01W-0372-09
TCGA-13-0725-01	1	TCGA-13-0725-01	377	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-13-0725	377	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-13-0725-F24510	Stage IIIC	-16086		377	0	377		190				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence				TCGA-13-0725.A6CD74F2-47A0-4790-BB81-6C636DA16ADC.pdf	50	50			0	0	50		40	0		10	60	90	90	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0725-01				6701705e-cbfb-4af1-b1ab-898298de7c02	TCGA-13-0725-01A-01R-0363-07	TCGA-13-0725-01A-01R-1986-13	TCGA-13-0725-01A-01D-0359-05			TCGA-13-0725-01A-01D-0356-01	TCGA-13-0725-01	TCGA-13-0725-01A-01D-0356-01	b31aaae9-a48c-4344-8b6e-69b5dbdc6c2c			b31aaae9-a48c-4344-8b6e-69b5dbdc6c2c	TCGA-13-0725-01A-21-20	TCGA-13-0725-01A-01R-1564-13			c030245e-982a-40d5-a03d-c7896105b062		TCGA-13-0725-01A-01R-1564-13		
TCGA-13-0726-01	1	TCGA-13-0726-01	949	1	Squamous		OV-like c1			miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0726	949	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-13-0726-F24515	Stage IIIC	-20134		949	0	946		392				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			GX	Recurrence				TCGA-13-0726.7165A995-69AE-4D74-9437-02C4730701C1.pdf		50			0	0		50	0	0	40	30	60	70	80	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0726-01		TCGA-13-0726-01A-01W-0372-09			TCGA-13-0726-01A-01R-0363-07	TCGA-13-0726-01A-01R-1564-13	TCGA-13-0726-01A-01D-0359-05			TCGA-13-0726-01A-01D-0356-01	TCGA-13-0726-01	TCGA-13-0726-01A-01D-0356-01	49926024-a499-4744-9ea6-5dc05da705e8			49926024-a499-4744-9ea6-5dc05da705e8		TCGA-13-0726-01A-01R-1564-13			ec64c4e0-8c79-4161-bc31-56abd101de2c		TCGA-13-0726-01A-01R-1564-13		TCGA-13-0726-01A-01W-0372-09
TCGA-13-0727-01	1	TCGA-13-0727-01	462	1	High		OV-like c1			miRNA cluster 1	cluster 3	mutation c1uster 9	TCGA-13-0727	462	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-13-0727-F24519	Stage IIIC	-26185		462	0	462		253				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2			G3	Recurrence				TCGA-13-0727.EA3709B4-0C79-4CF5-A7D6-DB9F08DD74B5.pdf					0	0			15	10	0	10	85	80	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2003	TCGA-13-0727-01A-01W-0370-10	TCGA-13-0727-01	TCGA-13-0727-01A-01W-0370-10	TCGA-13-0727-01A-01W-0370-10			TCGA-13-0727-01A-01R-0363-07	TCGA-13-0727-01A-01R-1564-13	TCGA-13-0727-01A-01D-0359-05			TCGA-13-0727-01A-01D-0356-01	TCGA-13-0727-01	TCGA-13-0727-01A-01D-0356-01	54cb8511-36a0-4af7-84eb-274263af1f05			54cb8511-36a0-4af7-84eb-274263af1f05		TCGA-13-0727-01A-01R-1564-13			ccf2280b-6308-40ad-bf39-f222aa67a91b		TCGA-13-0727-01A-01R-1564-13		
TCGA-13-0730-01	1	TCGA-13-0730-01	542	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0730	542	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Bilateral	TCGA-13-0730-F60695	Stage IIIC	-26086		542	0					Scheduled Follow-up Submission		2014-6-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		0.6	NO		1.1	NO		G3					TCGA-13-0730.2AF2844E-F1DC-4938-85D3-08B07BB9DCFF.pdf	50	50			5	5	50	50	0	0	5	15	90	80	95	95									Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2003	TCGA-13-0730-01A-01W-0370-10	TCGA-13-0730-01	TCGA-13-0730-01A-01W-0370-10	TCGA-13-0730-01A-01W-0370-10	754dfe07-22f4-4070-bbcb-10bfbb649def		TCGA-13-0730-01A-01R-0363-07	TCGA-13-0730-01A-01R-1564-13	TCGA-13-0730-01A-01D-0359-05	TCGA-13-0730-01	TCGA-13-0730-01	TCGA-13-0730-01A-01D-0356-01	TCGA-13-0730-01	TCGA-13-0730-01A-01D-0356-01	f17ead9c-d1d3-47fa-9f19-292fb6d9cbec	754dfe07-22f4-4070-bbcb-10bfbb649def	754dfe07-22f4-4070-bbcb-10bfbb649def	f17ead9c-d1d3-47fa-9f19-292fb6d9cbec		TCGA-13-0730-01A-01R-1564-13			1bd423e8-af33-4277-8ded-7d8c3f675f4b	754dfe07-22f4-4070-bbcb-10bfbb649def	TCGA-13-0730-01A-01R-1564-13		
TCGA-13-0751-01	1	TCGA-13-0751-01	1678	1	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0751	1678	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-13-0751-F24525	Stage IIIC	-16304		1678	0	1678		653				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			GX	Recurrence				TCGA-13-0751.61280768-69DF-4601-BED6-E78C1F82E5BC.pdf					1	0			5	0		5	94	95	95	98		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	1999		TCGA-13-0751-01		TCGA-13-0751-01				TCGA-13-0751-01A-01R-1564-13	TCGA-13-0751-01A-01D-0359-05			TCGA-13-0751-01A-01D-0356-01	TCGA-13-0751-01	TCGA-13-0751-01A-01D-0356-01	311c8442-9ccd-451d-bdfb-c7f99ad48253			311c8442-9ccd-451d-bdfb-c7f99ad48253			TCGA-13-0751-01A-01R-0363-07		625f1703-3f6c-4434-b30d-8bf174c438d7			TCGA-13-0751-01A-01D-0446-08	
TCGA-13-0755-01	1	TCGA-13-0755-01	76	1	Squamous		OV-like c1			miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-0755	76	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	75	Bilateral	TCGA-13-0755-F24531	Stage IV	-27438		76	0	76		34				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	40	1.1			G3	Progression of Disease				TCGA-13-0755.E72A1354-9F17-4BA4-8760-780EFB9C70AA.pdf					1	1			10	10			89	89	90	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2003		TCGA-13-0755-01		TCGA-13-0755-01A-01W-0372-09				TCGA-13-0755-01A-01R-1564-13	TCGA-13-0755-01A-01D-0359-05			TCGA-13-0755-01A-01D-0356-01	TCGA-13-0755-01	TCGA-13-0755-01A-01D-0356-01	3bb6dd39-dd32-4fc2-bf84-38ffa683b75a			3bb6dd39-dd32-4fc2-bf84-38ffa683b75a			TCGA-13-0755-01A-01R-0363-07		b14fdd08-b406-4db3-ac74-d1fdb6b213a2				TCGA-13-0755-01A-01W-0372-09
TCGA-13-0757-01	1	TCGA-13-0757-01	340	1	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0757	340	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-13-0757-F24534	Stage IIIC	-25999		340	0	340		293				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO	60	0.9			G3	Recurrence				TCGA-13-0757.81F1B0FB-CEB7-4313-AA0D-71DA495AEABE.pdf	90	100			10	5			10	20	5	1	75	75	85	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2005		TCGA-13-0757-01					TCGA-13-0757-01A-01R-0363-07	TCGA-13-0757-01A-01R-1564-13	TCGA-13-0757-01A-01D-0359-05			TCGA-13-0757-01A-01D-0356-01	TCGA-13-0757-01	TCGA-13-0757-01A-01D-0356-01	a7bcf22d-826a-4d23-a17f-4d6ad5c14666			a7bcf22d-826a-4d23-a17f-4d6ad5c14666					69337aad-1fe3-4b0e-943e-ca5ac6dc6076				
TCGA-13-0758-01	1	TCGA-13-0758-01	346	1	Squamous		OV-like c1						TCGA-13-0758	346	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-13-0758-F24539	Stage IV	-22088		346	0	346		212				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	60	1.3			G3	Progression of Disease				TCGA-13-0758.37B557BB-D2C4-42A9-B224-F1DFFC9B8FE3.pdf		70		30	5	5			20	10		1	75	84	80	89	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2005		TCGA-13-0758-01					TCGA-13-0758-01A-01R-0363-07		TCGA-13-0758-01A-01D-0359-05			TCGA-13-0758-01A-01D-0356-01	TCGA-13-0758-01	TCGA-13-0758-01A-01D-0356-01	ca1b94d2-05a4-48d5-81a1-4cb4da832e25			ca1b94d2-05a4-48d5-81a1-4cb4da832e25					4d8ca9f7-21f4-49d8-b985-53a096e48428				
TCGA-13-0760-01	1	TCGA-13-0760-01	351	1	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0760	351	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-13-0760-F24543	Stage IV	-23036		351	0	351						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.9	NO	80	1.5			G3										1	0			10	0		20	89	80	90	85	Pre-Adjuvant Therapy		YES				NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	DECEASED	2006		TCGA-13-0760-01		TCGA-13-0760-01A-01W-0372-09			TCGA-13-0760-01A-01R-0363-07	TCGA-13-0760-01A-01R-1564-13	TCGA-13-0760-01A-01D-0359-05			TCGA-13-0760-01A-01D-0356-01	TCGA-13-0760-01	TCGA-13-0760-01A-01D-0356-01	5b3a8dc0-c3ed-4616-8b9d-65673910c222			5b3a8dc0-c3ed-4616-8b9d-65673910c222		TCGA-13-0760-01A-01R-1564-13					TCGA-13-0760-01A-01R-1564-13		TCGA-13-0760-01A-01W-0372-09
TCGA-13-0761-01	0	TCGA-13-0761-01	1036	0	Squamous		OV-like c1			miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-13-0761	1036	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-13-0761-F24545	Stage IV	-18697			0	1036		424				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3	Recurrence									1	0			5	0		10	94	90	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2006	TCGA-13-0761-01A-01W-0370-10	TCGA-13-0761-01	TCGA-13-0761-01A-01W-0370-10	TCGA-13-0761-01A-01W-0370-10			TCGA-13-0761-01A-01R-0363-07	TCGA-13-0761-01A-01R-1564-13	TCGA-13-0761-01A-01D-0359-05			TCGA-13-0761-01A-01D-0356-01	TCGA-13-0761-01	TCGA-13-0761-01A-01D-0356-01	70bb7e2f-cb99-4960-a591-32e796c98f2f			70bb7e2f-cb99-4960-a591-32e796c98f2f					31361f65-a9de-4272-9de7-d884d15db3f0				
TCGA-13-0762-01	0	TCGA-13-0762-01	981	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 2	TCGA-13-0762	981	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			65	Bilateral	TCGA-13-0762-F24549	Stage IIIC	-23960			0	981						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection				80				G3																						Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				13	No Macroscopic disease	Ovary			LIVING	2006	TCGA-13-0762-01A-01W-0370-10	TCGA-13-0762-01	TCGA-13-0762-01A-01W-0370-10	TCGA-13-0762-01A-01W-0370-10			TCGA-13-0762-01A-01R-0363-07	TCGA-13-0762-01A-01R-1564-13	TCGA-13-0762-01A-01D-0359-05			TCGA-13-0762-01A-01D-0356-01	TCGA-13-0762-01	TCGA-13-0762-01A-01D-0356-01	a34ce5b9-fc4a-44ce-b89c-e8bcba934913			a34ce5b9-fc4a-44ce-b89c-e8bcba934913		TCGA-13-0762-01A-01R-1564-13			f33f5749-bed4-403d-b311-176f59fb32bc		TCGA-13-0762-01A-01R-1564-13		
TCGA-13-0764-01	0	TCGA-13-0764-01	944	0	High		OV-like c1						TCGA-13-0764	944	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62	Bilateral	TCGA-13-0764-F24554	Stage IV	-22965			0	944		272				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			1.3	NO	80	1.7			G3	Recurrence									1	1			2	20			97	79	98	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2006		TCGA-13-0764-01					TCGA-13-0764-01A-03R-0363-07		TCGA-13-0764-01A-03D-0359-05			TCGA-13-0764-01A-03D-0356-01	TCGA-13-0764-01	TCGA-13-0764-01A-03D-0356-01	0c0fe76e-4298-462c-9354-f7e92391a135			0c0fe76e-4298-462c-9354-f7e92391a135					b72f0610-8aaa-48ac-afed-333e5f4159cd				
TCGA-13-0765-01	0	TCGA-13-0765-01	869	0	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0765	869	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-13-0765-F24559	Stage IIIC	-18574			0	869		668				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2			G3	Recurrence									1	0			1	0		5	98	95	99	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2006				TCGA-13-0765-01A-01W-0372-09				TCGA-13-0765-01A-01R-1564-13	TCGA-13-0765-01A-01D-0359-05				TCGA-13-0765-01							TCGA-13-0765-01A-01R-1564-13	TCGA-13-0765-01A-01R-0363-07		17962695-e9c2-45f2-b4a2-00b7bfd1ffd6		TCGA-13-0765-01A-01R-1564-13		TCGA-13-0765-01A-01W-0372-09
TCGA-13-0766-01	0	TCGA-13-0766-01	651	0	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0766	651	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			42	Bilateral	TCGA-13-0766-F24567	Stage IIIC	-15571			0	651		628				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.7			G3	Recurrence									1	5			20	20			79	75	80	80		WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2006		TCGA-13-0766-01						TCGA-13-0766-01A-02R-1564-13	TCGA-13-0766-01A-02D-0359-05			TCGA-13-0766-01A-02D-0356-01	TCGA-13-0766-01	TCGA-13-0766-01A-02D-0356-01	643bcd2e-3b7a-4834-9050-bfc9bf6f2fcb			643bcd2e-3b7a-4834-9050-bfc9bf6f2fcb		TCGA-13-0766-01A-02R-1564-13	TCGA-13-0766-01A-02R-0363-07		2b1e48b5-b8f4-4f57-8089-8293f470f466		TCGA-13-0766-01A-02R-1564-13		
TCGA-13-0768-01	0	TCGA-13-0768-01	257	0	High		OV-like c1			miRNA cluster 3	cluster 5		TCGA-13-0768	257	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-13-0768-F24572	Stage IIIC	-26999			0	257						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO	60	0.8			G3					TCGA-13-0768.7D67D0D3-105C-4A00-B104-106BE26FEE2D.pdf					9	1			5	10	1		85	89	94	90	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-0768-01					TCGA-13-0768-01A-01R-0363-07	TCGA-13-0768-01A-01R-1569-13	TCGA-13-0768-01A-01D-0359-05			TCGA-13-0768-01A-01D-0356-01	TCGA-13-0768-01	TCGA-13-0768-01A-01D-0356-01	c26c83eb-091f-4940-ae98-62e16254cc05			c26c83eb-091f-4940-ae98-62e16254cc05		TCGA-13-0768-01A-01R-1569-13			282e4c72-a430-4a70-9393-c259a90d9ee3		TCGA-13-0768-01A-01R-1569-13		
TCGA-13-0791-01	0	TCGA-13-0791-01	1184	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0791	1184	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-13-0791-F24579	Stage IIIC	-21380			0	1184		281				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	80	1.8			G3	Recurrence						50			0	0			0	0	50	15	50	85	85	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2005		TCGA-13-0791-01		TCGA-13-0791-01A-01W-0372-09			TCGA-13-0791-01A-01R-0363-07	TCGA-13-0791-01A-01R-1564-13	TCGA-13-0791-01A-01D-0359-05			TCGA-13-0791-01A-01D-0356-01	TCGA-13-0791-01	TCGA-13-0791-01A-01D-0356-01	cfb6aa16-69ca-422f-b5c3-cf546d4964f5			cfb6aa16-69ca-422f-b5c3-cf546d4964f5					7290ea9e-baf6-4777-b512-ab1da9bf62cd				TCGA-13-0791-01A-01W-0372-09
TCGA-13-0791-02	0	TCGA-13-0791-02	1184	0			OV-like c1			miRNA cluster 2		mutation cluster 5	TCGA-13-0791	1184	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-13-0791-F24579	Stage IIIC	-21380			0	1184		281				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO	80	1			G3	Recurrence									5	2			0	0	15	8	80	90	90	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.1			13	No Macroscopic disease	Ovary		A	LIVING	2005								TCGA-13-0791-02A-01R-1564-13	TCGA-13-0791-02A-01D-0807-05						2560280e-62b8-4067-a7e4-8df8ac0c269a,a95e2235-b149-4930-ba1c-e18c454d03fd			2560280e-62b8-4067-a7e4-8df8ac0c269a,a95e2235-b149-4930-ba1c-e18c454d03fd			TCGA-13-0791-02A-01R-0810-07		3038dbe5-a4fd-4ebf-b582-503b3041822b				
TCGA-13-0792-01	0	TCGA-13-0792-01	1117	0	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0792	1117	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-13-0792-F24588	Stage IIIC	-14729			0	1117		816				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1.2			G3	Recurrence									0	0			0	0	30	15	70	85	85	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2005	TCGA-13-0792-01A-01W-0370-10	TCGA-13-0792-01	TCGA-13-0792-01A-01W-0370-10	TCGA-13-0792-01A-01W-0370-10			TCGA-13-0792-01A-01R-0363-07	TCGA-13-0792-01A-01R-1564-13	TCGA-13-0792-01A-01D-0359-05			TCGA-13-0792-01A-01D-0356-01	TCGA-13-0792-01	TCGA-13-0792-01A-01D-0356-01	7af29da0-5b60-4b08-9fed-074550dc5d1b			7af29da0-5b60-4b08-9fed-074550dc5d1b					3a6c89bc-5db4-4816-b7f4-d77cf1d8eb0b				
TCGA-13-0793-01	0	TCGA-13-0793-01	873	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0793	873	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Left	TCGA-13-0793-F24593	Stage IV	-14708			0	873		351				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO	80	1.6			G3	Recurrence				TCGA-13-0793.43781B94-0865-4824-94B9-1476AC2F8677.pdf					0	0			0	0	10	20	90	80	98	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2006	TCGA-13-0793-01A-01W-0370-10	TCGA-13-0793-01	TCGA-13-0793-01A-01W-0370-10	TCGA-13-0793-01A-01W-0370-10		7a9e7c44-9e41-4f1c-bf87-3faa086b0306	TCGA-13-0793-01A-01R-0363-07	TCGA-13-0793-01A-01R-1564-13	TCGA-13-0793-01A-01D-0359-05			TCGA-13-0793-01A-01D-0356-01	TCGA-13-0793-01	TCGA-13-0793-01A-01D-0356-01	5c792ad1-9591-4cb6-adce-4c09c75aa9c3			5c792ad1-9591-4cb6-adce-4c09c75aa9c3	TCGA-13-0793-01A-03-20				447c38c0-ac42-4a58-ad55-c1c68258cdf4				
TCGA-13-0794-01	0	TCGA-13-0794-01	923	0	BRCA-LUAD+		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0794	923	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-13-0794-F24598	Stage IIIC	-21945			0	923		845				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO	60	1.4			G3	Recurrence				TCGA-13-0794.7D220DC4-B90D-45C7-8C46-8AD4DB65D293.pdf					0	0			0	0	8	5	92	95	98	98	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2006		TCGA-13-0794-01				fde6d311-beb0-4efa-92af-36b426444dd4	TCGA-13-0794-01A-01R-0363-07	TCGA-13-0794-01A-01R-1564-13	TCGA-13-0794-01A-01D-0359-05			TCGA-13-0794-01A-01D-0356-01	TCGA-13-0794-01	TCGA-13-0794-01A-01D-0356-01	8568dd65-84a3-45e4-8a68-dd75afa5a8bc			8568dd65-84a3-45e4-8a68-dd75afa5a8bc	TCGA-13-0794-01A-03-20				c9dd6b81-e436-410c-abe3-aefea5b82103				
TCGA-13-0795-01	0	TCGA-13-0795-01	596	0	High		OV-like c1			miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-0795	596	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	66	Bilateral	TCGA-13-0795-F24602	Stage IIIC	-24403			0	596		325				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		0.9	NO	80	1.4			G3	Recurrence						75			0	0			0	0	5	15	95	85	98	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	LIVING	2007		TCGA-13-0795-01		TCGA-13-0795-01A-01W-0372-09			TCGA-13-0795-01A-01R-0363-07	TCGA-13-0795-01A-01R-1564-13	TCGA-13-0795-01A-01D-0359-05			TCGA-13-0795-01A-01D-0356-01	TCGA-13-0795-01	TCGA-13-0795-01A-01D-0356-01	797c5f18-5c06-4bf6-ae32-63b9a2a27150			797c5f18-5c06-4bf6-ae32-63b9a2a27150		TCGA-13-0795-01A-01R-1564-13			8a90ef9c-f444-4bff-92df-7356ec1c07ad		TCGA-13-0795-01A-01R-1564-13		TCGA-13-0795-01A-01W-0372-09
TCGA-13-0797-01	0	TCGA-13-0797-01	265	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-13-0797	265	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-13-0797-F24606	Stage IIIC	-18051			0	265						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO	80	1.6			G3					TCGA-13-0797.84ED21CA-E018-44C5-86E4-57927ABBCC9A.pdf					0	0			0	0	10	5	90	95	98	98	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-0797-01				0a64d08c-7d28-4c74-ab75-2ff02f1a4de0		TCGA-13-0797-01A-01R-1564-13	TCGA-13-0797-01A-01D-0359-05			TCGA-13-0797-01A-01D-0356-01	TCGA-13-0797-01	TCGA-13-0797-01A-01D-0356-01	14d6cfc7-8868-443e-8eaf-dc6c155958b0			14d6cfc7-8868-443e-8eaf-dc6c155958b0	TCGA-13-0797-01A-03-20	TCGA-13-0797-01A-01R-1564-13	TCGA-13-0797-01A-01R-0363-07		9efea7f4-e521-4520-8abb-c764fa2a6a8c		TCGA-13-0797-01A-01R-1564-13		
TCGA-13-0799-01	0	TCGA-13-0799-01	237	0	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-13-0799	237	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			44	Bilateral	TCGA-13-0799-F24610	Stage IIIC	-16171			0	237						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO	80	1.6			G3					TCGA-13-0799.CBB83CF3-9846-409B-858B-C8A7E74CDFF1.pdf					0	0			0	0	10	5	90	95	98	98	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-0799-01			a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	c91f1247-0579-4c10-8da1-2d62d276e58e		TCGA-13-0799-01A-01R-1564-13	TCGA-13-0799-01A-01D-0359-05	TCGA-13-0799-01	TCGA-13-0799-01	TCGA-13-0799-01A-01D-0356-01	TCGA-13-0799-01	TCGA-13-0799-01A-01D-0356-01	da529340-25e3-4b3d-8b36-3142a24c06ef	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	da529340-25e3-4b3d-8b36-3142a24c06ef	TCGA-13-0799-01A-03-1562-20	TCGA-13-0799-01A-01R-1564-13	TCGA-13-0799-01A-01R-0363-07		1197c1db-5ef3-475a-bbdb-c81da71b6ccf	a3fb40bd-3e6a-4a4b-89fb-5a9d5fb67ee3	TCGA-13-0799-01A-01R-1564-13		
TCGA-13-0800-01	0	TCGA-13-0800-01	247	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 3	TCGA-13-0800	247	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-13-0800-F24615	Stage IIIC	-19087			0	247						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G3					TCGA-13-0800.E3206F00-3BC6-44B4-848E-F2ED70E094BD.pdf					5	0			0	0	35	15	60	85	80	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-0800-01		TCGA-13-0800-01A-01W-0372-09	cd93531b-4d92-4be3-95e5-032636dd1ad8	81737798-92c9-46d7-a85c-751fc5b102e8	TCGA-13-0800-01A-01R-0363-07	TCGA-13-0800-01A-01R-1564-13	TCGA-13-0800-01A-01D-0359-05	TCGA-13-0800-01	TCGA-13-0800-01	TCGA-13-0800-01A-01D-0356-01	TCGA-13-0800-01	TCGA-13-0800-01A-01D-0356-01	c1508580-23b1-433b-adbb-70473a7105e6	cd93531b-4d92-4be3-95e5-032636dd1ad8	cd93531b-4d92-4be3-95e5-032636dd1ad8	c1508580-23b1-433b-adbb-70473a7105e6	TCGA-13-0800-01A-03-1562-20	TCGA-13-0800-01A-01R-1564-13			b637c4e1-2685-4843-9d5f-f63db155b468	cd93531b-4d92-4be3-95e5-032636dd1ad8	TCGA-13-0800-01A-01R-1564-13		TCGA-13-0800-01A-01W-0372-09
TCGA-13-0801-01	0	TCGA-13-0801-01	252	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-13-0801	252	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Bilateral	TCGA-13-0801-F24620	Stage IIIC	-16812			0	252						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.5			G3					TCGA-13-0801.FA63535E-7499-41E3-AFB1-98EB18DA7371.pdf					5	0			0	0	10	5	85	95	90	98	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-13-0801-01A-01W-0370-10	TCGA-13-0801-01	TCGA-13-0801-01A-01W-0370-10		c51dee3c-5047-4dde-b454-2474de5cf025	1c4d4161-a528-4601-b512-eb2d5ed8d992	TCGA-13-0801-01A-01R-0363-07	TCGA-13-0801-01A-01R-1564-13	TCGA-13-0801-01A-01D-0359-05	TCGA-13-0801-01	TCGA-13-0801-01	TCGA-13-0801-01A-01D-0356-01	TCGA-13-0801-01	TCGA-13-0801-01A-01D-0356-01	0905aeaa-d338-426f-ac9b-9550cdbd54d8	c51dee3c-5047-4dde-b454-2474de5cf025	c51dee3c-5047-4dde-b454-2474de5cf025	0905aeaa-d338-426f-ac9b-9550cdbd54d8	TCGA-13-0801-01A-03-20	TCGA-13-0801-01A-01R-1564-13			98d97019-658a-4493-bea0-5c571e196889	c51dee3c-5047-4dde-b454-2474de5cf025	TCGA-13-0801-01A-01R-1564-13		
TCGA-13-0802-01	0	TCGA-13-0802-01	249	0	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0802	249	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			79	Bilateral	TCGA-13-0802-F24625	Stage IIIC	-29075			0	249						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO	60	1.4			G3					TCGA-13-0802.2A9434EF-2FE0-478B-8F0C-454EE038F380.pdf					0	0			0	0	20	20	80	80	85	92	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008	TCGA-13-0802-01A-01W-0370-10	TCGA-13-0802-01	TCGA-13-0802-01A-01W-0370-10			e8448d63-f837-4512-89bf-06201938b152	TCGA-13-0802-01A-01R-0363-07	TCGA-13-0802-01A-01R-1564-13	TCGA-13-0802-01A-01D-0359-05			TCGA-13-0802-01A-01D-0356-01	TCGA-13-0802-01	TCGA-13-0802-01A-01D-0356-01	2633d35a-cf95-4ccd-a5f4-8ef7eda15177			2633d35a-cf95-4ccd-a5f4-8ef7eda15177	TCGA-13-0802-01A-03-1562-20				eb96b8fd-6402-434d-9b98-bfa40b4be522				
TCGA-13-0803-01	1	TCGA-13-0803-01	1334	1	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0803	1334	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	81	Bilateral	TCGA-13-0803-F24629	Stage IIIC	-29685		1334	0	1334		337				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.3			G3	Recurrence									0	0			0	0	15	25	85	75	90	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	DECEASED	2001		TCGA-13-0803-01					TCGA-13-0803-01A-01R-0363-07	TCGA-13-0803-01A-01R-1564-13	TCGA-13-0803-01A-01D-0359-05			TCGA-13-0803-01A-01D-0356-01	TCGA-13-0803-01	TCGA-13-0803-01A-01D-0356-01	051e9b48-2d5e-4585-96de-9fae27f59ac7			051e9b48-2d5e-4585-96de-9fae27f59ac7					f17806bc-e184-49dc-99aa-cd5547ebb032				
TCGA-13-0804-01	1	TCGA-13-0804-01	1073	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0804	1073	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73	Bilateral	TCGA-13-0804-F24633	Stage IIIC	-27021		1073	0	1073		329				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.5			G3	Recurrence				TCGA-13-0804.34870541-DEE9-4B39-A292-117E443B1CBF.pdf					1	0			0	0	4	5	95	95	98	98		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2003		TCGA-13-0804-01		TCGA-13-0804-01A-01W-0372-09		50ffbcf0-99c5-4528-bd60-8a054b3566a8	TCGA-13-0804-01A-01R-0363-07	TCGA-13-0804-01A-01R-1564-13	TCGA-13-0804-01A-01D-0359-05			TCGA-13-0804-01A-01D-0356-01	TCGA-13-0804-01	TCGA-13-0804-01A-01D-0356-01	b17d54a4-6801-452e-bb62-a9c403db4e92			b17d54a4-6801-452e-bb62-a9c403db4e92	TCGA-13-0804-01A-03-20	TCGA-13-0804-01A-01R-1564-13			a7711b62-2471-4ee7-8461-279e9732e83b		TCGA-13-0804-01A-01R-1564-13		TCGA-13-0804-01A-01W-0372-09
TCGA-13-0805-01	1	TCGA-13-0805-01	1074	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-13-0805	1074	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-13-0805-F24638	Stage IIIC	-21014		1074	0	1073		177				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease																						WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01				13	1-10 mm	Ovary			DECEASED	2005		TCGA-13-0805-01					TCGA-13-0805-01A-01R-0363-07	TCGA-13-0805-01A-01R-1564-13	TCGA-13-0805-01A-01D-0359-05			TCGA-13-0805-01A-01D-0356-01	TCGA-13-0805-01	TCGA-13-0805-01A-01D-0356-01	ca5be9a0-c15f-48c3-aaf0-f55d75a0ebca			ca5be9a0-c15f-48c3-aaf0-f55d75a0ebca					fbd0a639-044c-453b-a29c-3d914f431bd9				
TCGA-13-0807-01	1	TCGA-13-0807-01	414	1	Squamous		OV-like c1					mutation cluster 5	TCGA-13-0807	414	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54		TCGA-13-0807-F24642	Stage IIIC	-19890		414	0	414						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO					G3						100	100			5	10			0	0	20	20	75	70	80	80			YES				NO	R1	Primary Tumor	01				13	>20 mm	Ovary		B	DECEASED	2005		TCGA-13-0807-01		TCGA-13-0807-01B-02W-0421-09					TCGA-13-0807-01B-02D-0402-05			TCGA-13-0807-01B-02D-0399-01	TCGA-13-0807-01	TCGA-13-0807-01B-02D-0399-01	be50c3a9-64cd-4044-a3db-de08e59d9e64			be50c3a9-64cd-4044-a3db-de08e59d9e64			TCGA-13-0807-01B-01R-0406-07		8fee0dca-afdb-46a8-b7b3-e16ed7ba4e32				TCGA-13-0807-01B-02W-0421-09
TCGA-13-0883-01	1	TCGA-13-0883-01	2097	1	Squamous		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0883	2097	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-13-0883-F24646	Stage IIIC	-22395		2097	0	2097		819				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO		1.4			G3	Recurrence				TCGA-13-0883.7AC6471C-1BA0-4AA5-9A2E-70413C9768F8.pdf					2	2			10	20	0	0	88	78	90	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0883-01		TCGA-13-0883-01A-02W-0420-08				TCGA-13-0883-01A-02R-1569-13	TCGA-13-0883-01A-02D-0402-05			TCGA-13-0883-01A-02D-0399-01	TCGA-13-0883-01	TCGA-13-0883-01A-02D-0399-01	ceabd0be-fcb9-4fc3-9817-00452e386182			ceabd0be-fcb9-4fc3-9817-00452e386182		TCGA-13-0883-01A-02R-1569-13	TCGA-13-0883-01A-02R-0406-07		8b92a7da-e2b2-41c4-9ea2-8c3f87c2f5e9		TCGA-13-0883-01A-02R-1569-13	TCGA-13-0883-01A-02W-0420-08	
TCGA-13-0884-01	1	TCGA-13-0884-01	3260	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0884	3260	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	39	Bilateral	TCGA-13-0884-F24651	Stage IIIC	-14538		3260	0	3260		1251				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1.3			G3	Recurrence									1	1			0	0	10	10	89	89	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		B	DECEASED	1999		TCGA-13-0884-01		TCGA-13-0884-01B-01W-0494-09		2185ae8b-2257-4cc5-b08d-cf91dffa760d		TCGA-13-0884-01B-01R-1565-13	TCGA-13-0884-01B-01D-0460-05			TCGA-13-0884-01B-01D-0452-01	TCGA-13-0884-01	TCGA-13-0884-01B-01D-0452-01	7de5c913-6a77-47fc-8cac-af0c89b34e81			7de5c913-6a77-47fc-8cac-af0c89b34e81	TCGA-13-0884-01B-21-1562-20	TCGA-13-0884-01B-01R-1565-13	TCGA-13-0884-01B-01R-0456-07		3b4e9ec5-9001-40af-8397-8802341611ad		TCGA-13-0884-01B-01R-1565-13		TCGA-13-0884-01B-01W-0494-09
TCGA-13-0885-01	0	TCGA-13-0885-01	2780	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0885	2780	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			70	Left	TCGA-13-0885-F24658	Stage IIIC	-25763			0	2780						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	80	1.2			G3					TCGA-13-0885.81DFFD49-45F0-4A20-AC27-B8316B2E0289.pdf		90			2	2			20	19	0	1	78	78	80	80	Pre-Adjuvant Therapy		YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	LIVING	2000		TCGA-13-0885-01		TCGA-13-0885-01A-02W-0421-09				TCGA-13-0885-01A-02R-1569-13	TCGA-13-0885-01A-02D-0402-05			TCGA-13-0885-01A-02D-0399-01	TCGA-13-0885-01	TCGA-13-0885-01A-02D-0399-01	20b9a875-71ea-4849-8942-a9dc2728836d			20b9a875-71ea-4849-8942-a9dc2728836d		TCGA-13-0885-01A-02R-1569-13	TCGA-13-0885-01A-02R-0406-07		22d268ea-7e43-46f4-8d1c-7a557d2f1664		TCGA-13-0885-01A-02R-1569-13		TCGA-13-0885-01A-02W-0421-09
TCGA-13-0886-01	0	TCGA-13-0886-01	2259	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-0886	2259	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-13-0886-F24663	Stage IIIC	-24724			0	2259						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3					TCGA-13-0886.2FB5824C-F30B-4E0B-B787-CBF93A6A48AE.pdf					2	5			30	30	0	0	68	65	70	70		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2002		TCGA-13-0886-01		TCGA-13-0886-01A-01W-0420-08		97f40569-5280-4c67-831d-dc8fa952e0f8		TCGA-13-0886-01A-01R-1569-13	TCGA-13-0886-01A-01D-0402-05			TCGA-13-0886-01A-01D-0399-01	TCGA-13-0886-01	TCGA-13-0886-01A-01D-0399-01	cd9bfbe4-172b-4168-bdfe-636eff1767d0			cd9bfbe4-172b-4168-bdfe-636eff1767d0	TCGA-13-0886-01A-21-20	TCGA-13-0886-01A-01R-1569-13	TCGA-13-0886-01A-01R-0406-07		de22b463-bc0e-4f81-9a06-0e55353b1412		TCGA-13-0886-01A-01R-1569-13	TCGA-13-0886-01A-01W-0420-08	
TCGA-13-0887-01	1	TCGA-13-0887-01	2028	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0887	2028	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	42	Bilateral	TCGA-13-0887-F24668	Stage IIIC	-15669		2028	0	2028		514				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO	80	1.3			G3	Recurrence				TCGA-13-0887.AAEBFF3C-EA12-4D58-A424-2463307484A3.pdf					10	1			5	10	0	0	85	89	95	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2002		TCGA-13-0887-01		TCGA-13-0887-01A-01W-0421-09		0226becf-0ff4-4457-a446-0ed079324b0d		TCGA-13-0887-01A-01R-1564-13	TCGA-13-0887-01A-01D-0402-05			TCGA-13-0887-01A-01D-0399-01	TCGA-13-0887-01	TCGA-13-0887-01A-01D-0399-01	616b58ea-28e5-4d0c-aa5f-0f08a0c587f3			616b58ea-28e5-4d0c-aa5f-0f08a0c587f3	TCGA-13-0887-01A-21-20	TCGA-13-0887-01A-01R-1564-13	TCGA-13-0887-01A-01R-0406-07		3bc498df-2e02-4182-87f5-381fbde2f225		TCGA-13-0887-01A-01R-1564-13		TCGA-13-0887-01A-01W-0421-09
TCGA-13-0888-01	0	TCGA-13-0888-01	2141	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-13-0888	2141	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Right	TCGA-13-0888-F24673	Stage IIIC	-28498			0	2141						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1.2			G3					TCGA-13-0888.DFDEBDE5-C16E-4B29-9986-8EB557648AC5.pdf					15	20			15	15	0	0	70	65	85	85	Pre-Adjuvant Therapy	TUMOR FREE	YES	Partial Remission/Response			NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2003		TCGA-13-0888-01				bb0f85fb-5126-4934-89bc-39e1044dee03		TCGA-13-0888-01A-01R-1564-13	TCGA-13-0888-01A-01D-0402-05			TCGA-13-0888-01A-01D-0399-01	TCGA-13-0888-01	TCGA-13-0888-01A-01D-0399-01	e60603fe-0486-4ab6-8ae2-de80564bd5f3			e60603fe-0486-4ab6-8ae2-de80564bd5f3	TCGA-13-0888-01A-21-20	TCGA-13-0888-01A-01R-1564-13	TCGA-13-0888-01A-01R-0406-07		2b24ddb3-3774-46ac-aa6f-48abfec30a81		TCGA-13-0888-01A-01R-1564-13		
TCGA-13-0889-01	0	TCGA-13-0889-01	1881	0	Squamous		UCEC Serous c4			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0889	1881	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			75	Right	TCGA-13-0889-F24678	Stage IV	-27674			0	1881						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	60	1.5			GX					TCGA-13-0889.262B6A57-D2DF-47E3-BDB2-1FB956D8ABE9.pdf					1	5			20	20	0	0	79	75	80	80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2003	TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01	TCGA-13-0889-01A-01W-0419-10	TCGA-13-0889-01A-01W-0419-10				TCGA-13-0889-01A-01R-1564-13	TCGA-13-0889-01A-01D-0402-05			TCGA-13-0889-01A-01D-0399-01	TCGA-13-0889-01	TCGA-13-0889-01A-01D-0399-01	ee042cbd-47c0-4909-87eb-d168bc10e3f2			ee042cbd-47c0-4909-87eb-d168bc10e3f2			TCGA-13-0889-01A-01R-0406-07		8f64648c-7481-4814-865a-c392da1968bd				
TCGA-13-0890-01	0	TCGA-13-0890-01	2068	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0890	2068	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			56	Bilateral	TCGA-13-0890-F24682	Stage IIIC	-20770			0	2068						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5			G3					TCGA-13-0890.78888517-0ADC-4A78-B7FA-9ACE201795AB.pdf					1	5			20	20	0	0	79	75	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2003		TCGA-13-0890-01		TCGA-13-0890-01A-01W-0421-09	65cc3a15-cfa9-48fb-b9e4-801398b073b8			TCGA-13-0890-01A-01R-1564-13	TCGA-13-0890-01A-01D-0402-05	TCGA-13-0890-01	TCGA-13-0890-01	TCGA-13-0890-01A-01D-0399-01	TCGA-13-0890-01	TCGA-13-0890-01A-01D-0399-01	c34d9a57-203a-4bec-ab64-32e86784a143	65cc3a15-cfa9-48fb-b9e4-801398b073b8	65cc3a15-cfa9-48fb-b9e4-801398b073b8	c34d9a57-203a-4bec-ab64-32e86784a143		TCGA-13-0890-01A-01R-1564-13	TCGA-13-0890-01A-01R-0406-07		9b5c97b8-eba5-431b-96cc-c60f5ee91a62	65cc3a15-cfa9-48fb-b9e4-801398b073b8	TCGA-13-0890-01A-01R-1564-13		TCGA-13-0890-01A-01W-0421-09
TCGA-13-0891-01	0	TCGA-13-0891-01	2099	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-0891	2099	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73	Bilateral	TCGA-13-0891-F24686	Stage IV	-26886			0	2099		762				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO	80	1.4			G3	Recurrence				TCGA-13-0891.7DF79B3C-8CD7-446D-A13A-BBB69DFE2394.pdf					1	1			5	10	0	0	94	89	95	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2003		TCGA-13-0891-01		TCGA-13-0891-01A-01W-0420-08		f305890a-3b48-4e7b-8f31-f2653a5582b8		TCGA-13-0891-01A-01R-1564-13	TCGA-13-0891-01A-01D-0402-05			TCGA-13-0891-01A-01D-0399-01	TCGA-13-0891-01	TCGA-13-0891-01A-01D-0399-01	4ef881f1-e35b-4d60-bf1d-384a637384af			4ef881f1-e35b-4d60-bf1d-384a637384af	TCGA-13-0891-01A-21-20	TCGA-13-0891-01A-01R-1564-13	TCGA-13-0891-01A-01R-0406-07		7d27ea62-19e6-4032-9e7f-799be4d3eaef		TCGA-13-0891-01A-01R-1564-13	TCGA-13-0891-01A-01W-0420-08	
TCGA-13-0893-01	1	TCGA-13-0893-01	1319	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-0893	1319	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-13-0893-F24690	Stage IIIC	-17573		1319	0	1319		461				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.2			G3	Recurrence									1	1			0	0	10	10	89	89	90	90		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	11-20 mm	Ovary		B	DECEASED	2003		TCGA-13-0893-01		TCGA-13-0893-01B-01W-0494-09	2b2d5fc7-b109-4d11-a632-db8016268840			TCGA-13-0893-01B-01R-1565-13	TCGA-13-0893-01B-01D-0460-05	TCGA-13-0893-01	TCGA-13-0893-01	TCGA-13-0893-01B-01D-0452-01	TCGA-13-0893-01	TCGA-13-0893-01B-01D-0452-01	1062384d-2437-4f50-9f5f-ec5630d1b710	2b2d5fc7-b109-4d11-a632-db8016268840	2b2d5fc7-b109-4d11-a632-db8016268840	1062384d-2437-4f50-9f5f-ec5630d1b710		TCGA-13-0893-01B-01R-1565-13	TCGA-13-0893-01B-01R-0456-07		901a306b-6a5b-4f94-aac0-6eb7c767bb2e	2b2d5fc7-b109-4d11-a632-db8016268840	TCGA-13-0893-01B-01R-1565-13		TCGA-13-0893-01B-01W-0494-09
TCGA-13-0894-01	1	TCGA-13-0894-01	1509	1	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0894	1509	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-13-0894-F24695	Stage IIIC	-19466		1509	0	1509		565				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO	80	1.5			G3	Recurrence									1	0			0	0	20	20	79	80	80	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		B	DECEASED	2003				TCGA-13-0894-01B-01W-0494-09		7e63800a-f2db-4a2a-82ab-2867707caf14		TCGA-13-0894-01B-01R-1565-13	TCGA-13-0894-01B-01D-0460-05				TCGA-13-0894-01						TCGA-13-0894-01B-03-1562-20		TCGA-13-0894-01B-01R-0456-07		2f62cd27-7bac-44c6-baa8-7e8593962402				TCGA-13-0894-01B-01W-0494-09
TCGA-13-0897-01	0	TCGA-13-0897-01	1748	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-0897	1748	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Right	TCGA-13-0897-F24700	Stage IIIC	-19894			0	1748		554				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO	80	1.1			G3	Recurrence									2	1			10	10	0	0	88	89	90	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2004		TCGA-13-0897-01		TCGA-13-0897-01A-01W-0421-09	479b74bf-5003-45e1-9505-687146a5fc45	7a6431cb-6461-4534-89e9-fc15b639bfac		TCGA-13-0897-01A-01R-1564-13	TCGA-13-0897-01A-01D-0402-05	TCGA-13-0897-01	TCGA-13-0897-01	TCGA-13-0897-01A-01D-0399-01	TCGA-13-0897-01	TCGA-13-0897-01A-01D-0399-01	00f502c5-55b4-4a1b-987e-263ef1b9c3d6	479b74bf-5003-45e1-9505-687146a5fc45	479b74bf-5003-45e1-9505-687146a5fc45	00f502c5-55b4-4a1b-987e-263ef1b9c3d6	TCGA-13-0897-01A-21-20	TCGA-13-0897-01A-01R-1564-13	TCGA-13-0897-01A-01R-0406-07		5ae3b33e-162f-4784-b007-cce51fdcfa5e	479b74bf-5003-45e1-9505-687146a5fc45	TCGA-13-0897-01A-01R-1564-13		TCGA-13-0897-01A-01W-0421-09
TCGA-13-0899-01	0	TCGA-13-0899-01	1708	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0899	1708	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-13-0899-F24704	Stage IIIC	-22031			0	1708		547				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.6			G3	Recurrence				TCGA-13-0899.AB15D325-CCD6-452F-8662-158E3153AFC4.pdf					1	0			20	20	0	1	79	79	80	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2004		TCGA-13-0899-01		TCGA-13-0899-01A-01W-0420-08	605d0aed-4637-4a09-82dd-eedd1aa76ca0	eacc42b9-bd6e-468c-8560-6d699ae97737		TCGA-13-0899-01A-01R-1564-13	TCGA-13-0899-01A-01D-0402-05	TCGA-13-0899-01	TCGA-13-0899-01	TCGA-13-0899-01A-01D-0399-01	TCGA-13-0899-01	TCGA-13-0899-01A-01D-0399-01	b7573c04-ffcc-4757-833c-afdab85ac718	605d0aed-4637-4a09-82dd-eedd1aa76ca0	605d0aed-4637-4a09-82dd-eedd1aa76ca0	b7573c04-ffcc-4757-833c-afdab85ac718	TCGA-13-0899-01A-21-20	TCGA-13-0899-01A-01R-1564-13	TCGA-13-0899-01A-01R-0406-07		f5878d06-b37c-49fd-8a70-aaaaa270a14c	605d0aed-4637-4a09-82dd-eedd1aa76ca0	TCGA-13-0899-01A-01R-1564-13	TCGA-13-0899-01A-01W-0420-08	
TCGA-13-0900-01	0	TCGA-13-0900-01	1736	0	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 11	TCGA-13-0900	1736	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-13-0900-F24708	Stage IIIC	-21698			0	1736						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO	60	1.5			G3										5	1			0	0	20	15	75	84	80	85	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.1			13		Ovary		B	LIVING	2004	TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01	TCGA-13-0900-01B-01W-0490-10	TCGA-13-0900-01B-01W-0490-10				TCGA-13-0900-01B-01R-1565-13	TCGA-13-0900-01B-01D-0460-05			TCGA-13-0900-01B-01D-0452-01	TCGA-13-0900-01	TCGA-13-0900-01B-01D-0452-01	5aac8bab-59bb-4789-8428-432e23a3d1ce			5aac8bab-59bb-4789-8428-432e23a3d1ce		TCGA-13-0900-01B-01R-1565-13	TCGA-13-0900-01B-01R-0456-07		443f369f-d9cf-433a-a115-7934c20bf98a		TCGA-13-0900-01B-01R-1565-13		
TCGA-13-0901-01	0	TCGA-13-0901-01	589	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 5		TCGA-13-0901	589	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	41	Bilateral	TCGA-13-0901-F24712	Stage IIIC	-15333			0	589		390				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	80	1.3			G3	Recurrence				TCGA-13-0901.5613318C-D3D4-436D-B22F-BE8FC36D9686.pdf																	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2004	TCGA-13-0901-01B-01W-0490-10	TCGA-13-0901-01	TCGA-13-0901-01B-01W-0490-10			0f0ae870-f5a7-4572-998d-d39403507fbe		TCGA-13-0901-01B-01R-1565-13	TCGA-13-0901-01B-01D-0460-05			TCGA-13-0901-01B-01D-0452-01	TCGA-13-0901-01	TCGA-13-0901-01B-01D-0452-01	98468e98-0f7c-42ab-8271-97b2fb98d206			98468e98-0f7c-42ab-8271-97b2fb98d206	TCGA-13-0901-01A-21-20	TCGA-13-0901-01B-01R-1565-13	TCGA-13-0901-01B-01R-0456-07		9a07f778-ddd0-4290-af0b-9cf85da4b123		TCGA-13-0901-01B-01R-1565-13		
TCGA-13-0903-01	0	TCGA-13-0903-01	1441	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0903	1441	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			42	Bilateral	TCGA-13-0903-F24717	Stage IV	-15705			0	1441						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1			G3										15	15			10	10	0	0	75	75	90	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2004		TCGA-13-0903-01		TCGA-13-0903-01A-01W-0421-09		1eb38ad5-a108-4461-8d9c-2246c4e5174c		TCGA-13-0903-01A-01R-1564-13	TCGA-13-0903-01A-01D-0402-05			TCGA-13-0903-01A-01D-0399-01	TCGA-13-0903-01	TCGA-13-0903-01A-01D-0399-01	2430260f-1a0f-477e-83a4-4b18babf2a98			2430260f-1a0f-477e-83a4-4b18babf2a98	TCGA-13-0903-01A-21-20		TCGA-13-0903-01A-01R-0406-07		0931f0af-d4ff-4d49-9671-44f7f972ad49				TCGA-13-0903-01A-01W-0421-09
TCGA-13-0904-01	0	TCGA-13-0904-01	1470	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-13-0904	1470	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Bilateral	TCGA-13-0904-F24723	Stage IIIC	-23278			0	1470		330				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.7	NO	80	1.5			G3	Progression of Disease						50			1	1			10	8	1	1	88	90	89	91	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2004		TCGA-13-0904-01		TCGA-13-0904-01A-02W-0420-08				TCGA-13-0904-01A-02R-1564-13	TCGA-13-0904-01A-02D-0402-05			TCGA-13-0904-01A-02D-0399-01	TCGA-13-0904-01	TCGA-13-0904-01A-02D-0399-01	637af986-3c73-4b1a-927a-d0c6ed7acf56			637af986-3c73-4b1a-927a-d0c6ed7acf56			TCGA-13-0904-01A-02R-0406-07		8db1ce50-4f8c-40a6-a56b-8266f0a16d28			TCGA-13-0904-01A-02W-0420-08	
TCGA-13-0905-01	0	TCGA-13-0905-01	1455	0	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0905	1455	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Left	TCGA-13-0905-F24729	Stage IIIC	-18757			0	1455						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	80	1.2			G3										1	1			0	0	5	5	94	94	95	95	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13		Ovary		B	LIVING	2005		TCGA-13-0905-01		TCGA-13-0905-01B-01W-0492-08				TCGA-13-0905-01B-01R-1565-13	TCGA-13-0905-01B-01D-0460-05			TCGA-13-0905-01B-01D-0452-01	TCGA-13-0905-01	TCGA-13-0905-01B-01D-0452-01	8f5395db-eecc-4317-8f7a-eb7b73388676			8f5395db-eecc-4317-8f7a-eb7b73388676		TCGA-13-0905-01B-01R-1565-13	TCGA-13-0905-01B-01R-0456-07		05762312-1eb7-48bd-b497-97e2f94a86ff		TCGA-13-0905-01B-01R-1565-13	TCGA-13-0905-01B-01W-0492-08	
TCGA-13-0906-01	0	TCGA-13-0906-01	1367	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-0906	1367	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Bilateral	TCGA-13-0906-F24734	Stage IIIC	-18383			0	1367						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	60	1.1			G3										20	20			19	30	0	0	60	50	80	70	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2005	TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01	TCGA-13-0906-01A-01W-0419-10	TCGA-13-0906-01A-01W-0419-10		80aaf315-cf54-47e5-b82a-1343e25938ca		TCGA-13-0906-01A-01R-1564-13	TCGA-13-0906-01A-01D-0402-05			TCGA-13-0906-01A-01D-0399-01	TCGA-13-0906-01	TCGA-13-0906-01A-01D-0399-01	4e94ed63-34bb-45d8-9db6-6ed589f9585c			4e94ed63-34bb-45d8-9db6-6ed589f9585c	TCGA-13-0906-01A-21-20	TCGA-13-0906-01A-01R-1564-13	TCGA-13-0906-01A-01R-0406-07		8cba78d8-365d-4f21-9024-b1c65e7aebd9		TCGA-13-0906-01A-01R-1564-13		
TCGA-13-0908-01	0	TCGA-13-0908-01	1364	0	Squamous		OV-like c1			miRNA cluster 2	cluster 6		TCGA-13-0908	1364	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-13-0908-F24739	Stage IV	-21422			0	1364		552				2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.4			G3	Recurrence									0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		B	LIVING	2005		TCGA-13-0908-01						TCGA-13-0908-01B-01R-1565-13	TCGA-13-0908-01B-01D-0460-05			TCGA-13-0908-01B-01D-0452-01	TCGA-13-0908-01	TCGA-13-0908-01B-01D-0452-01	2a426242-071d-4ac0-b8d4-a01ee8aa11d2			2a426242-071d-4ac0-b8d4-a01ee8aa11d2		TCGA-13-0908-01B-01R-1565-13	TCGA-13-0908-01B-01R-0456-07		1a0d9712-cc09-46fa-a588-2d9db23c751b		TCGA-13-0908-01B-01R-1565-13		
TCGA-13-0910-01	0	TCGA-13-0910-01	1128	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0910	1128	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-13-0910-F24744	Stage IIIC	-21473			0	1128						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	60	1.2			G3						90	90			0	0			0	0	10	10	90	90	95	95	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2005		TCGA-13-0910-01		TCGA-13-0910-01A-01W-0421-09		a7d2bac8-709d-455d-8613-e87b8fd8fe19		TCGA-13-0910-01A-01R-1564-13	TCGA-13-0910-01A-01D-0402-05			TCGA-13-0910-01A-01D-0399-01	TCGA-13-0910-01	TCGA-13-0910-01A-01D-0399-01	72c6537f-1ae7-47d8-8b7c-43d393dffd3c			72c6537f-1ae7-47d8-8b7c-43d393dffd3c	TCGA-13-0910-01A-21-20		TCGA-13-0910-01A-01R-0406-07		c86a6b6b-046a-46c9-a89d-d365adafedd7				TCGA-13-0910-01A-01W-0421-09
TCGA-13-0911-01	0	TCGA-13-0911-01	843	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0911	843	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-13-0911-F24749	Stage IV	-20276			0	843		279				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	1.5			G3	Progression of Disease				TCGA-13-0911.0DE80BC5-8AA8-423A-B99B-9CD9883F27C2.pdf	10	100			9	5			0	0	1	20	90	75	99	85	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Molecular Marker(S)	NO	R1	Primary Tumor	01	0.8			13	1-10 mm	Ovary		A	LIVING	2005		TCGA-13-0911-01		TCGA-13-0911-01A-01W-0420-08		c2fbc465-c862-412d-8966-d88e0e414316		TCGA-13-0911-01A-01R-1564-13	TCGA-13-0911-01A-01D-0402-05			TCGA-13-0911-01A-01D-0399-01	TCGA-13-0911-01	TCGA-13-0911-01A-01D-0399-01	b0fb393b-8bbd-4af4-97bd-fb5bc61b1edf			b0fb393b-8bbd-4af4-97bd-fb5bc61b1edf	TCGA-13-0911-01A-21-20	TCGA-13-0911-01A-01R-1564-13	TCGA-13-0911-01A-01R-0406-07		68069103-49df-4246-8858-31d6b3571145		TCGA-13-0911-01A-01R-1564-13	TCGA-13-0911-01A-01W-0420-08	
TCGA-13-0912-01	0	TCGA-13-0912-01	1036	0	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0912	1036	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-13-0912-F24753	Stage IIIC	-21427			0	1036		469				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO	80	1.2			G3	Recurrence						100			1	2			10	0	0	8	89	90	90	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-13-0912-01		TCGA-13-0912-01A-01W-0421-09				TCGA-13-0912-01A-01R-1564-13	TCGA-13-0912-01A-01D-0402-05			TCGA-13-0912-01A-01D-0399-01	TCGA-13-0912-01	TCGA-13-0912-01A-01D-0399-01	475be2f7-8c12-45c1-9aa4-c94758d0a5cb			475be2f7-8c12-45c1-9aa4-c94758d0a5cb			TCGA-13-0912-01A-01R-0406-07		1daa5008-c4db-41ea-8e40-e551632f8bec				TCGA-13-0912-01A-01W-0421-09
TCGA-13-0913-01	0	TCGA-13-0913-01	912	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0913	912	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-13-0913-F24758	Stage IIIC	-19573			0	912		871				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.3			G3	Recurrence					100	100			0	1			0	0	25	4	75	95	85	99	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-13-0913-01		TCGA-13-0913-01A-01W-0420-08	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	8887c7f4-1bc4-4ec6-874f-453c17e1646e		TCGA-13-0913-01A-01R-1564-13	TCGA-13-0913-01A-01D-0402-05	TCGA-13-0913-01	TCGA-13-0913-01	TCGA-13-0913-01A-01D-0399-01	TCGA-13-0913-01	TCGA-13-0913-01A-01D-0399-01	055ce18b-41ec-4faf-baa4-863faef9be68	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	055ce18b-41ec-4faf-baa4-863faef9be68	TCGA-13-0913-01A-21-20	TCGA-13-0913-01A-01R-1564-13	TCGA-13-0913-01A-01R-0406-07		e993c6b2-05c7-4404-b8d8-a4e3ce8a8253	cdaf98b1-fdb5-4575-aa17-e2d2ccba31f9	TCGA-13-0913-01A-01R-1564-13	TCGA-13-0913-01A-01W-0420-08	
TCGA-13-0913-02	0	TCGA-13-0913-02	912	0		C9-OV	OV-like c1			miRNA cluster 2		mutation cluster 5	TCGA-13-0913	912	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-13-0913-F24758	Stage IIIC	-19573			0	912		871				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	80	1.4			G3	Recurrence									10	10			0	0	20	20	70	70	70	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2006								TCGA-13-0913-02A-01R-1564-13	TCGA-13-0913-02A-01D-0807-05						a03cdd75-db90-4a09-9eb4-23f2b95b0790			a03cdd75-db90-4a09-9eb4-23f2b95b0790		TCGA-13-0913-02A-01R-1564-13	TCGA-13-0913-02A-01R-0810-07		b9367a1a-2b4b-4beb-a02f-743f826bf85d		TCGA-13-0913-02A-01R-1564-13		
TCGA-13-0916-01	0	TCGA-13-0916-01	644	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0916	644	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-13-0916-F24765	Stage IIIC	-18189			0	644						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3										0	0			0	0	5	5	95	95	98	98		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			13	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-13-0916-01		TCGA-13-0916-01A-01W-0420-08	63c52e46-68cf-4dac-9bd7-37081daa4474	3a88bad5-3325-409f-8023-5e2df3ba1bf4		TCGA-13-0916-01A-01R-1564-13	TCGA-13-0916-01A-01D-0402-05	TCGA-13-0916-01	TCGA-13-0916-01	TCGA-13-0916-01A-01D-0399-01	TCGA-13-0916-01	TCGA-13-0916-01A-01D-0399-01	75cbdc12-abdd-44a0-ac21-0ad30e6c5628	63c52e46-68cf-4dac-9bd7-37081daa4474	63c52e46-68cf-4dac-9bd7-37081daa4474	75cbdc12-abdd-44a0-ac21-0ad30e6c5628	TCGA-13-0916-01A-21-20	TCGA-13-0916-01A-01R-1564-13	TCGA-13-0916-01A-01R-0406-07		468b249e-69a0-4728-a0a3-cbe7fad18499	63c52e46-68cf-4dac-9bd7-37081daa4474	TCGA-13-0916-01A-01R-1564-13	TCGA-13-0916-01A-01W-0420-08	
TCGA-13-0919-01	0	TCGA-13-0919-01	453	0	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-0919	453	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-13-0919-F24771	Stage IIIC	-19337			0	453						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection				80				G3																						Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				13	No Macroscopic disease	Ovary			LIVING	2007	TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01	TCGA-13-0919-01A-01W-0419-10	TCGA-13-0919-01A-01W-0419-10				TCGA-13-0919-01A-01R-1564-13	TCGA-13-0919-01A-01D-0402-05			TCGA-13-0919-01A-01D-0399-01	TCGA-13-0919-01	TCGA-13-0919-01A-01D-0399-01	e67b753d-1406-4186-b8ec-75ea0f01ab93			e67b753d-1406-4186-b8ec-75ea0f01ab93		TCGA-13-0919-01A-01R-1564-13	TCGA-13-0919-01A-01R-0406-07		f00f1225-2b6a-4d61-a3e1-909fd595b624		TCGA-13-0919-01A-01R-1564-13		
TCGA-13-0920-01	0	TCGA-13-0920-01	420	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-0920	420	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-13-0920-F24775	Stage IIIC	-24064			0	420		297				2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3	Recurrence									0	0			0	0	20	20	80	80	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2007		TCGA-13-0920-01		TCGA-13-0920-01A-01W-0421-09	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	1aaaee17-5206-42cc-b678-f4a4e712ae54		TCGA-13-0920-01A-01R-1564-13	TCGA-13-0920-01A-01D-0402-05	TCGA-13-0920-01	TCGA-13-0920-01	TCGA-13-0920-01A-01D-0399-01	TCGA-13-0920-01	TCGA-13-0920-01A-01D-0399-01	a2f4000b-1021-4696-8f3c-ed7de514cb2f	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	a2f4000b-1021-4696-8f3c-ed7de514cb2f	TCGA-13-0920-01A-21-20	TCGA-13-0920-01A-01R-1564-13	TCGA-13-0920-01A-01R-0406-07		f109f013-990a-4e2d-9bce-b3dce60e5b0f	2d8e1b4d-85d0-4bfd-99f7-59559dabe978	TCGA-13-0920-01A-01R-1564-13		TCGA-13-0920-01A-01W-0421-09
TCGA-13-0921-01	0	TCGA-13-0921-01	141	0	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 3		TCGA-13-0921	141	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			72	Bilateral	TCGA-13-0921-F24778	Stage IIIC	-26606			0	141						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3										0	0			0	0	15	5	85	95	90	98		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-0921-01				56e2b31e-e133-45fa-a38c-9f1c8825194c		TCGA-13-0921-01A-01R-1564-13	TCGA-13-0921-01A-01D-0402-05			TCGA-13-0921-01A-01D-0399-01	TCGA-13-0921-01	TCGA-13-0921-01A-01D-0399-01	bf96a59e-7403-42f6-99b2-e56a1010cdc7			bf96a59e-7403-42f6-99b2-e56a1010cdc7	TCGA-13-0921-01A-21-20		TCGA-13-0921-01A-01R-0406-07		d4b09b28-c890-406a-97d4-3354bb5484c6				
TCGA-13-0923-01	0	TCGA-13-0923-01	195	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0923	195	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Right	TCGA-13-0923-F24782	Stage IIIC	-27081			0	195						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO					G3					TCGA-13-0923.06AB5B8C-7B57-43B0-8376-7A05C58AFC1A.pdf					5	5			0	0	25	10	70	85	85	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-0923-01		TCGA-13-0923-01A-01W-0420-08				TCGA-13-0923-01A-01R-1564-13	TCGA-13-0923-01A-01D-0402-05			TCGA-13-0923-01A-01D-0399-01	TCGA-13-0923-01	TCGA-13-0923-01A-01D-0399-01	ea9edd51-f159-4f8d-8d59-3a6256dd4e33			ea9edd51-f159-4f8d-8d59-3a6256dd4e33		TCGA-13-0923-01A-01R-1564-13	TCGA-13-0923-01A-01R-0406-07		5e88feda-6485-4934-9c79-2c5c88e908de		TCGA-13-0923-01A-01R-1564-13	TCGA-13-0923-01A-01W-0420-08	
TCGA-13-0924-01	0	TCGA-13-0924-01	185	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-0924	185	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-13-0924-F24787	Stage IV	-16670			0	185						2009-2-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)			NO					G3										0	0			0	0	35	25	65	75	70	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-0924-01		TCGA-13-0924-01A-01W-0421-09	85a4c41b-9829-48f8-9c7a-a9de870332b6			TCGA-13-0924-01A-01R-1564-13	TCGA-13-0924-01A-01D-0402-05	TCGA-13-0924-01	TCGA-13-0924-01	TCGA-13-0924-01A-01D-0399-01	TCGA-13-0924-01	TCGA-13-0924-01A-01D-0399-01	6f7cae3d-aa66-4b4e-8e4d-78378952f19e	85a4c41b-9829-48f8-9c7a-a9de870332b6	85a4c41b-9829-48f8-9c7a-a9de870332b6	6f7cae3d-aa66-4b4e-8e4d-78378952f19e		TCGA-13-0924-01A-01R-1564-13	TCGA-13-0924-01A-01R-0406-07		b0dae9c4-1401-4b88-94cb-bef931901b94	85a4c41b-9829-48f8-9c7a-a9de870332b6	TCGA-13-0924-01A-01R-1564-13		TCGA-13-0924-01A-01W-0421-09
TCGA-13-1403-01	0	TCGA-13-1403-01	331	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1403	331	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Left	TCGA-13-1403-F24793	Stage IIIC	-17697			0	331						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.2			G3					TCGA-13-1403.435619AB-01F5-4AC3-8D28-A8CC0054699F.pdf					1	5			0	0	5	10	94	85	95	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13		Ovary		A	LIVING	2008		TCGA-13-1403-01		TCGA-13-1403-01A-01W-0494-09	3217dd54-d41c-4c63-8bab-ff2c4baaee10			TCGA-13-1403-01A-01R-1565-13	TCGA-13-1403-01A-01D-0460-05	TCGA-13-1403-01	TCGA-13-1403-01	TCGA-13-1403-01A-01D-0452-01	TCGA-13-1403-01	TCGA-13-1403-01A-01D-0452-01	78a6bb48-90a5-4353-8a06-49c2975760a0	3217dd54-d41c-4c63-8bab-ff2c4baaee10	3217dd54-d41c-4c63-8bab-ff2c4baaee10	78a6bb48-90a5-4353-8a06-49c2975760a0		TCGA-13-1403-01A-01R-1565-13	TCGA-13-1403-01A-01R-0456-07		88424970-6ba5-4c0f-ac01-f06513be5b42	3217dd54-d41c-4c63-8bab-ff2c4baaee10	TCGA-13-1403-01A-01R-1565-13		TCGA-13-1403-01A-01W-0494-09
TCGA-13-1404-01	0	TCGA-13-1404-01	201	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1404	201	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Bilateral	TCGA-13-1404-F24798	Stage IIIC	-17784			0	201						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	60	1.5			G3					TCGA-13-1404.39B73962-A374-4521-BFBB-F10D117979F9.pdf					1	5			0	0	20	20	79	75	80	80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1404-01		TCGA-13-1404-01A-01W-0494-09		b9dd3b0f-e45a-400a-8078-5d421d257726		TCGA-13-1404-01A-01R-1565-13	TCGA-13-1404-01A-01D-0460-05			TCGA-13-1404-01A-01D-0452-01	TCGA-13-1404-01	TCGA-13-1404-01A-01D-0452-01	358465d0-302b-4c00-bf6a-bf7fe703ed3f			358465d0-302b-4c00-bf6a-bf7fe703ed3f	TCGA-13-1404-01A-21-1562-20	TCGA-13-1404-01A-01R-1565-13	TCGA-13-1404-01A-01R-0456-07		454548ae-a10c-4811-a88b-5e893ffe1caa		TCGA-13-1404-01A-01R-1565-13		TCGA-13-1404-01A-01W-0494-09
TCGA-13-1405-01	0	TCGA-13-1405-01	224	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1405	224	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-13-1405-F24803	Stage IV	-18218			0	224						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO	80	1.3			G3					TCGA-13-1405.DFB9F8B2-986C-4963-B2D2-837E54174CF0.pdf					1	1			0	0	15	15	84	84	85	85	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1405-01		TCGA-13-1405-01A-01W-0494-09	044d949f-0eb4-44c9-8327-90226936fc7c	79cd114a-31d2-468d-92e6-5ea925e61918		TCGA-13-1405-01A-01R-1565-13	TCGA-13-1405-01A-01D-0460-05	TCGA-13-1405-01	TCGA-13-1405-01	TCGA-13-1405-01A-01D-0452-01	TCGA-13-1405-01	TCGA-13-1405-01A-01D-0452-01	ca2c5fe5-72fc-4cb1-b26c-708e72bf03a0	044d949f-0eb4-44c9-8327-90226936fc7c	044d949f-0eb4-44c9-8327-90226936fc7c	ca2c5fe5-72fc-4cb1-b26c-708e72bf03a0	TCGA-13-1405-01A-21-1562-20	TCGA-13-1405-01A-01R-1565-13	TCGA-13-1405-01A-01R-0456-07		04d8cf12-0689-4e2d-a8e9-771920563560	044d949f-0eb4-44c9-8327-90226936fc7c	TCGA-13-1405-01A-01R-1565-13		TCGA-13-1405-01A-01W-0494-09
TCGA-13-1407-01	0	TCGA-13-1407-01	184	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-13-1407	184	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-13-1407-F24807	Stage IIIC	-18896			0	184						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1.5			G3										0	0			0	0	5	5	95	95	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13		Ovary		A	LIVING	2008	TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01	TCGA-13-1407-01A-01W-0490-10	TCGA-13-1407-01A-01W-0490-10				TCGA-13-1407-01A-01R-1565-13	TCGA-13-1407-01A-01D-0460-05			TCGA-13-1407-01A-01D-0452-01	TCGA-13-1407-01	TCGA-13-1407-01A-01D-0452-01	1ff55131-13df-46a0-b7c1-e885389eff3b			1ff55131-13df-46a0-b7c1-e885389eff3b		TCGA-13-1407-01A-01R-1565-13	TCGA-13-1407-01A-01R-0456-07		ba5b2281-2b96-47e8-92b9-0221c434b4e9		TCGA-13-1407-01A-01R-1565-13		
TCGA-13-1408-01	0	TCGA-13-1408-01	180	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 14	TCGA-13-1408	180	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59		TCGA-13-1408-F24811	Stage IIIC	-21635			0	180						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G3					TCGA-13-1408.39435FCB-699F-4A2F-9005-E67C9A41C766.pdf					1	0			0	0	20	20	79	80	80	80		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	LIVING	2008	TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01	TCGA-13-1408-01A-01W-0490-10	TCGA-13-1408-01A-01W-0490-10		c9dc89ec-e887-4acc-90a5-6fd20f4a1483		TCGA-13-1408-01A-01R-1565-13	TCGA-13-1408-01A-01D-0460-05			TCGA-13-1408-01A-01D-0452-01	TCGA-13-1408-01	TCGA-13-1408-01A-01D-0452-01	fb4e1a8b-c686-4c4e-966c-8659c4f91852			fb4e1a8b-c686-4c4e-966c-8659c4f91852	TCGA-13-1408-01A-21-1562-20	TCGA-13-1408-01A-01R-1565-13	TCGA-13-1408-01A-01R-0456-07		3f056922-bdb4-4a8f-8a4d-9116cae32ae8		TCGA-13-1408-01A-01R-1565-13		
TCGA-13-1409-01	0	TCGA-13-1409-01	208	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1409	208	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73		TCGA-13-1409-F24818	Stage IIIC	-26836			0	208						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1	NO	60	1.6			G3										5	5			0	0	10	20	85	75	90	80	Pre-Adjuvant Therapy	WITH TUMOR	YES				NO		Primary Tumor	01	0.6			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1409-01		TCGA-13-1409-01A-01W-0492-08		8c0c5cc9-dbb0-49ed-96c4-7fde7d37fd25		TCGA-13-1409-01A-01R-1565-13	TCGA-13-1409-01A-01D-0460-05			TCGA-13-1409-01A-01D-0452-01	TCGA-13-1409-01	TCGA-13-1409-01A-01D-0452-01	e1e81ff9-3bdc-4ddb-81d0-dc524d0ef79d			e1e81ff9-3bdc-4ddb-81d0-dc524d0ef79d	TCGA-13-1409-01A-21-20	TCGA-13-1409-01A-01R-1565-13	TCGA-13-1409-01A-01R-0456-07		c4293c0c-8d5d-40b4-9f84-42633383f950		TCGA-13-1409-01A-01R-1565-13	TCGA-13-1409-01A-01W-0492-08	
TCGA-13-1410-01	0	TCGA-13-1410-01	143	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1410	143	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Bilateral	TCGA-13-1410-F24822	Stage IV	-20950			0	143						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO	60	1.9			GX					TCGA-13-1410.0F641D88-673B-48C4-97F5-730DA3FD343C.pdf					1	0			0	0	5	5	94	95	95	95	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			13		Ovary		A	LIVING	2008		TCGA-13-1410-01		TCGA-13-1410-01A-01W-0492-08	fdda1428-ad6b-4337-a959-83bae1f9664b	3f2151ce-1e04-4a0e-8ded-e59696b705cb		TCGA-13-1410-01A-01R-1565-13	TCGA-13-1410-01A-01D-0460-05	TCGA-13-1410-01	TCGA-13-1410-01	TCGA-13-1410-01A-01D-0452-01	TCGA-13-1410-01	TCGA-13-1410-01A-01D-0452-01	e52a7802-fd03-4d83-b0ec-b06cd7a1aedc	fdda1428-ad6b-4337-a959-83bae1f9664b	fdda1428-ad6b-4337-a959-83bae1f9664b	e52a7802-fd03-4d83-b0ec-b06cd7a1aedc	TCGA-13-1410-01A-21-20	TCGA-13-1410-01A-01R-1565-13	TCGA-13-1410-01A-01R-0456-07		e8da901b-05d8-4448-8e0c-52c558fe2ea8	fdda1428-ad6b-4337-a959-83bae1f9664b	TCGA-13-1410-01A-01R-1565-13	TCGA-13-1410-01A-01W-0492-08	
TCGA-13-1411-01	0	TCGA-13-1411-01	128	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-1411	128	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			81		TCGA-13-1411-F24828	Stage IIIC	-29874			0	128						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		1.7			G3					TCGA-13-1411.F73F2D6F-3FD9-4457-921A-9EE0E47A6470.pdf					0	1			0	0	10	10	90	89	90	90		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	LIVING	2008		TCGA-13-1411-01		TCGA-13-1411-01A-01W-0494-09		438d9016-0b99-46f7-b8ad-21c125f4bedd		TCGA-13-1411-01A-01R-1565-13	TCGA-13-1411-01A-01D-0460-05			TCGA-13-1411-01A-01D-0452-01	TCGA-13-1411-01	TCGA-13-1411-01A-01D-0452-01	46625639-1e23-44ed-8180-b609dc357e71			46625639-1e23-44ed-8180-b609dc357e71	TCGA-13-1411-01A-21-20	TCGA-13-1411-01A-01R-1565-13	TCGA-13-1411-01A-01R-0456-07		88a02ee5-0e09-4181-ad62-88ec7f877f45		TCGA-13-1411-01A-01R-1565-13		TCGA-13-1411-01A-01W-0494-09
TCGA-13-1412-01	0	TCGA-13-1412-01	162	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1412	162	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			41	Bilateral	TCGA-13-1412-F24832	Stage IV	-15119			0	162						2009-3-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.1			G3										1	1			0	0	10	10	89	89	90	90	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1412-01		TCGA-13-1412-01A-01W-0494-09		b22eb00b-8fcc-4fd5-b396-1169f7f025fd		TCGA-13-1412-01A-01R-1565-13	TCGA-13-1412-01A-01D-0460-05			TCGA-13-1412-01A-01D-0452-01	TCGA-13-1412-01	TCGA-13-1412-01A-01D-0452-01	5b959054-e2d3-415a-98c1-123174cb3733			5b959054-e2d3-415a-98c1-123174cb3733	TCGA-13-1412-01A-21-20		TCGA-13-1412-01A-01R-0456-07		54620fb3-d7d9-4d00-a77b-4d8dcfee4d55				TCGA-13-1412-01A-01W-0494-09
TCGA-13-1477-01	1	TCGA-13-1477-01	1662	1	Iq	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-13-1477	1662	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	49	Bilateral	TCGA-13-1477-F24839	Stage IV	-18111		1662	0	1662		235				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1.3	NO		1.3			G2	Progression of Disease				TCGA-13-1477.2507FA0F-9709-4B5D-9EC1-907637FB373A.pdf					0	5			0	0	20	15	80	80	70	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2000		TCGA-13-1477-01		TCGA-13-1477-01A-01D-0472-08		fa473bf9-b927-4d17-ac77-ad0e52f01cac		TCGA-13-1477-01A-01R-1565-13	TCGA-13-1477-01A-01D-0475-05			TCGA-13-1477-01A-01D-0472-01	TCGA-13-1477-01	TCGA-13-1477-01A-01D-0472-01	05a360b5-04ea-4f1b-be78-86470c58cb80			05a360b5-04ea-4f1b-be78-86470c58cb80	TCGA-13-1477-01A-21-1562-20	TCGA-13-1477-01A-01R-1565-13	TCGA-13-1477-01A-01R-0479-07		7bc1d947-f625-418c-b577-c66aea3e33c4		TCGA-13-1477-01A-01R-1565-13	TCGA-13-1477-01A-01D-0472-08	
TCGA-13-1479-01		TCGA-13-1479-01											TCGA-13-1479		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																																																																																			TCGA-13-1479-01A-01D-0475-05												TCGA-13-1479-01A-01R-0479-07						
TCGA-13-1481-01	1	TCGA-13-1481-01	2648	1	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1481	2648	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			76	Right	TCGA-13-1481-F24843	Stage IIIC	-27898		2648	0	2648						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.4			G2					TCGA-13-1481.4832CBA4-9482-4A2A-A9E1-4E8489B0F157.pdf	60	60	10	10	0	3	30	30	0	0	40	17	60	80	70	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	DECEASED	2000		TCGA-13-1481-01		TCGA-13-1481-01A-01W-0549-09	761f9668-304f-4e22-87cd-2005aa86152c	8b7b0f6e-4f3b-40f2-8ca0-7de1000f473a		TCGA-13-1481-01A-01R-1565-13	TCGA-13-1481-01A-01D-0475-05	TCGA-13-1481-01	TCGA-13-1481-01	TCGA-13-1481-01A-01D-0472-01	TCGA-13-1481-01	TCGA-13-1481-01A-01D-0472-01	69a7fc68-d6f9-4804-87d1-693346e176e8	761f9668-304f-4e22-87cd-2005aa86152c	761f9668-304f-4e22-87cd-2005aa86152c	69a7fc68-d6f9-4804-87d1-693346e176e8	TCGA-13-1481-01A-21-1562-20	TCGA-13-1481-01A-01R-1565-13	TCGA-13-1481-01A-01R-0479-07		2b0cdd7b-9556-4bd5-bf80-1daa495b38e3	761f9668-304f-4e22-87cd-2005aa86152c	TCGA-13-1481-01A-01R-1565-13		TCGA-13-1481-01A-01W-0549-09
TCGA-13-1482-01	1	TCGA-13-1482-01	1877	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1482	1877	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	52		TCGA-13-1482-F24848	Stage IV	-19178		1877	0	1877		602				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO	80	1.3			G2	Recurrence				TCGA-13-1482.58881EFF-AD88-4A0D-BC66-31E2B04D4B8C.pdf	65	65	5	5	0	0	30	30	0	0	20	15	80	85	85	90	Pre-Operative	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2000		TCGA-13-1482-01		TCGA-13-1482-01A-01W-0549-09		db641a43-1973-4213-a4ed-42fa9ff8e8ec		TCGA-13-1482-01A-01R-1565-13	TCGA-13-1482-01A-01D-0475-05			TCGA-13-1482-01A-01D-0472-01	TCGA-13-1482-01	TCGA-13-1482-01A-01D-0472-01	576a7db4-0c37-4d05-a4ed-cee6c88bc73c			576a7db4-0c37-4d05-a4ed-cee6c88bc73c	TCGA-13-1482-01A-21-1562-20	TCGA-13-1482-01A-01R-1565-13	TCGA-13-1482-01A-01R-0479-07		c2b1ef9b-a1b3-4fe9-b35f-841893a6092d		TCGA-13-1482-01A-01R-1565-13		TCGA-13-1482-01A-01W-0549-09
TCGA-13-1483-01	1	TCGA-13-1483-01	895	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1483	895	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61		TCGA-13-1483-F24852	Stage IIIC	-22342		895	0	895		297				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1.4	NO	60	1.8			G3	Recurrence				TCGA-13-1483.c5f81fb7-5cdc-4c0a-8d5a-74e93a11b7db.pdf	40	40	10	10	5	10	50	50	0	0	45	40	50	50	75	70	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2000		TCGA-13-1483-01		TCGA-13-1483-01A-01W-0549-09		3ab7ed23-61b4-4c74-8668-25b7ee186bf7		TCGA-13-1483-01A-01R-1565-13	TCGA-13-1483-01A-01D-0475-05			TCGA-13-1483-01A-01D-0472-01	TCGA-13-1483-01	TCGA-13-1483-01A-01D-0472-01	47e05fb0-cbc1-4edd-a8d6-ae4a20ceb7c2			47e05fb0-cbc1-4edd-a8d6-ae4a20ceb7c2	TCGA-13-1483-01A-21-1562-20	TCGA-13-1483-01A-01R-1565-13	TCGA-13-1483-01A-01R-0479-07		ba90cac1-6c52-4111-99f5-8cb3cb11faeb		TCGA-13-1483-01A-01R-1565-13		TCGA-13-1483-01A-01W-0549-09
TCGA-13-1484-01	0	TCGA-13-1484-01	2982	0	High	C9-OV	OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-13-1484	2982	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62		TCGA-13-1484-F24857	Stage IIIC	-22698			0	2982		497				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.6	NO	80	1.5			G3	Recurrence				TCGA-13-1484.CF223E16-1613-4FAB-A4DA-86D5ECE7B55E.pdf	60	60	10	10	0	2	20	20	0	0	5	3	95	95	95	98	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13		Ovary		A	LIVING	2000		TCGA-13-1484-01		TCGA-13-1484-01A-01W-0545-08		d48335c8-f1dd-472d-a4d6-6ad7eb5d081d		TCGA-13-1484-01A-01R-1565-13	TCGA-13-1484-01A-01D-0475-05			TCGA-13-1484-01A-01D-0472-01	TCGA-13-1484-01	TCGA-13-1484-01A-01D-0472-01	033073bd-6724-4b79-acd4-74aac34436c3			033073bd-6724-4b79-acd4-74aac34436c3	TCGA-13-1484-01A-21-1562-20		TCGA-13-1484-01A-01R-0479-07		53f117b0-5e33-4abf-9720-e3358f62ed9a			TCGA-13-1484-01A-01W-0545-08	
TCGA-13-1485-01	1	TCGA-13-1485-01	629	1	High		OV-like c1			miRNA cluster 3	cluster 6		TCGA-13-1485	629	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-13-1485-F24861	Stage IV	-17642		629	0	629		170				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1.1	NO	80	1.6			G2	Progression of Disease				TCGA-13-1485.5ABB28A5-1BF3-4E90-AD3B-3692893C8686.pdf					0	0			0	0	30	30	70	70	80	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	DECEASED	2001		TCGA-13-1485-01						TCGA-13-1485-01A-02R-1565-13	TCGA-13-1485-01A-02D-0475-05			TCGA-13-1485-01A-02D-0472-01	TCGA-13-1485-01	TCGA-13-1485-01A-02D-0472-01	04cab715-bbc8-48ab-b059-1ebcf740e3c3			04cab715-bbc8-48ab-b059-1ebcf740e3c3		TCGA-13-1485-01A-02R-1565-13	TCGA-13-1485-01A-02R-0479-07		a1378617-e3ff-4bfa-adef-03e4c07512fa		TCGA-13-1485-01A-02R-1565-13		
TCGA-13-1487-01	1	TCGA-13-1487-01	681	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1487	681	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74		TCGA-13-1487-F24865	Stage IV	-27176		681	0	681		412				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4			GX	Recurrence				TCGA-13-1487.30C193A0-7AB5-445D-AD37-3661A89DC06A.pdf					0	5			0	0	30	15	70	80	80	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.4			13		Ovary		A	DECEASED	2002		TCGA-13-1487-01		TCGA-13-1487-01A-01D-0472-08		f10389e0-3564-4067-b82a-d0be5d5eec92		TCGA-13-1487-01A-01R-1565-13	TCGA-13-1487-01A-01D-0475-05			TCGA-13-1487-01A-01D-0472-01	TCGA-13-1487-01	TCGA-13-1487-01A-01D-0472-01	97311d8d-2d1e-4076-8e65-0039a0b7d473			97311d8d-2d1e-4076-8e65-0039a0b7d473	TCGA-13-1487-01A-21-1562-20	TCGA-13-1487-01A-01R-1565-13	TCGA-13-1487-01A-01R-0479-07		a7c48735-a4be-424a-a3cd-125cf2e2a274		TCGA-13-1487-01A-01R-1565-13	TCGA-13-1487-01A-01D-0472-08	
TCGA-13-1488-01	1	TCGA-13-1488-01	2154	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1488	2154	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-13-1488-F24871	Stage IV	-21726		2154	0	2154		351				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	2.3			G3	Recurrence				TCGA-13-1488.79A91E41-0B59-4328-B7BB-2B4EEAD46A89.pdf		95			0	5		5	0	0	30	15	70	80	85	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	DECEASED	2002		TCGA-13-1488-01		TCGA-13-1488-01A-01W-0549-09		1ec3bf38-f06e-4789-a298-cde202cf3649		TCGA-13-1488-01A-01R-1565-13	TCGA-13-1488-01A-01D-0475-05			TCGA-13-1488-01A-01D-0472-01	TCGA-13-1488-01	TCGA-13-1488-01A-01D-0472-01	42496ce6-0aae-4ae4-a70b-6f339b5b7e62			42496ce6-0aae-4ae4-a70b-6f339b5b7e62	TCGA-13-1488-01A-21-1562-20	TCGA-13-1488-01A-01R-1565-13	TCGA-13-1488-01A-01R-0479-07		6b1d30b6-321c-4d55-bf9f-dfb4be92210b		TCGA-13-1488-01A-01R-1565-13		TCGA-13-1488-01A-01W-0549-09
TCGA-13-1489-01	0	TCGA-13-1489-01	2521	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-13-1489	2521	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Bilateral	TCGA-13-1489-F24875	Stage IIIC	-25768			0	2521		806				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection				80				G2	Recurrence																					Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				13		Ovary			LIVING	2002		TCGA-13-1489-01		TCGA-13-1489-01A-01W-0549-09		f99befac-a46e-43a1-91b7-e4a492dae82f		TCGA-13-1489-01A-01R-1565-13	TCGA-13-1489-01A-01D-0475-05			TCGA-13-1489-01A-01D-0472-01	TCGA-13-1489-01	TCGA-13-1489-01A-01D-0472-01	bd52755a-499d-40c7-9f23-7aec08e3e558			bd52755a-499d-40c7-9f23-7aec08e3e558	TCGA-13-1489-01A-21-1562-20	TCGA-13-1489-01A-01R-1565-13	TCGA-13-1489-01A-01R-0479-07		aeb47cad-0087-4bf3-aa09-3751a6dcb269		TCGA-13-1489-01A-01R-1565-13		TCGA-13-1489-01A-01W-0549-09
TCGA-13-1489-02	0	TCGA-13-1489-02	2521	0		C9-OV	OV-like c1		OV-like c16	miRNA cluster 3		mutation cluster 5	TCGA-13-1489	2521	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Bilateral	TCGA-13-1489-F24875	Stage IIIC	-25768			0	2521		806				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO	80	1			G2	Recurrence				TCGA-13-1489.639712E8-5C63-433C-8F23-4C78FF37D8FC.pdf					5	5			0	0	5	5	90	90	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.4			13		Ovary		A	LIVING	2002					d8cd1ca1-dc00-4a48-ab81-5d23daed6fce			TCGA-13-1489-02A-01R-1565-13	TCGA-13-1489-02A-01D-0807-05						ea12bb70-f529-4ed7-bcd1-690045a5ef99	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	ea12bb70-f529-4ed7-bcd1-690045a5ef99		TCGA-13-1489-02A-01R-1565-13	TCGA-13-1489-02A-01R-0810-07		141d2716-c6c3-4495-b30f-12dc204d77a3	d8cd1ca1-dc00-4a48-ab81-5d23daed6fce	TCGA-13-1489-02A-01R-1565-13		
TCGA-13-1491-01	1	TCGA-13-1491-01	1595	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1491	1595	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-13-1491-F24884	Stage IIIC	-20262		1595	0	1595		508				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.6	NO	60	2			G3	Recurrence				TCGA-13-1491.051EAB19-C9CF-407E-A0C3-19CB76368C22.pdf					1	0			0	0	5	5	94	95	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13		Ovary		A	DECEASED	2002		TCGA-13-1491-01		TCGA-13-1491-01A-01W-0549-09		a2142ff2-fb53-4517-b0d5-9f25ba91ea1a		TCGA-13-1491-01A-01R-1565-13	TCGA-13-1491-01A-01D-0475-05			TCGA-13-1491-01A-01D-0472-01	TCGA-13-1491-01	TCGA-13-1491-01A-01D-0472-01	945daa6e-1ec8-404a-a69e-3a3e79f0fa71			945daa6e-1ec8-404a-a69e-3a3e79f0fa71	TCGA-13-1491-01A-21-1562-20		TCGA-13-1491-01A-01R-0479-07		7ae5754b-5508-416e-96ec-fe3221d6e2ff				TCGA-13-1491-01A-01W-0549-09
TCGA-13-1492-01	0	TCGA-13-1492-01	2237	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1492	2237	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66		TCGA-13-1492-F24889	Stage IIIC	-24332			0	2237						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO	80	2.5			G3					TCGA-13-1492.566BE185-8A2E-43C4-9762-65216AB9AC44.pdf					5	5			0	0	1	1	94	94	99	99	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13		Ovary		A	LIVING	2002		TCGA-13-1492-01		TCGA-13-1492-01A-01D-0472-08		943e741f-3371-4167-99e0-fd795663874c		TCGA-13-1492-01A-01R-1565-13	TCGA-13-1492-01A-01D-0475-05			TCGA-13-1492-01A-01D-0472-01	TCGA-13-1492-01	TCGA-13-1492-01A-01D-0472-01	9f0b16d5-3947-49d3-87cf-86a67627ad66			9f0b16d5-3947-49d3-87cf-86a67627ad66	TCGA-13-1492-01A-21-1562-20	TCGA-13-1492-01A-01R-1565-13	TCGA-13-1492-01A-01R-0479-07		c37d0090-3b9a-4832-934a-299d8a7f6a2d		TCGA-13-1492-01A-01R-1565-13	TCGA-13-1492-01A-01D-0472-08	
TCGA-13-1494-01	0	TCGA-13-1494-01	1162	0	Squamous	C9-OV	OV-like c1	KIRC-like c1		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-13-1494	1162	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	43	Bilateral	TCGA-13-1494-F24893	Stage IV	-15993			0	1162		693				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1.5	NO		2			G3	Recurrence				TCGA-13-1494.BDB59532-0CA8-40F0-AE8E-A9951882F0D8.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13		Ovary		A	LIVING	2004		TCGA-13-1494-01		TCGA-13-1494-01A-01W-0545-08		af9b3f69-ef63-4303-85c6-8f6936dc6b6e		TCGA-13-1494-01A-01R-1565-13	TCGA-13-1494-01A-01D-0475-05			TCGA-13-1494-01A-01D-0472-01	TCGA-13-1494-01	TCGA-13-1494-01A-01D-0472-01	91d90e5d-92a7-43f2-88e5-e2a861b1d6a9			91d90e5d-92a7-43f2-88e5-e2a861b1d6a9	TCGA-13-1494-01A-21-1562-20		TCGA-13-1494-01A-01R-0479-07		d8a57388-6e4e-4865-a68f-7485dec8304f			TCGA-13-1494-01A-01W-0545-08	
TCGA-13-1495-01	0	TCGA-13-1495-01	1498	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-13-1495	1498	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Bilateral	TCGA-13-1495-F24897	Stage IIIC	-22046			0	1498		977				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	2.1			G2	Recurrence				TCGA-13-1495.51F0A8BF-0E86-402D-BE9F-D41771ED98A3.pdf					1	1			0	0	20	20	79	79	80	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2004		TCGA-13-1495-01		TCGA-13-1495-01A-01W-0545-08		15443f5b-51c9-496d-bf7a-99693ca3b943		TCGA-13-1495-01A-01R-1565-13	TCGA-13-1495-01A-01D-0475-05			TCGA-13-1495-01A-01D-0472-01	TCGA-13-1495-01	TCGA-13-1495-01A-01D-0472-01	c7844e0a-4d80-4c61-902d-5600c23eebd1			c7844e0a-4d80-4c61-902d-5600c23eebd1	TCGA-13-1495-01A-21-1562-20	TCGA-13-1495-01A-01R-1565-13	TCGA-13-1495-01A-01R-0479-07		2476b238-9e59-49ae-ac0d-456ad4fe4ffc		TCGA-13-1495-01A-01R-1565-13	TCGA-13-1495-01A-01W-0545-08	
TCGA-13-1496-01	1	TCGA-13-1496-01	129	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1496	129	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			65	Bilateral	TCGA-13-1496-F24904	Stage IIIC	-23993		129	0	129						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.1			G3					TCGA-13-1496.BCDD1BDE-689B-455D-81A7-C2522417E055.pdf					5	5			0	0	1	1	94	94	99	99			YES				NO		Primary Tumor	01	0.3			13	>20 mm	Ovary		A	DECEASED	2004		TCGA-13-1496-01		TCGA-13-1496-01A-01W-0545-08		35781069-501d-45c3-b3f0-7292b0186211		TCGA-13-1496-01A-01R-1565-13	TCGA-13-1496-01A-01D-0475-05			TCGA-13-1496-01A-01D-0472-01	TCGA-13-1496-01	TCGA-13-1496-01A-01D-0472-01	1b6ac59f-1dcb-4473-9af6-27d0d869f05e			1b6ac59f-1dcb-4473-9af6-27d0d869f05e	TCGA-13-1496-01A-21-1562-20	TCGA-13-1496-01A-01R-1565-13	TCGA-13-1496-01A-01R-0479-07		e75a75ac-204d-48b0-891e-c3d6e979d4d4		TCGA-13-1496-01A-01R-1565-13	TCGA-13-1496-01A-01W-0545-08	
TCGA-13-1497-01	0	TCGA-13-1497-01	1652	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1497	1652	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47		TCGA-13-1497-F24908	Stage IIIC	-17528			0	1652		813				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO	80	1.3			G3	Recurrence				TCGA-13-1497.108519AE-4684-4B6E-8A7D-225BFC5084F3.pdf					10	15			0	0	5	5	85	80	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			13		Ovary		A	LIVING	2004		TCGA-13-1497-01		TCGA-13-1497-01A-01W-0549-09	eb61bd52-e5fa-4c33-a2e4-1353a42184d9			TCGA-13-1497-01A-01R-1565-13	TCGA-13-1497-01A-01D-0475-05	TCGA-13-1497-01	TCGA-13-1497-01	TCGA-13-1497-01A-01D-0472-01	TCGA-13-1497-01	TCGA-13-1497-01A-01D-0472-01	7fe61c56-4c2b-497d-b9b4-55e57b3e634e	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	7fe61c56-4c2b-497d-b9b4-55e57b3e634e		TCGA-13-1497-01A-01R-1565-13	TCGA-13-1497-01A-01R-0479-07		d53c30c7-126f-40ec-9e02-4a1d2a3e2681	eb61bd52-e5fa-4c33-a2e4-1353a42184d9	TCGA-13-1497-01A-01R-1565-13		TCGA-13-1497-01A-01W-0549-09
TCGA-13-1498-01	0	TCGA-13-1498-01	1144	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1498	1144	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73		TCGA-13-1498-F24914	Stage IIIC	-26820			0	1144		534				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO	60	1.1			G3	Progression of Disease				TCGA-13-1498.0B03A4B9-61B9-43EA-9E7A-8EE1FF3B31F1.pdf					1	10			0	0	5	10	94	80	95	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2006		TCGA-13-1498-01		TCGA-13-1498-01A-01W-0549-09	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	17dca857-f830-4be9-9f2b-5619ae7eb73f		TCGA-13-1498-01A-01R-1565-13	TCGA-13-1498-01A-01D-0475-05	TCGA-13-1498-01	TCGA-13-1498-01	TCGA-13-1498-01A-01D-0472-01	TCGA-13-1498-01	TCGA-13-1498-01A-01D-0472-01	12975196-6e03-4f58-ab1d-ddbf2f9e9d15	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	12975196-6e03-4f58-ab1d-ddbf2f9e9d15	TCGA-13-1498-01A-21-1562-20	TCGA-13-1498-01A-01R-1565-13	TCGA-13-1498-01A-01R-0479-07		0fe423b7-115f-48a2-bc4a-9eec87f319e2	176d1ca2-eb1d-4f49-9b10-c129c822fa5a	TCGA-13-1498-01A-01R-1565-13		TCGA-13-1498-01A-01W-0549-09
TCGA-13-1499-01	0	TCGA-13-1499-01	1168	0	Squamous	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1499	1168	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56		TCGA-13-1499-F24919	Stage IIIC	-20668			0	1168		583				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1.1	NO	80	2.1			G3	Recurrence				TCGA-13-1499.3FC4A433-FAD1-4CC1-9BD6-A45E2707F6D0.pdf					5	1			0	0	20	20	75	79	80	80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13		Ovary		A	LIVING	2005		TCGA-13-1499-01		TCGA-13-1499-01A-01W-0549-09		21c833c6-d2bc-4308-a233-894c7a6636f1		TCGA-13-1499-01A-01R-1565-13	TCGA-13-1499-01A-01D-0475-05			TCGA-13-1499-01A-01D-0472-01	TCGA-13-1499-01	TCGA-13-1499-01A-01D-0472-01	55fae161-727b-441c-97ad-8bbc71cfdc32			55fae161-727b-441c-97ad-8bbc71cfdc32	TCGA-13-1499-01A-21-1562-20	TCGA-13-1499-01A-01R-1565-13	TCGA-13-1499-01A-01R-0479-07		f54b35ad-c934-4df9-ba57-089c4c9d5c1e		TCGA-13-1499-01A-01R-1565-13		TCGA-13-1499-01A-01W-0549-09
TCGA-13-1500-01	1	TCGA-13-1500-01	425	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-13-1500	425	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-13-1500-F24926	Stage IIIC	-26172		425	0	425		253				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO	80	1.7			G3	Recurrence				TCGA-13-1500.BFC92139-677F-4AD6-93D4-B479B8121449.pdf					1	1			0	0	10	10	89	89	90	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.4			13	11-20 mm	Ovary		A	DECEASED	2006		TCGA-13-1500-01				639afc90-9b92-45f2-a350-6b7e355bbcbc		TCGA-13-1500-01A-01R-1565-13	TCGA-13-1500-01A-01D-0475-05			TCGA-13-1500-01A-01D-0472-01	TCGA-13-1500-01	TCGA-13-1500-01A-01D-0472-01	1a7b8587-9482-43e4-a07f-0d49b9ec78d1			1a7b8587-9482-43e4-a07f-0d49b9ec78d1	TCGA-13-1500-01A-21-1562-20		TCGA-13-1500-01A-01R-0479-07		6bd685eb-c19d-404d-bb70-0d7590034653				
TCGA-13-1501-01	0	TCGA-13-1501-01	999	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 8	TCGA-13-1501	999	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-13-1501-F24931	Stage IV	-18393			0	999		392				2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO	80	1.5			G3	Progression of Disease				TCGA-13-1501.7D27D441-D069-4674-A761-299E315D67C1.pdf					1	0			0	0	30	30	69	70	70	70	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2006		TCGA-13-1501-01		TCGA-13-1501-01A-01W-0545-08		9f507427-22ed-408e-807f-39a90244bef4		TCGA-13-1501-01A-01R-1565-13	TCGA-13-1501-01A-01D-0475-05			TCGA-13-1501-01A-01D-0472-01	TCGA-13-1501-01	TCGA-13-1501-01A-01D-0472-01	886193e0-afe4-4d1b-9e48-7dd97ec354ce			886193e0-afe4-4d1b-9e48-7dd97ec354ce	TCGA-13-1501-01A-21-1562-20	TCGA-13-1501-01A-01R-1565-13	TCGA-13-1501-01A-01R-0479-07		cf8ec1d5-56c7-45b7-8208-58fc6f5d6aa6		TCGA-13-1501-01A-01R-1565-13	TCGA-13-1501-01A-01W-0545-08	
TCGA-13-1504-01	0	TCGA-13-1504-01	504	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1504	504	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			68	Bilateral	TCGA-13-1504-F24935	Stage IIIC	-25008			0	504						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	60	1.6			G3					TCGA-13-1504.DB8A8258-9893-4968-A91B-5D9D319D0585.pdf					1	1			0	0	5	5	94	94	95	95	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13		Ovary		A	LIVING	2007		TCGA-13-1504-01		TCGA-13-1504-01A-01W-0545-08		f1e3f6ff-3c3d-4045-9ab3-bf5803828428		TCGA-13-1504-01A-01R-1565-13	TCGA-13-1504-01A-01D-0475-05			TCGA-13-1504-01A-01D-0472-01	TCGA-13-1504-01	TCGA-13-1504-01A-01D-0472-01	e210eee4-4d99-4bc0-bbe4-09f143bc1f2c			e210eee4-4d99-4bc0-bbe4-09f143bc1f2c	TCGA-13-1504-01A-21-1562-20		TCGA-13-1504-01A-01R-0479-07		6ad70118-653d-4476-b26c-4e276f556aaf			TCGA-13-1504-01A-01W-0545-08	
TCGA-13-1505-01	0	TCGA-13-1505-01	128	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-13-1505	128	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-13-1505-F24939	Stage IIIC	-23238			0	128						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.2			G3					TCGA-13-1505.ACD1E3CC-53FC-4615-B31B-0AFDF4B259BF.pdf					0	0			0	0	20	10	80	90	80	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1505-01		TCGA-13-1505-01A-01D-0472-08	7774b7d4-2935-4b9b-bf76-312a625629e1	d15e55f3-d7f1-4276-9fe1-17cc18dc2515		TCGA-13-1505-01A-01R-1565-13	TCGA-13-1505-01A-01D-0475-05	TCGA-13-1505-01	TCGA-13-1505-01	TCGA-13-1505-01A-01D-0472-01	TCGA-13-1505-01	TCGA-13-1505-01A-01D-0472-01	41b3be7d-4f77-4065-af1b-a054a17e3810	7774b7d4-2935-4b9b-bf76-312a625629e1	7774b7d4-2935-4b9b-bf76-312a625629e1	41b3be7d-4f77-4065-af1b-a054a17e3810	TCGA-13-1505-01A-21-1562-20	TCGA-13-1505-01A-01R-1565-13	TCGA-13-1505-01A-01R-0479-07		3237c7be-aa7d-47d1-8c46-8d6b4ce5d1c4	7774b7d4-2935-4b9b-bf76-312a625629e1	TCGA-13-1505-01A-01R-1565-13	TCGA-13-1505-01A-01D-0472-08	
TCGA-13-1506-01	0	TCGA-13-1506-01	134	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-13-1506	134	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-13-1506-F24944	Stage IIIC	-16734			0	134						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	80	1.1			G3					TCGA-13-1506.88E423FF-4070-4F01-A0B0-41B45443E762.pdf					1	1			0	0	1	1	98	98	99	99	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			13		Ovary		A	LIVING	2008		TCGA-13-1506-01		TCGA-13-1506-01A-01W-0549-09	927c7b6d-3997-453b-81b1-b947341d5819	6bdc5656-6cff-48e4-9625-e953d683aed5		TCGA-13-1506-01A-01R-1565-13	TCGA-13-1506-01A-01D-0475-05	TCGA-13-1506-01	TCGA-13-1506-01	TCGA-13-1506-01A-01D-0472-01	TCGA-13-1506-01	TCGA-13-1506-01A-01D-0472-01	d846aadd-9cf1-41a8-8fa4-c55b666d0a37	927c7b6d-3997-453b-81b1-b947341d5819	927c7b6d-3997-453b-81b1-b947341d5819	d846aadd-9cf1-41a8-8fa4-c55b666d0a37	TCGA-13-1506-01A-21-1562-20	TCGA-13-1506-01A-01R-1565-13	TCGA-13-1506-01A-01R-0479-07		e9c25372-66bb-4c51-9b0f-8fb53262f48b	927c7b6d-3997-453b-81b1-b947341d5819	TCGA-13-1506-01A-01R-1565-13		TCGA-13-1506-01A-01W-0549-09
TCGA-13-1507-01	0	TCGA-13-1507-01	145	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1507	145	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			77	Bilateral	TCGA-13-1507-F24952	Stage IIIC	-28445			0	145			1			2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.1	NO	60	2			G3					TCGA-13-1507.0B6D1513-8119-459C-8D5A-8942B8C31179.pdf					5	5			0	0	5	5	90	90	95	95	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1507-01		TCGA-13-1507-01A-01W-0549-09	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	307d0834-99b0-416a-aafb-60d7ec74406f		TCGA-13-1507-01A-01R-1565-13	TCGA-13-1507-01A-01D-0475-05	TCGA-13-1507-01	TCGA-13-1507-01	TCGA-13-1507-01A-01D-0472-01	TCGA-13-1507-01	TCGA-13-1507-01A-01D-0472-01	bfed3408-33c3-40cd-9382-0bcf1b91af89	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	bfed3408-33c3-40cd-9382-0bcf1b91af89	TCGA-13-1507-01A-21-1562-20	TCGA-13-1507-01A-01R-1565-13	TCGA-13-1507-01A-01R-0479-07		c374d509-5dff-45a7-bb49-b7e273b6f229	41a5fa6b-4594-4ef8-b841-fe75c17a13c2	TCGA-13-1507-01A-01R-1565-13		TCGA-13-1507-01A-01W-0549-09
TCGA-13-1509-01	0	TCGA-13-1509-01	127	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-13-1509	127	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Bilateral	TCGA-13-1509-F24957	Stage IV	-23481			0	127						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	40	1.7			G3					TCGA-13-1509.5FB47FA9-299B-4466-A324-20D44C788F8B.pdf					5	5			0	0	10	10	85	85	90	90	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2008		TCGA-13-1509-01		TCGA-13-1509-01A-01W-0549-09		a35cc137-a072-4287-8248-dbc4df213144		TCGA-13-1509-01A-01R-1565-13	TCGA-13-1509-01A-01D-0475-05			TCGA-13-1509-01A-01D-0472-01	TCGA-13-1509-01	TCGA-13-1509-01A-01D-0472-01	0e3ff01f-4ce1-469b-9890-3040157b5976			0e3ff01f-4ce1-469b-9890-3040157b5976	TCGA-13-1509-01A-21-1562-20	TCGA-13-1509-01A-01R-1565-13	TCGA-13-1509-01A-01R-0479-07		36181328-ff8f-4ad6-9521-7020c689acfe		TCGA-13-1509-01A-01R-1565-13		TCGA-13-1509-01A-01W-0549-09
TCGA-13-1510-01	0	TCGA-13-1510-01	78	0	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-13-1510	78	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Left	TCGA-13-1510-F24961	Stage IIIC	-22708			0	78						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		2			G3					TCGA-13-1510.D6FA84A0-0DE4-42F8-9D15-9EDA4115AE4D.pdf					20	20			0	0	5	5	75	75	95	95		TUMOR FREE					NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-1510-01		TCGA-13-1510-01A-02D-0472-08				TCGA-13-1510-01A-02R-1565-13	TCGA-13-1510-01A-02D-0475-05			TCGA-13-1510-01A-02D-0472-01	TCGA-13-1510-01	TCGA-13-1510-01A-02D-0472-01	75bbf327-ce62-4a7e-b08a-3d8dcf7d95a1			75bbf327-ce62-4a7e-b08a-3d8dcf7d95a1		TCGA-13-1510-01A-02R-1565-13	TCGA-13-1510-01A-02R-0479-07		614859a5-6f16-4f6b-8c26-60646708c1ba		TCGA-13-1510-01A-02R-1565-13	TCGA-13-1510-01A-02D-0472-08	
TCGA-13-1511-01	0	TCGA-13-1511-01	119	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-13-1511	119	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-13-1511-F24965	Stage IV	-19258			0	119						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.6	NO	60	2.2			G3					TCGA-13-1511.CD73F0B8-0B90-40D1-B6FE-6046F84E9AB0.pdf					5	5			0	0	5	5	90	90	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	LIVING	2008		TCGA-13-1511-01			ccd83080-7a51-4952-b4af-d13e9c182bc0	a5d23561-577b-4b73-979e-8908b15b223e		TCGA-13-1511-01A-01R-1565-13	TCGA-13-1511-01A-01D-0475-05	TCGA-13-1511-01	TCGA-13-1511-01	TCGA-13-1511-01A-01D-0472-01	TCGA-13-1511-01	TCGA-13-1511-01A-01D-0472-01	0e7ef489-ce94-4404-8506-31d4b6cd02b9	ccd83080-7a51-4952-b4af-d13e9c182bc0	ccd83080-7a51-4952-b4af-d13e9c182bc0	0e7ef489-ce94-4404-8506-31d4b6cd02b9	TCGA-13-1511-01A-21-1562-20	TCGA-13-1511-01A-01R-1565-13	TCGA-13-1511-01A-01R-0479-07		96a8f10e-4b72-4262-9ad7-3ba062ce7f85	ccd83080-7a51-4952-b4af-d13e9c182bc0	TCGA-13-1511-01A-01R-1565-13		
TCGA-13-1512-01	0	TCGA-13-1512-01	94	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-13-1512	94	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-13-1512-F24970	Stage IIIC	-18134			0	94						2009-3-31	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1.4	NO	60	2			G3					TCGA-13-1512.66DC098E-9ADD-4446-AB6D-FEA35D5FD33B.pdf					10	5			0	0	1	1	89	94	99	99	Pre-Adjuvant Therapy		YES				NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-1512-01		TCGA-13-1512-01A-01W-0545-08	67e85198-4b8c-45db-b433-683b1899f3ea	70bd95ea-f6ca-4b5a-b744-e174576d1063		TCGA-13-1512-01A-01R-1565-13	TCGA-13-1512-01A-01D-0475-05	TCGA-13-1512-01	TCGA-13-1512-01	TCGA-13-1512-01A-01D-0472-01	TCGA-13-1512-01	TCGA-13-1512-01A-01D-0472-01	26516073-2e76-4c62-aeec-c2b40ae3ae2a	67e85198-4b8c-45db-b433-683b1899f3ea	67e85198-4b8c-45db-b433-683b1899f3ea	26516073-2e76-4c62-aeec-c2b40ae3ae2a	TCGA-13-1512-01A-21-1558-20	TCGA-13-1512-01A-01R-1565-13	TCGA-13-1512-01A-01R-0479-07		59b113ee-0571-4e46-b437-9c48e04697eb	67e85198-4b8c-45db-b433-683b1899f3ea	TCGA-13-1512-01A-01R-1565-13	TCGA-13-1512-01A-01W-0545-08	
TCGA-13-1817-01	1	TCGA-13-1817-01	1024	1	High		Cluster 6	OV-like c4					TCGA-13-1817	1024	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-13-1817-F24974	Stage IIIC	-20771		1024	0	1024		541				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3	Recurrence				TCGA-13-1817.76F55E61-714E-4C20-A9BD-2ECF28E5444F.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	>20 mm	Ovary		A	DECEASED	2001		TCGA-13-1817-01				82a5bb6f-81aa-4ba2-9a74-c0a7ea48cabc			TCGA-13-1817-01A-01D-0807-05			TCGA-13-1817-01A-01D-2069-01	TCGA-13-1817-01	TCGA-13-1817-01A-01D-2069-01	a7cf51ba-a017-4de1-ad5f-021d1369eb80			a7cf51ba-a017-4de1-ad5f-021d1369eb80	TCGA-13-1817-01A-21-1559-20		TCGA-13-1817-01A-01R-0810-07		aad798d8-5b4a-4f23-8ebe-fb68cb37fd51				
TCGA-13-1817-02	1	TCGA-13-1817-02	1024	1			Cluster 6						TCGA-13-1817	1024	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-13-1817-F24974	Stage IIIC	-20771		1024	0	1024		541				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3	Recurrence									0	0			0	0	20	10	80	80	80	80		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.4			13	>20 mm	Ovary		A	DECEASED	2001									TCGA-13-1817-02A-01D-0807-05						25af523c-c59e-478e-ae23-bd07cf9944f4			25af523c-c59e-478e-ae23-bd07cf9944f4			TCGA-13-1817-02A-01R-0810-07		29cf6928-081b-4498-89b3-89bd24b61608				
TCGA-13-1819-01	0	TCGA-13-1819-01	1946	0	High		OV-like c1	OV-like c4					TCGA-13-1819	1946	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	59	Right	TCGA-13-1819-F24982	Stage IIC	-21635			0	1946		429				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3	Recurrence				TCGA-13-1819.27225767-34C2-48F2-A347-867FDDC907E9.pdf	0	0	0	0	0	0	0	0	0	0	10	30	90	70	90	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			13	No Macroscopic disease	Ovary		A	LIVING	2004		TCGA-13-1819-01				249b311f-42e8-4ae2-88a1-11e80c3c02f9			TCGA-13-1819-01A-01D-0807-05			TCGA-13-1819-01A-01D-2069-01	TCGA-13-1819-01	TCGA-13-1819-01A-01D-2069-01	5876f156-ec7c-496e-9b1d-97d3824a239f,d33a61ad-a3ee-486d-bfbd-22f812221a32			5876f156-ec7c-496e-9b1d-97d3824a239f,d33a61ad-a3ee-486d-bfbd-22f812221a32	TCGA-13-1819-01A-21-1559-20		TCGA-13-1819-01A-01R-0810-07		3816ef10-585d-4480-bee6-d3d3fe9cbef5				
TCGA-13-1819-02	0	TCGA-13-1819-02	1946	0			OV-like c1						TCGA-13-1819	1946	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	59	Right	TCGA-13-1819-F24982	Stage IIC	-21635			0	1946		429				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2.1			G3	Recurrence					0	0	0	0	10	0	10	0	0	0	10	30	80	70	80	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2004									TCGA-13-1819-02A-01D-0807-05						b6a74c0d-28b7-453c-89e9-1a201594a88d			b6a74c0d-28b7-453c-89e9-1a201594a88d			TCGA-13-1819-02A-01R-0810-07		71492b0a-c202-4688-bb17-1828ed1d9d97				
TCGA-13-2057-01	0	TCGA-13-2057-01	433	0	High		UCEC Serous c4						TCGA-13-2057	433	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-13-2057-F24989	Stage IIIC	-21554			0	433						2010-2-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		1.5	NO	60	3			G3					TCGA-13-2057.112EC7A2-A410-4D98-A974-BD6BF75E156F.pdf	0	0	0	0	0	0	0	0	0	0	50	50	50	50	90	90	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			13	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-13-2057-01							TCGA-13-2057-01A-02D-1047-05			TCGA-13-2057-01A-02D-1043-01	TCGA-13-2057-01	TCGA-13-2057-01A-02D-1043-01	b1f90a25-d938-416b-948d-f5767460867a			b1f90a25-d938-416b-948d-f5767460867a			TCGA-13-2057-01A-02R-1050-07		0b1c95cf-0eb2-4297-956e-85702b3bbbc3				TCGA-13-2057-01A-02D-1526-09
TCGA-13-2059-01	0	TCGA-13-2059-01	372	0	High		OV-like c1	OV-like c4					TCGA-13-2059	372	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Bilateral	TCGA-13-2059-F24993	Stage IIIC	-18449			0	372						2010-2-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO	80	2			G3					TCGA-13-2059.E3673116-F004-4011-A609-D8E1693DBA62.pdf	5	5	2	2	0	0	0	0	0	0	10	10	90	90	85	80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			13	1-10 mm	Ovary		A	LIVING	2009		TCGA-13-2059-01				6af82345-1327-40dc-bbe3-1a4b5feb1da5			TCGA-13-2059-01A-01D-1047-05			TCGA-13-2059-01A-01D-1043-01	TCGA-13-2059-01	TCGA-13-2059-01A-01D-1043-01	019358e7-9795-4e8f-9751-3dfffe99c5ab			019358e7-9795-4e8f-9751-3dfffe99c5ab	TCGA-13-2059-01A-03-1563-20		TCGA-13-2059-01A-01R-1050-07		96ef4c4d-9292-4281-b23d-8e29fe47119f				TCGA-13-2059-01A-01D-1526-09
TCGA-13-2060-01	0	TCGA-13-2060-01	262	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-13-2060	262	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-13-2060-F24998	Stage IV	-18635			0	262						2009-12-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	2.5			G3					TCGA-13-2060.F6986C14-4627-424E-81C5-74E1CE38D52D.pdf	20	15	0	0	5	5	0	0	0	0	10	10	85	85	70	80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			13	1-10 mm	Ovary		A	LIVING	2009		TCGA-13-2060-01		TCGA-13-2060-01A-01W-0799-08	32de1e4d-198a-4616-8227-4d633c80124b	19465a94-b5e9-4700-8f19-0724f72dd3a4		TCGA-13-2060-01A-01R-1568-13	TCGA-13-2060-01A-01D-0708-05	TCGA-13-2060-01	TCGA-13-2060-01	TCGA-13-2060-01A-01D-0704-01	TCGA-13-2060-01	TCGA-13-2060-01A-01D-0704-01	4f64fc1e-d250-4438-bd6d-c1c4b8f50033	32de1e4d-198a-4616-8227-4d633c80124b	32de1e4d-198a-4616-8227-4d633c80124b	4f64fc1e-d250-4438-bd6d-c1c4b8f50033	TCGA-13-2060-01A-21-1560-20	TCGA-13-2060-01A-01R-1568-13	TCGA-13-2060-01A-01R-0711-07		60beab4b-53c5-4c97-af8f-21f4076b4850	32de1e4d-198a-4616-8227-4d633c80124b	TCGA-13-2060-01A-01R-1568-13	TCGA-13-2060-01A-01W-0799-08	
TCGA-13-2061-01	0	TCGA-13-2061-01	328	0	Squamous		OV-like c1	OV-like c4					TCGA-13-2061	328	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-13-2061-F25003	Stage IIIC	-21543			0	328						2010-2-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO	80	1.9			G3					TCGA-13-2061.57D9D913-A6F9-4406-BF4D-0770004131D5.pdf	15	20	5	0	2	5	0	0	0	0	10	10	88	85	75	75	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			13	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-13-2061-01				7fd07232-c71d-43b3-8f05-8855c8028871			TCGA-13-2061-01A-01D-1047-05			TCGA-13-2061-01A-01D-1043-01	TCGA-13-2061-01	TCGA-13-2061-01A-01D-1043-01	608ac686-8da4-4ca4-937f-a4d23663be6d			608ac686-8da4-4ca4-937f-a4d23663be6d	TCGA-13-2061-01A-03-1563-20		TCGA-13-2061-01A-01R-1050-07		7183ed35-46c8-49c5-b247-09d01df7f6de				TCGA-13-2061-01A-01D-1526-09
TCGA-13-2065-01	0	TCGA-13-2065-01	266	0	Squamous		OV-like c1	OV-like c4					TCGA-13-2065	266	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Bilateral	TCGA-13-2065-F25013	Stage IIIC	-25973			0	266						2010-2-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.5	NO		2			G3					TCGA-13-2065.F7B54330-BA29-4B49-B450-20109013C43C.pdf	5	5	0	0	0	0	0	0	0	0	30	40	70	60	85	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			13	1-10 mm	Ovary		A	LIVING	2009		TCGA-13-2065-01				c8f40939-b3f0-4392-bad8-38608d23f320			TCGA-13-2065-01A-01D-1047-05			TCGA-13-2065-01A-01D-1043-01	TCGA-13-2065-01	TCGA-13-2065-01A-01D-1043-01	0e9b8ff9-e998-4185-b8ce-d9446630383e			0e9b8ff9-e998-4185-b8ce-d9446630383e	TCGA-13-2065-01A-03-1563-20		TCGA-13-2065-01A-01R-1050-07		d020829d-93e8-4b1d-9b6e-006efc029547				TCGA-13-2065-01A-01D-1526-09
TCGA-13-2066-01	0	TCGA-13-2066-01	295	0			OV-like c1	UCEC-like c5					TCGA-13-2066	295	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-13-2066-F25018	Stage IV	-18170			0	295						2010-2-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection				80				G3																						Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				13	1-10 mm	Ovary			LIVING	2009						f2fa59a1-7ceb-4483-9925-3b2707f18d51			TCGA-13-2066-01A-01D-1047-05				TCGA-13-2066-01		bdda429f-5053-4937-8488-19a21aa95048			bdda429f-5053-4937-8488-19a21aa95048	TCGA-13-2066-01A-03-1562-20		TCGA-13-2066-01A-01R-1050-07		bfe15bbc-6ec4-4c49-b86d-4b01aa23093a				TCGA-13-2066-01A-01D-1526-09
TCGA-13-2071-01	0	TCGA-13-2071-01	191	0	Squamous		OV-like c1						TCGA-13-2071	191	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-13-2071-F25022	Stage IV	-23367			0	191						2010-2-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		2	NO	80	2.5			G3					TCGA-13-2071.882BE278-9263-466C-BF61-E30543690FD7.pdf	5	5	0	0	0	0	0	0	0	0	15	10	85	90	85	85	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			13	1-10 mm	Ovary		A	LIVING	2009		TCGA-13-2071-01							TCGA-13-2071-01A-02D-1047-05			TCGA-13-2071-01A-02D-1043-01	TCGA-13-2071-01	TCGA-13-2071-01A-02D-1043-01	51cd779f-e8f6-4a22-98b3-8a8dd199bcf5			51cd779f-e8f6-4a22-98b3-8a8dd199bcf5			TCGA-13-2071-01A-02R-1050-07		97c72a04-f6a3-4f0e-89ca-8b6a47ee6d25				TCGA-13-2071-01A-02D-1526-09
TCGA-13-A5FT-01	0	TCGA-13-A5FT-01	1666	0									TCGA-13-A5FT	1666	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-13-A5FT-F58072	Stage IIIC	-24743	1211		0	1666				Scheduled Follow-up Submission	Complete Remission/Response	2014-4-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection	230		NO	70		NO		G3			NO	true	TCGA-13-A5FT.B67517DE-A483-4563-8698-51CB95DC5CF1.pdf		1		0		8		0		0		0		92		80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	No		NO	RX	Primary Tumor	01		NO	YES	13	No Macroscopic disease	Ovary		A	LIVING	2009								TCGA-13-A5FT-01A-11R-A407-13				TCGA-13-A5FT-01A-11D-A402-01		TCGA-13-A5FT-01A-11D-A402-01	948a6d77-e8ca-4114-add3-77e7db75b3b3			948a6d77-e8ca-4114-add3-77e7db75b3b3				TCGA-13-A5FT-01A-11D-A409-05					
TCGA-13-A5FU-01	1	TCGA-13-A5FU-01	256	1									TCGA-13-A5FU	256	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Bilateral		Stage IV	-22256	1151	256	0							2013-5-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C80.9	YES	Tumor resection	210		NO	50				G3			NO	true	TCGA-13-A5FU.81DED60F-76BC-47E8-A15C-4488C6FDA1A5.pdf		1		0		0		0		0		0		100		80	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response	No		NO	R2	Primary Tumor	01		NO	YES	13	1-10 mm	Ovary		A	DECEASED	2009								TCGA-13-A5FU-01A-11R-A407-13				TCGA-13-A5FU-01A-11D-A402-01		TCGA-13-A5FU-01A-11D-A402-01	5a750811-6d30-463b-8f85-fc062087be51			5a750811-6d30-463b-8f85-fc062087be51				TCGA-13-A5FU-01A-11D-A409-05					
TCGA-20-0987-01	1	TCGA-20-0987-01	701	1	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0987	701	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-20-0987-F25518	Stage IIIC	-22287		701	0			442				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy								G3	Recurrence																						WITH TUMOR	YES			Physical Examination	NO		Primary Tumor	01				20	1-10 mm	Ovary			DECEASED	2004		TCGA-20-0987-01		TCGA-20-0987-01A-02W-0486-08				TCGA-20-0987-01A-02R-1564-13	TCGA-20-0987-01A-02D-0432-05			TCGA-20-0987-01A-02D-0428-01	TCGA-20-0987-01	TCGA-20-0987-01A-02D-0428-01	d0a0712d-97d3-4301-b693-8c55388dda13			d0a0712d-97d3-4301-b693-8c55388dda13		TCGA-20-0987-01A-02R-1564-13	TCGA-20-0987-01A-02R-0436-07		e770e1d2-f6bc-4fc0-87c5-15f0939a189b		TCGA-20-0987-01A-02R-1564-13	TCGA-20-0987-01A-02W-0486-08	
TCGA-20-0990-01	0	TCGA-20-0990-01	789	0	High		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-20-0990	789	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-20-0990-F25523	Stage IIIC	-27170			0	789		871	1			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		0.6	NO		0.7			G3	Recurrence				TCGA-20-0990.2380A6A4-8F10-40BE-BEE6-DCC116803763.pdf					2	2			18	6	2	1	78	91	80	95	Post-Adjuvant Therapy	WITH TUMOR	YES			Molecular Marker(S)	NO		Primary Tumor	01	0.3			20		Ovary		A	LIVING	2005		TCGA-20-0990-01		TCGA-20-0990-01A-01W-0486-08				TCGA-20-0990-01A-01R-1564-13	TCGA-20-0990-01A-01D-0432-05			TCGA-20-0990-01A-01D-0428-01	TCGA-20-0990-01	TCGA-20-0990-01A-01D-0428-01	54231a5f-a9b2-471b-88c8-05cf5e04dca1			54231a5f-a9b2-471b-88c8-05cf5e04dca1			TCGA-20-0990-01A-01R-0436-07		8179bb45-deba-42a6-9306-73030e4aa5d8			TCGA-20-0990-01A-01W-0486-08	
TCGA-20-0991-01	0	TCGA-20-0991-01	797	0	High		OV-like c1			miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-20-0991	797	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Right	TCGA-20-0991-F25530	Stage IIB	-28694			0	797			0			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8			G3					TCGA-20-0991.8FB04F5F-B278-4E3C-A88B-9597F7B93F6E.pdf					5	2			2	2	0	0	93	96	98	98	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			20	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-20-0991-01		TCGA-20-0991-01A-03D-0428-08				TCGA-20-0991-01A-01R-1564-13	TCGA-20-0991-01A-03D-0432-05			TCGA-20-0991-01A-03D-0428-01	TCGA-20-0991-01	TCGA-20-0991-01A-03D-0428-01	05fd7ce0-b787-48fa-baa6-3bfe9647f4ec			05fd7ce0-b787-48fa-baa6-3bfe9647f4ec		TCGA-20-0991-01A-01R-1564-13	TCGA-20-0991-01A-01R-0436-07		bc5c2691-a35b-4548-99ed-7a3e6e95153f		TCGA-20-0991-01A-01R-1564-13	TCGA-20-0991-01A-03D-0428-08	
TCGA-20-0996-01	0	TCGA-20-0996-01	2196	0	Kirc+		OV-like c1						TCGA-20-0996	2196	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-20-0996-F25533	Stage IIIC	-21572			0	2196			0			2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G2																						Post-Adjuvant Therapy	WITH TUMOR	YES				NO		Primary Tumor	01				20	1-10 mm	Ovary			LIVING	2001		TCGA-20-0996-01							TCGA-20-0996-01A-03D-0432-05			TCGA-20-0996-01A-03D-0428-01	TCGA-20-0996-01	TCGA-20-0996-01A-03D-0428-01	abd8131a-d16a-4a5f-9bca-2f0f1fede65d			abd8131a-d16a-4a5f-9bca-2f0f1fede65d			TCGA-20-0996-01A-02R-0436-07		c1396756-4582-49ae-ac88-857ff11b377d				
TCGA-20-1682-01	0	TCGA-20-1682-01	837	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-20-1682	837	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			56	Bilateral	TCGA-20-1682-F25540	Stage IIIC	-20583			0	837			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1		YES	GX					TCGA-20-1682.cf49ea4d-478c-469d-ace2-7ef52b66a332.pdf	5	5			1	2			0	0	14	38	85	60	80	80	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			20	11-20 mm	Ovary	YES	A	LIVING	2007		TCGA-20-1682-01			f03d023b-cba8-413d-a88d-0378ee7b7748	a999220b-fed5-446d-8bba-c4c59428d473		TCGA-20-1682-01A-01R-1564-13	TCGA-20-1682-01A-01D-0563-05	TCGA-20-1682-01	TCGA-20-1682-01	TCGA-20-1682-01A-01D-0559-01	TCGA-20-1682-01	TCGA-20-1682-01A-01D-0559-01	1b33cc7d-0965-441d-8853-2b6f37ca2bce	f03d023b-cba8-413d-a88d-0378ee7b7748	f03d023b-cba8-413d-a88d-0378ee7b7748	1b33cc7d-0965-441d-8853-2b6f37ca2bce	TCGA-20-1682-01A-21-1558-20	TCGA-20-1682-01A-01R-1564-13	TCGA-20-1682-01A-01R-0566-07		3feadfdb-a932-4ead-8a20-59698a0655ae	f03d023b-cba8-413d-a88d-0378ee7b7748	TCGA-20-1682-01A-01R-1564-13		TCGA-20-1682-01A-01W-0633-09
TCGA-20-1683-01	0	TCGA-20-1683-01	772	0	High	C9-OV	Cluster 6	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-20-1683	772	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Right	TCGA-20-1683-F25544	Stage IIIC	-24006			0	772		618	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1			G3	Recurrence				TCGA-20-1683.5a83e4b3-8be2-4628-bd4b-93d040b43856.pdf	2	3			5	3			0	0	30	20	65	72	95	90	Post-Adjuvant Therapy	TUMOR FREE	YES	Stable Disease		Molecular Marker(S)	NO		Primary Tumor	01	0.4			20	No Macroscopic disease	Ovary		A	LIVING	2007		TCGA-20-1683-01			e78c6cd7-67f2-4ac8-9dd9-c46392459835	78abd251-6a19-4b51-bd1d-7c8dba5f324e		TCGA-20-1683-01A-01R-1566-13	TCGA-20-1683-01A-01D-0563-05	TCGA-20-1683-01	TCGA-20-1683-01	TCGA-20-1683-01A-01D-0559-01	TCGA-20-1683-01	TCGA-20-1683-01A-01D-0559-01	504b5d05-7e0b-40ff-ad58-fcb5ce50edb3	e78c6cd7-67f2-4ac8-9dd9-c46392459835	e78c6cd7-67f2-4ac8-9dd9-c46392459835	504b5d05-7e0b-40ff-ad58-fcb5ce50edb3	TCGA-20-1683-01A-21-1558-20	TCGA-20-1683-01A-01R-1566-13	TCGA-20-1683-01A-01R-0566-07		f44d8a5e-bb22-4961-bfa5-be4ba92c8729	e78c6cd7-67f2-4ac8-9dd9-c46392459835	TCGA-20-1683-01A-01R-1566-13		TCGA-20-1683-01A-01W-0633-09
TCGA-20-1684-01	0	TCGA-20-1684-01	581	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-20-1684	581	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-20-1684-F25549	Stage IIIC	-18755			0	581			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3					TCGA-20-1684.3ce61823-9e89-424f-9ce2-a8987420b2a9.pdf					2	3			0	0	18	20	80	77	95	95	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			20	1-10 mm	Ovary	NO	A	LIVING	2007		TCGA-20-1684-01			91b2872a-73bc-4f52-a8f6-96ce81cbef8a	8ba9a6e5-3dc8-4e7b-80ca-17470663b495		TCGA-20-1684-01A-01R-1566-13	TCGA-20-1684-01A-01D-0563-05	TCGA-20-1684-01	TCGA-20-1684-01	TCGA-20-1684-01A-01D-0559-01	TCGA-20-1684-01	TCGA-20-1684-01A-01D-0559-01	5494acf1-6054-4d4f-8f5e-d39c5e9eafa4	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	5494acf1-6054-4d4f-8f5e-d39c5e9eafa4	TCGA-20-1684-01A-21-1558-20	TCGA-20-1684-01A-01R-1566-13	TCGA-20-1684-01A-01R-0566-07		c0d9b7e3-7c05-4db3-a77e-ae8a6a4ab4e7	91b2872a-73bc-4f52-a8f6-96ce81cbef8a	TCGA-20-1684-01A-01R-1566-13		TCGA-20-1684-01A-01W-0633-09
TCGA-20-1685-01	0	TCGA-20-1685-01	508	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-20-1685	508	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-20-1685-F25554	Stage IIIC	-16745			0	508			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		NO	G3					TCGA-20-1685.09b7c163-7ad3-42a2-bc06-32bd55f80327.pdf	1	1			1	1			0	0	9	19	90	80	95	95	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			20	1-10 mm	Ovary	NO	A	LIVING	2008		TCGA-20-1685-01			9f6dd4ad-0130-46fe-9c49-72f378a753fe	b1b57151-ff27-4b55-bf89-6e25a61f1060		TCGA-20-1685-01A-01R-1566-13	TCGA-20-1685-01A-01D-0563-05	TCGA-20-1685-01	TCGA-20-1685-01	TCGA-20-1685-01A-01D-0559-01	TCGA-20-1685-01	TCGA-20-1685-01A-01D-0559-01	351e95b2-e001-4804-974d-fdac83240259	9f6dd4ad-0130-46fe-9c49-72f378a753fe	9f6dd4ad-0130-46fe-9c49-72f378a753fe	351e95b2-e001-4804-974d-fdac83240259	TCGA-20-1685-01A-21-1558-20	TCGA-20-1685-01A-01R-1566-13	TCGA-20-1685-01A-01R-0566-07		923bc90c-b380-4710-b062-5c3deb27de44	9f6dd4ad-0130-46fe-9c49-72f378a753fe	TCGA-20-1685-01A-01R-1566-13		TCGA-20-1685-01A-01W-0633-09
TCGA-20-1686-01	0	TCGA-20-1686-01	89	0	High		OV-like c1	BRCA basal-like c6		miRNA cluster 2	cluster 2		TCGA-20-1686	89	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			75	Bilateral	TCGA-20-1686-F25559	Stage IIIC	-27588			0	89			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8		NO	G3					TCGA-20-1686.c87ff195-1793-455a-bb19-e495a915befe.pdf	1				0	0			0	0	30	35	70	65	80	80	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			20	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-20-1686-01				92c3ac1c-3e84-4448-8587-8c95329d0549		TCGA-20-1686-01A-01R-1566-13	TCGA-20-1686-01A-01D-0563-05			TCGA-20-1686-01A-01D-0559-01	TCGA-20-1686-01	TCGA-20-1686-01A-01D-0559-01	b56919c1-4fde-47bb-9b85-cf3b41fb51ce			b56919c1-4fde-47bb-9b85-cf3b41fb51ce	TCGA-20-1686-01A-21-1558-20	TCGA-20-1686-01A-01R-1566-13	TCGA-20-1686-01A-01R-0566-07		91fb24d3-6a1d-4fd1-9bf3-d891ab25017c		TCGA-20-1686-01A-01R-1566-13		TCGA-20-1686-01A-01W-0633-09
TCGA-20-1687-01	0	TCGA-20-1687-01	81	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-20-1687	81	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Bilateral	TCGA-20-1687-F25563	Stage IV	-16961			0	81						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.8		YES	G3					TCGA-20-1687.e966d90f-0e5f-42e6-b487-1f10fbef204f.pdf					0	0			0	0	15	35	85	65	90	85		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			20	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-20-1687-01			ad7529aa-47f7-4207-b0a9-8684ff1e6e80	a3332b9e-1a9c-4a7e-81c0-e19de968609b		TCGA-20-1687-01A-01R-1566-13	TCGA-20-1687-01A-01D-0563-05	TCGA-20-1687-01	TCGA-20-1687-01	TCGA-20-1687-01A-01D-0559-01	TCGA-20-1687-01	TCGA-20-1687-01A-01D-0559-01	70d07271-15ef-4a45-aa05-421a65f61846	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	70d07271-15ef-4a45-aa05-421a65f61846	TCGA-20-1687-01A-21-1558-20	TCGA-20-1687-01A-01R-1566-13	TCGA-20-1687-01A-01R-0566-07		7221f0cf-2235-4717-938b-425c949730e3	ad7529aa-47f7-4207-b0a9-8684ff1e6e80	TCGA-20-1687-01A-01R-1566-13		TCGA-20-1687-01A-01W-0633-09
TCGA-23-1021-01	1	TCGA-23-1021-01	1446	1	High		OV-like c1			miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1021	1446	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Right	TCGA-23-1021-F25567	Stage IV	-16484		1446	0	1446	1181					2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							YES	G3	Locoregional Disease	YES																					WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01				23	>20 mm	Ovary	YES		DECEASED	2004		TCGA-23-1021-01		TCGA-23-1021-01B-01W-0488-09				TCGA-23-1021-01B-01R-1564-13	TCGA-23-1021-01B-01D-0432-05			TCGA-23-1021-01B-01D-0428-01	TCGA-23-1021-01	TCGA-23-1021-01B-01D-0428-01	c3f1fd36-fc3e-48f9-9d09-14d678126742			c3f1fd36-fc3e-48f9-9d09-14d678126742		TCGA-23-1021-01B-01R-1564-13	TCGA-23-1021-01B-01R-0436-07		eb55cb66-59d1-4b7c-a99e-3dd5e38cca85		TCGA-23-1021-01B-01R-1564-13		TCGA-23-1021-01B-01W-0488-09
TCGA-23-1022-01	1	TCGA-23-1022-01	1511	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1022	1511	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67	Left	TCGA-23-1022-F25576	Stage IIIC	-24798		1511	0	1294		450				2009-2-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence				TCGA-23-1022.1A674838-E992-4E9B-82AE-FAFA0AD3BF56.pdf					0	0			10	5	15	5	75	90	75	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary	YES	A	DECEASED	2003		TCGA-23-1022-01		TCGA-23-1022-01A-02W-0488-09				TCGA-23-1022-01A-01R-1564-13	TCGA-23-1022-01A-02D-0432-05			TCGA-23-1022-01A-02D-0428-01	TCGA-23-1022-01	TCGA-23-1022-01A-02D-0428-01	3a8b9a57-2f04-40bd-85e7-2385fa37a913			3a8b9a57-2f04-40bd-85e7-2385fa37a913		TCGA-23-1022-01A-01R-1564-13	TCGA-23-1022-01A-01R-0436-07		430ab09f-2d3f-4a3d-9aac-d6c678e983db		TCGA-23-1022-01A-01R-1564-13		TCGA-23-1022-01A-02W-0488-09
TCGA-23-1023-01	0	TCGA-23-1023-01	1233	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-23-1023	1233	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Right	TCGA-23-1023-F25587	Stage IIIC	-23826			0	1233		490				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8		YES	G3	Recurrence				TCGA-23-1023.98EBC356-C54E-4C1E-9726-BA61397DDA38.pdf					0	20			20	5	10	5	70	70	70	80		WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary	YES	A	LIVING	2005	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01	TCGA-23-1023-01A-03W-0484-10	TCGA-23-1023-01A-03W-0484-10	69bec2db-02c3-46ca-b17b-60eae9a1e0bf			TCGA-23-1023-01R-01R-1564-13,TCGA-23-1023-01A-02R-1564-13	TCGA-23-1023-01A-03D-0432-05,TCGA-23-1023-01R-01D-0807-05	TCGA-23-1023-01	TCGA-23-1023-01	TCGA-23-1023-01A-03D-0428-01	TCGA-23-1023-01	TCGA-23-1023-01A-03D-0428-01	9eacb9f9-40d8-4ff0-803c-c93b169e7d9b	69bec2db-02c3-46ca-b17b-60eae9a1e0bf	69bec2db-02c3-46ca-b17b-60eae9a1e0bf	9eacb9f9-40d8-4ff0-803c-c93b169e7d9b		TCGA-23-1023-01A-02R-1564-13,TCGA-23-1023-01R-01R-1564-13	TCGA-23-1023-01R-01R-0810-07,TCGA-23-1023-01A-02R-0436-07		fcd199f1-6a2a-4b56-977a-6e0959335ca9,d00090cb-c5e2-427f-bdee-5602808ec406	69bec2db-02c3-46ca-b17b-60eae9a1e0bf	TCGA-23-1023-01R-01R-1564-13,TCGA-23-1023-01A-02R-1564-13		
TCGA-23-1024-01	0	TCGA-23-1024-01	468	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1024	468	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Right	TCGA-23-1024-F25604	Stage IV	-19052			0	468						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3					TCGA-23-1024.1CCE5978-6A4D-427A-9875-47617F6A4258.pdf					0	0			10	5	5	5	85	90	80	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			23	1-10 mm	Ovary		A	LIVING	2007	TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01	TCGA-23-1024-01A-02W-0484-10	TCGA-23-1024-01A-02W-0484-10				TCGA-23-1024-01A-02R-1564-13	TCGA-23-1024-01A-02D-0432-05			TCGA-23-1024-01A-02D-0428-01	TCGA-23-1024-01	TCGA-23-1024-01A-02D-0428-01	5b4bb383-e1cd-46a4-a623-a6c7883237dd			5b4bb383-e1cd-46a4-a623-a6c7883237dd		TCGA-23-1024-01A-02R-1564-13	TCGA-23-1024-01A-02R-0436-07		15e969ea-df91-4ade-9f5f-91f317ac7573		TCGA-23-1024-01A-02R-1564-13		
TCGA-23-1026-01	0	TCGA-23-1026-01	816	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-23-1026	816	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Left	TCGA-23-1026-F25610	Stage IIIC	-16442			0	816		797				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8			G3	Recurrence									5	5			0	0					80	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary		B	LIVING	2004	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01	TCGA-23-1026-01B-01W-0484-10	TCGA-23-1026-01B-01W-0484-10	973907c7-f259-4d1a-b9df-68db1837af91			TCGA-23-1026-01B-01R-1569-13	TCGA-23-1026-01B-01D-0432-05	TCGA-23-1026-01	TCGA-23-1026-01	TCGA-23-1026-01B-01D-0428-01	TCGA-23-1026-01	TCGA-23-1026-01B-01D-0428-01	205f2c4a-d28c-47bc-990e-5c11ff2017cd	973907c7-f259-4d1a-b9df-68db1837af91	973907c7-f259-4d1a-b9df-68db1837af91	205f2c4a-d28c-47bc-990e-5c11ff2017cd		TCGA-23-1026-01B-01R-1569-13	TCGA-23-1026-01B-01R-0436-07		fca7646c-094b-4720-a550-f3e066f24431	973907c7-f259-4d1a-b9df-68db1837af91	TCGA-23-1026-01B-01R-1569-13		
TCGA-23-1027-01	1	TCGA-23-1027-01	976	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1027	976	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Right	TCGA-23-1027-F25616	Stage IIIC	-17588		976	0	966		114				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence																							YES	Progressive Disease			NO		Primary Tumor	01				23	1-10 mm	Ovary	YES		DECEASED	2005		TCGA-23-1027-01		TCGA-23-1027-01A-02W-0486-08	edbc81a6-2593-45c5-8131-3c4615d1807f			TCGA-23-1027-01A-02R-1564-13	TCGA-23-1027-01A-02D-0432-05	TCGA-23-1027-01	TCGA-23-1027-01	TCGA-23-1027-01A-02D-0428-01	TCGA-23-1027-01	TCGA-23-1027-01A-02D-0428-01	aab18c3a-4453-43e9-aa21-1abcfe39f526	edbc81a6-2593-45c5-8131-3c4615d1807f	edbc81a6-2593-45c5-8131-3c4615d1807f	aab18c3a-4453-43e9-aa21-1abcfe39f526		TCGA-23-1027-01A-02R-1564-13	TCGA-23-1027-01A-02R-0436-07		acb73086-38dd-4ed6-9d1c-d14dcd155936	edbc81a6-2593-45c5-8131-3c4615d1807f	TCGA-23-1027-01A-02R-1564-13	TCGA-23-1027-01A-02W-0486-08	
TCGA-23-1028-01	0	TCGA-23-1028-01	1503	0	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1028	1503	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	43	Left	TCGA-23-1028-F25624	Stage IIIC	-16018			0	1503		133				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8		YES	G3	Recurrence				TCGA-23-1028.CCD0A1B3-DE92-473C-AA1B-8EE25DE408A2.pdf					5	5			15	10	10	10	70	75	75	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary	YES	A	LIVING	2004	TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01	TCGA-23-1028-01A-01W-0484-10	TCGA-23-1028-01A-01W-0484-10				TCGA-23-1028-01A-01R-1564-13	TCGA-23-1028-01A-01D-0432-05			TCGA-23-1028-01A-01D-0428-01	TCGA-23-1028-01	TCGA-23-1028-01A-01D-0428-01	773bff37-5ef8-462d-b742-56db7a09015a			773bff37-5ef8-462d-b742-56db7a09015a		TCGA-23-1028-01A-01R-1564-13	TCGA-23-1028-01A-01R-0436-07		511adb99-1cae-481e-8da7-f4cdc4d5f385		TCGA-23-1028-01A-01R-1564-13		
TCGA-23-1029-01	0	TCGA-23-1029-01	268	0	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-23-1029	268	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Right	TCGA-23-1029-F25639	Stage IIIC	-16889			0	268						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8			G3										5	0			0	0	20	20	75	80	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary		B	LIVING	2007		TCGA-23-1029-01			9a54d0fe-f998-4866-bb1f-92be472d843a			TCGA-23-1029-01B-01R-1567-13	TCGA-23-1029-01B-01D-0581-05	TCGA-23-1029-01	TCGA-23-1029-01	TCGA-23-1029-01B-01D-0577-01	TCGA-23-1029-01	TCGA-23-1029-01B-01D-0577-01	050b0445-dde0-48c6-9a0f-9c041567cf3a	9a54d0fe-f998-4866-bb1f-92be472d843a	9a54d0fe-f998-4866-bb1f-92be472d843a	050b0445-dde0-48c6-9a0f-9c041567cf3a		TCGA-23-1029-01B-01R-1567-13	TCGA-23-1029-01B-01R-0584-07		fcd48515-450a-4a24-b92d-8fb4eb4890b3	9a54d0fe-f998-4866-bb1f-92be472d843a	TCGA-23-1029-01B-01R-1567-13		TCGA-23-1029-01B-01W-0639-09
TCGA-23-1030-01	0	TCGA-23-1030-01	886	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-1030	886	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	64	Left	TCGA-23-1030-F25643	Stage IIIC	-23416			0	886		544				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5		YES	G3	Recurrence				TCGA-23-1030.E44D825F-89EE-4FF7-B6D6-B0B17E305B2C.pdf					5	0			5	5	5	0	85	95	95	95		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			23	1-10 mm	Ovary	YES	A	LIVING	2006		TCGA-23-1030-01		TCGA-23-1030-01A-02W-0486-08				TCGA-23-1030-01A-02R-1564-13	TCGA-23-1030-01A-02D-0432-05			TCGA-23-1030-01A-02D-0428-01	TCGA-23-1030-01	TCGA-23-1030-01A-02D-0428-01	674cc1fd-0abf-4b98-97a0-ef3870382296			674cc1fd-0abf-4b98-97a0-ef3870382296		TCGA-23-1030-01A-02R-1564-13	TCGA-23-1030-01A-02R-0436-07		b1f62bf0-8681-4b6d-ab78-a7c5757770a4		TCGA-23-1030-01A-02R-1564-13	TCGA-23-1030-01A-02W-0486-08	
TCGA-23-1031-01	1	TCGA-23-1031-01	575	1	High		OV-like c1					mutation cluster 5	TCGA-23-1031	575	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Left	TCGA-23-1031-F25649	Stage IV	-22225		575	0	575						2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7			G3					TCGA-23-1031.6D440E0F-B290-48CB-8445-C268B444ADE1.pdf					15	0			5	10	5	5	75	85	85	90		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary		A	DECEASED	2003		TCGA-23-1031-01		TCGA-23-1031-01A-01W-0486-08					TCGA-23-1031-01A-01D-0432-05			TCGA-23-1031-01A-01D-0428-01	TCGA-23-1031-01	TCGA-23-1031-01A-01D-0428-01	9d058d5f-d55f-4286-87cb-5654b838ee4e			9d058d5f-d55f-4286-87cb-5654b838ee4e			TCGA-23-1031-01A-01R-0436-07		c85b3936-20a5-41cb-ad0d-d184c2c1f6d9			TCGA-23-1031-01A-01W-0486-08	
TCGA-23-1032-01	1	TCGA-23-1032-01	84	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1032	84	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Right	TCGA-23-1032-F25659	Stage IV	-26715		84	0	68						2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1			G3					TCGA-23-1032.6E8A5413-EB7E-49D8-8E11-8CA6A912ED50.pdf					15	0			10	20	5	5	70	75	85	85		WITH TUMOR	NO				NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary		A	DECEASED	2002		TCGA-23-1032-01		TCGA-23-1032-01A-02W-0486-08				TCGA-23-1032-01A-02R-1564-13	TCGA-23-1032-01A-02D-0432-05			TCGA-23-1032-01A-02D-0428-01	TCGA-23-1032-01	TCGA-23-1032-01A-02D-0428-01	b16a8ed4-36b0-48b4-b5de-b48d6d4fb99d			b16a8ed4-36b0-48b4-b5de-b48d6d4fb99d		TCGA-23-1032-01A-02R-1564-13	TCGA-23-1032-01A-02R-0436-07		986863dd-b61b-48c2-a37c-af21fed7e778		TCGA-23-1032-01A-02R-1564-13	TCGA-23-1032-01A-02W-0486-08	
TCGA-23-1107-01	1	TCGA-23-1107-01	9	1	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-23-1107	9	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Left	TCGA-23-1107-F25661	Stage IV	-21561		9	0	9						2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3					TCGA-23-1107.700802e6-8058-4485-8210-3e5b8f10bbf3.pdf					5	5			0	0	0	0	0	0	90	90		WITH TUMOR	NO				NO		Primary Tumor	01	0.6			23	>20 mm	Ovary		A	DECEASED	1999	TCGA-23-1107-01A-01W-0484-10		TCGA-23-1107-01A-01W-0484-10					TCGA-23-1107-01A-01R-1564-13	TCGA-23-1107-01A-01D-0432-05				TCGA-23-1107-01							TCGA-23-1107-01A-01R-1564-13	TCGA-23-1107-01A-01R-0436-07		7f426322-5acf-4d04-8bd6-93ec56bffd0f		TCGA-23-1107-01A-01R-1564-13		
TCGA-23-1109-01	1	TCGA-23-1109-01	1562	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-23-1109	1562	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	62	Right	TCGA-23-1109-F25663	Stage IIIC	-23002		1562	0	1562		987				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01				23	1-10 mm	Ovary			DECEASED	1999	TCGA-23-1109-01A-01W-0484-10	TCGA-23-1109-01	TCGA-23-1109-01A-01W-0484-10		d47e074a-f78e-40c5-8af4-f737ce010041	b8d71b4b-6d11-47da-b15d-a3eac835a9a9		TCGA-23-1109-01A-01R-1564-13	TCGA-23-1109-01A-01D-0432-05	TCGA-23-1109-01	TCGA-23-1109-01	TCGA-23-1109-01A-01D-0428-01	TCGA-23-1109-01	TCGA-23-1109-01A-01D-0428-01	bbfeaa5c-22e3-4948-bcb9-db40a8e1f737	d47e074a-f78e-40c5-8af4-f737ce010041	d47e074a-f78e-40c5-8af4-f737ce010041	bbfeaa5c-22e3-4948-bcb9-db40a8e1f737	TCGA-23-1109-01A-21-1562-20	TCGA-23-1109-01A-01R-1564-13	TCGA-23-1109-01A-01R-0436-07		ef6ecfd8-badc-4863-a3d5-fc20161f09dc	d47e074a-f78e-40c5-8af4-f737ce010041	TCGA-23-1109-01A-01R-1564-13		
TCGA-23-1110-01	0	TCGA-23-1110-01	1658	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-23-1110	1658	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	42	Right	TCGA-23-1110-F25666	Stage IIIC	-15383			0	1658		326				2009-2-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3	Recurrence				TCGA-23-1110.07361efd-0b7d-4dcb-afe3-464200f59ac0.pdf					5	0			0	0					95	95		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			23	No Macroscopic disease	Ovary	YES	A	LIVING	2003		TCGA-23-1110-01		TCGA-23-1110-01A-01D-0428-08		e36ba512-a711-4e42-80ce-94edb0be836e		TCGA-23-1110-01A-01R-1564-13	TCGA-23-1110-01A-01D-0432-05			TCGA-23-1110-01A-01D-0428-01	TCGA-23-1110-01	TCGA-23-1110-01A-01D-0428-01	fd1d363e-fef7-4b4e-b8cf-581dac29eafe			fd1d363e-fef7-4b4e-b8cf-581dac29eafe	TCGA-23-1110-01A-11-1562-20	TCGA-23-1110-01A-01R-1564-13	TCGA-23-1110-01A-01R-0436-07		811e848e-6289-4821-8640-c645e2b3f57e		TCGA-23-1110-01A-01R-1564-13	TCGA-23-1110-01A-01D-0428-08	
TCGA-23-1111-01	0	TCGA-23-1111-01	98	0	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 4		TCGA-23-1111	98	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Right	TCGA-23-1111-F25672	Stage IIIC	-23171			0	98						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		0.9		YES	G3					TCGA-23-1111.ba3ae03c-74d4-4b5f-849f-71466bae7c0e.pdf					5	5									95	95			YES				NO		Primary Tumor	01	0.4			23	>20 mm	Ovary		A	LIVING	2008		TCGA-23-1111-01			f38e46dc-67b9-448a-8d24-507291e55bca	8e14b0f8-af54-486f-9ecc-8b62eb434ad4		TCGA-23-1111-01A-01R-1567-13	TCGA-23-1111-01A-01D-0581-05	TCGA-23-1111-01	TCGA-23-1111-01	TCGA-23-1111-01A-01D-0577-01	TCGA-23-1111-01	TCGA-23-1111-01A-01D-0577-01	abe2d46a-0cd4-420d-9194-8e3588f3e696	f38e46dc-67b9-448a-8d24-507291e55bca	f38e46dc-67b9-448a-8d24-507291e55bca	abe2d46a-0cd4-420d-9194-8e3588f3e696	TCGA-23-1111-01A-21-20	TCGA-23-1111-01A-01R-1567-13	TCGA-23-1111-01A-01R-0584-07		190f5d18-230f-417f-b10c-992c28dcf418	f38e46dc-67b9-448a-8d24-507291e55bca	TCGA-23-1111-01A-01R-1567-13		TCGA-23-1111-01A-01W-0639-09
TCGA-23-1113-01	1	TCGA-23-1113-01	949	1	Squamous		OV-like c1			miRNA cluster 2	cluster 1		TCGA-23-1113	949	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Left	TCGA-23-1113-F25677	Stage IV	-17791		949	0	949						2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		YES	G3					TCGA-23-1113.a7fa848e-2492-4802-9cb2-58ec66fc3dd4.pdf					1	5			0	0					95	95		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.8			23	1-10 mm	Ovary		A	DECEASED	2002		TCGA-23-1113-01						TCGA-23-1113-01A-01R-1564-13	TCGA-23-1113-01A-01D-0432-05			TCGA-23-1113-01A-01D-0428-01	TCGA-23-1113-01	TCGA-23-1113-01A-01D-0428-01	3ea8c102-7d7b-49a5-893b-a1ea2fdbe6ae			3ea8c102-7d7b-49a5-893b-a1ea2fdbe6ae		TCGA-23-1113-01A-01R-1564-13	TCGA-23-1113-01A-01R-0436-07		a418120d-175f-4f72-b81f-02528d563418		TCGA-23-1113-01A-01R-1564-13		
TCGA-23-1114-01	1	TCGA-23-1114-01	2089	1	High		OV-like c1		OV-like c16	miRNA cluster 2	cluster 1		TCGA-23-1114	2089	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Left	TCGA-23-1114-F25685	Stage IIIC	-20409		2089	0	2089		634				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3	Recurrence									0	0			0	0	20	20	80	80	80	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			23	No Macroscopic disease	Ovary		B	DECEASED	2000		TCGA-23-1114-01			7cfe1419-65be-4860-9f99-75f4a139d9ac			TCGA-23-1114-01B-01R-1566-13	TCGA-23-1114-01B-01D-0563-05	TCGA-23-1114-01	TCGA-23-1114-01	TCGA-23-1114-01B-01D-0559-01	TCGA-23-1114-01	TCGA-23-1114-01B-01D-0559-01	0f187781-18d6-4a79-8d57-e0076abf1440	7cfe1419-65be-4860-9f99-75f4a139d9ac	7cfe1419-65be-4860-9f99-75f4a139d9ac	0f187781-18d6-4a79-8d57-e0076abf1440		TCGA-23-1114-01B-01R-1566-13	TCGA-23-1114-01B-01R-0566-07		7ee203ae-339a-4534-9e72-0dd723890ad1	7cfe1419-65be-4860-9f99-75f4a139d9ac	TCGA-23-1114-01B-01R-1566-13		TCGA-23-1114-01B-01W-0633-09
TCGA-23-1116-01	0	TCGA-23-1116-01	139	0	High		OV-like c1					mutation cluster 8	TCGA-23-1116	139	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			83	Left	TCGA-23-1116-F25747	Stage IIIC	-30464			0	139						2009-2-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							YES	G3																								YES				NO		Primary Tumor	01				23	>20 mm	Ovary	YES		LIVING	2008		TCGA-23-1116-01		TCGA-23-1116-01A-01W-0486-08					TCGA-23-1116-01A-01D-0432-05			TCGA-23-1116-01A-01D-0428-01	TCGA-23-1116-01	TCGA-23-1116-01A-01D-0428-01	f18ae0f5-b5bf-48d6-afb0-10a7c816c8fa			f18ae0f5-b5bf-48d6-afb0-10a7c816c8fa		TCGA-23-1116-01A-01R-1564-13	TCGA-23-1116-01A-01R-0436-07		e7a2e1cf-9175-4d4b-9f6a-ccace71a5267		TCGA-23-1116-01A-01R-1564-13	TCGA-23-1116-01A-01W-0486-08	
TCGA-23-1117-01	1	TCGA-23-1117-01	1013	1	High		OV-like c1					mutation cluster 8	TCGA-23-1117	1013	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	42	Left	TCGA-23-1117-F25699	Stage IIIC	-15690		1013	0	1013		418				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence				TCGA-23-1117.abc636a1-677d-49e5-9259-5b5b828a575e.pdf					5	5			0	0					80	70		WITH TUMOR	NO	Complete Remission/Response		Other Method: Specify In Notes	YES		Primary Tumor	01	0.4			23	1-10 mm	Ovary	YES	A	DECEASED	1998		TCGA-23-1117-01		TCGA-23-1117-01A-02W-0488-09					TCGA-23-1117-01A-02D-0432-05			TCGA-23-1117-01A-02D-0428-01	TCGA-23-1117-01	TCGA-23-1117-01A-02D-0428-01	30fd69a7-2999-4688-a8fd-94924b2dbc9d			30fd69a7-2999-4688-a8fd-94924b2dbc9d			TCGA-23-1117-01A-02R-0436-07		7cf2b05a-4475-44db-af64-1889f8073941				TCGA-23-1117-01A-02W-0488-09
TCGA-23-1118-01	0	TCGA-23-1118-01	2616	0	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-1118	2616	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Left	TCGA-23-1118-F25708	Stage IIIC	-16471			0	2616						2009-2-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3					TCGA-23-1118.2f53a2c6-b67a-4966-b300-5e00968b15f3.pdf					10	0									90	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.7			23	>20 mm	Ovary	YES	A	LIVING	2001		TCGA-23-1118-01		TCGA-23-1118-01A-01W-0488-09				TCGA-23-1118-01A-01R-1564-13	TCGA-23-1118-01A-01D-0432-05			TCGA-23-1118-01A-01D-0428-01	TCGA-23-1118-01	TCGA-23-1118-01A-01D-0428-01	0c197459-f7e7-4097-9294-d7037c5f129d			0c197459-f7e7-4097-9294-d7037c5f129d		TCGA-23-1118-01A-01R-1564-13	TCGA-23-1118-01A-01R-0436-07		cbd86cfc-faa7-40dd-a544-3c0dba5849aa		TCGA-23-1118-01A-01R-1564-13		TCGA-23-1118-01A-01W-0488-09
TCGA-23-1119-01	0	TCGA-23-1119-01	3953	0	Squamous		OV-like c1			miRNA cluster 1	cluster 4		TCGA-23-1119	3953	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	64	Left	TCGA-23-1119-F25711	Stage IIIC	-23686			0	3953		3378				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3	Recurrence				TCGA-23-1119.86389912-6945-49e6-9255-e7a41fde197a.pdf					1	1			0	0	0	0	0	0	95	90		TUMOR FREE	YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary	YES	A	LIVING	1997	TCGA-23-1119-01A-02W-0484-10	TCGA-23-1119-01	TCGA-23-1119-01A-02W-0484-10					TCGA-23-1119-01A-02R-1565-13	TCGA-23-1119-01A-02D-0432-05			TCGA-23-1119-01A-02D-0428-01	TCGA-23-1119-01	TCGA-23-1119-01A-02D-0428-01	d8df3e6b-5174-4a19-9382-786b168a0afe			d8df3e6b-5174-4a19-9382-786b168a0afe		TCGA-23-1119-01A-02R-1565-13	TCGA-23-1119-01A-02R-0436-07		14dd1630-da1d-47ca-bae2-457903a26761		TCGA-23-1119-01A-02R-1565-13		
TCGA-23-1120-01	0	TCGA-23-1120-01	130	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 2	TCGA-23-1120	130	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Right	TCGA-23-1120-F25715	Stage IIIC	-22148			0	130						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.8		NO	G3					TCGA-23-1120.e12ef7d5-6fa8-46fa-bedc-da6ddbbecc37.pdf					10	10			0	0	0	0	0	0	95	95			YES				NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary	NO	A	LIVING	2008	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01	TCGA-23-1120-01A-02W-0484-10	TCGA-23-1120-01A-02W-0484-10	9b64998e-eed9-428b-97ac-4de398caaf81			TCGA-23-1120-01A-02R-1565-13	TCGA-23-1120-01A-02D-0432-05	TCGA-23-1120-01	TCGA-23-1120-01	TCGA-23-1120-01A-02D-0428-01	TCGA-23-1120-01	TCGA-23-1120-01A-02D-0428-01	63b975f5-48ad-42ca-b3e8-16c63c7cbcaa	9b64998e-eed9-428b-97ac-4de398caaf81	9b64998e-eed9-428b-97ac-4de398caaf81	63b975f5-48ad-42ca-b3e8-16c63c7cbcaa		TCGA-23-1120-01A-02R-1565-13	TCGA-23-1120-01A-02R-0436-07		0486be96-3c9f-41a7-9115-295646258378	9b64998e-eed9-428b-97ac-4de398caaf81	TCGA-23-1120-01A-02R-1565-13		
TCGA-23-1121-01	0	TCGA-23-1121-01	194	0	High		Cluster 5	OV-like c4		miRNA cluster 1	cluster 5		TCGA-23-1121	194	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Left	TCGA-23-1121-F25719	Stage IIIC	-18983			0	194						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.2		YES	G3					TCGA-23-1121.ed14039c-9ecf-4e01-9a1c-7a227847b8a3.pdf					5	1			0	0	0	0	0	0	95	95			YES				NO		Primary Tumor	01	0.6			23	>20 mm	Ovary		A	LIVING	2008		TCGA-23-1121-01				97eb2839-fc59-4c0a-a075-b5fd802799c6		TCGA-23-1121-01A-01R-1569-13	TCGA-23-1121-01A-01D-0432-05			TCGA-23-1121-01A-01D-0428-01	TCGA-23-1121-01	TCGA-23-1121-01A-01D-0428-01	5b4a72f9-5cee-49ad-8d8c-1639e20083ce			5b4a72f9-5cee-49ad-8d8c-1639e20083ce	TCGA-23-1121-01A-11-1562-20		TCGA-23-1121-01A-01R-0436-07		e3fca11d-248c-4852-ad4b-09867693fd39				
TCGA-23-1122-01	1	TCGA-23-1122-01	1189	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-23-1122	1189	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	53	Left	TCGA-23-1122-F25724	Stage IIIC	-19537		1189	0	1189		447				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1		NO	G3	Recurrence				TCGA-23-1122.9507d553-b1c7-4b71-90c1-064fd8ef15ba.pdf					1	1			0	0					80	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			23	1-10 mm	Ovary		A	DECEASED	1998		TCGA-23-1122-01		TCGA-23-1122-01A-01W-0486-08	54b75801-ad36-49a1-b0c2-edc0053b897e	2877f544-7459-4a43-9e89-a014008f6a58		TCGA-23-1122-01A-01R-1565-13	TCGA-23-1122-01A-01D-0432-05	TCGA-23-1122-01	TCGA-23-1122-01	TCGA-23-1122-01A-01D-0428-01	TCGA-23-1122-01	TCGA-23-1122-01A-01D-0428-01	6a4eb92b-ed80-40ce-8275-922cfcd1b1f2	54b75801-ad36-49a1-b0c2-edc0053b897e	54b75801-ad36-49a1-b0c2-edc0053b897e	6a4eb92b-ed80-40ce-8275-922cfcd1b1f2	TCGA-23-1122-01A-11-1562-20	TCGA-23-1122-01A-01R-1565-13	TCGA-23-1122-01A-01R-0436-07		c619e051-c770-4ed9-957b-b27ec8784864	54b75801-ad36-49a1-b0c2-edc0053b897e	TCGA-23-1122-01A-01R-1565-13	TCGA-23-1122-01A-01W-0486-08	
TCGA-23-1123-01	1	TCGA-23-1123-01	1018	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-23-1123	1018	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Left	TCGA-23-1123-F25733	Stage IIIC	-21552		1018	0	1018						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3					TCGA-23-1123.28f9189b-24eb-4540-8551-4eaacc296c20.pdf					5	0			0	0	0	0	0	0	95	95		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.6			23	11-20 mm	Ovary		A	DECEASED	1998		TCGA-23-1123-01		TCGA-23-1123-01A-01W-0488-09	71543abc-9f15-48d9-994d-e7b963a4d8f3	184da43f-2906-495a-a714-031b30a78cdb		TCGA-23-1123-01A-01R-1565-13	TCGA-23-1123-01A-01D-0432-05	TCGA-23-1123-01	TCGA-23-1123-01	TCGA-23-1123-01A-01D-0428-01	TCGA-23-1123-01	TCGA-23-1123-01A-01D-0428-01	68b7f950-ef65-40a8-8ead-3c28e800c770	71543abc-9f15-48d9-994d-e7b963a4d8f3	71543abc-9f15-48d9-994d-e7b963a4d8f3	68b7f950-ef65-40a8-8ead-3c28e800c770	TCGA-23-1123-01A-11-1562-20	TCGA-23-1123-01A-01R-1565-13	TCGA-23-1123-01A-01R-0436-07		c7657407-5f4d-441a-a943-90315de8c660	71543abc-9f15-48d9-994d-e7b963a4d8f3	TCGA-23-1123-01A-01R-1565-13		TCGA-23-1123-01A-01W-0488-09
TCGA-23-1124-01	1	TCGA-23-1124-01	1768	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-1124	1768	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62	Left	TCGA-23-1124-F25739	Stage IIIC	-23005		1768	0	1768		641				2009-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		YES	G3	Recurrence				TCGA-23-1124.71415169-cb24-4d07-b9c7-a71ce0424d0d.pdf					5	10			0	0	0	0	0	0	95	90		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.6			23	No Macroscopic disease	Ovary	YES	A	DECEASED	1999		TCGA-23-1124-01		TCGA-23-1124-01A-01W-0488-09		fe87e0a2-b27c-402c-81d8-ec0d24e7ce81		TCGA-23-1124-01A-01R-1565-13	TCGA-23-1124-01A-01D-0432-05			TCGA-23-1124-01A-01D-0428-01	TCGA-23-1124-01	TCGA-23-1124-01A-01D-0428-01	5fc24346-0d8a-4f26-9b42-f52d5fbd94e4			5fc24346-0d8a-4f26-9b42-f52d5fbd94e4	TCGA-23-1124-01A-11-1562-20		TCGA-23-1124-01A-01R-0436-07		e707d0a2-6e26-48dc-9020-ae36b666321a				TCGA-23-1124-01A-01W-0488-09
TCGA-23-1809-01	0	TCGA-23-1809-01	16	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-23-1809	16	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Right	TCGA-23-1809-F25753	Stage IIC	-23111			0	16						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.9		NO	G3					TCGA-23-1809.f69b3aba-61df-4fd8-94d7-9bb80692464c.pdf					10	10			0	0	20	20	70	70	80	80			YES				NO		Primary Tumor	01	0.4			23	1-10 mm	Ovary	NO	A	LIVING	2009		TCGA-23-1809-01			ac764277-4d48-489a-8625-f27541b11258	2341af5b-d30e-4ae0-9384-119f66a797ed		TCGA-23-1809-01A-01R-1566-13	TCGA-23-1809-01A-01D-0563-05	TCGA-23-1809-01	TCGA-23-1809-01	TCGA-23-1809-01A-01D-0559-01	TCGA-23-1809-01	TCGA-23-1809-01A-01D-0559-01	292a1f0d-0e96-48ab-b8c3-4a5b98cd9ca4	ac764277-4d48-489a-8625-f27541b11258	ac764277-4d48-489a-8625-f27541b11258	292a1f0d-0e96-48ab-b8c3-4a5b98cd9ca4	TCGA-23-1809-01A-21-1559-20	TCGA-23-1809-01A-01R-1566-13	TCGA-23-1809-01A-01R-0566-07		2bf22a99-e464-4889-9c1c-0208d5df2f36	ac764277-4d48-489a-8625-f27541b11258	TCGA-23-1809-01A-01R-1566-13		TCGA-23-1809-01A-01W-0633-09
TCGA-23-2072-01	1	TCGA-23-2072-01	759	1	High		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-23-2072	759	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Right	TCGA-23-2072-F25757	Stage IV	-21523		759	0	759		476				2009-11-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-23-2072.b0475cc1-edd5-451c-8f26-ec3594811f2e.pdf					5	1			0	0	10	5	85	94	90	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			23	>20 mm	Ovary		A	DECEASED	2000		TCGA-23-2072-01		TCGA-23-2072-01A-01W-0722-08				TCGA-23-2072-01A-01R-1568-13	TCGA-23-2072-01A-01D-0667-05			TCGA-23-2072-01A-01D-0663-01	TCGA-23-2072-01	TCGA-23-2072-01A-01D-0663-01	71165841-5984-4594-a722-cefc62ccf65f			71165841-5984-4594-a722-cefc62ccf65f			TCGA-23-2072-01A-01R-0670-07		5ba9bc54-191b-4a8b-8571-24a780a2e7d5			TCGA-23-2072-01A-01W-0722-08	
TCGA-23-2077-01	0	TCGA-23-2077-01	3525	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-23-2077	3525	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Left	TCGA-23-2077-F25763	Stage IIIC	-16552			0	3525		1232				2009-11-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.1		NO	G3	Recurrence				TCGA-23-2077.55589297-f28e-422c-beee-6cb19a2350be.pdf					0	0			0	0	5	5	95	95	95	95		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			23	No Macroscopic disease	Ovary	YES	A	LIVING	1999		TCGA-23-2077-01		TCGA-23-2077-01A-01W-0722-08	16c61c5a-a9b3-4022-9b79-d593e3519794	3848ccad-5f29-40f6-8407-05e548a3b8e5		TCGA-23-2077-01A-01R-1568-13	TCGA-23-2077-01A-01D-0667-05	TCGA-23-2077-01	TCGA-23-2077-01	TCGA-23-2077-01A-01D-0663-01	TCGA-23-2077-01	TCGA-23-2077-01A-01D-0663-01	ce80ec8f-3643-4ca1-9907-05aead9e9eab	16c61c5a-a9b3-4022-9b79-d593e3519794	16c61c5a-a9b3-4022-9b79-d593e3519794	ce80ec8f-3643-4ca1-9907-05aead9e9eab	TCGA-23-2077-01A-21-1560-20	TCGA-23-2077-01A-01R-1568-13	TCGA-23-2077-01A-01R-0670-07		2db607b0-cd7f-4686-9f85-a119b089ed7f	16c61c5a-a9b3-4022-9b79-d593e3519794	TCGA-23-2077-01A-01R-1568-13	TCGA-23-2077-01A-01W-0722-08	
TCGA-23-2078-01	0	TCGA-23-2078-01	2661	0	Squamous	C9-OV	OV-like c1	KIRC-like c1		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-23-2078	2661	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66	Bilateral	TCGA-23-2078-F25771	Stage IIIC	-24223			0	2661						2009-11-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.9		YES	G3					TCGA-23-2078.19ed5fbe-17e1-43f3-bfa0-32f474a00be8.pdf					1	1			0	0	10	10	89	89	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary	YES	A	LIVING	2001		TCGA-23-2078-01		TCGA-23-2078-01A-01W-0722-08		5ea02416-3cd8-443c-8336-4ad367757f38		TCGA-23-2078-01A-01R-1568-13	TCGA-23-2078-01A-01D-0667-05			TCGA-23-2078-01A-01D-0663-01	TCGA-23-2078-01	TCGA-23-2078-01A-01D-0663-01	71ed9464-f906-4796-9993-2662d32bf372			71ed9464-f906-4796-9993-2662d32bf372	TCGA-23-2078-01A-21-1560-20	TCGA-23-2078-01A-01R-1568-13	TCGA-23-2078-01A-01R-0670-07		ec2fe757-24f2-4ffc-bf20-f6d6632eb775		TCGA-23-2078-01A-01R-1568-13	TCGA-23-2078-01A-01W-0722-08	
TCGA-23-2079-01	0	TCGA-23-2079-01	2788	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-23-2079	2788	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	46	Bilateral	TCGA-23-2079-F25775	Stage IIIC	-17122			0	2788		283				2009-11-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3	Recurrence				TCGA-23-2079.66ace408-fc31-463b-a218-94fdef0afaaf.pdf					1	1			0	0	10	10	89	89	90	90		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			23	No Macroscopic disease	Ovary	YES	A	LIVING	2001		TCGA-23-2079-01		TCGA-23-2079-01A-01W-0722-08		527e6a80-10fe-4b9d-9169-63ea62681e4a		TCGA-23-2079-01A-01R-1568-13	TCGA-23-2079-01A-01D-0667-05			TCGA-23-2079-01A-01D-0663-01	TCGA-23-2079-01	TCGA-23-2079-01A-01D-0663-01	41902ab1-665f-40dd-88f6-89d3efdbf897			41902ab1-665f-40dd-88f6-89d3efdbf897	TCGA-23-2079-01A-21-1560-20		TCGA-23-2079-01A-01R-0670-07		6bbbfad0-800f-4537-99f2-6d5f1e5bdab0			TCGA-23-2079-01A-01W-0722-08	
TCGA-23-2081-01	1	TCGA-23-2081-01	2342	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-23-2081	2342	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-23-2081-F25781	Stage IV	-18162		2342	0	2342	250					2009-11-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.2	YES	Tumor resection		0.7	NO		0.8		YES	G3	Locoregional Disease	YES			TCGA-23-2081.05dc597f-052a-461e-a67c-27dac0d10972.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.5			23	1-10 mm	Ovary		A	DECEASED	2000		TCGA-23-2081-01		TCGA-23-2081-01A-01W-0722-08	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	330a8af7-1a12-46a0-8ede-ca4e244de117		TCGA-23-2081-01A-01R-1568-13	TCGA-23-2081-01A-01D-0667-05	TCGA-23-2081-01	TCGA-23-2081-01	TCGA-23-2081-01A-01D-0663-01	TCGA-23-2081-01	TCGA-23-2081-01A-01D-0663-01	02e34699-d3cd-4dba-b8ab-9038ca6a14a5	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	02e34699-d3cd-4dba-b8ab-9038ca6a14a5	TCGA-23-2081-01A-21-1560-20	TCGA-23-2081-01A-01R-1568-13	TCGA-23-2081-01A-01R-0670-07		c5bdab9f-b9fc-4f96-bc7b-b5a65ec3cf68	4c8dd391-5a1c-490e-a7d7-fde372c3ec47	TCGA-23-2081-01A-01R-1568-13	TCGA-23-2081-01A-01W-0722-08	
TCGA-23-2084-01	1	TCGA-23-2084-01	1516	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-23-2084	1516	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Right	TCGA-23-2084-F25795	Stage IV	-16493		1516	0	1516		619				2009-11-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.4		YES	G3	Recurrence				TCGA-23-2084.00fd3d04-b48e-434e-8d25-0f0949e796cc.pdf					0	0			1	1	14	9	85	90	85	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary	YES	A	DECEASED	2000		TCGA-23-2084-01			858a382c-49dc-4990-8c0f-017fedd9a6db			TCGA-23-2084-01A-02R-1568-13	TCGA-23-2084-01A-02D-0667-05	TCGA-23-2084-01	TCGA-23-2084-01	TCGA-23-2084-01A-02D-0663-01	TCGA-23-2084-01	TCGA-23-2084-01A-02D-0663-01	d92637ed-8213-4983-b661-16563f7ac3d6	858a382c-49dc-4990-8c0f-017fedd9a6db	858a382c-49dc-4990-8c0f-017fedd9a6db	d92637ed-8213-4983-b661-16563f7ac3d6		TCGA-23-2084-01A-02R-1568-13	TCGA-23-2084-01A-02R-0670-07		6c08e99a-bd74-4e72-8d22-4295edfe6225	858a382c-49dc-4990-8c0f-017fedd9a6db	TCGA-23-2084-01A-02R-1568-13		
TCGA-23-2641-01	0	TCGA-23-2641-01	84	0	Squamous		OV-like c1	OV-like c4					TCGA-23-2641	84	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			85	Left	TCGA-23-2641-F25810	Stage IIIC	-31232			0	84						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3					TCGA-23-2641.0b8f79ba-dbf1-4978-9661-bb0b0dcc8768.pdf					5	5			0	0	10	5	85	90	95	95			YES				NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary		A	LIVING	2009		TCGA-23-2641-01				42dc7e58-4deb-4a79-8b08-67295835b807			TCGA-23-2641-01A-01D-1047-05			TCGA-23-2641-01A-01D-1043-01	TCGA-23-2641-01	TCGA-23-2641-01A-01D-1043-01	aa165d1a-3a7a-47ee-91af-0db54af08ca2			aa165d1a-3a7a-47ee-91af-0db54af08ca2	TCGA-23-2641-01A-21-20		TCGA-23-2641-01A-01R-1050-07		c7559a8a-552e-44e1-97dd-d3a333a5e283				TCGA-23-2641-01A-01D-1526-09
TCGA-23-2643-01	0	TCGA-23-2643-01	143	0	High		OV-like c1	OV-like c4					TCGA-23-2643	143	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Right	TCGA-23-2643-F25812	Stage IIIC	-27093			0	143						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2			G3					TCGA-23-2643.8481bd3e-147d-4a67-acdd-08fea5be431a.pdf					0	0			0	0	20	30	80	70	90	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary		A	LIVING	2009		TCGA-23-2643-01				061c8e23-337c-49f7-84bb-9289b1e71595			TCGA-23-2643-01A-01D-1047-05			TCGA-23-2643-01A-01D-1043-01	TCGA-23-2643-01	TCGA-23-2643-01A-01D-1043-01	008c0e5f-0fd9-447e-a77c-afc20cb109e6			008c0e5f-0fd9-447e-a77c-afc20cb109e6	TCGA-23-2643-01A-21-20		TCGA-23-2643-01A-01R-1050-07		02d0fc82-4de5-4543-88e1-b069652b6c4b				TCGA-23-2643-01A-01D-1526-09
TCGA-23-2645-01	0	TCGA-23-2645-01	137	0	High		OV-like c1	OV-like c4					TCGA-23-2645	137	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54	Right	TCGA-23-2645-F25818	Stage IIIC	-19758			0	137						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		YES	G3					TCGA-23-2645.e1651bbc-ed16-4e45-b6f8-283459d72568.pdf					0	0			0	0	15	20	85	80	90	90			YES				NO		Primary Tumor	01	0.5			23	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-23-2645-01				7326a637-b5db-47d8-a114-030db3a91417			TCGA-23-2645-01A-01D-1047-05			TCGA-23-2645-01A-01D-1043-01	TCGA-23-2645-01	TCGA-23-2645-01A-01D-1043-01	dbe990e4-3dac-451c-85ec-6975ee9a6140			dbe990e4-3dac-451c-85ec-6975ee9a6140	TCGA-23-2645-01A-21-20		TCGA-23-2645-01A-01R-1050-07		f6880438-40e9-4c78-ac4b-fbdf71637a68				TCGA-23-2645-01A-01W-1091-09
TCGA-23-2647-01	0	TCGA-23-2647-01	135	0			OV-like c1	OV-like c4					TCGA-23-2647	135	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-23-2647-F25820	Stage IIIC	-18205			0	135						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.6		YES	G3					TCGA-23-2647.3da98ece-bece-4409-be21-a70037dcfd9f.pdf					0	0			0	0	30	30	70	70	80	80			YES				NO		Primary Tumor	01	0.6			23	1-10 mm	Ovary	YES	A	LIVING	2009						eeaa45e2-a17d-475c-b9a9-fbec7fa7ecd1			TCGA-23-2647-01A-01D-1047-05				TCGA-23-2647-01		246c6949-4565-4f69-8744-02e05764a274			246c6949-4565-4f69-8744-02e05764a274	TCGA-23-2647-01A-21-20		TCGA-23-2647-01A-01R-1050-07		f50b14e1-8106-4823-9bbd-68cf5f17189b				TCGA-23-2647-01A-01D-1526-09
TCGA-23-2649-01	0	TCGA-23-2649-01	116	0			OV-like c1	OV-like c4					TCGA-23-2649	116	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Left	TCGA-23-2649-F25822	Stage IIIC	-22210			0	116						2009-12-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G3					TCGA-23-2649.7a0bd8e4-1c7b-4bbc-bddc-e06902fc4db5.pdf					0	0			0	0	10	10	90	90	90	90			YES				NO		Primary Tumor	01	0.3			23	1-10 mm	Ovary	YES	A	LIVING	2009						2d3ae942-c1d4-4e80-a0e1-4b7fbc15952a			TCGA-23-2649-01A-01D-1047-05				TCGA-23-2649-01		9b345bb6-89dc-403a-b97b-3d4565942415			9b345bb6-89dc-403a-b97b-3d4565942415	TCGA-23-2649-01A-21-20		TCGA-23-2649-01A-01R-1050-07		408178f3-62ee-4c5d-a160-355deedc69c8				TCGA-23-2649-01A-01D-1526-09
TCGA-24-0966-01	0	TCGA-24-0966-01	232	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 2	TCGA-24-0966	232	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Bilateral	TCGA-24-0966-F25875	Stage IIIC	-28529			0	232						2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.3		YES	G3										0	0			0	0	10	5	90	95	95	98		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	LIVING	2008		TCGA-24-0966-01		TCGA-24-0966-01A-01W-0977-09		02ebd198-faca-4fb3-ba5a-531389b4fffa		TCGA-24-0966-01A-01R-1564-13	TCGA-24-0966-01A-01D-0402-05			TCGA-24-0966-01A-01D-0399-01	TCGA-24-0966-01	TCGA-24-0966-01A-01D-0399-01	9d3f40aa-e8d4-4031-b41b-6ccb637a8b66			9d3f40aa-e8d4-4031-b41b-6ccb637a8b66	TCGA-24-0966-01A-21-1562-20	TCGA-24-0966-01A-01R-1564-13	TCGA-24-0966-01A-01R-0406-07		5f1ed5e0-4a91-404f-a3b9-e855ff3ac303		TCGA-24-0966-01A-01R-1564-13		TCGA-24-0966-01A-01W-0977-09
TCGA-24-0968-01	1	TCGA-24-0968-01	598	1	Squamous		OV-like c1			miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-0968	598	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Left	TCGA-24-0968-F25880	Stage IIIC	-21664		598	0	598						2009-3-10	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2		YES	G3					TCGA-24-0968.887A21BF-12C4-47C7-A48D-A7FAA05C57B2.pdf					0	0			0	0	20	10	80	90	85	92		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2005	TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01	TCGA-24-0968-01A-01W-0484-10	TCGA-24-0968-01A-01W-0484-10				TCGA-24-0968-01A-01R-1569-13	TCGA-24-0968-01A-01D-0432-05			TCGA-24-0968-01A-01D-0428-01	TCGA-24-0968-01	TCGA-24-0968-01A-01D-0428-01	3658c6e3-6788-43c5-8cd8-0bdaeed8a3f2			3658c6e3-6788-43c5-8cd8-0bdaeed8a3f2		TCGA-24-0968-01A-01R-1569-13	TCGA-24-0968-01A-01R-0436-07		e6f5bb0e-aab8-4243-b233-e07b2e5811f4		TCGA-24-0968-01A-01R-1569-13		
TCGA-24-0970-01	1	TCGA-24-0970-01	354	1	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-0970	354	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Bilateral	TCGA-24-0970-F25870	Stage IIIC	-23276		354	0	354		280				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		0.8	NO		2		YES	G3	Recurrence									5	5			0	0	0	0			95	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			24	>20 mm	Ovary		B	DECEASED	2005		TCGA-24-0970-01		TCGA-24-0970-01B-01W-0486-08		02d6074d-90c9-472f-a355-c799e2c96f4a		TCGA-24-0970-01B-01R-1565-13	TCGA-24-0970-01B-01D-0432-05			TCGA-24-0970-01B-01D-0428-01	TCGA-24-0970-01	TCGA-24-0970-01B-01D-0428-01	40e41ce7-8a6b-440d-be49-8502f20b1c96			40e41ce7-8a6b-440d-be49-8502f20b1c96	TCGA-24-0970-01B-11-1562-20	TCGA-24-0970-01B-01R-1565-13	TCGA-24-0970-01B-01R-0436-07		ec3d35b4-27f6-4dd6-a6f2-596eed1a6547		TCGA-24-0970-01B-01R-1565-13	TCGA-24-0970-01B-01W-0486-08	
TCGA-24-0975-01	1	TCGA-24-0975-01	663	1	High	C9-OV	Low purity c2		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-0975	663	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-24-0975-F25861	Stage IIIC	-21417		663	0	663						2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.8			G3										20	10			0	0	0	0			80	80		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		B	DECEASED	2004		TCGA-24-0975-01		TCGA-24-0975-01B-02W-0486-08	a16723c4-d5b1-40a0-9890-570351738879			TCGA-24-0975-01A-02R-1565-13	TCGA-24-0975-01B-02D-0432-05	TCGA-24-0975-01	TCGA-24-0975-01	TCGA-24-0975-01B-02D-0428-01	TCGA-24-0975-01	TCGA-24-0975-01B-02D-0428-01	99ebcf7b-cbb1-421f-b4a8-7d3ab443ccd1	a16723c4-d5b1-40a0-9890-570351738879	a16723c4-d5b1-40a0-9890-570351738879	99ebcf7b-cbb1-421f-b4a8-7d3ab443ccd1		TCGA-24-0975-01A-02R-1565-13	TCGA-24-0975-01A-02R-0436-07		9f531d00-af98-4a8e-9614-74c063fa2f15	a16723c4-d5b1-40a0-9890-570351738879	TCGA-24-0975-01A-02R-1565-13	TCGA-24-0975-01B-02W-0486-08	
TCGA-24-0979-01	1	TCGA-24-0979-01	1264	1	High	C9-OV	Low purity c2	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-0979	1264	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	53	Bilateral	TCGA-24-0979-F25891	Stage IV	-19595		1264	0	1264		428				2009-5-11	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.8			G3	Recurrence				TCGA-24-0979.3385E5B4-EBD4-4317-8805-EE6EA47A2E4A.pdf	50				5	0			0	0	25	25	70	75	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	2003		TCGA-24-0979-01		TCGA-24-0979-01A-01W-0486-08		1c5c8013-17c7-4be1-888c-ab0da1e3afdd		TCGA-24-0979-01A-01R-1565-13	TCGA-24-0979-01A-01D-0432-05			TCGA-24-0979-01A-01D-0428-01	TCGA-24-0979-01	TCGA-24-0979-01A-01D-0428-01	17fad821-42e6-4165-b2ec-55e98864d94b			17fad821-42e6-4165-b2ec-55e98864d94b	TCGA-24-0979-01A-21-20	TCGA-24-0979-01A-01R-1565-13	TCGA-24-0979-01A-01R-0436-07		3a1401ac-2bfc-4baa-9018-bb71de5cfb51		TCGA-24-0979-01A-01R-1565-13	TCGA-24-0979-01A-01W-0486-08	
TCGA-24-0980-01	1	TCGA-24-0980-01	233	1	Squamous	C9-OV	OV-like c1	OV-like c4				mutation cluster 5	TCGA-24-0980	233	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-24-0980-F25896	Stage IIIC	-19579		233	0	233		145				2009-2-24	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)							YES	G3	Recurrence																						WITH TUMOR	YES	Progressive Disease		Other Method: Specify In Notes	NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	2003		TCGA-24-0980-01		TCGA-24-0980-01A-01W-0421-09		e09cff37-f92b-48f7-a2d6-e72b68d0a8b4			TCGA-24-0980-01A-01D-0402-05			TCGA-24-0980-01A-01D-0399-01	TCGA-24-0980-01	TCGA-24-0980-01A-01D-0399-01	ea0d83ca-b20e-426b-aca5-9ba06a936d89			ea0d83ca-b20e-426b-aca5-9ba06a936d89	TCGA-24-0980-01A-21-20		TCGA-24-0980-01A-01R-0406-07		eed170f8-eef5-4e58-8dda-64324bf900e2				TCGA-24-0980-01A-01W-0421-09
TCGA-24-0981-01		TCGA-24-0981-01											TCGA-24-0981		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																																																																																			TCGA-24-0981-01A-01D-0432-05						a98fbc28-cbb1-4716-bd08-2ae641924a9a			a98fbc28-cbb1-4716-bd08-2ae641924a9a			TCGA-24-0981-01A-01R-0436-07						
TCGA-24-0982-01	1	TCGA-24-0982-01	679	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-0982	679	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	77	Bilateral	TCGA-24-0982-F25900	Stage IIIC	-28201		679	0	679		153				2009-3-10	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1			G3	Recurrence				TCGA-24-0982.75BE9FE6-5606-4F29-A08F-69E3F50912D0.pdf					0	0			0	0	35	25	65	75	75	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			24	1-10 mm	Ovary		A	DECEASED	2003		TCGA-24-0982-01		TCGA-24-0982-01A-01W-0488-09		d712585f-3d02-4e1a-a11a-4ffac7295711		TCGA-24-0982-01A-01R-1565-13	TCGA-24-0982-01A-01D-0432-05			TCGA-24-0982-01A-01D-0428-01	TCGA-24-0982-01	TCGA-24-0982-01A-01D-0428-01	292ddf98-fc4e-4f92-8d5b-638de30cb924			292ddf98-fc4e-4f92-8d5b-638de30cb924	TCGA-24-0982-01A-21-20	TCGA-24-0982-01A-01R-1565-13	TCGA-24-0982-01A-01R-0436-07		fc2dbc4a-dd8a-4174-a186-15ceaaaac881		TCGA-24-0982-01A-01R-1565-13		TCGA-24-0982-01A-01W-0488-09
TCGA-24-1103-01	1	TCGA-24-1103-01	1646	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1103	1646	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-24-1103-F25824	Stage IIIC	-18583		1646	0	1646		678				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-24-1103.B9628222-5530-4A82-9F13-2773173A0C95.pdf					5	5			0	0	0	0	0	0	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1103-01		TCGA-24-1103-01A-01W-0488-09	202abe19-20e0-4ea9-8653-bf5145da351c	6f0a19c3-b3d6-44da-8962-79cd723f0fab		TCGA-24-1103-01A-01R-1565-13	TCGA-24-1103-01A-01D-0432-05	TCGA-24-1103-01	TCGA-24-1103-01	TCGA-24-1103-01A-01D-0428-01	TCGA-24-1103-01	TCGA-24-1103-01A-01D-0428-01	1d325c54-f0d1-4a78-a803-95239abbf8e1	202abe19-20e0-4ea9-8653-bf5145da351c	202abe19-20e0-4ea9-8653-bf5145da351c	1d325c54-f0d1-4a78-a803-95239abbf8e1	TCGA-24-1103-01A-11-1562-20	TCGA-24-1103-01A-01R-1565-13	TCGA-24-1103-01A-01R-0436-07		77d9fb44-1cbe-41aa-8abe-e66fa774a33e	202abe19-20e0-4ea9-8653-bf5145da351c	TCGA-24-1103-01A-01R-1565-13		TCGA-24-1103-01A-01W-0488-09
TCGA-24-1104-01	1	TCGA-24-1104-01	1933	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-1104	1933	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	56	Left	TCGA-24-1104-F25834	Stage IV	-20527		1933	0	1933		959				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence				TCGA-24-1104.4991D5F7-0259-430F-AFF7-1307DF563E41.pdf					1	1									90	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	DECEASED	2001		TCGA-24-1104-01		TCGA-24-1104-01A-01W-0488-09		14177a50-0360-47ce-b24b-3468b4a2b75f		TCGA-24-1104-01A-01R-1565-13	TCGA-24-1104-01A-01D-0432-05			TCGA-24-1104-01A-01D-0428-01	TCGA-24-1104-01	TCGA-24-1104-01A-01D-0428-01	3f7272d0-dda4-4232-a079-d77f1567d529			3f7272d0-dda4-4232-a079-d77f1567d529	TCGA-24-1104-01A-21-1562-20	TCGA-24-1104-01A-01R-1565-13	TCGA-24-1104-01A-01R-0436-07		14fde2bb-46b6-410f-89c6-f32a6f084668		TCGA-24-1104-01A-01R-1565-13		TCGA-24-1104-01A-01W-0488-09
TCGA-24-1105-01	1	TCGA-24-1105-01	1442	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1105	1442	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	36	Bilateral	TCGA-24-1105-F25844	Stage IIIC	-13187		1442	0	1442		470				2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.4			G3	Recurrence				TCGA-24-1105.DE593AFC-BC21-4183-94A6-B8BA9931B70F.pdf					5	1									90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			24	1-10 mm	Ovary		A	DECEASED	2001	TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01	TCGA-24-1105-01A-01W-0484-10	TCGA-24-1105-01A-01W-0484-10		ea5d304a-364c-4633-860b-f2e7be2ca00e		TCGA-24-1105-01A-01R-1565-13	TCGA-24-1105-01A-01D-0432-05			TCGA-24-1105-01A-01D-0428-01	TCGA-24-1105-01	TCGA-24-1105-01A-01D-0428-01	d94a3067-cc80-4110-91a3-3fe91a0b3d7f			d94a3067-cc80-4110-91a3-3fe91a0b3d7f	TCGA-24-1105-01A-21-1562-20	TCGA-24-1105-01A-01R-1565-13	TCGA-24-1105-01A-01R-0436-07		9840b4a9-5f2f-4263-905f-e395092e2cea		TCGA-24-1105-01A-01R-1565-13		
TCGA-24-1413-01	0	TCGA-24-1413-01	192	0	BRCA-LUAD+	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1413	192	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-24-1413-F25910	Stage IIIC	-18846			0	192						2009-3-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.1		YES	G3					TCGA-24-1413.2ca18d08-e930-4244-a0d5-316dfbca0fb4.pdf					20	10			20	40	0	0	60	50	85	85		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1413-01		TCGA-24-1413-01A-01W-0494-09	545867ef-1299-410d-bbbf-d6c189344b0f			TCGA-24-1413-01A-01R-1565-13	TCGA-24-1413-01A-01D-0460-05	TCGA-24-1413-01	TCGA-24-1413-01	TCGA-24-1413-01A-01D-0452-01	TCGA-24-1413-01	TCGA-24-1413-01A-01D-0452-01	522b0524-28c8-4f6b-8170-5d73c8193ada	545867ef-1299-410d-bbbf-d6c189344b0f	545867ef-1299-410d-bbbf-d6c189344b0f	522b0524-28c8-4f6b-8170-5d73c8193ada		TCGA-24-1413-01A-01R-1565-13	TCGA-24-1413-01A-01R-0456-07		78f0e50d-6dc9-4c74-8674-3cb6800ea7a6	545867ef-1299-410d-bbbf-d6c189344b0f	TCGA-24-1413-01A-01R-1565-13		TCGA-24-1413-01A-01W-0494-09
TCGA-24-1416-01	0	TCGA-24-1416-01	194	0	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 3	TCGA-24-1416	194	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			34	Bilateral	TCGA-24-1416-F25914	Stage IV	-12772			0	194						2009-4-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3					TCGA-24-1416.c5a7b8b5-65b5-47d0-84dc-882024042a6f.pdf					5	5			25	40	0	0	70	55	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1416-01		TCGA-24-1416-01A-01W-0549-09	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	0eda7c90-97fe-4184-b8ad-73e7820c3b7e		TCGA-24-1416-01A-01R-1565-13	TCGA-24-1416-01A-01D-0475-05	TCGA-24-1416-01	TCGA-24-1416-01	TCGA-24-1416-01A-01D-0472-01	TCGA-24-1416-01	TCGA-24-1416-01A-01D-0472-01	3037de81-f2ec-4f7c-ad35-649743bfdb2f	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	3037de81-f2ec-4f7c-ad35-649743bfdb2f	TCGA-24-1416-01A-21-20	TCGA-24-1416-01A-01R-1565-13	TCGA-24-1416-01A-01R-0479-07		f46fbaaf-21ba-40c3-9e27-db0febe3b250	67fcea16-d5bc-4edd-b66d-bfc5d56d976d	TCGA-24-1416-01A-01R-1565-13		TCGA-24-1416-01A-01W-0549-09
TCGA-24-1417-01	0	TCGA-24-1417-01	238	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1417	238	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54	Left	TCGA-24-1417-F25920	Stage IV	-19775			0	238						2009-4-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3			G3					TCGA-24-1417.4058a172-a0f6-4c91-9c79-aab63525340f.pdf					15	10			15	15	0	0	70	75	85	85		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1417-01		TCGA-24-1417-01A-01W-0549-09	e76a7745-3193-4650-9a7a-c96329690be3	4e9ef1e1-1dd3-4027-8a72-11dcbce7e12a		TCGA-24-1417-01A-01R-1565-13	TCGA-24-1417-01A-01D-0475-05	TCGA-24-1417-01	TCGA-24-1417-01	TCGA-24-1417-01A-01D-0472-01	TCGA-24-1417-01	TCGA-24-1417-01A-01D-0472-01	e5155eb2-5577-4e7a-9549-2ca02076e56d	e76a7745-3193-4650-9a7a-c96329690be3	e76a7745-3193-4650-9a7a-c96329690be3	e5155eb2-5577-4e7a-9549-2ca02076e56d	TCGA-24-1417-01A-21-20	TCGA-24-1417-01A-01R-1565-13	TCGA-24-1417-01A-01R-0479-07		68f0717d-5edc-43f0-bbde-606574f02b4f	e76a7745-3193-4650-9a7a-c96329690be3	TCGA-24-1417-01A-01R-1565-13		TCGA-24-1417-01A-01W-0549-09
TCGA-24-1418-01	0	TCGA-24-1418-01	243	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1418	243	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			68	Bilateral	TCGA-24-1418-F25924	Stage IIIC	-24842			0	243			0			2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1.2	NO		1.2			G3					TCGA-24-1418.14fdb291-ba79-4852-9242-02dc191ca8c5.pdf					5	5			10	20	0	0	85	75	70	70	Other	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	>20 mm	Ovary		A	LIVING	2008		TCGA-24-1418-01		TCGA-24-1418-01A-01W-0549-09	4e701e9f-9127-4d61-8a72-7e440b969fbe			TCGA-24-1418-01A-01R-1565-13	TCGA-24-1418-01A-01D-0475-05	TCGA-24-1418-01	TCGA-24-1418-01	TCGA-24-1418-01A-01D-0472-01	TCGA-24-1418-01	TCGA-24-1418-01A-01D-0472-01	d6aa4ef8-9bba-4e65-b546-b7a468bffe34	4e701e9f-9127-4d61-8a72-7e440b969fbe	4e701e9f-9127-4d61-8a72-7e440b969fbe	d6aa4ef8-9bba-4e65-b546-b7a468bffe34		TCGA-24-1418-01A-01R-1565-13	TCGA-24-1418-01A-01R-0479-07		8302128a-2f41-42d9-8ebc-ceedb67f2919	4e701e9f-9127-4d61-8a72-7e440b969fbe	TCGA-24-1418-01A-01R-1565-13		TCGA-24-1418-01A-01W-0549-09
TCGA-24-1419-01	0	TCGA-24-1419-01	239	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1419	239	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Bilateral	TCGA-24-1419-F25929	Stage IIIC	-22659			0	239						2009-4-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.8			G3					TCGA-24-1419.0a8c75aa-8031-4f1d-9dba-9029b009d677.pdf					2	0			15	25	0	0	83	75	90	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	11-20 mm	Ovary		A	LIVING	2008		TCGA-24-1419-01		TCGA-24-1419-01A-01W-0545-08	7bf43d51-2714-419e-a52f-863ca54c90e5	e55a0b2e-1cba-4732-a04d-2dc2eb49cdcc		TCGA-24-1419-01A-01R-1565-13	TCGA-24-1419-01A-01D-0475-05	TCGA-24-1419-01	TCGA-24-1419-01	TCGA-24-1419-01A-01D-0472-01	TCGA-24-1419-01	TCGA-24-1419-01A-01D-0472-01	f3b49cf8-8541-4971-8e5b-960e35ae8686	7bf43d51-2714-419e-a52f-863ca54c90e5	7bf43d51-2714-419e-a52f-863ca54c90e5	f3b49cf8-8541-4971-8e5b-960e35ae8686	TCGA-24-1419-01A-21-20	TCGA-24-1419-01A-01R-1565-13	TCGA-24-1419-01A-01R-0479-07		8edd134e-95e4-47d2-9a2a-b68b0ca427ea	7bf43d51-2714-419e-a52f-863ca54c90e5	TCGA-24-1419-01A-01R-1565-13	TCGA-24-1419-01A-01W-0545-08	
TCGA-24-1422-01	1	TCGA-24-1422-01	23	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1422	23	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			82	Bilateral	TCGA-24-1422-F25934	Stage IIIC	-30234		23	0	23						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.8			G3					TCGA-24-1422.8bcb6cf4-84ea-41a1-9113-061a7523c19f.pdf					8	10			10	40	0	0	82	50	75	90			NO				NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2008		TCGA-24-1422-01		TCGA-24-1422-01A-01W-0545-08		52fbe264-2840-4bae-86a9-17f09ebe5053		TCGA-24-1422-01A-01R-1565-13	TCGA-24-1422-01A-01D-0475-05			TCGA-24-1422-01A-01D-0472-01	TCGA-24-1422-01	TCGA-24-1422-01A-01D-0472-01	9b610217-9f59-46d7-ba9d-9d460c659802			9b610217-9f59-46d7-ba9d-9d460c659802	TCGA-24-1422-01A-21-1562-20	TCGA-24-1422-01A-01R-1565-13	TCGA-24-1422-01A-01R-0479-07		48e00661-f995-42b5-9400-3391914a90d9		TCGA-24-1422-01A-01R-1565-13	TCGA-24-1422-01A-01W-0545-08	
TCGA-24-1423-01	0	TCGA-24-1423-01	190	0	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1423	190	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			61	Bilateral	TCGA-24-1423-F25936	Stage IIIC	-22281			0	190						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.8		YES	G3					TCGA-24-1423.47331163-68e9-44fd-8b80-b9f70058957f.pdf					10	10			30	5	0	0	60	85	95	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1423-01		TCGA-24-1423-01A-01W-0545-08	b493df11-1929-4e35-ac44-49057cdbd86b	5a0afbd0-e504-46d6-b268-2b04d7f8be98		TCGA-24-1423-01A-01R-1565-13	TCGA-24-1423-01A-01D-0475-05	TCGA-24-1423-01	TCGA-24-1423-01	TCGA-24-1423-01A-01D-0472-01	TCGA-24-1423-01	TCGA-24-1423-01A-01D-0472-01	27599998-8559-4f7e-8288-6fdf8586e61a	b493df11-1929-4e35-ac44-49057cdbd86b	b493df11-1929-4e35-ac44-49057cdbd86b	27599998-8559-4f7e-8288-6fdf8586e61a	TCGA-24-1423-01A-21-1562-20	TCGA-24-1423-01A-01R-1565-13	TCGA-24-1423-01A-01R-0479-07		670fe1e4-f612-4797-a926-41cd2da84843	b493df11-1929-4e35-ac44-49057cdbd86b	TCGA-24-1423-01A-01R-1565-13	TCGA-24-1423-01A-01W-0545-08	
TCGA-24-1424-01	0	TCGA-24-1424-01	183	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1424	183	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-24-1424-F25941	Stage IIIC	-24545			0	183						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3																							TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				24	1-10 mm	Ovary			LIVING	2008		TCGA-24-1424-01		TCGA-24-1424-01A-01W-0549-09	d3fbcdaa-11af-4233-9700-57c6e1628c4b	b64c050d-b09e-4fbb-a906-b5d5e3904149		TCGA-24-1424-01A-01R-1565-13	TCGA-24-1424-01A-01D-0475-05	TCGA-24-1424-01	TCGA-24-1424-01	TCGA-24-1424-01A-01D-0472-01	TCGA-24-1424-01	TCGA-24-1424-01A-01D-0472-01	a6156dc4-597b-42ca-8e1a-258cebaa24fd	d3fbcdaa-11af-4233-9700-57c6e1628c4b	d3fbcdaa-11af-4233-9700-57c6e1628c4b	a6156dc4-597b-42ca-8e1a-258cebaa24fd	TCGA-24-1424-01A-21-1562-20	TCGA-24-1424-01A-01R-1565-13	TCGA-24-1424-01A-01R-0479-07		fdda2c0b-816d-4e49-83e8-2e40d4444f0c	d3fbcdaa-11af-4233-9700-57c6e1628c4b	TCGA-24-1424-01A-01R-1565-13		TCGA-24-1424-01A-01W-0549-09
TCGA-24-1425-01	0	TCGA-24-1425-01	181	0	Squamous		OV-like c1			miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-24-1425	181	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-24-1425-F25946	Stage IIIC	-16764			0	181			0			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5			G3					TCGA-24-1425.06592570-be8f-49d4-a42f-068ad60efe34.pdf					1	10			0	0	30	25	69	65	70	75	Other	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1425-01		TCGA-24-1425-01A-02W-0553-09				TCGA-24-1425-01A-02R-1566-13	TCGA-24-1425-01A-02D-0501-05			TCGA-24-1425-01A-02D-0497-01	TCGA-24-1425-01	TCGA-24-1425-01A-02D-0497-01	7fb66d68-7abc-4303-926a-8e6058705623			7fb66d68-7abc-4303-926a-8e6058705623		TCGA-24-1425-01A-02R-1566-13	TCGA-24-1425-01A-02R-0504-07		f112ed71-765e-48bc-a5ab-196f42740078		TCGA-24-1425-01A-02R-1566-13		TCGA-24-1425-01A-02W-0553-09
TCGA-24-1426-01	0	TCGA-24-1426-01	163	0	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1426	163	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			43	Bilateral	TCGA-24-1426-F25951	Stage IIIC	-15949			0	163						2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1.2		YES	G3					TCGA-24-1426.72914511-b2f7-484f-a7ab-3f4f1868f2cb.pdf					0	1			0	0	10	10	90	89	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1426-01		TCGA-24-1426-01A-01W-0549-09				TCGA-24-1426-01A-01R-1565-13	TCGA-24-1426-01A-01D-0475-05			TCGA-24-1426-01A-01D-0472-01	TCGA-24-1426-01	TCGA-24-1426-01A-01D-0472-01	80d9db35-2359-48a5-b716-c9b291eac51b			80d9db35-2359-48a5-b716-c9b291eac51b		TCGA-24-1426-01A-01R-1565-13	TCGA-24-1426-01A-01R-0479-07		8395c4e0-d327-472d-a7e6-3af3e2cbb0be		TCGA-24-1426-01A-01R-1565-13		TCGA-24-1426-01A-01W-0549-09
TCGA-24-1427-01	0	TCGA-24-1427-01	147	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1427	147	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Bilateral	TCGA-24-1427-F25956	Stage IIIC	-21423			0	147						2009-4-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.7		YES	G3					TCGA-24-1427.af63c4e2-2f77-4311-bfe2-ee45cfd200bb.pdf					1	1			0	0	10	20	89	79	90	80		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	LIVING	2008		TCGA-24-1427-01		TCGA-24-1427-01A-01W-0549-09	5a505632-422c-4083-b867-82a7a503b314	87a8658e-3143-4074-9988-b0fed3d25f8b		TCGA-24-1427-01A-01R-1565-13	TCGA-24-1427-01A-01D-0475-05	TCGA-24-1427-01	TCGA-24-1427-01	TCGA-24-1427-01A-01D-0472-01	TCGA-24-1427-01	TCGA-24-1427-01A-01D-0472-01	964da6cb-96ff-4da6-a8ea-20438f061d78	5a505632-422c-4083-b867-82a7a503b314	5a505632-422c-4083-b867-82a7a503b314	964da6cb-96ff-4da6-a8ea-20438f061d78	TCGA-24-1427-01A-21-1562-20	TCGA-24-1427-01A-01R-1565-13	TCGA-24-1427-01A-01R-0479-07		5beadb09-fe3f-44aa-8c20-fdf66e0a68ca	5a505632-422c-4083-b867-82a7a503b314	TCGA-24-1427-01A-01R-1565-13		TCGA-24-1427-01A-01W-0549-09
TCGA-24-1428-01	0	TCGA-24-1428-01	529	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1428	529	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Left	TCGA-24-1428-F25960	Stage IIIC	-18306			0	529		448				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5			G3	Recurrence				TCGA-24-1428.9fcdd584-25e6-4a5a-ae15-f2956de32822.pdf					5	1			0	0	10	10	85	89	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1428-01		TCGA-24-1428-01A-01W-0549-09	30b9b778-1422-4842-ae99-658b8b1d7605	66bafc53-dafe-493e-8ede-22866b714a76		TCGA-24-1428-01A-01R-1564-13	TCGA-24-1428-01A-01D-0475-05	TCGA-24-1428-01	TCGA-24-1428-01	TCGA-24-1428-01A-01D-0472-01	TCGA-24-1428-01	TCGA-24-1428-01A-01D-0472-01	563f35f6-fdff-45dd-b1d1-da2622820adc	30b9b778-1422-4842-ae99-658b8b1d7605	30b9b778-1422-4842-ae99-658b8b1d7605	563f35f6-fdff-45dd-b1d1-da2622820adc	TCGA-24-1428-01A-21-1562-20	TCGA-24-1428-01A-01R-1564-13	TCGA-24-1428-01A-01R-0479-07		c9eb8b63-8b8a-47eb-8fb1-11b089bf4a00	30b9b778-1422-4842-ae99-658b8b1d7605	TCGA-24-1428-01A-01R-1564-13		TCGA-24-1428-01A-01W-0549-09
TCGA-24-1430-01	1	TCGA-24-1430-01	863	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-1430	863	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	68	Bilateral	TCGA-24-1430-F25966	Stage IIIC	-24939		863	0	863		449	1			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.7	NO		2			G3	Recurrence				TCGA-24-1430.d0f95ced-e33f-4796-a6a4-3030f8e21761.pdf					0	0			0	0	5	5	95	95	95	95	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			24	>20 mm	Ovary		A	DECEASED	2000		TCGA-24-1430-01			4c19d12e-0160-4d01-b621-65335156488b	7dbdc93e-9d1d-48fe-92eb-9615eac2adb6		TCGA-24-1430-01A-01R-1566-13	TCGA-24-1430-01A-01D-0475-05	TCGA-24-1430-01	TCGA-24-1430-01	TCGA-24-1430-01A-01D-0472-01	TCGA-24-1430-01	TCGA-24-1430-01A-01D-0472-01	51b1e818-3048-4c41-9074-e36212c7dd7e	4c19d12e-0160-4d01-b621-65335156488b	4c19d12e-0160-4d01-b621-65335156488b	51b1e818-3048-4c41-9074-e36212c7dd7e	TCGA-24-1430-01A-21-1562-20	TCGA-24-1430-01A-01R-1566-13	TCGA-24-1430-01A-01R-0479-07		0bad8ba4-8a10-49d9-a2f6-5e833fb9f2da	4c19d12e-0160-4d01-b621-65335156488b	TCGA-24-1430-01A-01R-1566-13		
TCGA-24-1431-01	1	TCGA-24-1431-01	583	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-1431	583	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67	Bilateral	TCGA-24-1431-F25977	Stage IIIC	-24758		583	0	583		199				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							YES	G3	Recurrence																						WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01				24	1-10 mm	Ovary			DECEASED	1999		TCGA-24-1431-01		TCGA-24-1431-01A-01D-0472-08		a2ff2d82-073d-4ea0-b407-5a68de79f622		TCGA-24-1431-01A-01R-1566-13	TCGA-24-1431-01A-01D-0475-05			TCGA-24-1431-01A-01D-0472-01	TCGA-24-1431-01	TCGA-24-1431-01A-01D-0472-01	bf3ced77-b793-484a-8bfa-7ffabbf491cf			bf3ced77-b793-484a-8bfa-7ffabbf491cf	TCGA-24-1431-01A-21-1562-20	TCGA-24-1431-01A-01R-1566-13	TCGA-24-1431-01A-01R-0479-07		e5aed4a1-b8f1-44bd-957c-94acfca519a7		TCGA-24-1431-01A-01R-1566-13	TCGA-24-1431-01A-01D-0472-08	
TCGA-24-1434-01	1	TCGA-24-1434-01	568	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1434	568	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-24-1434-F25984	Stage IIIC	-21810		568	0	568		337				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5		YES	G3	Recurrence				TCGA-24-1434.0a5fd2a4-560b-4769-ba4e-868854471961.pdf					5	1			0	0	20	10	75	89	80	90		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1434-01		TCGA-24-1434-01A-01W-0545-08		0106e887-2791-4c17-9260-07bd927e5d9b		TCGA-24-1434-01A-01R-1566-13	TCGA-24-1434-01A-01D-0475-05			TCGA-24-1434-01A-01D-0472-01	TCGA-24-1434-01	TCGA-24-1434-01A-01D-0472-01	9b0d1252-3106-4bec-b8ff-35098deca4d5			9b0d1252-3106-4bec-b8ff-35098deca4d5	TCGA-24-1434-01A-21-1562-20	TCGA-24-1434-01A-01R-1566-13	TCGA-24-1434-01A-01R-0479-07		a6c7ca3f-b07b-46d5-a1ba-f1c88a358229		TCGA-24-1434-01A-01R-1566-13	TCGA-24-1434-01A-01W-0545-08	
TCGA-24-1435-01	1	TCGA-24-1435-01	1324	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 2	TCGA-24-1435	1324	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-24-1435-F25993	Stage IIIC	-21107		1324	0	1324		505				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5		NO	G3	Recurrence				TCGA-24-1435.d1574b6c-6cc1-45bc-86d0-97585d8a5c93.pdf					1	1			0	0	5	5	94	94	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1435-01		TCGA-24-1435-01A-01W-0549-09		591cd2fa-3920-42e9-a1ed-d76898930e6f		TCGA-24-1435-01A-01R-1566-13	TCGA-24-1435-01A-01D-0475-05			TCGA-24-1435-01A-01D-0472-01	TCGA-24-1435-01	TCGA-24-1435-01A-01D-0472-01	b3ea5fa8-61c8-462e-b013-0e4d44fec679			b3ea5fa8-61c8-462e-b013-0e4d44fec679	TCGA-24-1435-01A-21-1562-20	TCGA-24-1435-01A-01R-1566-13	TCGA-24-1435-01A-01R-0479-07		ac8a9858-933c-4d44-ae0c-e8b964344d0c		TCGA-24-1435-01A-01R-1566-13		TCGA-24-1435-01A-01W-0549-09
TCGA-24-1436-01	1	TCGA-24-1436-01	260	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1436	260	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Right	TCGA-24-1436-F26004	Stage IIIC	-20881		260	0	260						2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3					TCGA-24-1436.621d3f29-b555-4767-83dd-a6989af0be12.pdf					1	0			0	0	5	10	89	90	95	90		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1436-01		TCGA-24-1436-01A-01W-0549-09	45ff767a-721a-4d89-b5e9-0c6e7eba476d	d6aaae43-70fd-461e-b240-8ba220221828		TCGA-24-1436-01A-01R-1566-13	TCGA-24-1436-01A-01D-0475-05	TCGA-24-1436-01	TCGA-24-1436-01	TCGA-24-1436-01A-01D-0472-01	TCGA-24-1436-01	TCGA-24-1436-01A-01D-0472-01	279a61c4-12e9-4a4f-88bd-2cd122c43dea	45ff767a-721a-4d89-b5e9-0c6e7eba476d	45ff767a-721a-4d89-b5e9-0c6e7eba476d	279a61c4-12e9-4a4f-88bd-2cd122c43dea	TCGA-24-1436-01A-21-1563-20	TCGA-24-1436-01A-01R-1566-13	TCGA-24-1436-01A-01R-0479-07		432c75c7-ece9-49a3-8f6e-ceb61c30ca10	45ff767a-721a-4d89-b5e9-0c6e7eba476d	TCGA-24-1436-01A-01R-1566-13		TCGA-24-1436-01A-01W-0549-09
TCGA-24-1463-01	1	TCGA-24-1463-01	2218	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 2	mutation cluster 2	TCGA-24-1463	2218	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Bilateral	TCGA-24-1463-F26009	Stage IIIC	-25734		2218	0	2218		971				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		2			G3	Recurrence				TCGA-24-1463.864CB084-569A-47F0-A83D-F3FA649A6B00.pdf					1	1			0	0	19	24	80	75	80	75		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	2000		TCGA-24-1463-01		TCGA-24-1463-01A-01W-0549-09		62f0c11f-4f42-45f6-9916-f4470a096431		TCGA-24-1463-01A-01R-1566-13	TCGA-24-1463-01A-01D-0475-05			TCGA-24-1463-01A-01D-0472-01	TCGA-24-1463-01	TCGA-24-1463-01A-01D-0472-01	e0743db2-35b3-4a03-ad31-c7851b495a23			e0743db2-35b3-4a03-ad31-c7851b495a23	TCGA-24-1463-01A-21-1562-20	TCGA-24-1463-01A-01R-1566-13	TCGA-24-1463-01A-01R-0479-07		28787351-5cbd-4d64-910c-e306e7f65d8e		TCGA-24-1463-01A-01R-1566-13		TCGA-24-1463-01A-01W-0549-09
TCGA-24-1464-01	1	TCGA-24-1464-01	379	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1464	379	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	70	Left	TCGA-24-1464-F26022	Stage IIIC	-25874		379	0	379		323	1			2009-3-23	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.5		YES	G3	Recurrence				TCGA-24-1464.242047B0-E0E3-4BA3-A0DF-95887392602E.pdf					1	1			0	0	19	9	80	90	80	90	Post-Adjuvant Therapy	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.7			24	>20 mm	Ovary		A	DECEASED	1998		TCGA-24-1464-01		TCGA-24-1464-01A-01W-0549-09		eef306a8-dd2b-4d8e-90c2-cb05094fd5f2		TCGA-24-1464-01A-01R-1566-13	TCGA-24-1464-01A-01D-0475-05			TCGA-24-1464-01A-01D-0472-01	TCGA-24-1464-01	TCGA-24-1464-01A-01D-0472-01	f9aacc4e-2615-4434-a61b-664886f92289			f9aacc4e-2615-4434-a61b-664886f92289	TCGA-24-1464-01A-21-1562-20	TCGA-24-1464-01A-01R-1566-13	TCGA-24-1464-01A-01R-0479-07		2ed4bcf3-8abb-454c-a19d-54101ccf222f		TCGA-24-1464-01A-01R-1566-13		TCGA-24-1464-01A-01W-0549-09
TCGA-24-1466-01	1	TCGA-24-1466-01	1373	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-24-1466	1373	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-24-1466-F26028	Stage IIIC	-27307		1373	0	1373		491				2009-4-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.7			G3	Recurrence				TCGA-24-1466.BA86880B-184B-4CB7-8BBF-100D5CBD76C0.pdf					1	1			0	0	9	9	90	90	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1998		TCGA-24-1466-01		TCGA-24-1466-01A-01W-0545-08		b5bd0882-705b-4f50-a748-8dc096d39717		TCGA-24-1466-01A-01R-1566-13	TCGA-24-1466-01A-01D-0475-05			TCGA-24-1466-01A-01D-0472-01	TCGA-24-1466-01	TCGA-24-1466-01A-01D-0472-01	b18710e4-2d8f-4f32-8ba1-c526d43d4d0e			b18710e4-2d8f-4f32-8ba1-c526d43d4d0e	TCGA-24-1466-01A-21-1562-20		TCGA-24-1466-01A-01R-0479-07		2f2c0eed-dd98-42f0-af6e-7c2290a12f37			TCGA-24-1466-01A-01W-0545-08	
TCGA-24-1467-01	1	TCGA-24-1467-01	3224	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-1467	3224	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Right	TCGA-24-1467-F26039	Stage IIIC	-18652		3224	0	3224		1253				2009-4-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.3		YES	G3	Recurrence				TCGA-24-1467.6949EFBE-C2EA-4767-B194-2343254F2752.pdf					1	1			0	0	19	4	80	95	80	95		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	1998		TCGA-24-1467-01			22902cdb-69f7-4bfc-a5c3-a56229ee501d	efc7b16f-9e40-480e-b0ba-0a92cc54c0b9		TCGA-24-1467-01A-01R-1566-13	TCGA-24-1467-01A-01D-0475-05	TCGA-24-1467-01	TCGA-24-1467-01	TCGA-24-1467-01A-01D-0472-01	TCGA-24-1467-01	TCGA-24-1467-01A-01D-0472-01	61640eb0-8af4-4f10-99aa-f4fc652f7a36	22902cdb-69f7-4bfc-a5c3-a56229ee501d	22902cdb-69f7-4bfc-a5c3-a56229ee501d	61640eb0-8af4-4f10-99aa-f4fc652f7a36	TCGA-24-1467-01A-21-1562-20	TCGA-24-1467-01A-01R-1566-13	TCGA-24-1467-01A-01R-0479-07		f521b01e-14ea-4350-ad50-ce4dfa9594b6	22902cdb-69f7-4bfc-a5c3-a56229ee501d	TCGA-24-1467-01A-01R-1566-13		
TCGA-24-1469-01	0	TCGA-24-1469-01	277	0	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-24-1469	277	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Right	TCGA-24-1469-F26060	Stage IIIC	-25937			0	277						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5			G3					TCGA-24-1469.8f0b80d0-cf56-477c-898b-bb92934f64d4.pdf					1	1			0	0	4	4	95	95	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2008		TCGA-24-1469-01		TCGA-24-1469-01A-01W-0553-09	7b6fe6e3-145b-46e6-884e-fcec23514674	6f95df6b-dcdc-4727-8cf5-76b30b6ae455		TCGA-24-1469-01A-01R-1566-13	TCGA-24-1469-01A-01D-0501-05	TCGA-24-1469-01	TCGA-24-1469-01	TCGA-24-1469-01A-01D-0497-01	TCGA-24-1469-01	TCGA-24-1469-01A-01D-0497-01	66ce7bbf-1056-41e4-afb5-2bd052df849e	7b6fe6e3-145b-46e6-884e-fcec23514674	7b6fe6e3-145b-46e6-884e-fcec23514674	66ce7bbf-1056-41e4-afb5-2bd052df849e	TCGA-24-1469-01A-21-1562-20	TCGA-24-1469-01A-01R-1566-13	TCGA-24-1469-01A-01R-0504-07		1a83a75d-e788-407c-afae-326d9a553604	7b6fe6e3-145b-46e6-884e-fcec23514674	TCGA-24-1469-01A-01R-1566-13		TCGA-24-1469-01A-01W-0553-09
TCGA-24-1470-01	0	TCGA-24-1470-01	105	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1470	105	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54	Bilateral	TCGA-24-1470-F26064	Stage IIIB	-20007			0	105			1			2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3																						Other	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				24	1-10 mm	Ovary			LIVING	2009		TCGA-24-1470-01		TCGA-24-1470-01A-01W-0553-09		c9231718-6532-4ff2-b83f-4050d75b82fe		TCGA-24-1470-01A-01R-1566-13	TCGA-24-1470-01A-01D-0501-05			TCGA-24-1470-01A-01D-0497-01	TCGA-24-1470-01	TCGA-24-1470-01A-01D-0497-01	f5e1743a-9f6f-4dd5-9ff4-d87e87417699			f5e1743a-9f6f-4dd5-9ff4-d87e87417699	TCGA-24-1470-01A-21-1562-20	TCGA-24-1470-01A-01R-1566-13	TCGA-24-1470-01A-01R-0504-07		a10cd463-df96-48b7-a4cc-21268bce6eb0		TCGA-24-1470-01A-01R-1566-13		TCGA-24-1470-01A-01W-0553-09
TCGA-24-1471-01	0	TCGA-24-1471-01	36	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 13	TCGA-24-1471	36	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Left	TCGA-24-1471-F26069	Stage IIIC	-22081			0	36						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3					TCGA-24-1471.d20b8ed1-c74e-4ee8-9ae2-5512429810bc.pdf					1	1			0	0	1	1	98	98	99	99			YES				NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	LIVING	2009		TCGA-24-1471-01		TCGA-24-1471-01A-01W-0551-08		f9ddc125-66a3-4277-ac22-1b3b2acced36		TCGA-24-1471-01A-01R-1566-13	TCGA-24-1471-01A-01D-0501-05			TCGA-24-1471-01A-01D-0497-01	TCGA-24-1471-01	TCGA-24-1471-01A-01D-0497-01	20ca8b0a-b561-405f-89d4-5f12f40a5455			20ca8b0a-b561-405f-89d4-5f12f40a5455	TCGA-24-1471-01A-21-1562-20	TCGA-24-1471-01A-01R-1566-13	TCGA-24-1471-01A-01R-0504-07		2434de17-87b9-44f4-85b9-e07932d062ae		TCGA-24-1471-01A-01R-1566-13	TCGA-24-1471-01A-01W-0551-08	
TCGA-24-1474-01	1	TCGA-24-1474-01	676	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1474	676	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Left	TCGA-24-1474-F26073	Stage IIIC	-20902		676	0	676		332				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence				TCGA-24-1474.c4d49a95-0478-4399-a5eb-224ca6d16cd7.pdf					1	1			0	0	1	1	98	98	99	99		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	2000		TCGA-24-1474-01		TCGA-24-1474-01A-01W-0551-08	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	e5f26e9b-2fc8-4514-a028-cd97c5390b0a		TCGA-24-1474-01A-01R-1566-13	TCGA-24-1474-01A-01D-0501-05	TCGA-24-1474-01	TCGA-24-1474-01	TCGA-24-1474-01A-01D-0497-01	TCGA-24-1474-01	TCGA-24-1474-01A-01D-0497-01	17d5600b-8927-444b-96b2-82a3c8a81001	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	17d5600b-8927-444b-96b2-82a3c8a81001	TCGA-24-1474-01A-21-1562-20	TCGA-24-1474-01A-01R-1566-13	TCGA-24-1474-01A-01R-0504-07		c6e04760-3285-42ad-b307-cb00ffbe2e9e	4da3ccd5-53e1-46f5-874d-e5d131dbfc52	TCGA-24-1474-01A-01R-1566-13	TCGA-24-1474-01A-01W-0551-08	
TCGA-24-1544-01	1	TCGA-24-1544-01	820	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation c1uster 9	TCGA-24-1544	820	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-24-1544-F26080	Stage IIIC	-26141		820	0	820		643				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4			G3	Progression of Disease				TCGA-24-1544.2fd78a14-cc3f-4920-9c50-6051579b6ad4.pdf					10	5			0	0	20	20	70	75	80	80		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01	TCGA-24-1544-01A-01W-0615-10	TCGA-24-1544-01A-01W-0615-10	83333a5a-de0b-4d72-b886-e5488c619827	9653a9c6-37fa-4e38-9c7e-c48ae95933ec		TCGA-24-1544-01A-01R-1566-13	TCGA-24-1544-01A-01D-0536-05	TCGA-24-1544-01	TCGA-24-1544-01	TCGA-24-1544-01A-01D-0533-01	TCGA-24-1544-01	TCGA-24-1544-01A-01D-0533-01	7cce06da-3bb9-44e1-b971-e87ea08505d0	83333a5a-de0b-4d72-b886-e5488c619827	83333a5a-de0b-4d72-b886-e5488c619827	7cce06da-3bb9-44e1-b971-e87ea08505d0	TCGA-24-1544-01A-21-1558-20	TCGA-24-1544-01A-01R-1566-13	TCGA-24-1544-01A-01R-0540-07		d403d7b8-d8d8-47ba-9821-a314704866bb	83333a5a-de0b-4d72-b886-e5488c619827	TCGA-24-1544-01A-01R-1566-13		
TCGA-24-1545-01	1	TCGA-24-1545-01	1746	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1545	1746	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	69	Bilateral	TCGA-24-1545-F26088	Stage IIIC	-25460		1746	0	1746		861	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3	Recurrence				TCGA-24-1545.0D1CB67F-57E1-4234-AA1A-5EF0E6EC3975.pdf					0	0			0	0	20	30	80	70	90	80	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1997	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01	TCGA-24-1545-01A-01W-0615-10	TCGA-24-1545-01A-01W-0615-10		f3a3c3dc-4069-4c53-9017-c6dc610240e4		TCGA-24-1545-01A-01R-1566-13	TCGA-24-1545-01A-01D-0536-05			TCGA-24-1545-01A-01D-0533-01	TCGA-24-1545-01	TCGA-24-1545-01A-01D-0533-01	e8b27e1d-a6b3-4afd-b8fc-f8a77374697f			e8b27e1d-a6b3-4afd-b8fc-f8a77374697f	TCGA-24-1545-01A-21-1558-20	TCGA-24-1545-01A-01R-1566-13	TCGA-24-1545-01A-01R-0540-07		3ed80032-69ae-4f21-8e60-8f177787e9f0		TCGA-24-1545-01A-01R-1566-13		
TCGA-24-1546-01	1	TCGA-24-1546-01	1955	1	High		Low purity c2	OV-like c4		miRNA cluster 3	cluster 6		TCGA-24-1546	1955	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Bilateral	TCGA-24-1546-F26097	Stage IIIC	-17130		1955	0	1955						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1.5			G3					TCGA-24-1546.d6eec9a6-7bfd-40e2-891e-0a3cd7759ace.pdf					0	0			0	0	40	40	60	60	70	70			YES						Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1546-01A-01W-0615-10	TCGA-24-1546-01	TCGA-24-1546-01A-01W-0615-10			9cdbc7ad-cffd-4f34-b805-47e7c57d9978		TCGA-24-1546-01A-01R-1566-13	TCGA-24-1546-01A-01D-0536-05			TCGA-24-1546-01A-01D-0533-01	TCGA-24-1546-01	TCGA-24-1546-01A-01D-0533-01	69614804-5f34-4b8e-ac15-a4466ceb880b			69614804-5f34-4b8e-ac15-a4466ceb880b	TCGA-24-1546-01A-21-1563-20	TCGA-24-1546-01A-01R-1566-13	TCGA-24-1546-01A-01R-0540-07		67d70140-fcb4-4b5b-9821-498cbd5d53c2		TCGA-24-1546-01A-01R-1566-13		
TCGA-24-1548-01	1	TCGA-24-1548-01	493	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-1548	493	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-24-1548-F26101	Stage IIIC	-20945		493	0	493		207				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence				TCGA-24-1548.d7b9bc71-e243-478f-a116-7e9371b87327.pdf					2	0			0	0	20	5	78	95	95	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01	TCGA-24-1548-01A-01W-0615-10	TCGA-24-1548-01A-01W-0615-10	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	adc1690a-194c-44ea-8344-7bac461ab669		TCGA-24-1548-01A-01R-1566-13	TCGA-24-1548-01A-01D-0536-05	TCGA-24-1548-01	TCGA-24-1548-01	TCGA-24-1548-01A-01D-0533-01	TCGA-24-1548-01	TCGA-24-1548-01A-01D-0533-01	113a01ed-70f4-4c51-9b01-2c567aa5e9fb	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	113a01ed-70f4-4c51-9b01-2c567aa5e9fb	TCGA-24-1548-01A-21-1558-20	TCGA-24-1548-01A-01R-1566-13	TCGA-24-1548-01A-01R-0540-07		45cc6ed6-17ea-4291-8654-2b5b30c5a5e1	77b1c06b-46ef-4c8c-8a82-37f83e3c48cf	TCGA-24-1548-01A-01R-1566-13		
TCGA-24-1549-01	1	TCGA-24-1549-01	1721	1	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1549	1721	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-24-1549-F26113	Stage IIIB	-21432		1721	0	1721		1042				2009-5-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.6			G3	Recurrence				TCGA-24-1549.6431416b-d089-442d-9db8-32118eed41de.pdf					5	5			0	0	15	10	80	85	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24		Ovary		A	DECEASED	1997		TCGA-24-1549-01		TCGA-24-1549-01A-01W-0553-09	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	b18db100-89ea-409a-841a-e90e9e9b65b2		TCGA-24-1549-01A-01R-1566-13	TCGA-24-1549-01A-01D-0501-05	TCGA-24-1549-01	TCGA-24-1549-01	TCGA-24-1549-01A-01D-0497-01	TCGA-24-1549-01	TCGA-24-1549-01A-01D-0497-01	1b88b21c-f2cc-45aa-b55a-ad0cc299124f	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	1b88b21c-f2cc-45aa-b55a-ad0cc299124f	TCGA-24-1549-01A-21-1558-20	TCGA-24-1549-01A-01R-1566-13	TCGA-24-1549-01A-01R-0504-07		f0c19024-16a9-4bc1-af8a-5f55326a22d4	f8ead0c8-9072-4a1d-9e07-f724a0d74a0f	TCGA-24-1549-01A-01R-1566-13		TCGA-24-1549-01A-01W-0553-09
TCGA-24-1550-01	1	TCGA-24-1550-01	1249	1	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 1		TCGA-24-1550	1249	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Left	TCGA-24-1550-F26130	Stage IIIC	-18049		1249	0	1249		892	1			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-24-1550.7ebd8d19-0a81-4623-8127-f225ad650d46.pdf					10	5			0	0	10	25	80	70	85	80	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1550-01			648cb96f-df1c-48c1-bb15-c37a2784a9db	907ac822-b65b-45f3-87ea-fc78f06bab60		TCGA-24-1550-01A-01R-1566-13	TCGA-24-1550-01A-01D-0501-05	TCGA-24-1550-01	TCGA-24-1550-01	TCGA-24-1550-01A-01D-0497-01	TCGA-24-1550-01	TCGA-24-1550-01A-01D-0497-01	308919de-3238-4f7a-a68c-97bcae3252a9	648cb96f-df1c-48c1-bb15-c37a2784a9db	648cb96f-df1c-48c1-bb15-c37a2784a9db	308919de-3238-4f7a-a68c-97bcae3252a9	TCGA-24-1550-01A-21-1558-20	TCGA-24-1550-01A-01R-1566-13	TCGA-24-1550-01A-01R-0504-07		d5e13008-a81c-4dc5-b621-6d11b492883b	648cb96f-df1c-48c1-bb15-c37a2784a9db	TCGA-24-1550-01A-01R-1566-13		
TCGA-24-1551-01	1	TCGA-24-1551-01	1579	1	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1551	1579	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-24-1551-F26139	Stage IIIC	-19661		1579	0	1579		764	1			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence				TCGA-24-1551.474ac527-45a2-4258-bec4-0a48a3b80742.pdf					5	5			0	0	15	5	80	90	90	99	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1551-01		TCGA-24-1551-01A-01W-0551-08	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	48b26794-efa4-4e9a-b3c0-5a5391b17b03		TCGA-24-1551-01A-01R-1566-13	TCGA-24-1551-01A-01D-0501-05	TCGA-24-1551-01	TCGA-24-1551-01	TCGA-24-1551-01A-01D-0497-01	TCGA-24-1551-01	TCGA-24-1551-01A-01D-0497-01	2e61de9d-84bb-4b14-aa7c-17ad72c258db	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	2e61de9d-84bb-4b14-aa7c-17ad72c258db	TCGA-24-1551-01A-21-1558-20	TCGA-24-1551-01A-01R-1566-13	TCGA-24-1551-01A-01R-0504-07		6e9136b5-6f84-4b3d-9586-257b42d3d8e2	0f5f479c-c83b-404b-bd17-ebb2aa5b0dc8	TCGA-24-1551-01A-01R-1566-13	TCGA-24-1551-01A-01W-0551-08	
TCGA-24-1552-01	1	TCGA-24-1552-01	1259	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1552	1259	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	77	Left	TCGA-24-1552-F26148	Stage IIIC	-28129		1259	0	1259		403	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.9		YES	G3	Recurrence				TCGA-24-1552.FF7B6D0B-D13B-473E-A924-C63CB0B46511.pdf					5	2			0	0	5	3	90	95	99	99	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1552-01		TCGA-24-1552-01A-01W-0551-08	990bcb1f-7269-4020-8ea5-8ba338b390b8	ce833a2e-7c81-4720-baa7-49cf52f4f0bd		TCGA-24-1552-01A-01R-1566-13	TCGA-24-1552-01A-01D-0501-05	TCGA-24-1552-01	TCGA-24-1552-01	TCGA-24-1552-01A-01D-0497-01	TCGA-24-1552-01	TCGA-24-1552-01A-01D-0497-01	ba336da3-a3ac-4707-a55b-71fa7068a4e4	990bcb1f-7269-4020-8ea5-8ba338b390b8	990bcb1f-7269-4020-8ea5-8ba338b390b8	ba336da3-a3ac-4707-a55b-71fa7068a4e4	TCGA-24-1552-01A-21-1558-20	TCGA-24-1552-01A-01R-1566-13	TCGA-24-1552-01A-01R-0504-07		62b27771-c8c0-41f8-852f-07b188f7b8e3	990bcb1f-7269-4020-8ea5-8ba338b390b8	TCGA-24-1552-01A-01R-1566-13	TCGA-24-1552-01A-01W-0551-08	
TCGA-24-1553-01	1	TCGA-24-1553-01	1767	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1553	1767	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-24-1553-F26157	Stage IIIB	-19393		1767	0	1767		553				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3	Recurrence				TCGA-24-1553.5abe7782-ca53-4add-9a9a-01955859420b.pdf					0	0			0	0	15	5	85	95	95	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01	TCGA-24-1553-01A-01W-0552-10	TCGA-24-1553-01A-01W-0552-10	7c607e77-a353-4995-855b-36ccaaf3bde6	64c63ba8-750c-4ac7-a0e9-57044507a0a4		TCGA-24-1553-01A-01R-1566-13	TCGA-24-1553-01A-01D-0501-05	TCGA-24-1553-01	TCGA-24-1553-01	TCGA-24-1553-01A-01D-0497-01	TCGA-24-1553-01	TCGA-24-1553-01A-01D-0497-01	70af5fdb-fd28-4671-9532-38438ac83d75	7c607e77-a353-4995-855b-36ccaaf3bde6	7c607e77-a353-4995-855b-36ccaaf3bde6	70af5fdb-fd28-4671-9532-38438ac83d75	TCGA-24-1553-01A-21-1558-20	TCGA-24-1553-01A-01R-1566-13	TCGA-24-1553-01A-01R-0504-07		6007eb37-11b8-4127-b498-f3ada326b0e1	7c607e77-a353-4995-855b-36ccaaf3bde6	TCGA-24-1553-01A-01R-1566-13		
TCGA-24-1555-01	1	TCGA-24-1555-01	2692	1	Squamous	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-24-1555	2692	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-24-1555-F26171	Stage IIIC	-18404		2692	0	2692		1577	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence				TCGA-24-1555.b7b2f370-207a-4849-b7a0-528789363a02.pdf					0	0			0	0	25	20	75	80	90	95	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24		Ovary		A	DECEASED	1997	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01	TCGA-24-1555-01A-01W-0552-10	TCGA-24-1555-01A-01W-0552-10	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	10cb1259-03bf-4d9e-946e-bea05e4f23bd		TCGA-24-1555-01A-01R-1566-13	TCGA-24-1555-01A-01D-0501-05	TCGA-24-1555-01	TCGA-24-1555-01	TCGA-24-1555-01A-01D-0497-01	TCGA-24-1555-01	TCGA-24-1555-01A-01D-0497-01	7575e343-6f72-42a9-9011-2b7e02cf01cc	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	7575e343-6f72-42a9-9011-2b7e02cf01cc	TCGA-24-1555-01A-21-1558-20	TCGA-24-1555-01A-01R-1566-13	TCGA-24-1555-01A-01R-0504-07		b3e00fd1-65a1-4254-ac59-1d56b879c253	0ec7ea28-7bd4-45c3-b03c-d855014fa4f4	TCGA-24-1555-01A-01R-1566-13		
TCGA-24-1556-01	1	TCGA-24-1556-01	2148	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1556	2148	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	50	Left	TCGA-24-1556-F26184	Stage IIB	-18517		2148	0	2148		539				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.9			G3	Recurrence				TCGA-24-1556.75c91323-45a7-4629-b014-f7eda2f1075e.pdf					0	0			0	0	5	10	95	90	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01	TCGA-24-1556-01A-01W-0615-10	TCGA-24-1556-01A-01W-0615-10	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	7c4dcb9c-346b-4b52-9b64-f835ebc85dba		TCGA-24-1556-01A-01R-1566-13	TCGA-24-1556-01A-01D-0536-05	TCGA-24-1556-01	TCGA-24-1556-01	TCGA-24-1556-01A-01D-0533-01	TCGA-24-1556-01	TCGA-24-1556-01A-01D-0533-01	30477fb0-3b9b-4b2e-aeff-69d84d2b2647	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	30477fb0-3b9b-4b2e-aeff-69d84d2b2647	TCGA-24-1556-01A-21-1558-20	TCGA-24-1556-01A-01R-1566-13	TCGA-24-1556-01A-01R-0540-07		3602ad67-bdfb-48a8-8a58-8019bee04630	31e8ae73-7c3f-45ec-b4c9-d3f2ee1ca4fd	TCGA-24-1556-01A-01R-1566-13		
TCGA-24-1557-01	1	TCGA-24-1557-01	1213	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2	mutation cluster 5	TCGA-24-1557	1213	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-24-1557-F26194	Stage IIIC	-17943		1213	0	1213		447				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G3	Progression of Disease				TCGA-24-1557.ec04339c-f1ae-4519-bddf-e60cc1f30d52.pdf					5	2			0	0	10	8	85	90	85	90		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	2000	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01	TCGA-24-1557-01A-01W-0615-10	TCGA-24-1557-01A-01W-0615-10	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	d534bbdd-5827-426e-ad74-9346b06716f5		TCGA-24-1557-01A-01R-1566-13	TCGA-24-1557-01A-01D-0536-05	TCGA-24-1557-01	TCGA-24-1557-01	TCGA-24-1557-01A-01D-0533-01	TCGA-24-1557-01	TCGA-24-1557-01A-01D-0533-01	5cbc430f-495b-44e2-ac1c-5bcab1e43d22	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	5cbc430f-495b-44e2-ac1c-5bcab1e43d22	TCGA-24-1557-01A-21-1558-20	TCGA-24-1557-01A-01R-1566-13	TCGA-24-1557-01A-01R-0540-07		e9f05aba-2e25-44c7-b49f-9300cb5c61e1	bca48aa6-25bc-49e4-8bb5-edf38362b4a8	TCGA-24-1557-01A-01R-1566-13		
TCGA-24-1558-01	1	TCGA-24-1558-01	594	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 2	TCGA-24-1558	594	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73	Bilateral	TCGA-24-1558-F26212	Stage IIIC	-27004		594	0	594		273				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.9			G3	Recurrence				TCGA-24-1558.62143e5f-4452-47ca-a67c-cd87036424b1.pdf					0	0			0	0	2	2	98	98	95	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.9			24	1-10 mm	Ovary		A	DECEASED	2000	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01	TCGA-24-1558-01A-01W-0615-10	TCGA-24-1558-01A-01W-0615-10	1b8d5b5e-f671-419a-844a-6640fe5a896d	b37713e8-e63a-4dba-b7fb-aebc5914676d		TCGA-24-1558-01A-01R-1566-13	TCGA-24-1558-01A-01D-0536-05	TCGA-24-1558-01	TCGA-24-1558-01	TCGA-24-1558-01A-01D-0533-01	TCGA-24-1558-01	TCGA-24-1558-01A-01D-0533-01	59734a4a-9daf-4a2f-b772-443dc12a9100	1b8d5b5e-f671-419a-844a-6640fe5a896d	1b8d5b5e-f671-419a-844a-6640fe5a896d	59734a4a-9daf-4a2f-b772-443dc12a9100	TCGA-24-1558-01A-21-1558-20	TCGA-24-1558-01A-01R-1566-13	TCGA-24-1558-01A-01R-0540-07		beca71a6-9c32-4f27-9419-32d96cafed27	1b8d5b5e-f671-419a-844a-6640fe5a896d	TCGA-24-1558-01A-01R-1566-13		
TCGA-24-1560-01	1	TCGA-24-1560-01	1341	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1560	1341	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Left	TCGA-24-1560-F26221	Stage IIIC	-18671		1341	0	1341		143				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G4	Recurrence				TCGA-24-1560.464e1a20-b2d1-49c4-8da5-11b8c0f96b4e.pdf					0	0			0	0	2	2	98	98	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01	TCGA-24-1560-01A-01W-0615-10	TCGA-24-1560-01A-01W-0615-10	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	15295f32-7794-43cb-a943-03a38d4b6016		TCGA-24-1560-01A-01R-1566-13	TCGA-24-1560-01A-01D-0536-05	TCGA-24-1560-01	TCGA-24-1560-01	TCGA-24-1560-01A-01D-0533-01	TCGA-24-1560-01	TCGA-24-1560-01A-01D-0533-01	92fcc5c5-9d98-49f8-ada9-b4a663d7f2bf	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	92fcc5c5-9d98-49f8-ada9-b4a663d7f2bf	TCGA-24-1560-01A-21-1558-20	TCGA-24-1560-01A-01R-1566-13	TCGA-24-1560-01A-01R-0540-07		5b6e5bbe-fe20-4613-b55c-2e544ea51a2b	a7ea40ed-6cfb-42b7-92b7-64d6ba988414	TCGA-24-1560-01A-01R-1566-13		
TCGA-24-1562-01	1	TCGA-24-1562-01	1384	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-1562	1384	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67	Bilateral	TCGA-24-1562-F26237	Stage IIIC	-24747		1384	0	1384		229	0			2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1			G3	Recurrence				TCGA-24-1562.0ce36daf-9512-4860-a5a3-b2ff7f487c5a.pdf					5	10			0	0	10	10	85	80	90	90	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1562-01		TCGA-24-1562-01A-01W-0553-09	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	9082bc34-1aa2-4e77-bb64-22778ee28635		TCGA-24-1562-01A-01R-1566-13	TCGA-24-1562-01A-01D-0501-05	TCGA-24-1562-01	TCGA-24-1562-01	TCGA-24-1562-01A-01D-0497-01	TCGA-24-1562-01	TCGA-24-1562-01A-01D-0497-01	55792c9d-411b-4188-8681-7febc219f995	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	55792c9d-411b-4188-8681-7febc219f995	TCGA-24-1562-01A-21-1558-20	TCGA-24-1562-01A-01R-1566-13	TCGA-24-1562-01A-01R-0504-07		f36d78a7-5e27-4a7a-8055-a7ca51b8c371	eb8cb3b3-d1b1-4d2d-b048-7394931040bd	TCGA-24-1562-01A-01R-1566-13		TCGA-24-1562-01A-01W-0553-09
TCGA-24-1563-01	1	TCGA-24-1563-01	1451	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1563	1451	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	66	Left	TCGA-24-1563-F26248	Stage IIIC	-24274		1451	0	1451		396				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3	Recurrence				TCGA-24-1563.6fdeb714-439d-49d7-aae0-99166a3e8eba.pdf					1	5			0	0	30	10	69	85	70	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1563-01		TCGA-24-1563-01A-01W-0553-09	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	e52eaae7-ae99-43fe-a752-89045be81447		TCGA-24-1563-01A-01R-1566-13	TCGA-24-1563-01A-01D-0501-05	TCGA-24-1563-01	TCGA-24-1563-01	TCGA-24-1563-01A-01D-0497-01	TCGA-24-1563-01	TCGA-24-1563-01A-01D-0497-01	ebfb5ea7-457c-49f1-830b-d2ec9e10d930	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	ebfb5ea7-457c-49f1-830b-d2ec9e10d930	TCGA-24-1563-01A-21-1558-20	TCGA-24-1563-01A-01R-1566-13	TCGA-24-1563-01A-01R-0504-07		70951f22-8982-42be-bf1e-15f24b415708	a9c4a08c-1db7-49eb-8685-b5ca442c3e7a	TCGA-24-1563-01A-01R-1566-13		TCGA-24-1563-01A-01W-0553-09
TCGA-24-1564-01	1	TCGA-24-1564-01	787	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1564	787	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	67	Bilateral	TCGA-24-1564-F26260	Stage IIIC	-24668		787	0	787		221				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4			G3	Recurrence				TCGA-24-1564.fa1c8286-2e55-4137-93ae-c19d470ce2e4.pdf					1	1			0	0	10	20	89	79	90	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1564-01		TCGA-24-1564-01A-01W-0551-08	03b8480f-d19e-43e4-8a09-f9230c525c1e	b6e7fde5-418d-4848-a99e-6fc8c943bd7b		TCGA-24-1564-01A-01R-1566-13	TCGA-24-1564-01A-01D-0501-05	TCGA-24-1564-01	TCGA-24-1564-01	TCGA-24-1564-01A-01D-0497-01	TCGA-24-1564-01	TCGA-24-1564-01A-01D-0497-01	eaf70996-ac08-4e56-8747-06a8af702dd5	03b8480f-d19e-43e4-8a09-f9230c525c1e	03b8480f-d19e-43e4-8a09-f9230c525c1e	eaf70996-ac08-4e56-8747-06a8af702dd5	TCGA-24-1564-01A-21-1558-20	TCGA-24-1564-01A-01R-1566-13	TCGA-24-1564-01A-01R-0504-07		3b4f61f1-616b-4995-bcb6-6eb2e11be681	03b8480f-d19e-43e4-8a09-f9230c525c1e	TCGA-24-1564-01A-01R-1566-13	TCGA-24-1564-01A-01W-0551-08	
TCGA-24-1565-01	1	TCGA-24-1565-01	312	1	Iq	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation c1uster 9	TCGA-24-1565	312	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-24-1565-F26274	Stage IIIC	-27048		312	0	312		145				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		YES	G3	Recurrence				TCGA-24-1565.f424905e-3dc2-4e37-b6c4-8a77c7ce817b.pdf					0	0			0	0	5	5	95	95	95	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1565-01		TCGA-24-1565-01A-01W-0551-08		bd856415-5235-4086-a72f-9d0a65b8867b		TCGA-24-1565-01A-01R-1566-13	TCGA-24-1565-01A-01D-0501-05			TCGA-24-1565-01A-01D-0497-01	TCGA-24-1565-01	TCGA-24-1565-01A-01D-0497-01	ef759014-dfd0-4f35-ab00-20f9a884114f			ef759014-dfd0-4f35-ab00-20f9a884114f	TCGA-24-1565-01A-21-1558-20	TCGA-24-1565-01A-01R-1566-13	TCGA-24-1565-01A-01R-0504-07		8c0e5f5a-fd1e-40de-9746-1b22572df7b8		TCGA-24-1565-01A-01R-1566-13	TCGA-24-1565-01A-01W-0551-08	
TCGA-24-1567-01	1	TCGA-24-1567-01	524	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1567	524	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-24-1567-F26279	Stage IIIB	-19843		524	0	524		319				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.3	NO		1.1			G3	Recurrence				TCGA-24-1567.90910bbc-49e1-495b-9b06-11056ff401df.pdf					1	0			0	0	5	5	94	95	95	95		WITH TUMOR	YES			Molecular Marker(S)	NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	1999	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01	TCGA-24-1567-01A-01W-0615-10	TCGA-24-1567-01A-01W-0615-10	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	e4b66de6-faab-41b2-af46-ad0f9f81bed7		TCGA-24-1567-01A-01R-1566-13	TCGA-24-1567-01A-01D-0536-05	TCGA-24-1567-01	TCGA-24-1567-01	TCGA-24-1567-01A-01D-0533-01	TCGA-24-1567-01	TCGA-24-1567-01A-01D-0533-01	0b5247be-fdf5-4d54-84fb-12e5387b5a30	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	0b5247be-fdf5-4d54-84fb-12e5387b5a30	TCGA-24-1567-01A-21-1558-20	TCGA-24-1567-01A-01R-1566-13	TCGA-24-1567-01A-01R-0540-07		b39f67ca-abb2-4f96-a0c4-79ea6cbe523e	97c0b20f-ee65-42b2-af2d-92dcf48b2cd5	TCGA-24-1567-01A-01R-1566-13		
TCGA-24-1603-01	1	TCGA-24-1603-01	2742	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1603	2742	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-24-1603-F26284	Stage IIIB	-19681		2742	0	2742		992				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence				TCGA-24-1603.b5ea4cb8-5f2a-4a6d-88ed-f36c1b12e3f9.pdf					12	5			8	8	0	0	80	87	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.7			24		Ovary		A	DECEASED	1996		TCGA-24-1603-01		TCGA-24-1603-01A-01W-0551-08	f4187f4f-9c52-4065-818b-c884183a5a70	eecacbb1-98ef-4194-957d-5a49f9548657		TCGA-24-1603-01A-01R-1566-13	TCGA-24-1603-01A-01D-0501-05	TCGA-24-1603-01	TCGA-24-1603-01	TCGA-24-1603-01A-01D-0497-01	TCGA-24-1603-01	TCGA-24-1603-01A-01D-0497-01	3d33275f-9562-43c1-8f6b-1a5ace3895e8	f4187f4f-9c52-4065-818b-c884183a5a70	f4187f4f-9c52-4065-818b-c884183a5a70	3d33275f-9562-43c1-8f6b-1a5ace3895e8	TCGA-24-1603-01A-21-1558-20	TCGA-24-1603-01A-01R-1566-13	TCGA-24-1603-01A-01R-0504-07		74a46153-942a-42e8-b6a0-ac066c006e5d	f4187f4f-9c52-4065-818b-c884183a5a70	TCGA-24-1603-01A-01R-1566-13	TCGA-24-1603-01A-01W-0551-08	
TCGA-24-1604-01	1	TCGA-24-1604-01	2688	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-1604	2688	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66	Bilateral	TCGA-24-1604-F26299	Stage IIIC	-24471		2688	0	2688						2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.4			G3					TCGA-24-1604.de978a3d-92f9-4bd8-98f4-f8a3ec09b362.pdf					5	5			25	45	0	0	70	50	93	90		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			24		Ovary		A	DECEASED	1996	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01	TCGA-24-1604-01A-01W-0552-10	TCGA-24-1604-01A-01W-0552-10	a658045c-93a6-4aac-abbb-1cd6093b7735	2350016d-f638-4c02-a24b-76f1df75cb69		TCGA-24-1604-01A-01R-1566-13	TCGA-24-1604-01A-01D-0501-05	TCGA-24-1604-01	TCGA-24-1604-01	TCGA-24-1604-01A-01D-0497-01	TCGA-24-1604-01	TCGA-24-1604-01A-01D-0497-01	644ce6b1-1823-4eb8-bc5d-029b3f51fe2f	a658045c-93a6-4aac-abbb-1cd6093b7735	a658045c-93a6-4aac-abbb-1cd6093b7735	644ce6b1-1823-4eb8-bc5d-029b3f51fe2f	TCGA-24-1604-01A-21-1558-20	TCGA-24-1604-01A-01R-1566-13	TCGA-24-1604-01A-01R-0504-07		08109bba-5c11-4400-a968-c858329cbedf	a658045c-93a6-4aac-abbb-1cd6093b7735	TCGA-24-1604-01A-01R-1566-13		
TCGA-24-1614-01	1	TCGA-24-1614-01	1470	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-1614	1470	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Right	TCGA-24-1614-F26306	Stage IIIC	-20993		1470	0	1470		644				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO	100	1.2			G3	Recurrence				TCGA-24-1614.4e371c15-c0d1-454a-997d-dfbe98b02f7e.pdf					2	2			0	0	8	8	90	90	95	95	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	2001	TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01	TCGA-24-1614-01A-01W-0552-10	TCGA-24-1614-01A-01W-0552-10		6ceece0c-56d0-41e6-93e9-12e2a4fdb4c4		TCGA-24-1614-01A-01R-1566-13	TCGA-24-1614-01A-01D-0501-05			TCGA-24-1614-01A-01D-0497-01	TCGA-24-1614-01	TCGA-24-1614-01A-01D-0497-01	28fdfe2a-9e7e-465f-8d05-a232d01be466			28fdfe2a-9e7e-465f-8d05-a232d01be466	TCGA-24-1614-01A-21-1558-20		TCGA-24-1614-01A-01R-0504-07		a85349ef-886c-4d39-8c23-ff13b920059a				
TCGA-24-1616-01	1	TCGA-24-1616-01	1163	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-24-1616	1163	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-24-1616-F26315	Stage IIIC	-20785		1163	0	1163		405				2009-5-13	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9			G3	Recurrence				TCGA-24-1616.d8c764d9-0fe8-488e-8aa1-da73a8c10b01.pdf					0	5			0	0	30	35	70	60	80	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1616-01		TCGA-24-1616-01A-01W-0553-09	c334b353-0652-49fb-8cd6-5bcf8485e5d0	3e449bae-1749-47d9-adc1-6e70b0c829dc		TCGA-24-1616-01A-01R-1566-13	TCGA-24-1616-01A-01D-0501-05	TCGA-24-1616-01	TCGA-24-1616-01	TCGA-24-1616-01A-01D-0497-01	TCGA-24-1616-01	TCGA-24-1616-01A-01D-0497-01	9cfb8540-1bc2-479f-b408-d662cdb6b990	c334b353-0652-49fb-8cd6-5bcf8485e5d0	c334b353-0652-49fb-8cd6-5bcf8485e5d0	9cfb8540-1bc2-479f-b408-d662cdb6b990	TCGA-24-1616-01A-21-1558-20	TCGA-24-1616-01A-01R-1566-13	TCGA-24-1616-01A-01R-0504-07		e40e646a-09da-49ad-bcca-1e56df395a36	c334b353-0652-49fb-8cd6-5bcf8485e5d0	TCGA-24-1616-01A-01R-1566-13		TCGA-24-1616-01A-01W-0553-09
TCGA-24-1842-01	0	TCGA-24-1842-01	253	0	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1842	253	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-24-1842-F26325	Stage IIIC	-18227			0	253			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	G3					TCGA-24-1842.3465aae7-0664-44e5-a27f-c02fd73526a1.pdf	0	0	0	0	0	0	0	0	0	0	15	15	85	85	85	85	Other	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.7			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1842-01			6cb78602-e09f-4dbc-b3e5-684ebe77bddc	5dcf27b7-8966-4c46-a0f6-5a1450f60d1d		TCGA-24-1842-01A-01R-1567-13	TCGA-24-1842-01A-01D-0581-05	TCGA-24-1842-01	TCGA-24-1842-01	TCGA-24-1842-01A-01D-0577-01	TCGA-24-1842-01	TCGA-24-1842-01A-01D-0577-01	8b89f646-2877-40ee-b91a-2bb8f843d9e9	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	8b89f646-2877-40ee-b91a-2bb8f843d9e9	TCGA-24-1842-01A-21-1559-20	TCGA-24-1842-01A-01R-1567-13	TCGA-24-1842-01A-01R-0584-07		af43832d-2996-4a7f-8e5c-6bd2ec938cfe	6cb78602-e09f-4dbc-b3e5-684ebe77bddc	TCGA-24-1842-01A-01R-1567-13		TCGA-24-1842-01A-01W-0639-09
TCGA-24-1843-01	0	TCGA-24-1843-01	106	0	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1843	106	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66	Right	TCGA-24-1843-F26330	Stage IIIC	-24469			0	106						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4		YES	G3					TCGA-24-1843.d2625c77-0f03-42ea-b5ea-df45769f0fbb.pdf	0	0	0	0	0	0	0	0	0	0	20	25	80	75	80	75			YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1843-01			c50cf5af-3375-4748-9894-1f9521f746da			TCGA-24-1843-01A-01R-1567-13	TCGA-24-1843-01A-01D-0581-05	TCGA-24-1843-01	TCGA-24-1843-01	TCGA-24-1843-01A-01D-0577-01	TCGA-24-1843-01	TCGA-24-1843-01A-01D-0577-01	e2790b61-5daa-40de-85fa-763cb86fcfc4	c50cf5af-3375-4748-9894-1f9521f746da	c50cf5af-3375-4748-9894-1f9521f746da	e2790b61-5daa-40de-85fa-763cb86fcfc4		TCGA-24-1843-01A-01R-1567-13	TCGA-24-1843-01A-01R-0584-07		51ac296a-c599-47db-9a67-5aacf572efab	c50cf5af-3375-4748-9894-1f9521f746da	TCGA-24-1843-01A-01R-1567-13		TCGA-24-1843-01A-01W-0639-09
TCGA-24-1844-01	0	TCGA-24-1844-01	113	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1844	113	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Bilateral	TCGA-24-1844-F26335	Stage IIIC	-23542			0	113						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3					TCGA-24-1844.5fd30c3c-9734-40dd-b81e-ae3f364c8fa8.pdf	0	0	0	0	0	0	0	0	0	0	10	20	90	80	90	80			YES				NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1844-01			53a60e9f-3541-4fe7-a7ea-87ee888c0446	d95c8065-b35e-47b0-899a-305b14ed2a56		TCGA-24-1844-01A-01R-1567-13	TCGA-24-1844-01A-01D-0581-05	TCGA-24-1844-01	TCGA-24-1844-01	TCGA-24-1844-01A-01D-0577-01	TCGA-24-1844-01	TCGA-24-1844-01A-01D-0577-01	d40bb484-46c5-48dd-8394-7e503053f1a1	53a60e9f-3541-4fe7-a7ea-87ee888c0446	53a60e9f-3541-4fe7-a7ea-87ee888c0446	d40bb484-46c5-48dd-8394-7e503053f1a1	TCGA-24-1844-01A-21-1559-20	TCGA-24-1844-01A-01R-1567-13	TCGA-24-1844-01A-01R-0584-07		5f13ef2d-8e72-4552-8ace-f089597b1131	53a60e9f-3541-4fe7-a7ea-87ee888c0446	TCGA-24-1844-01A-01R-1567-13		TCGA-24-1844-01A-01W-0639-09
TCGA-24-1845-01	0	TCGA-24-1845-01	116	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-24-1845	116	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			42	Bilateral	TCGA-24-1845-F26340	Stage IIIC	-15599			0	116						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.8			G3					TCGA-24-1845.1fda446a-e0d2-422a-a023-57ec5bfae62b.pdf	0	0	0	0	10	0	10	0	0	0	0	5	90	95	90	95			YES				NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1845-01				cd017460-81cb-4e71-b352-42612cae745e		TCGA-24-1845-01A-01R-1567-13	TCGA-24-1845-01A-01D-0581-05			TCGA-24-1845-01A-01D-0577-01	TCGA-24-1845-01	TCGA-24-1845-01A-01D-0577-01	8f021990-860f-4883-ba30-e2d7f1956280			8f021990-860f-4883-ba30-e2d7f1956280	TCGA-24-1845-01A-21-1559-20	TCGA-24-1845-01A-01R-1567-13	TCGA-24-1845-01A-01R-0584-07		24d1e3ea-44ad-4bb9-8aa7-cd448b8bec21		TCGA-24-1845-01A-01R-1567-13		TCGA-24-1845-01A-01W-0639-09
TCGA-24-1846-01	0	TCGA-24-1846-01	133	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-1846	133	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-24-1846-F26346	Stage IIIC	-16534			0	133			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1		YES	G3					TCGA-24-1846.fb12e5b3-1529-4873-90fd-7ba0a78dd9f4.pdf	0	0	0	0	15	20	15	20	0	0	5	10	80	70	80	70	Other		YES				NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1846-01			4b073708-9525-4340-90dc-ede08ee24977	15134c0c-7253-481e-83e3-7d1c57bc521d		TCGA-24-1846-01A-01R-1567-13	TCGA-24-1846-01A-01D-0581-05	TCGA-24-1846-01	TCGA-24-1846-01	TCGA-24-1846-01A-01D-0577-01	TCGA-24-1846-01	TCGA-24-1846-01A-01D-0577-01	8426d54f-4075-4012-a5e6-59d4237db996	4b073708-9525-4340-90dc-ede08ee24977	4b073708-9525-4340-90dc-ede08ee24977	8426d54f-4075-4012-a5e6-59d4237db996	TCGA-24-1846-01A-21-1559-20	TCGA-24-1846-01A-01R-1567-13	TCGA-24-1846-01A-01R-0584-07		50b9dcb5-0fb8-4be7-97ce-5cd477d6c351	4b073708-9525-4340-90dc-ede08ee24977	TCGA-24-1846-01A-01R-1567-13		TCGA-24-1846-01A-01W-0639-09
TCGA-24-1847-01	0	TCGA-24-1847-01	343	0	High		OV-like c1		OV-like c16	miRNA cluster 3	cluster 6		TCGA-24-1847	343	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-24-1847-F26350	Stage IV	-16529			0	343						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		1		YES	G3					TCGA-24-1847.20d96d45-40d3-44ad-a9e8-fdc7e545ed5d.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1847-01			83354694-078e-411e-89d2-029649708528			TCGA-24-1847-01A-01R-1566-13	TCGA-24-1847-01A-01D-0563-05	TCGA-24-1847-01	TCGA-24-1847-01	TCGA-24-1847-01A-01D-0559-01	TCGA-24-1847-01	TCGA-24-1847-01A-01D-0559-01	4302237f-ebcb-49bb-93e0-17c4130b47c7	83354694-078e-411e-89d2-029649708528	83354694-078e-411e-89d2-029649708528	4302237f-ebcb-49bb-93e0-17c4130b47c7		TCGA-24-1847-01A-01R-1566-13	TCGA-24-1847-01A-01R-0566-07		74b939d6-c502-4edf-a412-df6dc9484eb6	83354694-078e-411e-89d2-029649708528	TCGA-24-1847-01A-01R-1566-13		TCGA-24-1847-01A-01W-0633-09
TCGA-24-1849-01	0	TCGA-24-1849-01	176	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-24-1849	176	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			80	Bilateral	TCGA-24-1849-F26355	Stage IIIC	-29555			0	176						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.1	YES	Tumor resection		1.4	NO		1.8		YES	G3					TCGA-24-1849.a2181913-086c-42a2-99fd-057b17025deb.pdf					0	0			0	0	15	20	85	80	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1849-01				66dc2c60-9fa1-4fb7-8bd4-76da1e11229a		TCGA-24-1849-01A-01R-1567-13	TCGA-24-1849-01A-01D-0581-05			TCGA-24-1849-01A-01D-0577-01	TCGA-24-1849-01	TCGA-24-1849-01A-01D-0577-01	4d9a4714-924f-42b5-881d-f6223a34852b			4d9a4714-924f-42b5-881d-f6223a34852b	TCGA-24-1849-01A-21-1562-20	TCGA-24-1849-01A-01R-1567-13	TCGA-24-1849-01A-01R-0584-07		36592a9b-a440-4741-95bc-51e700d14b52		TCGA-24-1849-01A-01R-1567-13		TCGA-24-1849-01A-01W-0639-09
TCGA-24-1850-01	0	TCGA-24-1850-01	168	0	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-24-1850	168	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			72	Bilateral	TCGA-24-1850-F26359	Stage IIIC	-26369			0	168			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2		YES	G3					TCGA-24-1850.a8c2f09f-6971-48e1-b890-f1d63611cdbd.pdf					5	0			0	0	10	20	85	80	95	95	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1850-01			9d88c064-c348-4f3f-a1f1-5884e0b66d9e	eacc0479-97ed-45f6-a4cb-9cca12252bd2		TCGA-24-1850-01A-01R-1567-13	TCGA-24-1850-01A-01D-0581-05	TCGA-24-1850-01	TCGA-24-1850-01	TCGA-24-1850-01A-01D-0577-01	TCGA-24-1850-01	TCGA-24-1850-01A-01D-0577-01	e8c8377f-2037-4b8b-a915-cfdc8d12cfd7	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	e8c8377f-2037-4b8b-a915-cfdc8d12cfd7	TCGA-24-1850-01A-21-1559-20	TCGA-24-1850-01A-01R-1567-13	TCGA-24-1850-01A-01R-0584-07		717a05a3-2930-4f69-a497-d884d493edaa	9d88c064-c348-4f3f-a1f1-5884e0b66d9e	TCGA-24-1850-01A-01R-1567-13		TCGA-24-1850-01A-01W-0639-09
TCGA-24-1852-01	1	TCGA-24-1852-01	2201	1	High		OV-like c1	OV-like c4					TCGA-24-1852	2201	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-24-1852-F26363	Stage IIIC	-20390		2201	0	2201		1009				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8461/3	C56.9	YES	Tumor resection		0.5	NO		1.4			G3	Recurrence									0	0			0	0	20	20	80	80	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1997		TCGA-24-1852-01				6800890d-adf7-4831-8a21-68fc3b583fe6			TCGA-24-1852-01A-01D-0807-05			TCGA-24-1852-01A-01D-0803-01	TCGA-24-1852-01	TCGA-24-1852-01A-01D-0803-01	5e6dcf92-01c3-4eb2-8c8a-5bbeda37fc37			5e6dcf92-01c3-4eb2-8c8a-5bbeda37fc37	TCGA-24-1852-01A-21-1559-20		TCGA-24-1852-01A-01R-0810-07		8bc4b5b7-b987-475b-90f7-28c8bd19a0fa				
TCGA-24-1852-02	1	TCGA-24-1852-02	2201	1			OV-like c1						TCGA-24-1852	2201	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-24-1852-F26363	Stage IIIC	-20390		2201	0	2201		1009				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8461/3	C56.9	YES	Tumor resection		0.9	NO		1.2			G3	Recurrence									0	0			0	0	1	5	99	95	99	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			24	1-10 mm	Ovary		A	DECEASED	1997									TCGA-24-1852-02A-01D-0807-05						1272a812-779f-45fb-a7df-9b1a29a4550e			1272a812-779f-45fb-a7df-9b1a29a4550e			TCGA-24-1852-02A-01R-0810-07		7c459b65-7eca-4081-83f0-ff67f0410a9b				
TCGA-24-1920-01	0	TCGA-24-1920-01	298	0	High		OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 3		TCGA-24-1920	298	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Right	TCGA-24-1920-F26373	Stage IIIC	-27042			0	298			0			2010-2-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		2			G3					TCGA-24-1920.292d7fe5-e949-458b-b7da-cc55009b1c06.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	90	90	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-1920-01				300fb12e-d372-4a03-ae7f-95d0cef8027a		TCGA-24-1920-01A-01R-1567-13	TCGA-24-1920-01A-01D-0652-05			TCGA-24-1920-01A-01D-0648-01	TCGA-24-1920-01	TCGA-24-1920-01A-01D-0648-01	e058bfd2-dc21-4951-98df-ee2ce1f579a1			e058bfd2-dc21-4951-98df-ee2ce1f579a1	TCGA-24-1920-01A-21-1559-20		TCGA-24-1920-01A-01R-0655-07		678cbaa5-cd2a-4cf5-a7e5-34b3db7281cc				
TCGA-24-1923-01	1	TCGA-24-1923-01	690	1	Squamous		Low purity c2	OV-like c4		miRNA cluster 3	cluster 6		TCGA-24-1923	690	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-24-1923-F26379	Stage IIIC	-18628		690	0	690		343				2010-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.6	NO		1.3		YES	G3	Recurrence				TCGA-24-1923.6ae8158a-e236-4cc0-88d2-50756216f0e7.pdf	0	0	0	0	5	15	5	10	0	0	5	15	90	70	90	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1923-01				9c88c21f-4bb9-41cc-b942-9c6e73a46511		TCGA-24-1923-01A-01R-1567-13	TCGA-24-1923-01A-01D-0652-05			TCGA-24-1923-01A-01D-0648-01	TCGA-24-1923-01	TCGA-24-1923-01A-01D-0648-01	ef194766-b0df-43cd-ba19-677605132446			ef194766-b0df-43cd-ba19-677605132446	TCGA-24-1923-01A-21-1559-20	TCGA-24-1923-01A-01R-1567-13	TCGA-24-1923-01A-01R-0655-07		fde22a7e-62c4-4c20-ac40-ac1b873edf9a		TCGA-24-1923-01A-01R-1567-13		
TCGA-24-1924-01	1	TCGA-24-1924-01	919	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-1924	919	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-24-1924-F26386	Stage IIIC	-23801		919	0	919		320				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence				TCGA-24-1924.4199b57a-81f5-4d5f-9f4c-1e514dcd26dc.pdf	0	0	0	0	10	20	5	10	0	0	20	10	70	70	70	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	2001		TCGA-24-1924-01			2592f314-cc0a-4d00-bdcf-6376afd32bb7	d4067ae4-665b-4539-938c-e86a08523d3f		TCGA-24-1924-01A-01R-1567-13	TCGA-24-1924-01A-01D-0652-05	TCGA-24-1924-01	TCGA-24-1924-01	TCGA-24-1924-01A-01D-0648-01	TCGA-24-1924-01	TCGA-24-1924-01A-01D-0648-01	77b5d8df-a1b5-4cb2-90aa-26878994b48d	2592f314-cc0a-4d00-bdcf-6376afd32bb7	2592f314-cc0a-4d00-bdcf-6376afd32bb7	77b5d8df-a1b5-4cb2-90aa-26878994b48d	TCGA-24-1924-01A-21-1559-20	TCGA-24-1924-01A-01R-1567-13	TCGA-24-1924-01A-01R-0655-07		16cd57f0-1334-447e-828e-989c2339c282	2592f314-cc0a-4d00-bdcf-6376afd32bb7	TCGA-24-1924-01A-01R-1567-13		
TCGA-24-1927-01	1	TCGA-24-1927-01	500	1	Squamous		OV-like c1	OV-like c4					TCGA-24-1927	500	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-24-1927-F26396	Stage IIIC	-21719		500	0	500		290				2010-3-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5			G3	Recurrence				TCGA-24-1927.67121ef6-223f-47b5-8094-81ffffcc6951.pdf	0	0	0	0	5	10	5	5	0	0	5	0	90	90	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	1999		TCGA-24-1927-01				f9b9b275-8678-4ff8-95fe-dd804f20713d			TCGA-24-1927-01A-01D-0652-05			TCGA-24-1927-01A-01D-0648-01	TCGA-24-1927-01	TCGA-24-1927-01A-01D-0648-01	5c90d04e-2693-49ce-bf06-79de908598d9			5c90d04e-2693-49ce-bf06-79de908598d9	TCGA-24-1927-01A-21-1559-20		TCGA-24-1927-01A-01R-0655-07						
TCGA-24-1928-01	1	TCGA-24-1928-01	336	1	High		OV-like c1			miRNA cluster 2	cluster 2		TCGA-24-1928	336	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	77	Bilateral	TCGA-24-1928-F26403	Stage IIIC	-28126		336	0	336		70				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO		1.5			G3	Recurrence				TCGA-24-1928.dc4407fb-d15b-44d5-9c3b-129cca67d8f1.pdf	0	0	0	0	10	5	10	5	0	0	10	15	80	80	80	80		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.3			24	11-20 mm	Ovary		A	DECEASED	1998		TCGA-24-1928-01						TCGA-24-1928-01A-01R-1567-13	TCGA-24-1928-01A-01D-0652-05			TCGA-24-1928-01A-01D-0648-01	TCGA-24-1928-01	TCGA-24-1928-01A-01D-0648-01	3fbc2630-ca7b-44f2-b331-bcf6dfbf6982			3fbc2630-ca7b-44f2-b331-bcf6dfbf6982		TCGA-24-1928-01A-01R-1567-13	TCGA-24-1928-01A-01R-0655-07		681d19fb-e521-4105-8d76-275624c1d3b0		TCGA-24-1928-01A-01R-1567-13		
TCGA-24-1930-01	1	TCGA-24-1930-01	2467	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-1930	2467	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	53	Bilateral	TCGA-24-1930-F26410	Stage IIIC	-19387		2467	0	2467		544	0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO	100	1			G3	Recurrence				TCGA-24-1930.746ac85a-ea6d-4d60-859f-69bf580a707c.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	1-10 mm	Ovary		A	DECEASED	1998		TCGA-24-1930-01			d85ca8ac-9458-4f3a-b2ef-db4df852f75e	bf3c2d8b-6072-4f59-8f19-128cfff7314e		TCGA-24-1930-01A-01R-1567-13	TCGA-24-1930-01A-01D-0652-05	TCGA-24-1930-01	TCGA-24-1930-01	TCGA-24-1930-01A-01D-0648-01	TCGA-24-1930-01	TCGA-24-1930-01A-01D-0648-01	2a2cad37-1da4-4b68-b16d-6d2ba3ce6ab8	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	2a2cad37-1da4-4b68-b16d-6d2ba3ce6ab8	TCGA-24-1930-01A-21-1559-20	TCGA-24-1930-01A-01R-1567-13	TCGA-24-1930-01A-01R-0655-07		3412c513-36c6-459c-9f66-3dd15d0d8e72	d85ca8ac-9458-4f3a-b2ef-db4df852f75e	TCGA-24-1930-01A-01R-1567-13		
TCGA-24-2019-01	0	TCGA-24-2019-01	148	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-24-2019	148	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Bilateral	TCGA-24-2019-F26429	Stage IIIC	-17009			0	148			1			2010-3-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3					TCGA-24-2019.15a77e5d-acfb-4013-81de-ef9d2f6398d1.pdf	0	0	0	0	2	2	0	0	0	0	18	33	80	65	85	80	Other		YES				NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	LIVING	2009		TCGA-24-2019-01		TCGA-24-2019-01A-02W-0722-08	52908652-f29a-4517-8ff6-6f4cd31c691b			TCGA-24-2019-01A-02R-1568-13	TCGA-24-2019-01A-02D-0667-05	TCGA-24-2019-01	TCGA-24-2019-01	TCGA-24-2019-01A-02D-0663-01	TCGA-24-2019-01	TCGA-24-2019-01A-02D-0663-01	61a93ace-fc9c-44c5-a6fd-341bbc767f25	52908652-f29a-4517-8ff6-6f4cd31c691b	52908652-f29a-4517-8ff6-6f4cd31c691b	61a93ace-fc9c-44c5-a6fd-341bbc767f25		TCGA-24-2019-01A-02R-1568-13	TCGA-24-2019-01A-02R-0670-07		437a6ae6-ad96-446e-ad48-d2d8f608e915	52908652-f29a-4517-8ff6-6f4cd31c691b	TCGA-24-2019-01A-02R-1568-13	TCGA-24-2019-01A-02W-0722-08	
TCGA-24-2020-01	1	TCGA-24-2020-01	4624	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-2020	4624	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67	Bilateral	TCGA-24-2020-F26431	Stage IIIC	-24682		4624	0	4624		723				2010-3-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3	Recurrence				TCGA-24-2020.4f529d42-acb0-4c02-bd0f-d4a650655df8.pdf	0	0	0	0	5	0	0	0	0	0	5	0	90	100	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1994		TCGA-24-2020-01			19765b4f-458e-4f02-bf96-01498d80ac83	809ac07d-5244-462e-a41e-531eeb193296		TCGA-24-2020-01A-01R-1567-13	TCGA-24-2020-01A-01D-0652-05	TCGA-24-2020-01	TCGA-24-2020-01	TCGA-24-2020-01A-01D-0648-01	TCGA-24-2020-01	TCGA-24-2020-01A-01D-0648-01	354d346e-f49a-410e-90fc-073cd4977286	19765b4f-458e-4f02-bf96-01498d80ac83	19765b4f-458e-4f02-bf96-01498d80ac83	354d346e-f49a-410e-90fc-073cd4977286	TCGA-24-2020-01A-21-1560-20	TCGA-24-2020-01A-01R-1567-13	TCGA-24-2020-01A-01R-0655-07		dfccfa2b-c85a-4ef7-815f-75d1042b5c6d	19765b4f-458e-4f02-bf96-01498d80ac83	TCGA-24-2020-01A-01R-1567-13		
TCGA-24-2023-01	1	TCGA-24-2023-01	1364	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-24-2023	1364	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-24-2023-F26442	Stage IIIA	-19901		1364	0	1364		1069				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence				TCGA-24-2023.2a255fa6-65cd-4fb7-9d08-1b6aadd6682b.pdf	5	0	0	0	0	0	0	0	0	0	20	20	80	80	85	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1994		TCGA-24-2023-01			11fd4bb1-0f8d-4830-a7f0-83897a5df11d	53cd60af-85e4-468e-a6f8-f21be9631a23		TCGA-24-2023-01A-01R-1567-13	TCGA-24-2023-01A-01D-0652-05	TCGA-24-2023-01	TCGA-24-2023-01	TCGA-24-2023-01A-01D-0648-01	TCGA-24-2023-01	TCGA-24-2023-01A-01D-0648-01	ae92c485-b80f-452c-b45d-013c366a9e89	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	ae92c485-b80f-452c-b45d-013c366a9e89	TCGA-24-2023-01A-21-1560-20	TCGA-24-2023-01A-01R-1567-13	TCGA-24-2023-01A-01R-0655-07		feeee3cc-2213-4b46-b985-4575d7dcbf23	11fd4bb1-0f8d-4830-a7f0-83897a5df11d	TCGA-24-2023-01A-01R-1567-13		
TCGA-24-2024-01	1	TCGA-24-2024-01	1769	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2024	1769	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	72	Bilateral	TCGA-24-2024-F26450	Stage IIIC	-26476		1769	0	1769		421				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3	Recurrence				TCGA-24-2024.4189cfa0-00c3-42fb-91b9-d2f4b4887061.pdf	0	0	0	0	0	0	0	0	0	0	5	5	95	95	80	80		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1994		TCGA-24-2024-01		TCGA-24-2024-01A-02W-0722-08	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	c3771a58-897b-4427-8dbb-70214f74dc03		TCGA-24-2024-01A-02R-1568-13	TCGA-24-2024-01A-02D-0667-05	TCGA-24-2024-01	TCGA-24-2024-01	TCGA-24-2024-01A-02D-0663-01	TCGA-24-2024-01	TCGA-24-2024-01A-02D-0663-01	7faa8eaf-a19f-40df-bc1c-2dddd37dac9a	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	7faa8eaf-a19f-40df-bc1c-2dddd37dac9a	TCGA-24-2024-01A-03-1563-20	TCGA-24-2024-01A-02R-1568-13	TCGA-24-2024-01A-02R-0670-07		3f66920b-c10b-4768-a706-c8a6cef1c149	bdd5afb1-a251-4541-bbbe-0fcd1126a3ce	TCGA-24-2024-01A-02R-1568-13	TCGA-24-2024-01A-02W-0722-08	
TCGA-24-2026-01	1	TCGA-24-2026-01	1059	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-2026	1059	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			79	Bilateral	TCGA-24-2026-F26456	Stage IIIC	-29050		1059	0	1059						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1		YES	G3					TCGA-24-2026.7fc3cf2f-b132-4dce-b16a-2b4a1162da14.pdf	0	0	2	0	0	0	0	0	0	0	10	15	90	85	90	80			YES				NO		Primary Tumor	01	1			24	>20 mm	Ovary		A	DECEASED	1995		TCGA-24-2026-01			ce0fd762-e18f-4cca-a4c4-c064dca62e60	f68086f7-8d41-4631-9346-849088f1f577		TCGA-24-2026-01A-01R-1567-13	TCGA-24-2026-01A-01D-0652-05	TCGA-24-2026-01	TCGA-24-2026-01	TCGA-24-2026-01A-01D-0648-01	TCGA-24-2026-01	TCGA-24-2026-01A-01D-0648-01	0a35f5c8-aad8-45f8-aaf2-94f16c84a273	ce0fd762-e18f-4cca-a4c4-c064dca62e60	ce0fd762-e18f-4cca-a4c4-c064dca62e60	0a35f5c8-aad8-45f8-aaf2-94f16c84a273	TCGA-24-2026-01A-21-1560-20	TCGA-24-2026-01A-01R-1567-13	TCGA-24-2026-01A-01R-0655-07		ccb2b163-3da6-4594-b55b-c63221fc8ad5	ce0fd762-e18f-4cca-a4c4-c064dca62e60	TCGA-24-2026-01A-01R-1567-13		
TCGA-24-2027-01	1	TCGA-24-2027-01	3337	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-24-2027	3337	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-24-2027-F26460	Stage IV	-18835		3337	0	3337		617	0			2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence				TCGA-24-2027.8a4d0373-9d57-4cf7-ac78-d8b558d43df6.pdf	0	0	0	0	3	0	0	0	0	0	7	5	90	95	85	85	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			24	>20 mm	Ovary		A	DECEASED	1995		TCGA-24-2027-01			fc1f34ba-12e1-46d8-85ef-15b9486b37c2	55afc19d-b001-47f3-9d3d-9bc9a8681031		TCGA-24-2027-01A-01R-1567-13	TCGA-24-2027-01A-01D-0652-05	TCGA-24-2027-01	TCGA-24-2027-01	TCGA-24-2027-01A-01D-0648-01	TCGA-24-2027-01	TCGA-24-2027-01A-01D-0648-01	e226211e-4a19-4406-b6e8-45fab717d9c8	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	e226211e-4a19-4406-b6e8-45fab717d9c8	TCGA-24-2027-01A-21-1560-20	TCGA-24-2027-01A-01R-1567-13	TCGA-24-2027-01A-01R-0655-07		e9c0e81a-4be2-4ab2-a0fe-33ea200f4047	fc1f34ba-12e1-46d8-85ef-15b9486b37c2	TCGA-24-2027-01A-01R-1567-13		
TCGA-24-2029-01	1	TCGA-24-2029-01	439	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-24-2029	439	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	75	Bilateral	TCGA-24-2029-F26476	Stage IIIC	-27527		439	0	439		372				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				24	>20 mm	Ovary			DECEASED	1995		TCGA-24-2029-01				c10a5aef-aa73-4f20-acef-a5bd42e29fca		TCGA-24-2029-01A-01R-1567-13	TCGA-24-2029-01A-01D-0652-05			TCGA-24-2029-01A-01D-0648-01	TCGA-24-2029-01	TCGA-24-2029-01A-01D-0648-01	e27ac436-4b5b-4ec7-901d-bc17e16da28e			e27ac436-4b5b-4ec7-901d-bc17e16da28e	TCGA-24-2029-01A-21-1560-20		TCGA-24-2029-01A-01R-0655-07		fc252b6a-222d-4529-a609-012e71c0b436				
TCGA-24-2030-01	1	TCGA-24-2030-01	1701	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-24-2030	1701	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	87	Left	TCGA-24-2030-F26480	Stage IIIC	-31900		1701	0	1641		646				2010-2-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.5			G3	Recurrence				TCGA-24-2030.bb1b63ab-1e13-4401-ab6a-0325da96b17f.pdf	10	0	0	0	5	0	0	0	0	0	10	10	85	90	80	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1995		TCGA-24-2030-01		TCGA-24-2030-01A-01W-0722-08		827506c7-c89c-4301-971d-b42ace20769e		TCGA-24-2030-01A-01R-1568-13	TCGA-24-2030-01A-01D-0667-05			TCGA-24-2030-01A-01D-0663-01	TCGA-24-2030-01	TCGA-24-2030-01A-01D-0663-01	efc9ea53-2994-4a8e-abe2-b4dd7faf65f5			efc9ea53-2994-4a8e-abe2-b4dd7faf65f5	TCGA-24-2030-01A-21-1560-20		TCGA-24-2030-01A-01R-0670-07		07894e29-8a70-415e-a10d-389d652f11a5			TCGA-24-2030-01A-01W-0722-08	
TCGA-24-2033-01	1	TCGA-24-2033-01	562	1	High	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-2033	562	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	87	Bilateral	TCGA-24-2033-F26490	Stage IIIC	-31977		562	0	562		351				2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Primary Tumor	01				24	>20 mm	Ovary			DECEASED	1995		TCGA-24-2033-01			b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	d671c1b8-d45e-4d50-bf32-458677874c49		TCGA-24-2033-01A-01R-1568-13	TCGA-24-2033-01A-01D-0667-05	TCGA-24-2033-01	TCGA-24-2033-01	TCGA-24-2033-01A-01D-0663-01	TCGA-24-2033-01	TCGA-24-2033-01A-01D-0663-01	eeb3061c-910c-407b-a949-a65bf1b74689	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	eeb3061c-910c-407b-a949-a65bf1b74689	TCGA-24-2033-01A-21-1560-20	TCGA-24-2033-01A-01R-1568-13	TCGA-24-2033-01A-01R-0670-07		a735c975-e05c-4389-a39d-80c25462dfe6	b03b75e2-d1d0-4fd7-b66e-891f7b0acb76	TCGA-24-2033-01A-01R-1568-13		
TCGA-24-2035-01	1	TCGA-24-2035-01	857	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2035	857	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Left	TCGA-24-2035-F26496	Stage IIIC	-23855		857	0	857		287	0			2010-3-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3	Recurrence				TCGA-24-2035.025d4b31-5832-451a-9f70-e0281f698aa6.pdf	5	0	0	0	0	0	0	0	0	0	90	50	10	50	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			24	1-10 mm	Ovary		A	DECEASED	1996		TCGA-24-2035-01		TCGA-24-2035-01A-01W-0722-08	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0			TCGA-24-2035-01A-01R-1568-13	TCGA-24-2035-01A-01D-0667-05	TCGA-24-2035-01	TCGA-24-2035-01	TCGA-24-2035-01A-01D-0663-01	TCGA-24-2035-01	TCGA-24-2035-01A-01D-0663-01	501f96cc-6600-48c6-bb6f-3bd38b1d4d09	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	501f96cc-6600-48c6-bb6f-3bd38b1d4d09		TCGA-24-2035-01A-01R-1568-13	TCGA-24-2035-01A-01R-0670-07		ede49e4b-e555-4d20-99cb-e98ea98ddec2	e78f43ff-0b31-4f9b-a9c1-02155ee3d8b0	TCGA-24-2035-01A-01R-1568-13	TCGA-24-2035-01A-01W-0722-08	
TCGA-24-2036-01	1	TCGA-24-2036-01	1947	1	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-24-2036	1947	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	50		TCGA-24-2036-F26505	Stage IIIA	-18582		1947	0	1947		914	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3	Recurrence				TCGA-24-2036.3c1ecc69-a121-4c32-b15a-1e5bbf2f8d7e.pdf	2	0	0	0	0	0	0	0	0	0	0	10	100	90	90	80	Other	WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1996		TCGA-24-2036-01			788ade22-382b-49ca-b2b1-447a2072d0ea	bcde7ed3-4bc7-41c7-99af-f132bda4a6ef		TCGA-24-2036-01A-01R-1568-13	TCGA-24-2036-01A-01D-0667-05	TCGA-24-2036-01	TCGA-24-2036-01	TCGA-24-2036-01A-01D-0663-01	TCGA-24-2036-01	TCGA-24-2036-01A-01D-0663-01	8e634032-9206-4635-a1d9-faeaef6c3fbb	788ade22-382b-49ca-b2b1-447a2072d0ea	788ade22-382b-49ca-b2b1-447a2072d0ea	8e634032-9206-4635-a1d9-faeaef6c3fbb	TCGA-24-2036-01A-21-1560-20	TCGA-24-2036-01A-01R-1568-13	TCGA-24-2036-01A-01R-0670-07		b7b09d06-e228-4549-b19a-99561867345b	788ade22-382b-49ca-b2b1-447a2072d0ea	TCGA-24-2036-01A-01R-1568-13		
TCGA-24-2038-01	1	TCGA-24-2038-01	1354	1	Iq	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 12	TCGA-24-2038	1354	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	68	Right	TCGA-24-2038-F26518	Stage IIIA	-24957		1354	0	1354		1169				2010-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			GB	Recurrence				TCGA-24-2038.82958234-9de0-429f-8e63-3e8891f1df81.pdf	2	0	0	0	0	0	0	0	0	0	40	5	60	95	90	90		WITH TUMOR	NO	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2000		TCGA-24-2038-01		TCGA-24-2038-01A-01W-0722-08	372a8471-dff3-44c0-9393-94ad511a7374	b9526a72-d01f-46bc-896d-4798319abebf		TCGA-24-2038-01A-01R-1568-13	TCGA-24-2038-01A-01D-0667-05	TCGA-24-2038-01	TCGA-24-2038-01	TCGA-24-2038-01A-01D-0663-01	TCGA-24-2038-01	TCGA-24-2038-01A-01D-0663-01	e765cea0-7987-4b98-bbe6-14c21afe6b58	372a8471-dff3-44c0-9393-94ad511a7374	372a8471-dff3-44c0-9393-94ad511a7374	e765cea0-7987-4b98-bbe6-14c21afe6b58	TCGA-24-2038-01A-21-1560-20	TCGA-24-2038-01A-01R-1568-13	TCGA-24-2038-01A-01R-0670-07		05783372-9fc0-426a-a1ea-203af160b5b6	372a8471-dff3-44c0-9393-94ad511a7374	TCGA-24-2038-01A-01R-1568-13	TCGA-24-2038-01A-01W-0722-08	
TCGA-24-2254-01	1	TCGA-24-2254-01	1736	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 2	TCGA-24-2254	1736	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	66	Bilateral	TCGA-24-2254-F26523	Stage IIIC	-24407		1736	0	1736		606	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1		YES	G3	Recurrence				TCGA-24-2254.3788629f-17da-4075-af61-cf124bdfb48e.pdf					0	0			0	0	10	10	90	90	90	90	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	2003		TCGA-24-2254-01		TCGA-24-2254-01A-01W-0722-08	e496319b-df71-44a0-bfa6-90f50ae54654	9525da91-59ae-487e-b9cb-925f263dfcb6		TCGA-24-2254-01A-01R-1568-13	TCGA-24-2254-01A-01D-0667-05	TCGA-24-2254-01	TCGA-24-2254-01	TCGA-24-2254-01A-01D-0663-01	TCGA-24-2254-01	TCGA-24-2254-01A-01D-0663-01	ad900317-46f7-4681-8fb1-692f07f48e38	e496319b-df71-44a0-bfa6-90f50ae54654	e496319b-df71-44a0-bfa6-90f50ae54654	ad900317-46f7-4681-8fb1-692f07f48e38	TCGA-24-2254-01A-21-1560-20	TCGA-24-2254-01A-01R-1568-13	TCGA-24-2254-01A-01R-0670-07		b8cac420-a963-4be2-9ecf-dd92700477e1	e496319b-df71-44a0-bfa6-90f50ae54654	TCGA-24-2254-01A-01R-1568-13	TCGA-24-2254-01A-01W-0722-08	
TCGA-24-2260-01	1	TCGA-24-2260-01	1100	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2260	1100	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-24-2260-F26532	Stage IIIB	-27112		1100	0	1100		667				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1	NO		1.7			G3	Recurrence				TCGA-24-2260.920817f6-bd04-4e9a-8f41-ba28be22cbc8.pdf					10	10			0	0	10	10	80	80	90	90		WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.5			24	1-10 mm	Ovary		A	DECEASED	1992		TCGA-24-2260-01		TCGA-24-2260-01A-01W-0722-08		34ce0e32-d482-45e5-8663-edf50b16309a		TCGA-24-2260-01A-01R-1568-13	TCGA-24-2260-01A-01D-0667-05			TCGA-24-2260-01A-01D-0663-01	TCGA-24-2260-01	TCGA-24-2260-01A-01D-0663-01	eddece9c-b67d-4628-bf3a-5f419574bd6a			eddece9c-b67d-4628-bf3a-5f419574bd6a	TCGA-24-2260-01A-21-1560-20		TCGA-24-2260-01A-01R-0670-07		0bfc4955-78bd-4883-b7b0-a262b6c1594f			TCGA-24-2260-01A-01W-0722-08	
TCGA-24-2261-01	1	TCGA-24-2261-01	24	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-24-2261	24	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			76	Left	TCGA-24-2261-F26540	Stage IIIC	-27897		24	0	24						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		1.7		YES	G3					TCGA-24-2261.6145afd6-e7d7-47bc-a659-ac84c3434e86.pdf					5	5			1	1	9	9	85	85	90	90		WITH TUMOR	NO				NO		Primary Tumor	01	0.4			24	11-20 mm	Ovary		A	DECEASED	1992		TCGA-24-2261-01		TCGA-24-2261-01A-01W-0722-08	75e9506a-d007-4fb2-8bdd-7e7780653a63	cbbb0190-5bfe-4a4f-aabe-63d68021b388		TCGA-24-2261-01A-01R-1568-13	TCGA-24-2261-01A-01D-0667-05	TCGA-24-2261-01	TCGA-24-2261-01	TCGA-24-2261-01A-01D-0663-01	TCGA-24-2261-01	TCGA-24-2261-01A-01D-0663-01	ef885a49-a605-4f56-8d82-08eddf0a0850	75e9506a-d007-4fb2-8bdd-7e7780653a63	75e9506a-d007-4fb2-8bdd-7e7780653a63	ef885a49-a605-4f56-8d82-08eddf0a0850	TCGA-24-2261-01A-21-1560-20	TCGA-24-2261-01A-01R-1568-13	TCGA-24-2261-01A-01R-0670-07		8c41ba6a-3315-4903-9cd5-ac3f82576008	75e9506a-d007-4fb2-8bdd-7e7780653a63	TCGA-24-2261-01A-01R-1568-13	TCGA-24-2261-01A-01W-0722-08	
TCGA-24-2262-01	1	TCGA-24-2262-01	11	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2262	11	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Right	TCGA-24-2262-F26542	Stage IIIC	-20861		11	0	11						2010-3-15	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3					TCGA-24-2262.d58b58ac-365c-43d0-a893-0becfb6e9fff.pdf					10	15			1	1	9	9	80	75	90	90		WITH TUMOR	NO				NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	DECEASED	1992		TCGA-24-2262-01		TCGA-24-2262-01A-01W-0799-08	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	5d31db74-24ef-4322-9880-5189dee10ccb		TCGA-24-2262-01A-01R-1568-13	TCGA-24-2262-01A-01D-0708-05	TCGA-24-2262-01	TCGA-24-2262-01	TCGA-24-2262-01A-01D-0704-01	TCGA-24-2262-01	TCGA-24-2262-01A-01D-0704-01	9c67fe94-0cb2-4fc5-8349-5fb77875ce28	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	9c67fe94-0cb2-4fc5-8349-5fb77875ce28	TCGA-24-2262-01A-21-1560-20	TCGA-24-2262-01A-01R-1568-13	TCGA-24-2262-01A-01R-0711-07		8462f214-6bf7-4018-b40b-f9a3f3847542	efb87f4e-6fc7-4b2c-9d56-62b0f7834fbe	TCGA-24-2262-01A-01R-1568-13	TCGA-24-2262-01A-01W-0799-08	
TCGA-24-2267-01	1	TCGA-24-2267-01	1446	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2267	1446	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-24-2267-F26544	Stage IIB	-21293		1446	0	1446		512				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5		YES	G3	Recurrence				TCGA-24-2267.24844312-f32c-4366-945e-96d9a923f82a.pdf					1	1			0	0	14	4	85	95	90	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			24	No Macroscopic disease	Ovary		A	DECEASED	1993		TCGA-24-2267-01		TCGA-24-2267-01A-01W-0799-08	9ebb3535-6536-49fc-a88b-473235972378	25f1b635-6318-41d5-a0c8-37e8d263dddd		TCGA-24-2267-01A-01R-1568-13	TCGA-24-2267-01A-01D-0708-05	TCGA-24-2267-01	TCGA-24-2267-01	TCGA-24-2267-01A-01D-0704-01	TCGA-24-2267-01	TCGA-24-2267-01A-01D-0704-01	c908d760-4c66-4be4-9e87-66ab733a7be6	9ebb3535-6536-49fc-a88b-473235972378	9ebb3535-6536-49fc-a88b-473235972378	c908d760-4c66-4be4-9e87-66ab733a7be6	TCGA-24-2267-01A-21-1560-20	TCGA-24-2267-01A-01R-1568-13	TCGA-24-2267-01A-01R-0711-07		7d6e82dd-4715-42df-8325-444be465aa24	9ebb3535-6536-49fc-a88b-473235972378	TCGA-24-2267-01A-01R-1568-13	TCGA-24-2267-01A-01W-0799-08	
TCGA-24-2271-01	1	TCGA-24-2271-01	962	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2271	962	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-24-2271-F26557	Stage IIIC	-20399		962	0	962		827				2010-4-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6		YES	G3	Recurrence				TCGA-24-2271.87d64a93-9b08-48a5-a26e-1cc4b5ac8bde.pdf					0	0			0	0	15	20	85	80	80	80		WITH TUMOR	YES			Physical Examination	NO		Primary Tumor	01	0.5			24	>20 mm	Ovary	YES	A	DECEASED	1999		TCGA-24-2271-01		TCGA-24-2271-01A-01W-0799-08	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	9651ae11-92cc-4085-b9f5-b141eff0fb99		TCGA-24-2271-01A-01R-1568-13	TCGA-24-2271-01A-01D-0708-05	TCGA-24-2271-01	TCGA-24-2271-01	TCGA-24-2271-01A-01D-0704-01	TCGA-24-2271-01	TCGA-24-2271-01A-01D-0704-01	256a9e3d-46f8-465f-8157-354e3b9e47b8	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	256a9e3d-46f8-465f-8157-354e3b9e47b8	TCGA-24-2271-01A-21-1560-20	TCGA-24-2271-01A-01R-1568-13	TCGA-24-2271-01A-01R-0711-07		3f1bd8a1-5a33-4c68-9d62-a65289c677dd	f3581696-e1db-4d0f-9ce7-5fb0f5c08906	TCGA-24-2271-01A-01R-1568-13	TCGA-24-2271-01A-01W-0799-08	
TCGA-24-2280-01	0	TCGA-24-2280-01	2143	0	Squamous		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-24-2280	2143	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Bilateral	TCGA-24-2280-F26561	Stage IIIC	-27356			0	2143		535	0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence				TCGA-24-2280.deb1a0d1-92a0-4c10-b491-a6a1ca5e3192.pdf					2	2			0	0	10	15	88	83	80	75	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	1-10 mm	Ovary		A	LIVING	2004		TCGA-24-2280-01		TCGA-24-2280-01A-01W-0799-08				TCGA-24-2280-01A-01R-1568-13	TCGA-24-2280-01A-01D-0708-05			TCGA-24-2280-01A-01D-0704-01	TCGA-24-2280-01	TCGA-24-2280-01A-01D-0704-01	4d5e8e9e-46a0-4b04-ba87-edb5d1c79347			4d5e8e9e-46a0-4b04-ba87-edb5d1c79347		TCGA-24-2280-01A-01R-1568-13	TCGA-24-2280-01A-01R-0711-07		964fcf21-982e-474f-ab2d-cfcb0bbd0e15		TCGA-24-2280-01A-01R-1568-13	TCGA-24-2280-01A-01W-0799-08	
TCGA-24-2281-01	0	TCGA-24-2281-01	1357	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-24-2281	1357	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			68	Bilateral	TCGA-24-2281-F26570	Stage IIA	-25019			0	1357			0			2010-4-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5		YES	G3					TCGA-24-2281.363dc00f-480d-4a3f-8950-80a6bc0b7dd8.pdf					5	5			0	0	35	25	60	70	70	70	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			24	1-10 mm	Ovary		A	LIVING	2006		TCGA-24-2281-01		TCGA-24-2281-01A-01W-0799-08	44948279-405d-42f6-ad29-465150ee6d85	e83257be-084b-405a-8098-b10055d1ad85		TCGA-24-2281-01A-01R-1568-13	TCGA-24-2281-01A-01D-0708-05	TCGA-24-2281-01	TCGA-24-2281-01	TCGA-24-2281-01A-01D-0704-01	TCGA-24-2281-01	TCGA-24-2281-01A-01D-0704-01	89a06d96-e657-4d09-89c4-3e0a679ba9ac	44948279-405d-42f6-ad29-465150ee6d85	44948279-405d-42f6-ad29-465150ee6d85	89a06d96-e657-4d09-89c4-3e0a679ba9ac	TCGA-24-2281-01A-21-1560-20	TCGA-24-2281-01A-01R-1568-13	TCGA-24-2281-01A-01R-0711-07		0ca4dc50-aee3-49e2-b327-b86ddfce658f	44948279-405d-42f6-ad29-465150ee6d85	TCGA-24-2281-01A-01R-1568-13	TCGA-24-2281-01A-01W-0799-08	
TCGA-24-2288-01	1	TCGA-24-2288-01	25	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 8	TCGA-24-2288	25	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			70	Bilateral	TCGA-24-2288-F26574	Stage IIIC	-25831		25	0	25						2010-2-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2		YES	G3					TCGA-24-2288.a8d48a3e-3f22-44ec-8cbd-2ad8bb43bb45.pdf					5	5			0	0	10	10	85	85	90	90		WITH TUMOR	YES				NO		Primary Tumor	01	0.5			24	>20 mm	Ovary		A	DECEASED	1999		TCGA-24-2288-01		TCGA-24-2288-01A-01W-0799-08	dbc2cfac-df65-4750-af39-37760bad1057	7c143023-df5b-42cb-958b-962d6f607e92		TCGA-24-2288-01A-01R-1568-13	TCGA-24-2288-01A-01D-0708-05	TCGA-24-2288-01	TCGA-24-2288-01	TCGA-24-2288-01A-01D-0704-01	TCGA-24-2288-01	TCGA-24-2288-01A-01D-0704-01	c5ca843c-5bcf-4d73-adba-4c40036f1c67	dbc2cfac-df65-4750-af39-37760bad1057	dbc2cfac-df65-4750-af39-37760bad1057	c5ca843c-5bcf-4d73-adba-4c40036f1c67	TCGA-24-2288-01A-21-1560-20	TCGA-24-2288-01A-01R-1568-13	TCGA-24-2288-01A-01R-0711-07		bea203c5-e349-4941-aa28-d3b9372ad7a2	dbc2cfac-df65-4750-af39-37760bad1057	TCGA-24-2288-01A-01R-1568-13	TCGA-24-2288-01A-01W-0799-08	
TCGA-24-2289-01	1	TCGA-24-2289-01	2049	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 8	TCGA-24-2289	2049	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	68	Bilateral	TCGA-24-2289-F26578	Stage IV	-25191		2049	0	2049		568				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.2	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		1.5			G3	Recurrence				TCGA-24-2289.3c9bb67a-702f-4e9b-bd0f-c0ef8a5d237d.pdf					1	1			0	0	10	10	89	89	90	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1997		TCGA-24-2289-01		TCGA-24-2289-01A-01W-0799-08		992227e4-86a6-4703-ac81-cae8ea4a5dac		TCGA-24-2289-01A-01R-1568-13	TCGA-24-2289-01A-01D-0708-05			TCGA-24-2289-01A-01D-0704-01	TCGA-24-2289-01	TCGA-24-2289-01A-01D-0704-01	2805596c-3015-489a-8683-8df919934cb8			2805596c-3015-489a-8683-8df919934cb8	TCGA-24-2289-01A-21-1560-20	TCGA-24-2289-01A-01R-1568-13	TCGA-24-2289-01A-01R-0711-07		9ef0fcf7-e7c3-4c19-ab2b-185392963182		TCGA-24-2289-01A-01R-1568-13	TCGA-24-2289-01A-01W-0799-08	
TCGA-24-2290-01	1	TCGA-24-2290-01	1102	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-24-2290	1102	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56		TCGA-24-2290-F26583	Stage IIIC	-20530		1102	0	1102		324	0			2010-2-19	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-24-2290.71036f77-0d99-427a-883c-75624453890d.pdf					5	15			0	0	5	15	90	70	95	85	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			24	1-10 mm	Omentum		A	DECEASED	1997		TCGA-24-2290-01		TCGA-24-2290-01A-01W-0799-08	a3173b33-aa16-48a2-b733-0345aad49755	7ede9f43-4fe6-4cd4-a1fe-b6a0677b40d9		TCGA-24-2290-01A-01R-1568-13	TCGA-24-2290-01A-01D-0708-05	TCGA-24-2290-01	TCGA-24-2290-01	TCGA-24-2290-01A-01D-0704-01	TCGA-24-2290-01	TCGA-24-2290-01A-01D-0704-01	52fce37e-fd7f-4b44-81ae-b2a3253f8699	a3173b33-aa16-48a2-b733-0345aad49755	a3173b33-aa16-48a2-b733-0345aad49755	52fce37e-fd7f-4b44-81ae-b2a3253f8699	TCGA-24-2290-01A-21-1560-20	TCGA-24-2290-01A-01R-1568-13	TCGA-24-2290-01A-01R-0711-07		ad9e04b7-2000-411e-81bd-d1d22381d5c8	a3173b33-aa16-48a2-b733-0345aad49755	TCGA-24-2290-01A-01R-1568-13	TCGA-24-2290-01A-01W-0799-08	
TCGA-24-2293-01	1	TCGA-24-2293-01	506	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation c1uster 9	TCGA-24-2293	506	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			47	Right	TCGA-24-2293-F26598		-17235		506	0	506						2010-2-26	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3			G3					TCGA-24-2293.caf7dd79-d1f9-4061-8b50-aa8e5a4f18b7.pdf					2	2			58	43	0	0	40	55	66	74			YES	Partial Remission/Response			NO		Primary Tumor	01	0.3			24	>20 mm	Omentum		A	DECEASED	1995		TCGA-24-2293-01		TCGA-24-2293-01A-01W-0799-08		a40fdeac-ebb6-4f9f-9f90-837deef5095e		TCGA-24-2293-01A-01R-1568-13	TCGA-24-2293-01A-01D-0708-05			TCGA-24-2293-01A-01D-0704-01	TCGA-24-2293-01	TCGA-24-2293-01A-01D-0704-01	a8a9d81b-94c8-47b7-a261-4611c6fbabe0			a8a9d81b-94c8-47b7-a261-4611c6fbabe0	TCGA-24-2293-01A-21-1560-20	TCGA-24-2293-01A-01R-1568-13	TCGA-24-2293-01A-01R-0711-07		87480009-8495-4826-9d10-dbe6dc6281f1		TCGA-24-2293-01A-01R-1568-13	TCGA-24-2293-01A-01W-0799-08	
TCGA-24-2295-01	1	TCGA-24-2295-01	1007	1	High		OV-like c1	OV-like c4					TCGA-24-2295	1007	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	69	Right	TCGA-24-2295-F26605	Stage IIIC	-25416		1007	0	1007		281				2010-4-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.1		YES	G3	Recurrence				TCGA-24-2295.44d946e9-12ae-437b-9211-1be42b4d6439.pdf					1	5			5	5	0	0	94	90	97	73		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1995		TCGA-24-2295-01				eb245ed7-60fc-47eb-9d75-4704c337b943			TCGA-24-2295-01A-01D-0708-05			TCGA-24-2295-01A-01D-0704-01	TCGA-24-2295-01	TCGA-24-2295-01A-01D-0704-01	958cb1b0-38bf-42d1-a4de-fac9901717b9			958cb1b0-38bf-42d1-a4de-fac9901717b9	TCGA-24-2295-01A-21-1560-20		TCGA-24-2295-01A-01R-0711-07		8a525a38-29e3-457d-a665-e05297e6b07a				
TCGA-24-2297-01	1	TCGA-24-2297-01	1699	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-24-2297	1699	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			56	Bilateral	TCGA-24-2297-F26612	Stage IIIC	-20487		1699	0	1699						2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G3					TCGA-24-2297.12b02227-4050-4d02-bdb8-939d348a4c19.pdf					10	2			30	8	0	0	60	90	81	97			YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			24	>20 mm	Ovary		A	DECEASED	1993		TCGA-24-2297-01			2b0089bc-b493-4179-bf5c-e58550e1ee5b	f700e3e2-462f-4889-82fa-ac614983d642		TCGA-24-2297-01A-01R-1568-13	TCGA-24-2297-01A-01D-0708-05	TCGA-24-2297-01	TCGA-24-2297-01	TCGA-24-2297-01A-01D-0704-01	TCGA-24-2297-01	TCGA-24-2297-01A-01D-0704-01	1d8caa41-37c3-4a40-8d3e-bb356efdbb77	2b0089bc-b493-4179-bf5c-e58550e1ee5b	2b0089bc-b493-4179-bf5c-e58550e1ee5b	1d8caa41-37c3-4a40-8d3e-bb356efdbb77	TCGA-24-2297-01A-21-1560-20	TCGA-24-2297-01A-01R-1568-13	TCGA-24-2297-01A-01R-0711-07		971a0b51-b807-436b-ac4c-ef9cc2e2038d	2b0089bc-b493-4179-bf5c-e58550e1ee5b	TCGA-24-2297-01A-01R-1568-13		
TCGA-24-2298-01	1	TCGA-24-2298-01	1620	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-24-2298	1620	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-24-2298-F26616	Stage IIIC	-20453		1620	0	1620		469				2010-3-16	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence				TCGA-24-2298.fe9d7bf4-a278-4842-b911-018d0127ef20.pdf					3	1			27	25	0	0	70	74	88	89		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			24	>20 mm	Ovary		A	DECEASED	1993		TCGA-24-2298-01		TCGA-24-2298-01A-01W-0799-08	7b39cb0a-7152-4037-9989-57545a1df980	a99356d2-7d94-4274-9720-3defe513159a		TCGA-24-2298-01A-01R-1569-13	TCGA-24-2298-01A-01D-0708-05	TCGA-24-2298-01	TCGA-24-2298-01	TCGA-24-2298-01A-01D-0704-01	TCGA-24-2298-01	TCGA-24-2298-01A-01D-0704-01	9b422094-dde1-4ed5-9431-cb15e6d90b35	7b39cb0a-7152-4037-9989-57545a1df980	7b39cb0a-7152-4037-9989-57545a1df980	9b422094-dde1-4ed5-9431-cb15e6d90b35	TCGA-24-2298-01A-21-1560-20	TCGA-24-2298-01A-01R-1569-13	TCGA-24-2298-01A-01R-0711-07		9c71ce7f-4e80-46bc-b66c-c893614dd207	7b39cb0a-7152-4037-9989-57545a1df980	TCGA-24-2298-01A-01R-1569-13	TCGA-24-2298-01A-01W-0799-08	
TCGA-25-1312-01	1	TCGA-25-1312-01	31	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-25-1312	31	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			69	Left	TCGA-25-1312-F26626	Stage IV	-25537		31	0	31						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3					TCGA-25-1312.9AD5ADDB-713E-4FF7-97F1-123FA771AC5B.pdf					0	0			0	0	15	10	85	90	95	95							NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001		TCGA-25-1312-01			0d7561dc-7069-41df-ba49-8fcd4df52efb	43e59c4e-4bf0-45d0-9c02-1d1c43eeef9b		TCGA-25-1312-01A-01R-1565-13	TCGA-25-1312-01A-01D-0460-05	TCGA-25-1312-01	TCGA-25-1312-01	TCGA-25-1312-01A-01D-0452-01	TCGA-25-1312-01	TCGA-25-1312-01A-01D-0452-01	ab0cc4c2-aa3b-4c0c-904e-090c5ce00162	0d7561dc-7069-41df-ba49-8fcd4df52efb	0d7561dc-7069-41df-ba49-8fcd4df52efb	ab0cc4c2-aa3b-4c0c-904e-090c5ce00162	TCGA-25-1312-01A-11-1562-20	TCGA-25-1312-01A-01R-1565-13	TCGA-25-1312-01A-01R-0456-07		c31a0d45-5e8c-4fcb-b773-1bd3744b5eea	0d7561dc-7069-41df-ba49-8fcd4df52efb	TCGA-25-1312-01A-01R-1565-13		
TCGA-25-1313-01	1	TCGA-25-1313-01	820	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 13	TCGA-25-1313	820	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62	Bilateral	TCGA-25-1313-F26628	Stage IV	-22982		820	0	820		394				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2			G3	Recurrence				TCGA-25-1313.3F5AAE21-3694-4AC2-8A18-4970090A08F4.pdf					0	0			0	0	20	30	80	70	90	90		WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)			Primary Tumor	01	1.5			25	1-10 mm	Ovary		A	DECEASED	2000		TCGA-25-1313-01		TCGA-25-1313-01A-01W-0492-08	ab99683f-6116-463d-8bf6-5782809d4729	291a8a6a-23e2-42c9-a260-8696b9795cf2		TCGA-25-1313-01A-01R-1565-13	TCGA-25-1313-01A-01D-0460-05	TCGA-25-1313-01	TCGA-25-1313-01	TCGA-25-1313-01A-01D-0452-01	TCGA-25-1313-01	TCGA-25-1313-01A-01D-0452-01	568acf95-5e03-406b-ac0d-4d0e7d6855eb	ab99683f-6116-463d-8bf6-5782809d4729	ab99683f-6116-463d-8bf6-5782809d4729	568acf95-5e03-406b-ac0d-4d0e7d6855eb	TCGA-25-1313-01A-21-1562-20	TCGA-25-1313-01A-01R-1565-13	TCGA-25-1313-01A-01R-0456-07		5e71901f-ac21-4d6d-8705-ab20c65ec0f0	ab99683f-6116-463d-8bf6-5782809d4729	TCGA-25-1313-01A-01R-1565-13	TCGA-25-1313-01A-01W-0492-08	
TCGA-25-1314-01	1	TCGA-25-1314-01	1004	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1314	1004	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	42	Bilateral	TCGA-25-1314-F26633	Stage IV	-15462		1004	0	974		274				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		4.5			G3	Progression of Disease				TCGA-25-1314.B208F8AC-5F06-4DAD-A410-5D65D36674D6.pdf					0	0			0	0	5	2	95	98	98	98		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.8			25	1-10 mm	Ovary		A	DECEASED	2000		TCGA-25-1314-01			b571f7cf-e9b8-493f-822b-a489f114420b	b17945ba-39d6-400d-8e3e-e81123595c51		TCGA-25-1314-01A-01R-1565-13	TCGA-25-1314-01A-01D-0460-05	TCGA-25-1314-01	TCGA-25-1314-01	TCGA-25-1314-01A-01D-0452-01	TCGA-25-1314-01	TCGA-25-1314-01A-01D-0452-01	5d71d039-8fd3-447b-bddd-98aacbfa2582	b571f7cf-e9b8-493f-822b-a489f114420b	b571f7cf-e9b8-493f-822b-a489f114420b	5d71d039-8fd3-447b-bddd-98aacbfa2582	TCGA-25-1314-01A-21-1562-20	TCGA-25-1314-01A-01R-1565-13	TCGA-25-1314-01A-01R-0456-07		da862d11-c970-44ee-af78-1179902f9310	b571f7cf-e9b8-493f-822b-a489f114420b	TCGA-25-1314-01A-01R-1565-13		
TCGA-25-1315-01	1	TCGA-25-1315-01	1583	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1315	1583	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-25-1315-F26639	Stage IIIC	-18263		1583	0	1553		153				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		3.5			G3	Progression of Disease				TCGA-25-1315.486E22A0-A224-4471-BA52-9F52E021B131.pdf					0	0			0	0	5	5	95	95	95	95		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.9			25	1-10 mm	Ovary		A	DECEASED	2000		TCGA-25-1315-01		TCGA-25-1315-01A-01W-0494-09	b6908d33-80c8-4fc0-bd1d-829ec3161527	1ecf4db0-2d32-4ad5-a14a-ce5065f7fb01		TCGA-25-1315-01A-01R-1565-13	TCGA-25-1315-01A-01D-0460-05	TCGA-25-1315-01	TCGA-25-1315-01	TCGA-25-1315-01A-01D-0452-01	TCGA-25-1315-01	TCGA-25-1315-01A-01D-0452-01	2471a056-c835-4330-ac57-a98b31d44bbe	b6908d33-80c8-4fc0-bd1d-829ec3161527	b6908d33-80c8-4fc0-bd1d-829ec3161527	2471a056-c835-4330-ac57-a98b31d44bbe	TCGA-25-1315-01A-21-1562-20	TCGA-25-1315-01A-01R-1565-13	TCGA-25-1315-01A-01R-0456-07		6f8cdfc3-aada-43e2-a9ce-9d8d437b9442	b6908d33-80c8-4fc0-bd1d-829ec3161527	TCGA-25-1315-01A-01R-1565-13		TCGA-25-1315-01A-01W-0494-09
TCGA-25-1316-01	1	TCGA-25-1316-01	1279	1	BRCA-LUAD+	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 12	TCGA-25-1316	1279	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Right	TCGA-25-1316-F26646	Stage IIIC	-20331		1279	0	1126		276				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Progression of Disease				TCGA-25-1316.B766CB7E-C4EC-489C-AEF0-BE28132D5BA5.pdf					0	0			0	0	5	2	95	98	98	98		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	1.5			25	1-10 mm	Ovary		A	DECEASED	2000		TCGA-25-1316-01		TCGA-25-1316-01A-01W-0494-09	6cb5e275-1284-482b-a4e9-933acf9aad44	4d3e28c0-7510-4c0e-a4c2-d2af7bcb82b4		TCGA-25-1316-01A-01R-1565-13	TCGA-25-1316-01A-01D-0460-05	TCGA-25-1316-01	TCGA-25-1316-01	TCGA-25-1316-01A-01D-0452-01	TCGA-25-1316-01	TCGA-25-1316-01A-01D-0452-01	fbc1848d-a366-49d3-96f0-befdaa9a2cb1	6cb5e275-1284-482b-a4e9-933acf9aad44	6cb5e275-1284-482b-a4e9-933acf9aad44	fbc1848d-a366-49d3-96f0-befdaa9a2cb1	TCGA-25-1316-01A-21-20	TCGA-25-1316-01A-01R-1565-13	TCGA-25-1316-01A-01R-0456-07		5c167e3e-7757-4a02-b218-81c2ba107bfa	6cb5e275-1284-482b-a4e9-933acf9aad44	TCGA-25-1316-01A-01R-1565-13		TCGA-25-1316-01A-01W-0494-09
TCGA-25-1317-01	1	TCGA-25-1317-01	61	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1317	61	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66	Bilateral	TCGA-25-1317-F26651	Stage IIIC	-24199		61	0							2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3										0	10			0	0	30	40	70	50	90	85			YES				NO		Primary Tumor	01	0.5			25		Ovary		A	DECEASED	2000	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01	TCGA-25-1317-01A-01W-0490-10	TCGA-25-1317-01A-01W-0490-10	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf			TCGA-25-1317-01A-01R-1565-13	TCGA-25-1317-01A-01D-0460-05	TCGA-25-1317-01	TCGA-25-1317-01	TCGA-25-1317-01A-01D-0452-01	TCGA-25-1317-01	TCGA-25-1317-01A-01D-0452-01	bd6da330-a14d-424a-8bb6-ac244273969e	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	bd6da330-a14d-424a-8bb6-ac244273969e		TCGA-25-1317-01A-01R-1565-13	TCGA-25-1317-01A-01R-0456-07		5b49f5cc-28fd-4b1e-ae8e-6391f99ccb46	423f3c95-8bf5-4c2c-8b7a-343d9af1d0bf	TCGA-25-1317-01A-01R-1565-13		
TCGA-25-1318-01	1	TCGA-25-1318-01	1064	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1318	1064	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-25-1318-F26655	Stage IIIC	-19755		1064	0	1064		185				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		4.5			G3	Recurrence				TCGA-25-1318.D9B9F69A-265C-42F4-BCD2-4B136A7FE935.pdf					5	5					10	15	85	80	95	98		WITH TUMOR	YES	Partial Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.8			25	1-10 mm	Ovary		A	DECEASED	2000	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01	TCGA-25-1318-01A-01W-0490-10	TCGA-25-1318-01A-01W-0490-10	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	2f954b2b-ab8d-4f81-8717-e85d500987ee		TCGA-25-1318-01A-01R-1565-13	TCGA-25-1318-01A-01D-0460-05	TCGA-25-1318-01	TCGA-25-1318-01	TCGA-25-1318-01A-01D-0452-01	TCGA-25-1318-01	TCGA-25-1318-01A-01D-0452-01	376e5a23-7824-4935-b63c-454fc1c99627	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	376e5a23-7824-4935-b63c-454fc1c99627	TCGA-25-1318-01A-21-1562-20	TCGA-25-1318-01A-01R-1565-13	TCGA-25-1318-01A-01R-0456-07		f912d9b2-2f49-4c3f-aed0-3edc0065d54b	4d3e0164-1346-4e8e-b478-29bd8b1f1ce5	TCGA-25-1318-01A-01R-1565-13		
TCGA-25-1319-01	1	TCGA-25-1319-01	1977	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1319	1977	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73	Bilateral	TCGA-25-1319-F26660	Stage IIIC	-26786		1977	0	1977		730				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Recurrence				TCGA-25-1319.62BFD64E-1C60-49A8-BAD0-B173DD22C951.pdf					0	5			10	0	40	5	50	90	95	95			YES				NO		Primary Tumor	01	1			25	11-20 mm	Ovary		A	DECEASED	2000		TCGA-25-1319-01		TCGA-25-1319-01A-01W-0492-08	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	09ef1041-497f-409f-9892-b5a1631a647f		TCGA-25-1319-01A-01R-1565-13	TCGA-25-1319-01A-01D-0460-05	TCGA-25-1319-01	TCGA-25-1319-01	TCGA-25-1319-01A-01D-0452-01	TCGA-25-1319-01	TCGA-25-1319-01A-01D-0452-01	11cc2243-9785-4894-a8de-52d32cd4e466	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	11cc2243-9785-4894-a8de-52d32cd4e466	TCGA-25-1319-01A-21-1562-20	TCGA-25-1319-01A-01R-1565-13	TCGA-25-1319-01A-01R-0456-07		7f028062-e863-4f7d-8ec6-8e91da60fc74	8f0f34fb-bbef-4a17-8324-4ebda56f9e0e	TCGA-25-1319-01A-01R-1565-13	TCGA-25-1319-01A-01W-0492-08	
TCGA-25-1320-01	1	TCGA-25-1320-01	1155	1	High	C9-OV	OV-like c1	BRCA basal-like c6		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-1320	1155	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-25-1320-F26664	Stage IIIC	-24018		1155	0	1124		424				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		3	NO		3.4			G3	Recurrence				TCGA-25-1320.AF68EF8D-A31D-453B-8083-CF6B9EE4E838.pdf					0	5			0	0	30	25	70	70	95	85		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001		TCGA-25-1320-01		TCGA-25-1320-01A-01W-0492-08		d1b3fd86-d1f2-4621-980a-19f3d9ee76f4		TCGA-25-1320-01A-01R-1565-13	TCGA-25-1320-01A-01D-0460-05			TCGA-25-1320-01A-01D-0452-01	TCGA-25-1320-01	TCGA-25-1320-01A-01D-0452-01	299330bc-594b-43a2-b4df-72b668d3797a			299330bc-594b-43a2-b4df-72b668d3797a	TCGA-25-1320-01A-21-1562-20	TCGA-25-1320-01A-01R-1565-13	TCGA-25-1320-01A-01R-0456-07		7a1cfa3d-a19e-42b1-91b5-485891ff2d34		TCGA-25-1320-01A-01R-1565-13	TCGA-25-1320-01A-01W-0492-08	
TCGA-25-1321-01	1	TCGA-25-1321-01	1033	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1321	1033	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-25-1321-F26670	Stage IIIC	-23987		1033	0	1033		454	0			2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.6	NO		3			G3	Recurrence				TCGA-25-1321.5D309784-AED1-4946-817D-37AC8969315C.pdf					5	0			0	0	10	10	85	90	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.8			25	No Macroscopic disease	Ovary		A	DECEASED	2001		TCGA-25-1321-01		TCGA-25-1321-01A-01W-0492-08	74ad9d3e-97a9-419d-8842-3fb37d3f099a	9790631d-f673-415e-8644-5419b2b956b2		TCGA-25-1321-01A-01R-1565-13	TCGA-25-1321-01A-01D-0460-05	TCGA-25-1321-01	TCGA-25-1321-01	TCGA-25-1321-01A-01D-0452-01	TCGA-25-1321-01	TCGA-25-1321-01A-01D-0452-01	8a0d15e0-9f45-4ec6-a19d-d4aa0c3bbf28	74ad9d3e-97a9-419d-8842-3fb37d3f099a	74ad9d3e-97a9-419d-8842-3fb37d3f099a	8a0d15e0-9f45-4ec6-a19d-d4aa0c3bbf28	TCGA-25-1321-01A-21-1562-20	TCGA-25-1321-01A-01R-1565-13	TCGA-25-1321-01A-01R-0456-07		8f9bea4f-6738-429b-8ebb-8ae8cf65d294	74ad9d3e-97a9-419d-8842-3fb37d3f099a	TCGA-25-1321-01A-01R-1565-13	TCGA-25-1321-01A-01W-0492-08	
TCGA-25-1322-01	1	TCGA-25-1322-01	91	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1322	91	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Bilateral	TCGA-25-1322-F26676	Stage IV	-22646		91	0	91						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.8	NO		2.6			G3					TCGA-25-1322.6EAF4358-51F9-4999-A219-39178418CC9C.pdf					15	15					10	10	75	75	95	95		WITH TUMOR	YES				NO		Primary Tumor	01	0.8			25	>20 mm	Ovary		A	DECEASED	2001		TCGA-25-1322-01		TCGA-25-1322-01A-01W-0494-09	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	90cba3ae-e75e-4a1e-bc31-293ac260cf96		TCGA-25-1322-01A-01R-1565-13	TCGA-25-1322-01A-01D-0460-05	TCGA-25-1322-01	TCGA-25-1322-01	TCGA-25-1322-01A-01D-0452-01	TCGA-25-1322-01	TCGA-25-1322-01A-01D-0452-01	6655a8af-6e09-4618-83a0-aa2db334795b	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	6655a8af-6e09-4618-83a0-aa2db334795b	TCGA-25-1322-01A-21-20	TCGA-25-1322-01A-01R-1565-13	TCGA-25-1322-01A-01R-0456-07		34a7dcf3-fc87-4334-8ee0-77166a5398fa	bce04e1e-a90c-4e81-bd16-415cccc9d7e2	TCGA-25-1322-01A-01R-1565-13		TCGA-25-1322-01A-01W-0494-09
TCGA-25-1323-01	1	TCGA-25-1323-01	395	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 1		TCGA-25-1323	395	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	72	Bilateral	TCGA-25-1323-F26680	Stage IIIC	-26602		395	0	365		365				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2.5			G3	Progression of Disease				TCGA-25-1323.AFE55BB2-F0FC-4B39-A61A-2287B62354AD.pdf					10	10			0	20	25	0	65	70	75	80		WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.6			25	1-10 mm	Ovary		A	DECEASED	2001		TCGA-25-1323-01			cd401b89-ae05-4775-94b0-6800f88652b0	e89ce7f4-4c3f-4c48-a222-506d3806ad33		TCGA-25-1323-01A-01R-1565-13	TCGA-25-1323-01A-01D-0460-05	TCGA-25-1323-01	TCGA-25-1323-01	TCGA-25-1323-01A-01D-0452-01	TCGA-25-1323-01	TCGA-25-1323-01A-01D-0452-01	0255205f-8e52-4d29-aa0a-7eecf30fc836	cd401b89-ae05-4775-94b0-6800f88652b0	cd401b89-ae05-4775-94b0-6800f88652b0	0255205f-8e52-4d29-aa0a-7eecf30fc836	TCGA-25-1323-01A-21-1562-20	TCGA-25-1323-01A-01R-1565-13	TCGA-25-1323-01A-01R-0456-07		61b1bbe5-434f-4d88-aadb-a42344b0e0fb	cd401b89-ae05-4775-94b0-6800f88652b0	TCGA-25-1323-01A-01R-1565-13		
TCGA-25-1324-01	1	TCGA-25-1324-01	1035	1			OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 11	TCGA-25-1324	1035	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Bilateral	TCGA-25-1324-F26685	Stage IIIC	-27090		1035	0	1035						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3						20				0	0			0	0	10	10	90	90	95	97			YES				NO		Primary Tumor	01	0.8			25	1-10 mm	Ovary		A	DECEASED	2001	TCGA-25-1324-01A-01W-0490-10		TCGA-25-1324-01A-01W-0490-10	TCGA-25-1324-01A-01W-0490-10	790c6d79-9f7d-4e9a-89db-43b26fe16816			TCGA-25-1324-01A-01R-1565-13	TCGA-25-1324-01A-01D-0460-05		TCGA-25-1324-01		TCGA-25-1324-01			790c6d79-9f7d-4e9a-89db-43b26fe16816	790c6d79-9f7d-4e9a-89db-43b26fe16816			TCGA-25-1324-01A-01R-1565-13	TCGA-25-1324-01A-01R-0456-07		dadc9a44-fbec-4109-b5e5-4a21ad28eb63	790c6d79-9f7d-4e9a-89db-43b26fe16816	TCGA-25-1324-01A-01R-1565-13		
TCGA-25-1325-01	1	TCGA-25-1325-01	976	1			OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-25-1325	976	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			77	Left	TCGA-25-1325-F26689	Stage IV	-28183		976	0	976						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		5			G3					TCGA-25-1325.E9315413-584C-4F29-B05D-657DB9A0B4F5.pdf					5	0				0	5	5	95	95	97	95							NO		Primary Tumor	01	1.3			25	>20 mm	Ovary		A	DECEASED	2002	TCGA-25-1325-01A-01W-0490-10		TCGA-25-1325-01A-01W-0490-10			8896ef4e-3809-4ed8-befa-a014b7b81da1		TCGA-25-1325-01A-01R-1565-13	TCGA-25-1325-01A-01D-0460-05				TCGA-25-1325-01						TCGA-25-1325-01A-21-1562-20		TCGA-25-1325-01A-01R-0456-07		7d8ca51a-3995-47a6-89ad-63ffd81e32a0				
TCGA-25-1326-01	1	TCGA-25-1326-01	1249	1		C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1326	1249	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-25-1326-F26691	Stage IIIC	-22339		1249	0	945		396				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2.5	NO		3			G3	Recurrence				TCGA-25-1326.B17E5B27-48DB-4E64-A1C3-CAE4921C14DF.pdf					20	5					20	20	60	75	85	85		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	1.2			25	1-10 mm	Ovary		A	DECEASED	2002				TCGA-25-1326-01A-01W-0492-08	b29bd766-95b1-46fa-a070-d2206cd5722a	6e7bb043-ec9a-4648-9acd-14526dca800e		TCGA-25-1326-01A-01R-1565-13	TCGA-25-1326-01A-01D-0460-05		TCGA-25-1326-01		TCGA-25-1326-01			b29bd766-95b1-46fa-a070-d2206cd5722a	b29bd766-95b1-46fa-a070-d2206cd5722a		TCGA-25-1326-01A-21-1562-20	TCGA-25-1326-01A-01R-1565-13	TCGA-25-1326-01A-01R-0456-07		f01d69dc-1d50-4afb-83de-8124b93685a9	b29bd766-95b1-46fa-a070-d2206cd5722a	TCGA-25-1326-01A-01R-1565-13	TCGA-25-1326-01A-01W-0492-08	
TCGA-25-1328-01	1	TCGA-25-1328-01	2009	1		C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-25-1328	2009	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	38	Bilateral	TCGA-25-1328-F26698	Stage IIIC	-13911		2009	0	1979		244				2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.8	NO		2.8			G3	Recurrence				TCGA-25-1328.A2DA7EB3-8E42-4E86-9352-99673F51AEFF.pdf					20	5					10	5	70	90	95	95		WITH TUMOR	YES	Partial Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	1			25	1-10 mm	Ovary		A	DECEASED	2001				TCGA-25-1328-01A-01W-0492-08	9ba8d6bf-1541-4127-bc60-73091d2d81c7	d064cdc4-ad95-4e85-b9b0-6871d9c2698d		TCGA-25-1328-01A-01R-1565-13	TCGA-25-1328-01A-01D-0460-05		TCGA-25-1328-01		TCGA-25-1328-01			9ba8d6bf-1541-4127-bc60-73091d2d81c7	9ba8d6bf-1541-4127-bc60-73091d2d81c7		TCGA-25-1328-01A-21-1562-20	TCGA-25-1328-01A-01R-1565-13	TCGA-25-1328-01A-01R-0456-07		73b10e0b-cb82-49ec-8bdd-07d79bc2b8d6	9ba8d6bf-1541-4127-bc60-73091d2d81c7	TCGA-25-1328-01A-01R-1565-13	TCGA-25-1328-01A-01W-0492-08	
TCGA-25-1329-01	1	TCGA-25-1329-01	457	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1329	457	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			76	Bilateral	TCGA-25-1329-F26705	Stage IIIC	-28093		457	0	90						2009-3-27	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2.6	NO		3			G3					TCGA-25-1329.857409C6-75EC-4935-85BC-6D5F66AF4DB3.pdf					5	10			0	0	25	5	70	75	95	95			YES						Primary Tumor	01	0.6			25	11-20 mm	Ovary		A	DECEASED	2002		TCGA-25-1329-01		TCGA-25-1329-01A-01W-0492-08	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	299168d0-39ac-4d64-9345-88fe0f6746ee		TCGA-25-1329-01A-01R-1565-13	TCGA-25-1329-01A-01D-0460-05	TCGA-25-1329-01	TCGA-25-1329-01	TCGA-25-1329-01A-01D-0452-01	TCGA-25-1329-01	TCGA-25-1329-01A-01D-0452-01	5b2ef5e1-b131-4220-9a34-6650e8656e76	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	5b2ef5e1-b131-4220-9a34-6650e8656e76	TCGA-25-1329-01A-21-1562-20	TCGA-25-1329-01A-01R-1565-13	TCGA-25-1329-01A-01R-0456-07		3bd2e158-9743-44cd-a5c3-0ba7179b8660	5cf09ce6-44b1-4f0e-89ac-3ea302d684d8	TCGA-25-1329-01A-01R-1565-13	TCGA-25-1329-01A-01W-0492-08	
TCGA-25-1623-01	1	TCGA-25-1623-01	565	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1623	565	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-25-1623-F26707	Stage IV	-26060		565	0	565		342				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3	Recurrence				TCGA-25-1623.A57CB221-076A-4EE5-8C77-D1E33070597C.pdf					5	5			0	0	25	40	70	55	80	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			25	No Macroscopic disease	Ovary		A	DECEASED	2006	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01	TCGA-25-1623-01A-01W-0615-10	TCGA-25-1623-01A-01W-0615-10	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	ef62a625-cf2c-45d1-aa59-9d44e16a37fa		TCGA-25-1623-01A-01R-1566-13	TCGA-25-1623-01A-01D-0536-05	TCGA-25-1623-01	TCGA-25-1623-01	TCGA-25-1623-01A-01D-0533-01	TCGA-25-1623-01	TCGA-25-1623-01A-01D-0533-01	fb6d2d72-8352-495b-96c7-69e45636ad78	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	fb6d2d72-8352-495b-96c7-69e45636ad78	TCGA-25-1623-01A-21-1558-20	TCGA-25-1623-01A-01R-1566-13	TCGA-25-1623-01A-01R-0540-07		47640c72-6c10-4956-8a89-0c5f0b12cc49	3e4f0ca7-8428-47df-80a3-3bc9153aedfa	TCGA-25-1623-01A-01R-1566-13		
TCGA-25-1625-01	1	TCGA-25-1625-01	840	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1625	840	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	66	Bilateral	TCGA-25-1625-F26712	Stage IIIC	-24298		840	0	548		526				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence				TCGA-25-1625.BDE314E3-1E2C-440E-8561-A260C1D0933A.pdf					5	5			15	30	10	5	70	60	80	90		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2006	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01	TCGA-25-1625-01A-01W-0615-10	TCGA-25-1625-01A-01W-0615-10	921fab94-5522-4c08-8e02-13fb6ea2d388	ffb78d5c-46f5-4f3a-8572-55df5db80a1d		TCGA-25-1625-01A-01R-1566-13	TCGA-25-1625-01A-01D-0536-05	TCGA-25-1625-01	TCGA-25-1625-01	TCGA-25-1625-01A-01D-0533-01	TCGA-25-1625-01	TCGA-25-1625-01A-01D-0533-01	8fe6c12e-d500-468e-ae71-1ccbe71457a3	921fab94-5522-4c08-8e02-13fb6ea2d388	921fab94-5522-4c08-8e02-13fb6ea2d388	8fe6c12e-d500-468e-ae71-1ccbe71457a3	TCGA-25-1625-01A-21-1558-20	TCGA-25-1625-01A-01R-1566-13	TCGA-25-1625-01A-01R-0540-07		b176a30a-0977-46e6-b577-a421ca9bb340	921fab94-5522-4c08-8e02-13fb6ea2d388	TCGA-25-1625-01A-01R-1566-13		
TCGA-25-1626-01	1	TCGA-25-1626-01	518	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1626	518	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Right	TCGA-25-1626-F26716	Stage IIIC	-23932		518	0	481		318				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.4			G3	Recurrence				TCGA-25-1626.4B54A1C9-6F08-435B-B85F-736D4278EA82.pdf					5	5			0	0	30	40	65	55	75	70		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			25	>20 mm	Ovary		A	DECEASED	2006	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01	TCGA-25-1626-01A-01W-0615-10	TCGA-25-1626-01A-01W-0615-10		7a9090de-0e14-4fc3-a2d7-c42629b3afd7		TCGA-25-1626-01A-01R-1566-13	TCGA-25-1626-01A-01D-0536-05			TCGA-25-1626-01A-01D-0533-01	TCGA-25-1626-01	TCGA-25-1626-01A-01D-0533-01	e112fed6-8e4f-4bc6-9f93-d6c73ba9b223			e112fed6-8e4f-4bc6-9f93-d6c73ba9b223	TCGA-25-1626-01A-21-1558-20	TCGA-25-1626-01A-01R-1566-13	TCGA-25-1626-01A-01R-0540-07		a1ed5a8a-8ac2-4d94-96e0-92bb4dcc8af6		TCGA-25-1626-01A-01R-1566-13		
TCGA-25-1627-01	1	TCGA-25-1627-01	394	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-25-1627	394	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-25-1627-F26722	Stage IIIC	-26784		394	0	11						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3										0	2			0	0	10	8	90	90	95	95			YES				NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2003	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01	TCGA-25-1627-01A-01W-0615-10	TCGA-25-1627-01A-01W-0615-10	0fc68715-c7fc-4481-a5bf-68a281f5ec64	a2210172-a1e0-4bbf-a38a-363571251f90		TCGA-25-1627-01A-01R-1566-13	TCGA-25-1627-01A-01D-0536-05	TCGA-25-1627-01	TCGA-25-1627-01	TCGA-25-1627-01A-01D-0533-01	TCGA-25-1627-01	TCGA-25-1627-01A-01D-0533-01	1e7d7cbc-8e20-4f54-971d-09a1264d0401	0fc68715-c7fc-4481-a5bf-68a281f5ec64	0fc68715-c7fc-4481-a5bf-68a281f5ec64	1e7d7cbc-8e20-4f54-971d-09a1264d0401	TCGA-25-1627-01A-21-1558-20	TCGA-25-1627-01A-01R-1566-13	TCGA-25-1627-01A-01R-0540-07		d1eafd5b-5036-44dd-b902-92951e9d31c5	0fc68715-c7fc-4481-a5bf-68a281f5ec64	TCGA-25-1627-01A-01R-1566-13		
TCGA-25-1628-01	1	TCGA-25-1628-01	627	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1628	627	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67		TCGA-25-1628-F26724	Stage IIIC	-24488		627	0	627		287				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		2			G3	Recurrence				TCGA-25-1628.790D6E48-15D0-45F9-B6DD-182787298EBA.pdf					5	5			0	0	10	10	85	85	95	95		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01	TCGA-25-1628-01A-01W-0615-10	TCGA-25-1628-01A-01W-0615-10		f7ac6f1b-7ee1-4536-84ae-48d20a61df99		TCGA-25-1628-01A-01R-1566-13	TCGA-25-1628-01A-01D-0536-05			TCGA-25-1628-01A-01D-0533-01	TCGA-25-1628-01	TCGA-25-1628-01A-01D-0533-01	9b968b89-9c5c-47eb-8402-e33a4161f42e			9b968b89-9c5c-47eb-8402-e33a4161f42e	TCGA-25-1628-01A-21-1558-20	TCGA-25-1628-01A-01R-1566-13	TCGA-25-1628-01A-01R-0540-07		7db7c522-1983-4b98-b630-2ddbd5d4aefa		TCGA-25-1628-01A-01R-1566-13		
TCGA-25-1630-01	1	TCGA-25-1630-01	1162	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1630	1162	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-25-1630-F26729	Stage IIIC	-27006		1162	0	239						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4			G3										5	1			0	0	10	10	85	89	90	90			YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01	TCGA-25-1630-01A-01W-0615-10	TCGA-25-1630-01A-01W-0615-10	c5a82b6e-048d-4377-9b6c-4417ba1876fe	c0b3ff41-c34a-4f86-b029-5a761ff85b2e		TCGA-25-1630-01A-01R-1566-13	TCGA-25-1630-01A-01D-0536-05	TCGA-25-1630-01	TCGA-25-1630-01	TCGA-25-1630-01A-01D-0533-01	TCGA-25-1630-01	TCGA-25-1630-01A-01D-0533-01	6ff06087-e0a3-4c0c-90d4-f30437d25f15	c5a82b6e-048d-4377-9b6c-4417ba1876fe	c5a82b6e-048d-4377-9b6c-4417ba1876fe	6ff06087-e0a3-4c0c-90d4-f30437d25f15	TCGA-25-1630-01A-21-1558-20	TCGA-25-1630-01A-01R-1566-13	TCGA-25-1630-01A-01R-0540-07		f497f9fd-9a0e-446e-98fa-265e325e194e	c5a82b6e-048d-4377-9b6c-4417ba1876fe	TCGA-25-1630-01A-01R-1566-13		
TCGA-25-1631-01	1	TCGA-25-1631-01	9	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-1631	9	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-25-1631-F26733	Stage IIIC	-26687		9	0	9						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2			G3					TCGA-25-1631.1C74F61E-1131-4782-8117-20C59B86D845.pdf					10	10			0	0	10	10	80	80	90	90		TUMOR FREE	NO				NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01	TCGA-25-1631-01A-01W-0615-10	TCGA-25-1631-01A-01W-0615-10	29c4cab9-c19e-4416-ad88-484cc02a980f	51225525-5680-46ab-8e00-f35ed4df6470		TCGA-25-1631-01A-01R-1569-13	TCGA-25-1631-01A-01D-0536-05	TCGA-25-1631-01	TCGA-25-1631-01	TCGA-25-1631-01A-01D-0533-01	TCGA-25-1631-01	TCGA-25-1631-01A-01D-0533-01	0c5f4350-1f10-498c-bd92-e3db1a2492bd	29c4cab9-c19e-4416-ad88-484cc02a980f	29c4cab9-c19e-4416-ad88-484cc02a980f	0c5f4350-1f10-498c-bd92-e3db1a2492bd	TCGA-25-1631-01A-21-1558-20	TCGA-25-1631-01A-01R-1569-13	TCGA-25-1631-01A-01R-0540-07		2fab3946-dfac-449c-971a-9312801bbe51	29c4cab9-c19e-4416-ad88-484cc02a980f	TCGA-25-1631-01A-01R-1569-13		
TCGA-25-1632-01	1	TCGA-25-1632-01	1799	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 8	TCGA-25-1632	1799	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	68	Bilateral	TCGA-25-1632-F26735	Stage IV	-24993		1799	0	1732		537				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4			G3	Recurrence									1	1			0	0	5	5	94	94	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01	TCGA-25-1632-01A-01W-0615-10	TCGA-25-1632-01A-01W-0615-10	12c78d62-6045-4f77-bd84-9ab5a38f4635	105464b7-4efd-4ed6-a906-2dab64b49ad0		TCGA-25-1632-01A-01R-1566-13	TCGA-25-1632-01A-01D-0536-05	TCGA-25-1632-01	TCGA-25-1632-01	TCGA-25-1632-01A-01D-0533-01	TCGA-25-1632-01	TCGA-25-1632-01A-01D-0533-01	2ba3a197-86fc-466a-a9be-54e24daba3a4	12c78d62-6045-4f77-bd84-9ab5a38f4635	12c78d62-6045-4f77-bd84-9ab5a38f4635	2ba3a197-86fc-466a-a9be-54e24daba3a4	TCGA-25-1632-01A-21-1558-20	TCGA-25-1632-01A-01R-1566-13	TCGA-25-1632-01A-01R-0540-07		8736b37d-cdc1-4e9e-8215-edb675c8a072	12c78d62-6045-4f77-bd84-9ab5a38f4635	TCGA-25-1632-01A-01R-1566-13		
TCGA-25-1633-01	1	TCGA-25-1633-01	1891	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-25-1633	1891	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	64	Bilateral	TCGA-25-1633-F26742	Stage IIIC	-23407		1891	0	1843		616				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G3	Recurrence									1	1			0	0	20	5	79	94	80	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01	TCGA-25-1633-01A-01W-0615-10	TCGA-25-1633-01A-01W-0615-10	7517c446-401d-4501-bf27-916e0835deac	a9062738-4ec8-464c-b5c9-abd82bf322bc		TCGA-25-1633-01A-01R-1566-13	TCGA-25-1633-01A-01D-0536-05	TCGA-25-1633-01	TCGA-25-1633-01	TCGA-25-1633-01A-01D-0533-01	TCGA-25-1633-01	TCGA-25-1633-01A-01D-0533-01	3ea2b821-8f7a-4430-9b27-16bdc5f0b4d4	7517c446-401d-4501-bf27-916e0835deac	7517c446-401d-4501-bf27-916e0835deac	3ea2b821-8f7a-4430-9b27-16bdc5f0b4d4	TCGA-25-1633-01A-21-1558-20	TCGA-25-1633-01A-01R-1566-13	TCGA-25-1633-01A-01R-0540-07		9f229f84-97c9-4684-8eb7-f2af666e3399	7517c446-401d-4501-bf27-916e0835deac	TCGA-25-1633-01A-01R-1566-13		
TCGA-25-1634-01	1	TCGA-25-1634-01	1091	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 1	mutation cluster 5	TCGA-25-1634	1091	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	75	Bilateral	TCGA-25-1634-F26749	Stage IIIC	-27749		1091	0	1081		380				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01				25	No Macroscopic disease	Ovary			DECEASED	2002	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01	TCGA-25-1634-01A-01W-0615-10	TCGA-25-1634-01A-01W-0615-10	d10f0cee-d755-43cc-8d3d-8974cea0defb			TCGA-25-1634-01A-01R-1566-13	TCGA-25-1634-01A-01D-0536-05	TCGA-25-1634-01	TCGA-25-1634-01	TCGA-25-1634-01A-01D-0533-01	TCGA-25-1634-01	TCGA-25-1634-01A-01D-0533-01	cee2a595-164b-4263-9f5c-fb80463b0675	d10f0cee-d755-43cc-8d3d-8974cea0defb	d10f0cee-d755-43cc-8d3d-8974cea0defb	cee2a595-164b-4263-9f5c-fb80463b0675		TCGA-25-1634-01A-01R-1566-13	TCGA-25-1634-01A-01R-0540-07		e3aae8d6-511b-40ce-8ade-6208c6fcdb9f	d10f0cee-d755-43cc-8d3d-8974cea0defb	TCGA-25-1634-01A-01R-1566-13		
TCGA-25-1635-01	1	TCGA-25-1635-01	1583	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-25-1635	1583	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-25-1635-F26756	Stage IIIC	-26200		1583	0	1558		614				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.7			G3	Recurrence				TCGA-25-1635.28168C52-FD75-4B43-918B-C48CC8DA9C66.pdf					5	5			0	0	15	15	80	80	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2002	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01	TCGA-25-1635-01A-01W-0615-10	TCGA-25-1635-01A-01W-0615-10	877d96a2-6e5c-472c-b190-59fcfd1febb4	e22c9a04-50e5-40e2-9df0-66c86b6f3b38		TCGA-25-1635-01A-01R-1566-13	TCGA-25-1635-01A-01D-0536-05	TCGA-25-1635-01	TCGA-25-1635-01	TCGA-25-1635-01A-01D-0533-01	TCGA-25-1635-01	TCGA-25-1635-01A-01D-0533-01	ad7b6bfa-58a2-47ef-8dea-981ccd71b872	877d96a2-6e5c-472c-b190-59fcfd1febb4	877d96a2-6e5c-472c-b190-59fcfd1febb4	ad7b6bfa-58a2-47ef-8dea-981ccd71b872	TCGA-25-1635-01A-21-1558-20	TCGA-25-1635-01A-01R-1566-13	TCGA-25-1635-01A-01R-0540-07		2fc96f18-9f32-4d5f-b768-587981329254	877d96a2-6e5c-472c-b190-59fcfd1febb4	TCGA-25-1635-01A-01R-1566-13		
TCGA-25-1870-01	1	TCGA-25-1870-01	455	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1870	455	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-25-1870-F26763	Stage IIIC	-21550		455	0	455		243				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Partial Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01				25	11-20 mm	Ovary			DECEASED	1994		TCGA-25-1870-01			c446d667-ea88-40fe-ad97-fd3fcceb7dd1			TCGA-25-1870-01A-01R-1567-13	TCGA-25-1870-01A-01D-0652-05	TCGA-25-1870-01	TCGA-25-1870-01	TCGA-25-1870-01A-01D-0648-01	TCGA-25-1870-01	TCGA-25-1870-01A-01D-0648-01	d86ee094-af3a-4be2-9ac6-35f6cc825ebb	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	d86ee094-af3a-4be2-9ac6-35f6cc825ebb		TCGA-25-1870-01A-01R-1567-13	TCGA-25-1870-01A-01R-0655-07		fc0c9f6b-6603-4200-9190-25422af07078	c446d667-ea88-40fe-ad97-fd3fcceb7dd1	TCGA-25-1870-01A-01R-1567-13		
TCGA-25-1871-01	1	TCGA-25-1871-01	760	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 3		TCGA-25-1871	760	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	70	Bilateral	TCGA-25-1871-F26769	Stage IIIC	-25627		760	0	760		230				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7			G3	Recurrence				TCGA-25-1871.737827A6-C99E-49BE-90AD-004FE8DF11F1.pdf	0	0	0	0	0	0	0	0	0	0	20	30	80	70	80	70		WITH TUMOR	YES	Progressive Disease		Physical Examination	NO		Primary Tumor	01	0.1			25	11-20 mm	Ovary		A	DECEASED	1993		TCGA-25-1871-01			efcc36b2-e351-4875-b743-df58480bc9fb			TCGA-25-1871-01A-01R-1567-13	TCGA-25-1871-01A-01D-0652-05	TCGA-25-1871-01	TCGA-25-1871-01	TCGA-25-1871-01A-01D-0648-01	TCGA-25-1871-01	TCGA-25-1871-01A-01D-0648-01	dec54b8f-0a64-47c3-acd7-cec92f30e0ef	efcc36b2-e351-4875-b743-df58480bc9fb	efcc36b2-e351-4875-b743-df58480bc9fb	dec54b8f-0a64-47c3-acd7-cec92f30e0ef		TCGA-25-1871-01A-01R-1567-13	TCGA-25-1871-01A-01R-0655-07		2ee780b4-d0ac-4d56-9120-fdf5e98b4249	efcc36b2-e351-4875-b743-df58480bc9fb	TCGA-25-1871-01A-01R-1567-13		
TCGA-25-1877-01	1	TCGA-25-1877-01	730	1	High		OV-like c1			miRNA cluster 1	cluster 3		TCGA-25-1877	730	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	81	Left	TCGA-25-1877-F26774	Stage IIIC	-29615		730	0	549		549				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.7			G3	Recurrence				TCGA-25-1877.D98B5A1F-DF34-43E7-826F-BCB45DEC582D.pdf	0	0	0	0	0	0	0	0	0	0	10	10	90	90	90	90		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	1993		TCGA-25-1877-01						TCGA-25-1877-01A-01R-1567-13	TCGA-25-1877-01A-01D-0652-05			TCGA-25-1877-01A-01D-0648-01	TCGA-25-1877-01	TCGA-25-1877-01A-01D-0648-01	a6bd71ab-f853-4170-91f3-e32429cfdd43			a6bd71ab-f853-4170-91f3-e32429cfdd43		TCGA-25-1877-01A-01R-1567-13	TCGA-25-1877-01A-01R-0655-07		8918bbfe-a867-41ea-a137-46e704232e6d		TCGA-25-1877-01A-01R-1567-13		
TCGA-25-1878-01	1	TCGA-25-1878-01	2587	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-25-1878	2587	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-25-1878-F26779	Stage IIIC	-22035		2587	0	2587		971				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																						WITH TUMOR	YES	Complete Remission/Response		Molecular Marker(S)	NO		Primary Tumor	01				25	1-10 mm	Ovary			DECEASED	1994		TCGA-25-1878-01				c747a216-2d46-4b01-a34d-651fa616109a		TCGA-25-1878-01A-01R-1567-13	TCGA-25-1878-01A-01D-0652-05			TCGA-25-1878-01A-01D-0648-01	TCGA-25-1878-01	TCGA-25-1878-01A-01D-0648-01	d0c4dcaa-e4f3-453a-bff5-accc4edaf5dc			d0c4dcaa-e4f3-453a-bff5-accc4edaf5dc	TCGA-25-1878-01A-21-1559-20		TCGA-25-1878-01A-01R-0655-07		f38efeef-0f8b-48f8-8ad9-caaaad82eecc				
TCGA-25-2042-01	1	TCGA-25-2042-01	396	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation c1uster 9	TCGA-25-2042	396	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Bilateral	TCGA-25-2042-F26785	Stage IIIC	-22127		396	0	396	123					2009-11-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.4			G3	Metastatic	YES								2	2			0	0	68	68	30	30	85	85		WITH TUMOR	YES	Progressive Disease		First Seen At Further Surgery	NO		Primary Tumor	01	0.3			25	>20 mm	Ovary		A	DECEASED	2006		TCGA-25-2042-01		TCGA-25-2042-01A-01W-0799-08		59676524-6b40-4bcc-b488-120781e23d22		TCGA-25-2042-01A-01R-1568-13	TCGA-25-2042-01A-01D-0708-05			TCGA-25-2042-01A-01D-0704-01	TCGA-25-2042-01	TCGA-25-2042-01A-01D-0704-01	3a1d29f8-0300-4798-9b2e-d0bed27dcd45			3a1d29f8-0300-4798-9b2e-d0bed27dcd45	TCGA-25-2042-01A-21-1560-20	TCGA-25-2042-01A-01R-1568-13	TCGA-25-2042-01A-01R-0711-07		4873bfbf-079c-407d-9d8f-5bab18d1c3a0		TCGA-25-2042-01A-01R-1568-13	TCGA-25-2042-01A-01W-0799-08	
TCGA-25-2390-01		TCGA-25-2390-01					OV-like c1	OV-like c4					TCGA-25-2390		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			80				-29257			0							2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES			0.6	NO		1.6													0	0			0	0	5	5	95	95	95	95									Primary Tumor	01	0.3			25		Ovary		A		2003						29f6e462-4410-445e-8777-3402fc8488be			TCGA-25-2390-01A-01D-0708-05										TCGA-25-2390-01A-21-1560-20		TCGA-25-2390-01A-01R-0711-07						
TCGA-25-2391-01	1	TCGA-25-2391-01	1492	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2391	1492	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Bilateral	TCGA-25-2391-F26796	Stage IIIC	-20939		1492	0	1492						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3										1	1			1	0	9	10	89	89	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			25	>20 mm	Ovary		A	DECEASED	2003		TCGA-25-2391-01		TCGA-25-2391-01A-01W-0799-08	0ee0c708-77c4-4ac3-be13-0d08e6444003	53220d7f-967c-4101-82ce-24495a3e2b9a		TCGA-25-2391-01A-01R-1569-13	TCGA-25-2391-01A-01D-0708-05	TCGA-25-2391-01	TCGA-25-2391-01	TCGA-25-2391-01A-01D-0704-01	TCGA-25-2391-01	TCGA-25-2391-01A-01D-0704-01	e77f1b20-4c6a-4a79-999f-7caa799d2476	0ee0c708-77c4-4ac3-be13-0d08e6444003	0ee0c708-77c4-4ac3-be13-0d08e6444003	e77f1b20-4c6a-4a79-999f-7caa799d2476	TCGA-25-2391-01A-21-1560-20	TCGA-25-2391-01A-01R-1569-13	TCGA-25-2391-01A-01R-0711-07		bf367755-354c-4d12-a8a8-7a1373b8d397	0ee0c708-77c4-4ac3-be13-0d08e6444003	TCGA-25-2391-01A-01R-1569-13	TCGA-25-2391-01A-01W-0799-08	
TCGA-25-2392-01	1	TCGA-25-2392-01	31	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 2	TCGA-25-2392	31	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			75	Bilateral	TCGA-25-2392-F26801	Stage IV	-27667		31	0	31						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3										0	1			0	0	15	5	85	94	85	95			NO				NO		Primary Tumor	01	0.3			25	11-20 mm	Ovary		A	DECEASED	2003		TCGA-25-2392-01		TCGA-25-2392-01A-01W-0799-08	95b7a71d-8cf5-4660-ac1d-52a888cd2f20			TCGA-25-2392-01A-01R-1569-13	TCGA-25-2392-01A-01D-0708-05	TCGA-25-2392-01	TCGA-25-2392-01	TCGA-25-2392-01A-01D-0704-01	TCGA-25-2392-01	TCGA-25-2392-01A-01D-0704-01	ed1cf8c6-d594-49f7-9aa5-9a13cafc0f4a	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	ed1cf8c6-d594-49f7-9aa5-9a13cafc0f4a		TCGA-25-2392-01A-01R-1569-13	TCGA-25-2392-01A-01R-0711-07		62414e51-fd9a-4ed8-bc34-c4d194fdc884	95b7a71d-8cf5-4660-ac1d-52a888cd2f20	TCGA-25-2392-01A-01R-1569-13	TCGA-25-2392-01A-01W-0799-08	
TCGA-25-2393-01	1	TCGA-25-2393-01	1157	1	High	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2393	1157	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	81	Left	TCGA-25-2393-F26803	Stage IIIC	-29585		1157	0	1157		305				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.3			G3	Recurrence									5	5			1	1	14	14	80	80	85	85		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			25	11-20 mm	Ovary		A	DECEASED	2003		TCGA-25-2393-01		TCGA-25-2393-01A-01W-0799-08	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	7ab7162d-0b8e-42de-80ee-70a7aa8ef6a5		TCGA-25-2393-01A-01R-1569-13	TCGA-25-2393-01A-01D-0708-05	TCGA-25-2393-01	TCGA-25-2393-01	TCGA-25-2393-01A-01D-0704-01	TCGA-25-2393-01	TCGA-25-2393-01A-01D-0704-01	dcc7bdda-71fa-4e79-8a0e-28259dc2cdaf	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	dcc7bdda-71fa-4e79-8a0e-28259dc2cdaf	TCGA-25-2393-01A-21-1560-20	TCGA-25-2393-01A-01R-1569-13	TCGA-25-2393-01A-01R-0711-07		93d53663-d5fc-4a27-8844-d58f09f47c64	93a88ec4-e3ed-4e8d-a83c-3e6c4605e89e	TCGA-25-2393-01A-01R-1569-13	TCGA-25-2393-01A-01W-0799-08	
TCGA-25-2396-01	1	TCGA-25-2396-01	92	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2396	92	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Bilateral	TCGA-25-2396-F26808	Stage IIIC	-26145		92	0	92						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G3					TCGA-25-2396.5AD36576-BDCD-4DE8-9D8C-CD8BE71E4FCF.pdf					1	0			1	0	10	10	88	90	90	90							NO		Primary Tumor	01	1			25	No Macroscopic disease	Ovary		A	DECEASED	2004		TCGA-25-2396-01		TCGA-25-2396-01A-01W-0799-08	43352a4d-f866-4ed7-81f5-5dc478c10992	abf3ad2e-f8d1-4a58-a48b-eaf3b553e793		TCGA-25-2396-01A-01R-1569-13	TCGA-25-2396-01A-01D-0708-05	TCGA-25-2396-01	TCGA-25-2396-01	TCGA-25-2396-01A-01D-0704-01	TCGA-25-2396-01	TCGA-25-2396-01A-01D-0704-01	81983782-4b6f-4b83-937d-e4ac8676a0f0	43352a4d-f866-4ed7-81f5-5dc478c10992	43352a4d-f866-4ed7-81f5-5dc478c10992	81983782-4b6f-4b83-937d-e4ac8676a0f0	TCGA-25-2396-01A-21-1560-20	TCGA-25-2396-01A-01R-1569-13	TCGA-25-2396-01A-01R-0711-07		5cbceba0-c820-45dc-926d-ee4893659503	43352a4d-f866-4ed7-81f5-5dc478c10992	TCGA-25-2396-01A-01R-1569-13	TCGA-25-2396-01A-01W-0799-08	
TCGA-25-2397-01	1	TCGA-25-2397-01	365	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-25-2397	365	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-25-2397-F26810	Stage IV	-21581		365	0	365						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		2.2			G3					TCGA-25-2397.D67C4E1F-6A68-4EE6-B143-22038C05C926.pdf					1	0			0	0	5	5	94	95	95	95							NO		Primary Tumor	01	0.7			25	No Macroscopic disease	Ovary		A	DECEASED	2004		TCGA-25-2397-01			7ad7080c-730b-4a5d-a8c1-f6387fbee72e	eac7612a-49d6-4b40-84b7-c68db54e56c1		TCGA-25-2397-01A-01R-1569-13	TCGA-25-2397-01A-01D-0708-05	TCGA-25-2397-01	TCGA-25-2397-01	TCGA-25-2397-01A-01D-0704-01	TCGA-25-2397-01	TCGA-25-2397-01A-01D-0704-01	a01002c1-8053-41b0-b055-ce45f4091349	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	a01002c1-8053-41b0-b055-ce45f4091349	TCGA-25-2397-01A-21-1560-20	TCGA-25-2397-01A-01R-1569-13	TCGA-25-2397-01A-01R-0711-07		3faab68c-41ef-4eef-8ed1-1d5c7c5b9a8b	7ad7080c-730b-4a5d-a8c1-f6387fbee72e	TCGA-25-2397-01A-01R-1569-13		
TCGA-25-2398-01	1	TCGA-25-2398-01	1369	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2398	1369	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-25-2398-F26812	Stage IIIC	-26267		1369	0	1369		577				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.5			G3	Recurrence				TCGA-25-2398.CFF4E9E3-AC10-4A50-BE90-5A12822FEF42.pdf					5	5			0	0	25	35	70	60	75	65		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.5			25	1-10 mm	Ovary		A	DECEASED	2004		TCGA-25-2398-01		TCGA-25-2398-01A-01W-0799-08		b081cedd-6727-478d-9ebf-22ad78c34b27		TCGA-25-2398-01A-01R-1569-13	TCGA-25-2398-01A-01D-0708-05			TCGA-25-2398-01A-01D-0704-01	TCGA-25-2398-01	TCGA-25-2398-01A-01D-0704-01	153cbdd2-f7cd-4eff-8e91-20feba468aa1			153cbdd2-f7cd-4eff-8e91-20feba468aa1	TCGA-25-2398-01A-21-1563-20	TCGA-25-2398-01A-01R-1569-13	TCGA-25-2398-01A-01R-0711-07		bcdd8efe-1f50-4bb6-904a-b8bdfd32dfbd		TCGA-25-2398-01A-01R-1569-13	TCGA-25-2398-01A-01W-0799-08	
TCGA-25-2399-01	1	TCGA-25-2399-01	608	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2399	608	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	80	Bilateral	TCGA-25-2399-F26818	Stage IIIC	-29373		608	0	608		243				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6			G3	Recurrence				TCGA-25-2399.38AEA3BF-A853-4719-B308-63884A6F8F13.pdf					5	5			0	0	5	5	90	90	95	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			25	>20 mm	Ovary		A	DECEASED	2004		TCGA-25-2399-01		TCGA-25-2399-01A-01W-0799-08	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	27dde0e4-5be8-4045-910b-24c0535a4623		TCGA-25-2399-01A-01R-1569-13	TCGA-25-2399-01A-01D-0708-05	TCGA-25-2399-01	TCGA-25-2399-01	TCGA-25-2399-01A-01D-0704-01	TCGA-25-2399-01	TCGA-25-2399-01A-01D-0704-01	bf4172d6-d044-4dca-9e8b-a44a7a24ab4a	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	bf4172d6-d044-4dca-9e8b-a44a7a24ab4a	TCGA-25-2399-01A-21-1560-20	TCGA-25-2399-01A-01R-1569-13	TCGA-25-2399-01A-01R-0711-07		a05df1ef-35d1-4fe3-a944-ab5c6b52d468	28a681dc-3e0f-4a9c-ad0c-f2bb10aab0e1	TCGA-25-2399-01A-01R-1569-13	TCGA-25-2399-01A-01W-0799-08	
TCGA-25-2400-01	1	TCGA-25-2400-01	1278	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-25-2400	1278	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76	Bilateral	TCGA-25-2400-F26823	Stage IIIC	-27789		1278	0	1278		577				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3	Recurrence				TCGA-25-2400.0C87DA7B-EBA1-4998-88D5-6DF2B0E6A40C.pdf					1	1			0	0	10	10	89	89	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			25	No Macroscopic disease	Ovary		A	DECEASED	2004		TCGA-25-2400-01		TCGA-25-2400-01A-01W-0799-08	5c98c2c5-806f-4562-ad57-e152ea8388ab	ab4e5114-ba2a-4706-8be1-a359c4e5b547		TCGA-25-2400-01A-01R-1569-13	TCGA-25-2400-01A-01D-0708-05	TCGA-25-2400-01	TCGA-25-2400-01	TCGA-25-2400-01A-01D-0704-01	TCGA-25-2400-01	TCGA-25-2400-01A-01D-0704-01	0f0a599b-d0df-44be-811c-d79bbfa918cf	5c98c2c5-806f-4562-ad57-e152ea8388ab	5c98c2c5-806f-4562-ad57-e152ea8388ab	0f0a599b-d0df-44be-811c-d79bbfa918cf	TCGA-25-2400-01A-21-1560-20	TCGA-25-2400-01A-01R-1569-13	TCGA-25-2400-01A-01R-0711-07		1dab017a-bf35-4cec-9bef-f03b5c5b363c	5c98c2c5-806f-4562-ad57-e152ea8388ab	TCGA-25-2400-01A-01R-1569-13	TCGA-25-2400-01A-01W-0799-08	
TCGA-25-2401-01	1	TCGA-25-2401-01	90	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-25-2401	90	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Bilateral	TCGA-25-2401-F26829	Stage IIIC	-23711		90	0	90						2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.8			G3					TCGA-25-2401.5B192072-1F11-4316-AC39-81085F7E425D.pdf					5	1			1	0	19	10	75	89	80	90							NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2004		TCGA-25-2401-01		TCGA-25-2401-01A-01W-0799-08		8b55fa70-3074-4209-ab77-4634075aa0d1		TCGA-25-2401-01A-01R-1569-13	TCGA-25-2401-01A-01D-0708-05			TCGA-25-2401-01A-01D-0704-01	TCGA-25-2401-01	TCGA-25-2401-01A-01D-0704-01	a4fd7722-6def-42c0-a910-239b48cee2bd			a4fd7722-6def-42c0-a910-239b48cee2bd	TCGA-25-2401-01A-21-1560-20	TCGA-25-2401-01A-01R-1569-13	TCGA-25-2401-01A-01R-0711-07		d34e80bb-5261-478c-9aa8-6732cc107f9f		TCGA-25-2401-01A-01R-1569-13	TCGA-25-2401-01A-01W-0799-08	
TCGA-25-2404-01	1	TCGA-25-2404-01	883	1	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-25-2404	883	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	38	Bilateral	TCGA-25-2404-F26831	Stage IIIC	-14184		883	0	883		426				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2			G3	Recurrence				TCGA-25-2404.7B13E549-204D-47F8-93EB-D8C5C8D259FA.pdf					0	1			1	1	14	28	85	70	85	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			25	No Macroscopic disease	Ovary		A	DECEASED	2005		TCGA-25-2404-01		TCGA-25-2404-01A-01W-0799-08	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	2300785c-d77b-4d40-94e5-7947b18f9c24		TCGA-25-2404-01A-01R-1569-13	TCGA-25-2404-01A-01D-0708-05	TCGA-25-2404-01	TCGA-25-2404-01	TCGA-25-2404-01A-01D-0704-01	TCGA-25-2404-01	TCGA-25-2404-01A-01D-0704-01	b71494e2-1f72-45de-bf6b-2f5ae0b0c1f8	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	b71494e2-1f72-45de-bf6b-2f5ae0b0c1f8	TCGA-25-2404-01A-21-1560-20	TCGA-25-2404-01A-01R-1569-13	TCGA-25-2404-01A-01R-0711-07		df215206-d33b-40b7-94dc-86d5a3cfbc87	05ab6bb9-0cb1-47f1-8dd2-92a48239e82e	TCGA-25-2404-01A-01R-1569-13	TCGA-25-2404-01A-01W-0799-08	
TCGA-25-2408-01	1	TCGA-25-2408-01	943	1	Iq	C9-OV	Low purity c2	OV-like c4		miRNA cluster 1	cluster 6	mutation c1uster 9	TCGA-25-2408	943	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma		NO	37	Bilateral	TCGA-25-2408-F26837	Stage IV	-13606		943	0	943		334				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence				TCGA-25-2408.2A91BE69-31C8-456E-8EBB-8AD08AAAB3A9.pdf					0	0			1	1	9	9	90	90	90	90		WITH TUMOR	YES	Partial Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.3			25	1-10 mm	Ovary		A	DECEASED	2005		TCGA-25-2408-01		TCGA-25-2408-01A-01W-0799-08		19590adb-d236-4acf-a78f-275de0e8f0e1		TCGA-25-2408-01A-01R-1569-13	TCGA-25-2408-01A-01D-0708-05			TCGA-25-2408-01A-01D-0704-01	TCGA-25-2408-01	TCGA-25-2408-01A-01D-0704-01	24b8fdc6-d6bc-45ac-be26-b31d4e00b1e8			24b8fdc6-d6bc-45ac-be26-b31d4e00b1e8	TCGA-25-2408-01A-21-1562-20		TCGA-25-2408-01A-01R-0711-07		a693a4be-bb91-4608-bacb-4ffa101e413a			TCGA-25-2408-01A-01W-0799-08	
TCGA-25-2409-01	1	TCGA-25-2409-01	821	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-25-2409	821	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-25-2409-F26841	Stage IV	-26267		821	0	821		304				2010-1-5	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		1.5			G3	Recurrence				TCGA-25-2409.89A631C6-5000-4A96-B752-879EAA7231CB.pdf					1	1			1	1	4	4	94	94	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			25	1-10 mm	Ovary		A	DECEASED	2005		TCGA-25-2409-01		TCGA-25-2409-01A-01W-0799-08	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	bfaa6831-b085-4b98-90a5-fef72266d642		TCGA-25-2409-01A-01R-1569-13	TCGA-25-2409-01A-01D-0708-05	TCGA-25-2409-01	TCGA-25-2409-01	TCGA-25-2409-01A-01D-0704-01	TCGA-25-2409-01	TCGA-25-2409-01A-01D-0704-01	e7acdc39-9016-45df-bb67-56626afa7fe3	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	e7acdc39-9016-45df-bb67-56626afa7fe3	TCGA-25-2409-01A-21-1560-20	TCGA-25-2409-01A-01R-1569-13	TCGA-25-2409-01A-01R-0711-07		71b8d6ab-57cb-411e-89f3-9ea82e67abff	4e5f3a15-68fd-4be0-b368-e0bd04eaf872	TCGA-25-2409-01A-01R-1569-13	TCGA-25-2409-01A-01W-0799-08	
TCGA-29-1688-01	1	TCGA-29-1688-01	2400	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-29-1688	2400	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	39	Bilateral	TCGA-29-1688-F27124	Stage IIIC	-14574		2400	0	2400		184				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2.5			G2	Recurrence				TCGA-29-1688.cb2bd608-b9d4-497e-9058-2269dc86b5b3.pdf					0	0			0	0	0	0	100	100	80	70		WITH TUMOR	YES	Stable Disease		First Seen At Further Surgery	NO		Primary Tumor	01	0.5			29		Ovary	YES	A	DECEASED	1992		TCGA-29-1688-01			5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	46d8cea8-b5a2-4136-bfeb-4969e3ccbd85		TCGA-29-1688-01A-01R-1566-13	TCGA-29-1688-01A-01D-0563-05	TCGA-29-1688-01	TCGA-29-1688-01	TCGA-29-1688-01A-01D-0559-01	TCGA-29-1688-01	TCGA-29-1688-01A-01D-0559-01	1b084de1-516a-4f05-9153-47c54489b649	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	1b084de1-516a-4f05-9153-47c54489b649	TCGA-29-1688-01A-21-1558-20	TCGA-29-1688-01A-01R-1566-13	TCGA-29-1688-01A-01R-0566-07		065ec84d-9986-4b99-8c58-3d0a578cd8fb	5be6bdbd-61ed-4ceb-bad5-9559cbe5bebf	TCGA-29-1688-01A-01R-1566-13		TCGA-29-1688-01A-01W-0633-09
TCGA-29-1690-01	1	TCGA-29-1690-01	1448	1	Iq	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1690	1448	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66	Bilateral	TCGA-29-1690-F27142	Stage IIIC	-24319		1448	0	1360						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.3	NO		1.4			G2					TCGA-29-1690.a44f0507-fc95-410a-a6b2-b66caacee30e.pdf					0	0		1	0	0	0	0	100	100	90	95		WITH TUMOR	YES				NO		Primary Tumor	01	0.7			29	11-20 mm	Ovary		A	DECEASED	1993		TCGA-29-1690-01			d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	865fd9bb-d8c0-43d0-874c-ce6e69ce93be		TCGA-29-1690-01A-01R-1566-13	TCGA-29-1690-01A-01D-0563-05	TCGA-29-1690-01	TCGA-29-1690-01	TCGA-29-1690-01A-01D-0559-01	TCGA-29-1690-01	TCGA-29-1690-01A-01D-0559-01	c40243b2-89d4-4f9d-8674-09e2a35103d9	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	c40243b2-89d4-4f9d-8674-09e2a35103d9	TCGA-29-1690-01A-21-1558-20	TCGA-29-1690-01A-01R-1566-13	TCGA-29-1690-01A-01R-0566-07		21ed8b03-3122-4467-8542-a90a261e9934	d78906d7-c8f2-4bf0-86cc-2b60b067aaa6	TCGA-29-1690-01A-01R-1566-13		TCGA-29-1690-01A-01W-0633-09
TCGA-29-1691-01	1	TCGA-29-1691-01	1470	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-1691	1470	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-29-1691-F27148	Stage IIIC	-18664		1470	0	1435		613				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.5			G2	Recurrence				TCGA-29-1691.74e45220-b3ac-4404-8bb6-811f3d4ba611.pdf				1	2	2			0	0	0	0	98	98	95	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.05			29	1-10 mm	Ovary		A	DECEASED	1995		TCGA-29-1691-01			f83833b8-8cb2-44d8-8ac7-c4d2d2463053	e634e64b-7b5c-4d33-88f9-c5c83442fdc1		TCGA-29-1691-01A-01R-1566-13	TCGA-29-1691-01A-01D-0563-05	TCGA-29-1691-01	TCGA-29-1691-01	TCGA-29-1691-01A-01D-0559-01	TCGA-29-1691-01	TCGA-29-1691-01A-01D-0559-01	4f153dda-e919-4502-aa9f-0d52487e60eb	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	4f153dda-e919-4502-aa9f-0d52487e60eb	TCGA-29-1691-01A-21-1558-20	TCGA-29-1691-01A-01R-1566-13	TCGA-29-1691-01A-01R-0566-07		cbacc51e-d8b4-4dab-8ba8-7e769d19c26a	f83833b8-8cb2-44d8-8ac7-c4d2d2463053	TCGA-29-1691-01A-01R-1566-13		TCGA-29-1691-01A-01W-0633-09
TCGA-29-1692-01	1	TCGA-29-1692-01	2872	1	High		OV-like c1						TCGA-29-1692	2872	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Right	TCGA-29-1692-F27159	Stage IIIC	-21193		2872	0	2872		544	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7			G2	Recurrence									10	0			0	0	20	40	70	60	80	80	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response			NO	R1	Primary Tumor	01	0.2			29	11-20 mm	Ovary		B	DECEASED	1997		TCGA-29-1692-01							TCGA-29-1692-01B-01D-0807-05			TCGA-29-1692-01B-01D-2069-01	TCGA-29-1692-01	TCGA-29-1692-01B-01D-2069-01	a8a0d815-8d32-4735-a550-cac3a9bfc703,e46e8032-51ae-43f3-b87d-b50ece857c96			a8a0d815-8d32-4735-a550-cac3a9bfc703,e46e8032-51ae-43f3-b87d-b50ece857c96			TCGA-29-1692-01B-01R-0810-07		2ecbe10e-1afc-4a38-91ee-cb0cc670f254				
TCGA-29-1692-02	1	TCGA-29-1692-02	2872	1			OV-like c1						TCGA-29-1692	2872	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Right	TCGA-29-1692-F27159	Stage IIIC	-21193		2872	0	2872		544	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1			G2	Recurrence									20	20			0	0	20	20	60	60	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response			NO	R1	Recurrent Tumor	02	0.6			29	11-20 mm	Ovary		A	DECEASED	1997									TCGA-29-1692-02A-01D-0807-05						90cade38-c7fd-407c-aba9-72c9dbc53a5e			90cade38-c7fd-407c-aba9-72c9dbc53a5e			TCGA-29-1692-02A-01R-0810-07		4001650f-30d3-46dd-8ba2-7f148afe4ba7				
TCGA-29-1693-01	0	TCGA-29-1693-01	3096	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1693	3096	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	72	Left	TCGA-29-1693-F27174	Stage IIIC	-26300			0	3096		694	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.7		YES	G3	Recurrence				TCGA-29-1693.90087244-634d-45eb-a877-ff7cc6bd2282.pdf					2	2			0	0	0	0	98	98	90	85	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary	YES	A	LIVING	2001		TCGA-29-1693-01			7e5d2390-1e04-4e46-aa48-4b0131076007	75dd78d6-cd26-476f-927f-ddb0d4a9c66f		TCGA-29-1693-01A-01R-1567-13	TCGA-29-1693-01A-01D-0563-05	TCGA-29-1693-01	TCGA-29-1693-01	TCGA-29-1693-01A-01D-0559-01	TCGA-29-1693-01	TCGA-29-1693-01A-01D-0559-01	f2104888-eb63-43d0-afae-a6ebedc57db5	7e5d2390-1e04-4e46-aa48-4b0131076007	7e5d2390-1e04-4e46-aa48-4b0131076007	f2104888-eb63-43d0-afae-a6ebedc57db5	TCGA-29-1693-01A-21-1558-20	TCGA-29-1693-01A-01R-1567-13	TCGA-29-1693-01A-01R-0566-07		111c7bf6-d79d-48e4-adf8-94bc0c538ab5	7e5d2390-1e04-4e46-aa48-4b0131076007	TCGA-29-1693-01A-01R-1567-13		TCGA-29-1693-01A-01W-0633-09
TCGA-29-1694-01	1	TCGA-29-1694-01	1187	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1694	1187	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	45	Bilateral	TCGA-29-1694-F27192	Stage IIIC	-16523		1187	0	1172	206		1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			GX	Locoregional Disease	YES			TCGA-29-1694.ccfb9f1d-1779-4fae-a34f-c46a19d4b095.pdf					0	0			0	0	20	15	80	85	80	85	Other	WITH TUMOR	YES	Stable Disease		First Seen At Further Surgery	NO		Primary Tumor	01	0.3			29	11-20 mm	Ovary		A	DECEASED	2002		TCGA-29-1694-01			e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	463fec61-5758-4225-b43e-b77f36ece717		TCGA-29-1694-01A-01R-1567-13	TCGA-29-1694-01A-01D-0563-05	TCGA-29-1694-01	TCGA-29-1694-01	TCGA-29-1694-01A-01D-0559-01	TCGA-29-1694-01	TCGA-29-1694-01A-01D-0559-01	d38cff49-cc65-4b8d-87f7-6a5e3deeaf69	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	d38cff49-cc65-4b8d-87f7-6a5e3deeaf69	TCGA-29-1694-01A-21-1558-20	TCGA-29-1694-01A-01R-1567-13	TCGA-29-1694-01A-01R-0566-07		57cead11-58b6-4d8e-ab66-b742de63ae1d	e0667b02-b4cf-43e7-8cd7-b9fd11b3cec6	TCGA-29-1694-01A-01R-1567-13		TCGA-29-1694-01A-01W-0633-09
TCGA-29-1695-01	1	TCGA-29-1695-01	1229	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1695	1229	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Left	TCGA-29-1695-F27204	Stage IIIC	-22895		1229	0	24						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G2					TCGA-29-1695.136a4380-2a2a-489f-8675-886e876f17f7.pdf					2	0			0	0	0	0	98	100	85	85							NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2003		TCGA-29-1695-01			33f1dda6-7601-48c6-b46d-f0ba759e4048	997dba94-b0d4-4872-b93b-d561f71f6ba3		TCGA-29-1695-01A-01R-1567-13	TCGA-29-1695-01A-01D-0563-05	TCGA-29-1695-01	TCGA-29-1695-01	TCGA-29-1695-01A-01D-0559-01	TCGA-29-1695-01	TCGA-29-1695-01A-01D-0559-01	85c10346-60f7-45e9-9948-a150ef623db1	33f1dda6-7601-48c6-b46d-f0ba759e4048	33f1dda6-7601-48c6-b46d-f0ba759e4048	85c10346-60f7-45e9-9948-a150ef623db1	TCGA-29-1695-01A-21-1558-20	TCGA-29-1695-01A-01R-1567-13	TCGA-29-1695-01A-01R-0566-07		43c657df-dd50-4c53-a5de-e73d3a5e1b0c	33f1dda6-7601-48c6-b46d-f0ba759e4048	TCGA-29-1695-01A-01R-1567-13		TCGA-29-1695-01A-01W-0633-09
TCGA-29-1696-01	1	TCGA-29-1696-01	1032	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1696	1032	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	43	Right	TCGA-29-1696-F27206	Stage IIIC	-15818		1032	0	1025		342				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		0.8		NO	G2	Recurrence				TCGA-29-1696.5e817943-3108-4838-bf8c-85c4507eb873.pdf					0	0			0	0	0	0	100	100	70	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	DECEASED	2003		TCGA-29-1696-01			23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	93ea52c3-dc03-4845-9493-f1ecdd9e9124		TCGA-29-1696-01A-01R-1567-13	TCGA-29-1696-01A-01D-0563-05	TCGA-29-1696-01	TCGA-29-1696-01	TCGA-29-1696-01A-01D-0559-01	TCGA-29-1696-01	TCGA-29-1696-01A-01D-0559-01	0dc98f7b-7321-4599-a587-1f71e53db3ed	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	0dc98f7b-7321-4599-a587-1f71e53db3ed	TCGA-29-1696-01A-21-1558-20	TCGA-29-1696-01A-01R-1567-13	TCGA-29-1696-01A-01R-0566-07		fea497c6-293b-49aa-9d5f-021f2f89913e	23c4ab1a-f8ce-47be-ab03-abfc66ea70ef	TCGA-29-1696-01A-01R-1567-13		TCGA-29-1696-01A-01W-0633-09
TCGA-29-1697-01	1	TCGA-29-1697-01	949	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5		TCGA-29-1697	949	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	62	Bilateral	TCGA-29-1697-F27216	Stage IIIC	-22933		949	0	949		500	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.9			G3	Recurrence				TCGA-29-1697.294ba09f-347a-4129-847d-211cdf73ca99.pdf					2	2			0	0	0	0	98	98	95	95	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2003		TCGA-29-1697-01			75435634-4311-49d8-8e42-ae1069c1e2ef	9efe9dcc-44d7-47ae-b404-d324e821910e		TCGA-29-1697-01A-01R-1567-13	TCGA-29-1697-01A-01D-0563-05	TCGA-29-1697-01	TCGA-29-1697-01	TCGA-29-1697-01A-01D-0559-01	TCGA-29-1697-01	TCGA-29-1697-01A-01D-0559-01	1f92e42b-0684-4c2d-b4b4-353d83d7a891	75435634-4311-49d8-8e42-ae1069c1e2ef	75435634-4311-49d8-8e42-ae1069c1e2ef	1f92e42b-0684-4c2d-b4b4-353d83d7a891	TCGA-29-1697-01A-21-1558-20	TCGA-29-1697-01A-01R-1567-13	TCGA-29-1697-01A-01R-0566-07		bd90331c-acc6-49f5-8943-065fbfb16519	75435634-4311-49d8-8e42-ae1069c1e2ef	TCGA-29-1697-01A-01R-1567-13		TCGA-29-1697-01A-01W-0633-09
TCGA-29-1698-01	0	TCGA-29-1698-01	2078	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1698	2078	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-29-1698-F27227	Stage IIIC	-19611			0	2078		181				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.4			G3	Recurrence				TCGA-29-1698.133f2df5-6c22-4653-9d2e-f3d5971502b0.pdf					5	5			0	0	45	45	50	50	70	70		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	LIVING	2004		TCGA-29-1698-01				a40be7ea-f682-4d3e-a749-74aec6961b88		TCGA-29-1698-01A-01R-1567-13	TCGA-29-1698-01A-01D-0563-05			TCGA-29-1698-01A-01D-0559-01	TCGA-29-1698-01	TCGA-29-1698-01A-01D-0559-01	e8feef4b-7e7f-49b3-8b44-e4606e005a16			e8feef4b-7e7f-49b3-8b44-e4606e005a16	TCGA-29-1698-01A-21-1558-20	TCGA-29-1698-01A-01R-1567-13	TCGA-29-1698-01A-01R-0566-07		86e20816-f37a-4686-876b-3ef6f0be521a		TCGA-29-1698-01A-01R-1567-13		TCGA-29-1698-01A-01W-0633-09
TCGA-29-1699-01	1	TCGA-29-1699-01	1106	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1699	1106	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Bilateral	TCGA-29-1699-F41729	Stage IIIC	-21130		1106	0	16			1		Progressive Disease	2013-8-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5		YES	G3			NO		TCGA-29-1699.9e2cf2f9-c45c-4702-8b6f-565c59730036.pdf	5				2	2			0	0	0	0	98	98	90	90	Pre-Operative								Primary Tumor	01	0.6			29	1-10 mm	Ovary		A	DECEASED	2004		TCGA-29-1699-01			6d1d8c8a-fea0-4a47-bd2a-124270561406	21c96f53-087e-42c2-86ce-ea45cf876627		TCGA-29-1699-01A-01R-1567-13	TCGA-29-1699-01A-01D-0563-05	TCGA-29-1699-01	TCGA-29-1699-01	TCGA-29-1699-01A-01D-0559-01	TCGA-29-1699-01	TCGA-29-1699-01A-01D-0559-01	4524d67a-604f-44a9-8638-dd472da98b91	6d1d8c8a-fea0-4a47-bd2a-124270561406	6d1d8c8a-fea0-4a47-bd2a-124270561406	4524d67a-604f-44a9-8638-dd472da98b91	TCGA-29-1699-01A-21-1558-20	TCGA-29-1699-01A-01R-1567-13	TCGA-29-1699-01A-01R-0566-07		036b4d31-1291-4092-9442-9950564a6699	6d1d8c8a-fea0-4a47-bd2a-124270561406	TCGA-29-1699-01A-01R-1567-13		TCGA-29-1699-01A-01W-0633-09
TCGA-29-1701-01	1	TCGA-29-1701-01	515	1	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-1701	515	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-29-1701-F27243	Stage IIIC	-20737		515	0	514		298	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3		YES	G3	Recurrence				TCGA-29-1701.f7568046-b77a-4654-9f94-8978bd3e22c4.pdf					2	2			0	0	0	0	98	98	90	90	Post-Adjuvant Therapy	WITH TUMOR	NO	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.6			29		Ovary	YES	A	DECEASED	2004		TCGA-29-1701-01			e5e6f25b-d641-4598-8bb1-0850750ef048	d770980a-b6ef-4e85-8ed6-a22702326573		TCGA-29-1701-01A-01R-1567-13	TCGA-29-1701-01A-01D-0563-05	TCGA-29-1701-01	TCGA-29-1701-01	TCGA-29-1701-01A-01D-0559-01	TCGA-29-1701-01	TCGA-29-1701-01A-01D-0559-01	fe1cab9b-cff2-4467-ba52-134831acf48d	e5e6f25b-d641-4598-8bb1-0850750ef048	e5e6f25b-d641-4598-8bb1-0850750ef048	fe1cab9b-cff2-4467-ba52-134831acf48d	TCGA-29-1701-01A-21-1558-20	TCGA-29-1701-01A-01R-1567-13	TCGA-29-1701-01A-01R-0566-07		9ffceda1-d2ab-4689-baee-eab0b133ded9	e5e6f25b-d641-4598-8bb1-0850750ef048	TCGA-29-1701-01A-01R-1567-13		TCGA-29-1701-01A-01W-0633-09
TCGA-29-1702-01	1	TCGA-29-1702-01	728	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-29-1702	728	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	84	Right	TCGA-29-1702-F27249	Stage IIIC	-30910		728	0	568		286	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence				TCGA-29-1702.f825bb6c-afc2-48ea-9286-09c09c7e9918.pdf					2	2			0	0	0	0	98	98	95	95	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	DECEASED	2005		TCGA-29-1702-01			c317689f-a405-4486-9a22-ff6eadd2d5b8	0160cfab-a19a-415e-a418-5679ae8d6779		TCGA-29-1702-01A-01R-1567-13	TCGA-29-1702-01A-01D-0563-05	TCGA-29-1702-01	TCGA-29-1702-01	TCGA-29-1702-01A-01D-0559-01	TCGA-29-1702-01	TCGA-29-1702-01A-01D-0559-01	5b8c15f0-5635-42d1-849d-66dacecfb6c0	c317689f-a405-4486-9a22-ff6eadd2d5b8	c317689f-a405-4486-9a22-ff6eadd2d5b8	5b8c15f0-5635-42d1-849d-66dacecfb6c0	TCGA-29-1702-01A-21-1558-20	TCGA-29-1702-01A-01R-1567-13	TCGA-29-1702-01A-01R-0566-07		3a13cc49-5376-4695-9e64-45b457b9d36b	c317689f-a405-4486-9a22-ff6eadd2d5b8	TCGA-29-1702-01A-01R-1567-13		TCGA-29-1702-01A-01W-0633-09
TCGA-29-1703-01	1	TCGA-29-1703-01	1815	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-1703	1815	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-29-1703-F27255	Stage IIIC	-20622		1815	0	1815		324	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4			G2	Recurrence				TCGA-29-1703.c8397af0-67d2-4e69-993b-7349657e9953.pdf					2	10			0	0	0	0	98	90	95	95	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	DECEASED	2005		TCGA-29-1703-01			64e3f978-d213-45e2-bb52-e9b9a2032dc0	13530c03-540d-4e0d-a760-c0f6946f0480		TCGA-29-1703-01A-01R-1567-13	TCGA-29-1703-01A-01D-0563-05	TCGA-29-1703-01	TCGA-29-1703-01	TCGA-29-1703-01A-01D-0559-01	TCGA-29-1703-01	TCGA-29-1703-01A-01D-0559-01	0cf0722f-55bc-438b-92fd-d7f65d6b4ef4	64e3f978-d213-45e2-bb52-e9b9a2032dc0	64e3f978-d213-45e2-bb52-e9b9a2032dc0	0cf0722f-55bc-438b-92fd-d7f65d6b4ef4	TCGA-29-1703-01A-21-1558-20	TCGA-29-1703-01A-01R-1567-13	TCGA-29-1703-01A-01R-0566-07		059bf2b5-7752-44aa-935c-8b9c482e29e2	64e3f978-d213-45e2-bb52-e9b9a2032dc0	TCGA-29-1703-01A-01R-1567-13		TCGA-29-1703-01A-01W-0633-09
TCGA-29-1704-01	0	TCGA-29-1704-01	1587	0	High		OV-like c1						TCGA-29-1704	1587	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	61	Bilateral	TCGA-29-1704-F27269	Stage IIIC	-22511			0	1587		568	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																					Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO	R1	Primary Tumor	01				29	11-20 mm	Ovary			LIVING	2005		TCGA-29-1704-01							TCGA-29-1704-01B-01D-0807-05			TCGA-29-1704-01B-01D-0803-01	TCGA-29-1704-01	TCGA-29-1704-01B-01D-0803-01	eeb37d58-b09e-4a3b-a134-1f553c22127a			eeb37d58-b09e-4a3b-a134-1f553c22127a			TCGA-29-1704-01B-01R-0810-07		bbc42149-d2c4-44f9-a59f-bd9397bc96e8				
TCGA-29-1704-02	0	TCGA-29-1704-02	1587	0			OV-like c1						TCGA-29-1704	1587	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	61	Bilateral	TCGA-29-1704-F27269	Stage IIIC	-22511			0	1587		568	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3	Recurrence									0	0			0	0	10	10	90	90	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO	R1	Recurrent Tumor	02	0.2			29	11-20 mm	Ovary		A	LIVING	2005									TCGA-29-1704-02A-01D-0807-05						3471e589-f7cc-41cd-badd-5768cf0e9866,c6577ae4-0596-4d37-b886-b756cf6fc80a			3471e589-f7cc-41cd-badd-5768cf0e9866,c6577ae4-0596-4d37-b886-b756cf6fc80a									
TCGA-29-1705-01	1	TCGA-29-1705-01	555	1	BRCA-LUAD+	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1705	555	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-29-1705-F27279	Stage IIIC	-17530		555	0	555		283	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G2	Recurrence				TCGA-29-1705.e7a899e9-2c61-4bda-874c-0f1b456e5dfc.pdf					15	2			0	0	0	0	85	98	80	85	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.7			29	>20 mm	Ovary		A	DECEASED	2005		TCGA-29-1705-01			d1603029-2b45-4c5c-b313-8846d0ebdbdb	94faea93-a4a5-45c7-9b05-b342bec4e176		TCGA-29-1705-01A-01R-1567-13	TCGA-29-1705-01A-01D-0563-05	TCGA-29-1705-01	TCGA-29-1705-01	TCGA-29-1705-01A-01D-0559-01	TCGA-29-1705-01	TCGA-29-1705-01A-01D-0559-01	c848015b-7d16-4074-9253-1d4dcc070a70	d1603029-2b45-4c5c-b313-8846d0ebdbdb	d1603029-2b45-4c5c-b313-8846d0ebdbdb	c848015b-7d16-4074-9253-1d4dcc070a70	TCGA-29-1705-01A-21-1558-20	TCGA-29-1705-01A-01R-1567-13	TCGA-29-1705-01A-01R-0566-07		3d4c3c05-1760-43b8-9a4d-e66ebfaf9533	d1603029-2b45-4c5c-b313-8846d0ebdbdb	TCGA-29-1705-01A-01R-1567-13		TCGA-29-1705-01A-01W-0633-09
TCGA-29-1705-02	1	TCGA-29-1705-02	555	1		C9-OV	OV-like c1			miRNA cluster 3			TCGA-29-1705	555	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-29-1705-F27279	Stage IIIC	-17530		555	0	555		283	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.3			G2	Recurrence									5	10			0	0	15	40	80	50	90	80	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.4			29	>20 mm	Ovary		A	DECEASED	2005								TCGA-29-1705-02A-01R-1567-13	TCGA-29-1705-02A-01D-0807-05						0d6bedbe-ff61-47a2-9ded-c15c88db91c8,ea0b3b10-e81d-44fb-b753-3cace9e92e4c			0d6bedbe-ff61-47a2-9ded-c15c88db91c8,ea0b3b10-e81d-44fb-b753-3cace9e92e4c		TCGA-29-1705-02A-01R-1567-13	TCGA-29-1705-02A-01R-0810-07		83b8567f-7316-4c8b-877d-b5db5bf8c9da		TCGA-29-1705-02A-01R-1567-13		
TCGA-29-1707-01	0	TCGA-29-1707-01	1277	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1707	1277	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	41	Left	TCGA-29-1707-F27288	Stage IIC	-15017			0	1277		1201	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G3	Recurrence				TCGA-29-1707.da725324-2b94-47d4-a35c-a5f2233a024f.pdf					2	2			0	0	0	0	98	98	95	95	Post-Adjuvant Therapy		YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-29-1707-01				c7511c99-d363-45ed-9d27-cff988927e46		TCGA-29-1707-01A-01R-1567-13	TCGA-29-1707-01A-01D-0563-05			TCGA-29-1707-01A-01D-0559-01	TCGA-29-1707-01	TCGA-29-1707-01A-01D-0559-01	6182c67e-8016-470c-a817-322d3c7f37d4			6182c67e-8016-470c-a817-322d3c7f37d4	TCGA-29-1707-01A-21-1559-20		TCGA-29-1707-01A-01R-0566-07		5a0fb2e7-59de-4180-9b11-456580ad1d78				TCGA-29-1707-01A-01W-0633-09
TCGA-29-1707-02	0	TCGA-29-1707-02	1277	0			OV-like c1			miRNA cluster 1			TCGA-29-1707	1277	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	41	Left	TCGA-29-1707-F27288	Stage IIC	-15017			0	1277		1201	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence									0	0			0	0	10	10	90	90	95	95	Post-Adjuvant Therapy		YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Recurrent Tumor	02	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2006								TCGA-29-1707-02A-01R-1567-13	TCGA-29-1707-02A-01D-0807-05						f71f4047-5a0f-45d3-ac81-d0610a19c3b9			f71f4047-5a0f-45d3-ac81-d0610a19c3b9		TCGA-29-1707-02A-01R-1567-13	TCGA-29-1707-02A-01R-0810-07		ef4e079b-c946-4598-a7dd-575e48a4a133		TCGA-29-1707-02A-01R-1567-13		
TCGA-29-1710-01	1	TCGA-29-1710-01	951	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-29-1710	951	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-29-1710-F27294	Stage IIIC	-19969		951	0	889		315	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.8			G2	Recurrence				TCGA-29-1710.52a0d2ae-7467-40f0-b8f3-59812cfac52a.pdf	15	10			15	10			0	0	0	0	85	90	75	80	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	DECEASED	2006		TCGA-29-1710-01			3bf24456-4b70-4313-a04d-19aba239108d			TCGA-29-1710-01A-02R-1567-13	TCGA-29-1710-01A-02D-0563-05	TCGA-29-1710-01	TCGA-29-1710-01	TCGA-29-1710-01A-02D-0559-01	TCGA-29-1710-01	TCGA-29-1710-01A-02D-0559-01	39807bf8-d0a9-4817-9094-2577dd21157b	3bf24456-4b70-4313-a04d-19aba239108d	3bf24456-4b70-4313-a04d-19aba239108d	39807bf8-d0a9-4817-9094-2577dd21157b		TCGA-29-1710-01A-02R-1567-13	TCGA-29-1710-01A-02R-0566-07		31aaa27c-8eaf-4030-9067-d505d9abf983	3bf24456-4b70-4313-a04d-19aba239108d	TCGA-29-1710-01A-02R-1567-13		TCGA-29-1710-01A-02W-0633-09
TCGA-29-1710-02	1	TCGA-29-1710-02	951	1			OV-like c1						TCGA-29-1710	951	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-29-1710-F27294	Stage IIIC	-19969		951	0	889		315	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G2	Recurrence									20	20			0	0	30	30	50	50	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			29	1-10 mm	Ovary		A	DECEASED	2006									TCGA-29-1710-02A-01D-0807-05						9f89fea0-54eb-4954-8ea4-d0c87631d40f			9f89fea0-54eb-4954-8ea4-d0c87631d40f			TCGA-29-1710-02A-01R-0810-07		4a8f0084-d5a6-4f5b-bc46-8494a2bfe6b1				
TCGA-29-1711-01	0	TCGA-29-1711-01	1053	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-29-1711	1053	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			45	Bilateral	TCGA-29-1711-F27307	Stage IIIC	-16485			0	1053			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.2			G2					TCGA-29-1711.e0e207a0-c3c2-4bfc-9d7d-d00c5c953d3d.pdf	2		3		2	2			0	0	0	0	98	98	90	90	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2006		TCGA-29-1711-01			c512a6e3-8bc8-4188-b264-89b2fe02baa8	8aedfe25-9010-4502-a25c-88ed899eeb22		TCGA-29-1711-01A-01R-1567-13	TCGA-29-1711-01A-01D-0563-05	TCGA-29-1711-01	TCGA-29-1711-01	TCGA-29-1711-01A-01D-0559-01	TCGA-29-1711-01	TCGA-29-1711-01A-01D-0559-01	b51f1b66-75c2-4878-91b0-4293f81097ea	c512a6e3-8bc8-4188-b264-89b2fe02baa8	c512a6e3-8bc8-4188-b264-89b2fe02baa8	b51f1b66-75c2-4878-91b0-4293f81097ea	TCGA-29-1711-01A-21-1559-20	TCGA-29-1711-01A-01R-1567-13	TCGA-29-1711-01A-01R-0566-07		299a04e7-e90f-4a24-a211-7f0bd18b3ea0	c512a6e3-8bc8-4188-b264-89b2fe02baa8	TCGA-29-1711-01A-01R-1567-13		TCGA-29-1711-01A-01W-0633-09
TCGA-29-1761-01	1	TCGA-29-1761-01	528	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1761	528	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			80	Bilateral	TCGA-29-1761-F27312	Stage IIIC	-29337		528	0	517						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.9			G3					TCGA-29-1761.63defa27-e729-4514-bdd2-d887c4100854.pdf	15	10			5	5			0	0	5	10	90	85	75	80		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	1998		TCGA-29-1761-01			c4446f6f-fae9-414c-8bae-7c78bb894982	1dfcb901-e9df-4eee-af4c-5c9c22cbe0e8		TCGA-29-1761-01A-01R-1567-13	TCGA-29-1761-01A-01D-0563-05	TCGA-29-1761-01	TCGA-29-1761-01	TCGA-29-1761-01A-01D-0559-01	TCGA-29-1761-01	TCGA-29-1761-01A-01D-0559-01	99d32dd3-0594-46be-96ba-6a981950aa0f	c4446f6f-fae9-414c-8bae-7c78bb894982	c4446f6f-fae9-414c-8bae-7c78bb894982	99d32dd3-0594-46be-96ba-6a981950aa0f	TCGA-29-1761-01A-21-1559-20	TCGA-29-1761-01A-01R-1567-13	TCGA-29-1761-01A-01R-0566-07		288d1cec-45f2-448c-8bf1-ce001420d126	c4446f6f-fae9-414c-8bae-7c78bb894982	TCGA-29-1761-01A-01R-1567-13		TCGA-29-1761-01A-01W-0633-09
TCGA-29-1762-01	1	TCGA-29-1762-01	2634	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-1762	2634	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-29-1762-F27316	Stage IV	-21879		2634	0	2606		1375	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		0.9			G2	Recurrence				TCGA-29-1762.f94712a1-78da-4341-9ac9-6ea41c11610e.pdf					10	20			0	0	5	5	85	75	90	85	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	1998		TCGA-29-1762-01			c3559ae3-3355-4f38-9c07-e557e435fcbd	a8bcbfb3-7a83-4170-8b2c-fa5447b5abce		TCGA-29-1762-01A-01R-1567-13	TCGA-29-1762-01A-01D-0563-05	TCGA-29-1762-01	TCGA-29-1762-01	TCGA-29-1762-01A-01D-0559-01	TCGA-29-1762-01	TCGA-29-1762-01A-01D-0559-01	dfcb305a-ff38-4426-9baf-9e8154cd6e1b	c3559ae3-3355-4f38-9c07-e557e435fcbd	c3559ae3-3355-4f38-9c07-e557e435fcbd	dfcb305a-ff38-4426-9baf-9e8154cd6e1b	TCGA-29-1762-01A-21-1559-20	TCGA-29-1762-01A-01R-1567-13	TCGA-29-1762-01A-01R-0566-07		49c0d36f-14fc-49f0-90a0-57cfbd8ec25b	c3559ae3-3355-4f38-9c07-e557e435fcbd	TCGA-29-1762-01A-01R-1567-13		TCGA-29-1762-01A-01W-0633-09
TCGA-29-1763-01	0	TCGA-29-1763-01	2032	0	High		Low purity c2		OV-like c16	miRNA cluster 1	cluster 2		TCGA-29-1763	2032	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	43	Bilateral	TCGA-29-1763-F27325	Stage IIC	-16021			0	2032		428	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.3			G2	Recurrence				TCGA-29-1763.f90e0db8-f656-411c-be72-8e0774d2336b.pdf					5	5			0	0	0	0	95	95	75	70	Other	WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	LIVING	2004		TCGA-29-1763-01			af63aa43-ab5f-44c5-85cf-01d84be261a3			TCGA-29-1763-01A-02R-1567-13	TCGA-29-1763-01A-02D-0563-05	TCGA-29-1763-01	TCGA-29-1763-01	TCGA-29-1763-01A-02D-0559-01	TCGA-29-1763-01	TCGA-29-1763-01A-02D-0559-01	8a64e2fc-7ca4-47da-9985-c2a06052518f	af63aa43-ab5f-44c5-85cf-01d84be261a3	af63aa43-ab5f-44c5-85cf-01d84be261a3	8a64e2fc-7ca4-47da-9985-c2a06052518f		TCGA-29-1763-01A-02R-1567-13	TCGA-29-1763-01A-02R-0566-07		afc40d40-daf1-4bb5-8813-017913722541	af63aa43-ab5f-44c5-85cf-01d84be261a3	TCGA-29-1763-01A-02R-1567-13		TCGA-29-1763-01A-02W-0633-09
TCGA-29-1764-01	0	TCGA-29-1764-01	1914	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-29-1764	1914	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-29-1764-F27338	Stage IIIC	-18012			0	1914		792	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.6			G2	Recurrence				TCGA-29-1764.3bae7a57-63d7-4770-a960-cd8f0749ca17.pdf	5	5	3	3	10	3			0	0	0	12	90	85	70	85	Other	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2004		TCGA-29-1764-01				3c3a33be-9e62-4a32-946a-15f32661e2a1		TCGA-29-1764-01A-01R-1567-13	TCGA-29-1764-01A-01D-0563-05			TCGA-29-1764-01A-01D-0559-01	TCGA-29-1764-01	TCGA-29-1764-01A-01D-0559-01	286c3c1e-c00f-4d29-b805-ecd1432a6a78			286c3c1e-c00f-4d29-b805-ecd1432a6a78	TCGA-29-1764-01A-21-1559-20		TCGA-29-1764-01A-01R-0566-07		523d9b2a-4c0b-479c-917c-2086480c8558				TCGA-29-1764-01A-01W-0633-09
TCGA-29-1766-01	1	TCGA-29-1766-01	1199	1	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 1		TCGA-29-1766	1199	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	74	Right	TCGA-29-1766-F27350	Stage IIIC	-27359		1199	0	1190		672	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G2	Recurrence																					Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01				29	11-20 mm	Peritoneum ovary			DECEASED	2006		TCGA-29-1766-01				dd8951d2-5b83-4b78-9b04-52d474639e2f		TCGA-29-1766-01A-01R-1567-13	TCGA-29-1766-01A-01D-0563-05			TCGA-29-1766-01A-01D-0559-01	TCGA-29-1766-01	TCGA-29-1766-01A-01D-0559-01	fef20c85-59fd-4c83-a61d-e7cdc277917a			fef20c85-59fd-4c83-a61d-e7cdc277917a	TCGA-29-1766-01A-21-1559-20	TCGA-29-1766-01A-01R-1567-13	TCGA-29-1766-01A-01R-0566-07		a7005558-9983-48f6-8252-943b8a9dd384		TCGA-29-1766-01A-01R-1567-13		TCGA-29-1766-01A-01W-0633-09
TCGA-29-1768-01	1	TCGA-29-1768-01	952	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-29-1768	952	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-29-1768-F27358	Stage IV	-18396		952	0	950		547	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1			G3	Recurrence				TCGA-29-1768.12d9b343-a52d-4a36-ba7b-31bfeb66da50.pdf	5				0	0			0	0	75	50	25	50	80	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2006		TCGA-29-1768-01				f70a1542-3bd5-4ebe-880a-e8f7c75faaba		TCGA-29-1768-01A-01R-1567-13	TCGA-29-1768-01A-01D-0563-05			TCGA-29-1768-01A-01D-0559-01	TCGA-29-1768-01	TCGA-29-1768-01A-01D-0559-01	c71e4fb2-5a26-45eb-843f-dbe50191f3be			c71e4fb2-5a26-45eb-843f-dbe50191f3be	TCGA-29-1768-01A-21-1559-20	TCGA-29-1768-01A-01R-1567-13	TCGA-29-1768-01A-01R-0566-07		83edce75-1b96-4e56-8042-76fc6e87f25f		TCGA-29-1768-01A-01R-1567-13		TCGA-29-1768-01A-01W-0633-09
TCGA-29-1769-01	0	TCGA-29-1769-01	699	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-29-1769	699	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			40	Bilateral	TCGA-29-1769-F27366	Stage IIIC	-14754			0	699			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1		NO	G3					TCGA-29-1769.67f144b3-c10b-4f96-a70b-6794d817170f.pdf	2	2			0	0			0	10	15	5	85	85	80	90	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	LIVING	2007		TCGA-29-1769-01				161fd24e-ed8c-41ef-8f00-000b3554d9e8		TCGA-29-1769-01A-01R-1567-13	TCGA-29-1769-01A-01D-0581-05			TCGA-29-1769-01A-01D-0577-01	TCGA-29-1769-01	TCGA-29-1769-01A-01D-0577-01	4ca2c9fb-cff8-45b6-8a58-5b5926996519			4ca2c9fb-cff8-45b6-8a58-5b5926996519	TCGA-29-1769-01A-21-1559-20	TCGA-29-1769-01A-01R-1567-13	TCGA-29-1769-01A-01R-0584-07		8e7a34f7-d49b-46c8-8b74-374232c60b71		TCGA-29-1769-01A-01R-1567-13		TCGA-29-1769-01A-01W-0639-09
TCGA-29-1770-01	0	TCGA-29-1770-01	741	0	High	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1770	741	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-29-1770-F27373	Stage IIIC	-20015			0	741		377	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.2			G2	Recurrence				TCGA-29-1770.05816aac-55d2-4604-9300-e268f73338fe.pdf					5	0			0	0	35	20	60	80	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	LIVING	2007		TCGA-29-1770-01			5ba75bb8-6229-4d6a-80e5-9a79a548e167	1577dc3d-937d-4fbb-b280-25f969e43f81		TCGA-29-1770-01A-01R-1567-13	TCGA-29-1770-01A-01D-0563-05	TCGA-29-1770-01	TCGA-29-1770-01	TCGA-29-1770-01A-01D-0559-01	TCGA-29-1770-01	TCGA-29-1770-01A-01D-0559-01	9f90944b-ee3c-4f43-93b1-e2bf5829a325	5ba75bb8-6229-4d6a-80e5-9a79a548e167	5ba75bb8-6229-4d6a-80e5-9a79a548e167	9f90944b-ee3c-4f43-93b1-e2bf5829a325	TCGA-29-1770-01A-21-1559-20	TCGA-29-1770-01A-01R-1567-13	TCGA-29-1770-01A-01R-0566-07		17024b36-bf59-4753-bcb3-7ddda14f1556	5ba75bb8-6229-4d6a-80e5-9a79a548e167	TCGA-29-1770-01A-01R-1567-13		TCGA-29-1770-01A-01W-0633-09
TCGA-29-1770-02	0	TCGA-29-1770-02	741	0		C9-OV	Low purity c2		OV-like c16	miRNA cluster 3			TCGA-29-1770	741	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-29-1770-F27373	Stage IIIC	-20015			0	741		377	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.4			G2	Recurrence									0	0			0	0	10	20	90	80	95	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.2			29	1-10 mm	Ovary		A	LIVING	2007					ea119111-5217-4b8a-88e0-36dc77782241			TCGA-29-1770-02A-01R-1567-13	TCGA-29-1770-02A-01D-0807-05						36e9cb1c-3de7-4aae-88a6-afa1005a145c	ea119111-5217-4b8a-88e0-36dc77782241	ea119111-5217-4b8a-88e0-36dc77782241	36e9cb1c-3de7-4aae-88a6-afa1005a145c		TCGA-29-1770-02A-01R-1567-13	TCGA-29-1770-02A-01R-0810-07		4ccece6b-c6cf-4921-81e5-af3780afffbc	ea119111-5217-4b8a-88e0-36dc77782241	TCGA-29-1770-02A-01R-1567-13		
TCGA-29-1771-01	0	TCGA-29-1771-01	686	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1771	686	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76	Bilateral	TCGA-29-1771-F27383	Stage IIIC	-28093			0	686		595	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G2	Recurrence				TCGA-29-1771.005ca6aa-3326-4b7c-b8a5-86a6dfb70a93.pdf					0	0			0	0	60	20	40	80	95	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2007		TCGA-29-1771-01				b69387b5-4b22-4ef1-8711-d1e406c1afdc		TCGA-29-1771-01A-01R-1567-13	TCGA-29-1771-01A-01D-0563-05			TCGA-29-1771-01A-01D-0559-01	TCGA-29-1771-01	TCGA-29-1771-01A-01D-0559-01	22e5525a-26b5-4140-968f-0be63cb751d2			22e5525a-26b5-4140-968f-0be63cb751d2	TCGA-29-1771-01A-21-1559-20		TCGA-29-1771-01A-01R-0566-07		d95ccef1-6cfa-4bda-ab09-c931f8c7a344				TCGA-29-1771-01A-01W-0633-09
TCGA-29-1774-01	0	TCGA-29-1774-01	527	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-29-1774	527	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	82	Bilateral	TCGA-29-1774-F27391	Stage IIIC	-29991			0	527		234	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-29-1774.8d8dd2f0-09d8-42a2-84e0-4209e45e2330.pdf					2	2			0	0	20	20	78	78	90	90		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	1			29	>20 mm	Ovary		A	LIVING	2008		TCGA-29-1774-01				eed4cd8b-16bc-419f-8474-248270a93780		TCGA-29-1774-01A-01R-1567-13	TCGA-29-1774-01A-01D-0581-05			TCGA-29-1774-01A-01D-0577-01	TCGA-29-1774-01	TCGA-29-1774-01A-01D-0577-01	5770446c-7705-4d03-b049-f00601f076f5			5770446c-7705-4d03-b049-f00601f076f5	TCGA-29-1774-01A-21-1559-20	TCGA-29-1774-01A-01R-1567-13	TCGA-29-1774-01A-01R-0584-07		d9a5abd2-9d18-48b7-a38a-c69c134e6086		TCGA-29-1774-01A-01R-1567-13		TCGA-29-1774-01A-01W-0639-09
TCGA-29-1775-01	0	TCGA-29-1775-01	376	0	High		OV-like c1	OV-like c4					TCGA-29-1775	376	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-29-1775-F27398	Stage IIIC	-18943			0	376		341	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Incisional Biopsy		0.7	NO		1.1			G2	Recurrence				TCGA-29-1775.8f5dd3e0-b6c8-443e-88d9-c9d02a531f60.pdf	5	5			0	0			0	0	25	20	75	80	90	85	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.5			29	1-10 mm	Ovary		A	LIVING	2008		TCGA-29-1775-01				8a55a793-3d3c-455f-a342-3c5cbd01f849			TCGA-29-1775-01A-01D-0581-05			TCGA-29-1775-01A-01D-0577-01	TCGA-29-1775-01	TCGA-29-1775-01A-01D-0577-01	ae4de736-1f04-4b8d-bc66-f8389cc74b9f			ae4de736-1f04-4b8d-bc66-f8389cc74b9f	TCGA-29-1775-01A-21-1559-20		TCGA-29-1775-01A-01R-0584-07		8ead8627-a2d2-4952-9d59-cb15c2ae2021				TCGA-29-1775-01A-01W-0639-09
TCGA-29-1776-01	0	TCGA-29-1776-01	360	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6		TCGA-29-1776	360	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-29-1776-F27409	Stage IIIC	-23016			0	360			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9			G3					TCGA-29-1776.eb6df66e-c6ee-4c63-889d-9f4b6ca170c7.pdf	5	5			0	0			0	0	15	25	85	75	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2008		TCGA-29-1776-01			50867fed-2fda-4c45-aa08-042087e7daa9	3da0c471-ede3-480f-b692-f94939ed8ac3		TCGA-29-1776-01A-01R-1567-13	TCGA-29-1776-01A-01D-0581-05	TCGA-29-1776-01	TCGA-29-1776-01	TCGA-29-1776-01A-01D-0577-01	TCGA-29-1776-01	TCGA-29-1776-01A-01D-0577-01	655c6e8d-4972-44cb-84e1-60197b73fb58	50867fed-2fda-4c45-aa08-042087e7daa9	50867fed-2fda-4c45-aa08-042087e7daa9	655c6e8d-4972-44cb-84e1-60197b73fb58	TCGA-29-1776-01A-21-1559-20	TCGA-29-1776-01A-01R-1567-13	TCGA-29-1776-01A-01R-0584-07		1549eee5-f999-4053-b926-baae183792f1	50867fed-2fda-4c45-aa08-042087e7daa9	TCGA-29-1776-01A-01R-1567-13		TCGA-29-1776-01A-01W-0639-09
TCGA-29-1777-01	0	TCGA-29-1777-01	374	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-29-1777	374	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			47	Bilateral	TCGA-29-1777-F27415	Stage IIIC	-17356			0	374			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3			G2					TCGA-29-1777.bfd59906-509b-4ca3-9282-c881f9962e15.pdf	5	5			0	0			0	0	25	20	75	80	80	85	Post-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2008		TCGA-29-1777-01				9b5e802b-56e7-4f93-8869-2db3170006bc		TCGA-29-1777-01A-01R-1567-13	TCGA-29-1777-01A-01D-0581-05			TCGA-29-1777-01A-01D-0577-01	TCGA-29-1777-01	TCGA-29-1777-01A-01D-0577-01	7a40175f-a23d-4540-a3b2-5a147430ffc7			7a40175f-a23d-4540-a3b2-5a147430ffc7	TCGA-29-1777-01A-21-1559-20	TCGA-29-1777-01A-01R-1567-13	TCGA-29-1777-01A-01R-0584-07		79992944-6a6c-4f97-baf4-132689a69fff		TCGA-29-1777-01A-01R-1567-13		TCGA-29-1777-01A-01W-0639-09
TCGA-29-1778-01	0	TCGA-29-1778-01	454	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1778	454	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			77	Right	TCGA-29-1778-F27420	Stage IIIC	-28147			0	454						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1			G3					TCGA-29-1778.439a81dd-dc54-49e5-942c-4aa8d0be8701.pdf	10	15			0	0			0	0	40	20	60	80	85	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			29	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-29-1778-01			7ecd0f7a-d186-422b-a2e1-833dfc400e39	9a724a0a-6807-4995-889b-4b80a32e280d		TCGA-29-1778-01A-01R-1567-13	TCGA-29-1778-01A-01D-0581-05	TCGA-29-1778-01	TCGA-29-1778-01	TCGA-29-1778-01A-01D-0577-01	TCGA-29-1778-01	TCGA-29-1778-01A-01D-0577-01	3ac1c2dd-76bc-4769-af18-b8e952e78513	7ecd0f7a-d186-422b-a2e1-833dfc400e39	7ecd0f7a-d186-422b-a2e1-833dfc400e39	3ac1c2dd-76bc-4769-af18-b8e952e78513	TCGA-29-1778-01A-21-1559-20	TCGA-29-1778-01A-01R-1567-13	TCGA-29-1778-01A-01R-0584-07		0654179f-2887-47e8-b4f4-051312a4907c	7ecd0f7a-d186-422b-a2e1-833dfc400e39	TCGA-29-1778-01A-01R-1567-13		TCGA-29-1778-01A-01W-0639-09
TCGA-29-1781-01	0	TCGA-29-1781-01	255	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-29-1781	255	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			69	Bilateral	TCGA-29-1781-F27427	Stage IIIC	-25404			0	255			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3					TCGA-29-1781.959c11fe-f170-49bc-a1fe-73b799741b93.pdf	10	5			10	20			0	0	5	0	85	80	85	90	Pre-Adjuvant Therapy	TUMOR FREE	NO	Complete Remission/Response			NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-29-1781-01			5fd66773-ed5a-438c-a7c1-d029f05798e5	7b26743c-756e-45d0-8eaa-cffb1c11fef1		TCGA-29-1781-01A-01R-1567-13	TCGA-29-1781-01A-01D-0563-05	TCGA-29-1781-01	TCGA-29-1781-01	TCGA-29-1781-01A-01D-0559-01	TCGA-29-1781-01	TCGA-29-1781-01A-01D-0559-01	e6d40df2-a74c-4a7e-903a-fdcb488457af	5fd66773-ed5a-438c-a7c1-d029f05798e5	5fd66773-ed5a-438c-a7c1-d029f05798e5	e6d40df2-a74c-4a7e-903a-fdcb488457af	TCGA-29-1781-01A-21-1559-20	TCGA-29-1781-01A-01R-1567-13	TCGA-29-1781-01A-01R-0566-07		b87d2ec7-4fbf-4ecd-99fd-4983eb2fb7d8	5fd66773-ed5a-438c-a7c1-d029f05798e5	TCGA-29-1781-01A-01R-1567-13		TCGA-29-1781-01A-01W-0633-09
TCGA-29-1783-01	0	TCGA-29-1783-01	220	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1783	220	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Right	TCGA-29-1783-F27431	Stage IIIC	-21284			0	220			1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3					TCGA-29-1783.6ebf4763-bb2a-4ef5-ab22-23460980df1c.pdf	5	5			0	2			0	0	15	20	85	78	90	90	Post-Adjuvant Therapy	TUMOR FREE	YES				NO		Primary Tumor	01	0.4			29	1-10 mm	Ovary		A	LIVING	2009		TCGA-29-1783-01			dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	82dd8748-e0c5-4030-bf40-fe5d229adeae		TCGA-29-1783-01A-01R-1567-13	TCGA-29-1783-01A-01D-0563-05	TCGA-29-1783-01	TCGA-29-1783-01	TCGA-29-1783-01A-01D-0559-01	TCGA-29-1783-01	TCGA-29-1783-01A-01D-0559-01	394c6744-3478-4a86-939d-34ec5641067b	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	394c6744-3478-4a86-939d-34ec5641067b	TCGA-29-1783-01A-21-1559-20	TCGA-29-1783-01A-01R-1567-13	TCGA-29-1783-01A-01R-0566-07		2981b53e-f39a-4c5e-9254-dd1a6bf6c4e6	dad3688e-fdd7-4c85-a1df-cf0e1cc0a235	TCGA-29-1783-01A-01R-1567-13		TCGA-29-1783-01A-01W-0633-09
TCGA-29-1784-01	0	TCGA-29-1784-01	163	0	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1784	163	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Right	TCGA-29-1784-F27436	Stage IIIC	-20210			0	163			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3					TCGA-29-1784.e4614e5d-eb1f-4ac7-a17f-105936745e80.pdf	15	20			0	0			0	0	5	10	95	90	80	75	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-29-1784-01			c72e442b-36f5-4ea6-a893-505b5ccd8c4f			TCGA-29-1784-01A-02R-1567-13	TCGA-29-1784-01A-02D-0563-05	TCGA-29-1784-01	TCGA-29-1784-01	TCGA-29-1784-01A-02D-0559-01	TCGA-29-1784-01	TCGA-29-1784-01A-02D-0559-01	1799e1a3-740c-4f31-8278-9d80c60f699e	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	1799e1a3-740c-4f31-8278-9d80c60f699e		TCGA-29-1784-01A-02R-1567-13	TCGA-29-1784-01A-02R-0566-07		3720cc8a-5b9c-44cb-ba9d-5540f1ece950	c72e442b-36f5-4ea6-a893-505b5ccd8c4f	TCGA-29-1784-01A-02R-1567-13		TCGA-29-1784-01A-02W-0633-09
TCGA-29-1785-01	1	TCGA-29-1785-01	1104	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4		TCGA-29-1785	1104	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Right	TCGA-29-1785-F27442	Stage IIIC	-20417		1104	0	1053		473	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2		YES	G3	Recurrence				TCGA-29-1785.b520ed75-17dd-420f-b444-4436bb03f40f.pdf	15	15			0	2			0	0	10	10	90	88	80	70	Post-Adjuvant Therapy		YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			29	>20 mm	Ovary		A	DECEASED	2006		TCGA-29-1785-01			dcff1416-56fd-4d8e-a472-a40a00ef3066	c7002a87-0a3e-4ffb-b976-b1d7f768dd30		TCGA-29-1785-01A-01R-1567-13	TCGA-29-1785-01A-01D-0563-05	TCGA-29-1785-01	TCGA-29-1785-01	TCGA-29-1785-01A-01D-0559-01	TCGA-29-1785-01	TCGA-29-1785-01A-01D-0559-01	9f35633c-a588-4469-8103-108308f76323	dcff1416-56fd-4d8e-a472-a40a00ef3066	dcff1416-56fd-4d8e-a472-a40a00ef3066	9f35633c-a588-4469-8103-108308f76323	TCGA-29-1785-01A-21-1559-20	TCGA-29-1785-01A-01R-1567-13	TCGA-29-1785-01A-01R-0566-07		89db2b71-04a7-42f7-8480-a8ba3f118bcc	dcff1416-56fd-4d8e-a472-a40a00ef3066	TCGA-29-1785-01A-01R-1567-13		TCGA-29-1785-01A-01W-0633-09
TCGA-29-2414-01	1	TCGA-29-2414-01	2621	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 6		TCGA-29-2414	2621	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	75	Left	TCGA-29-2414-F27451	Stage IIIC	-27417		2621	0	2621		552				2010-2-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G2	Recurrence				TCGA-29-2414.c480ee08-d996-40e6-bd86-3e614625d98b.pdf					6	5			45	35	0	0	49	60	70	76		WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO	R1	Primary Tumor	01	0.5			29	11-20 mm	Ovary	NO	A	DECEASED	1998		TCGA-29-2414-01			ecbadb01-01ec-4d9f-877c-75709d6f5914			TCGA-29-2414-01A-02R-1569-13	TCGA-29-2414-01A-02D-0708-05	TCGA-29-2414-01	TCGA-29-2414-01	TCGA-29-2414-01A-02D-2069-01	TCGA-29-2414-01	TCGA-29-2414-01A-02D-2069-01	63eee62a-faf8-439d-bb1b-d2b5d6f47aa2,93456d1b-d452-4f93-b378-affe6880bbd2	ecbadb01-01ec-4d9f-877c-75709d6f5914	ecbadb01-01ec-4d9f-877c-75709d6f5914	63eee62a-faf8-439d-bb1b-d2b5d6f47aa2,93456d1b-d452-4f93-b378-affe6880bbd2		TCGA-29-2414-01A-02R-1569-13	TCGA-29-2414-01A-02R-0711-07		9d580db8-ad4f-4ecb-affd-e9ae032e8ebb	ecbadb01-01ec-4d9f-877c-75709d6f5914	TCGA-29-2414-01A-02R-1569-13		
TCGA-29-2414-02	1	TCGA-29-2414-02	2621	1			OV-like c1		OV-like c16	miRNA cluster 1			TCGA-29-2414	2621	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	75	Left	TCGA-29-2414-F27451	Stage IIIC	-27417		2621	0	2621		552				2010-2-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G2	Recurrence									0	10			0	0	20	30	80	60	90	90		WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO	R1	Recurrent Tumor	02	0.3			29	11-20 mm	Ovary	NO	A	DECEASED	1998					1558c0c4-6bd2-482d-9c4e-2430a402dacc			TCGA-29-2414-02A-01R-1569-13	TCGA-29-2414-02A-01D-0807-05						949b13bf-0d1f-4e2c-abb5-10d1951b25dc	1558c0c4-6bd2-482d-9c4e-2430a402dacc	1558c0c4-6bd2-482d-9c4e-2430a402dacc	949b13bf-0d1f-4e2c-abb5-10d1951b25dc		TCGA-29-2414-02A-01R-1569-13	TCGA-29-2414-02A-01R-0810-07		4e488bb5-78b0-4a28-b276-109b203230d4	1558c0c4-6bd2-482d-9c4e-2430a402dacc	TCGA-29-2414-02A-01R-1569-13		
TCGA-29-2425-01	0	TCGA-29-2425-01	1977	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-29-2425	1977	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60		TCGA-29-2425-F27462	Stage IIIC	-22089			0	1977		1577	0			2010-2-9	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		NO	G2	Progression of Disease				TCGA-29-2425.ec04e6ae-ae66-4fc2-b77b-485f77ce39bc.pdf					10	5			0	0	10	15	80	80	97	97	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2004		TCGA-29-2425-01			3ce6b8c4-7020-447a-8eb8-5370eef05344	8d87815d-6b5a-4713-9f0b-0ca8609996f2		TCGA-29-2425-01A-01R-1569-13	TCGA-29-2425-01A-01D-0708-05	TCGA-29-2425-01	TCGA-29-2425-01	TCGA-29-2425-01A-01D-0704-01	TCGA-29-2425-01	TCGA-29-2425-01A-01D-0704-01	8c4197c4-c7bd-49e2-8efa-c6c5ea968e69	3ce6b8c4-7020-447a-8eb8-5370eef05344	3ce6b8c4-7020-447a-8eb8-5370eef05344	8c4197c4-c7bd-49e2-8efa-c6c5ea968e69	TCGA-29-2425-01A-21-1560-20	TCGA-29-2425-01A-01R-1569-13	TCGA-29-2425-01A-01R-0711-07		572ffa30-3fd6-49b7-a250-f8505555bde9	3ce6b8c4-7020-447a-8eb8-5370eef05344	TCGA-29-2425-01A-01R-1569-13		
TCGA-29-2427-01	0	TCGA-29-2427-01	1900	0	BRCA-LUAD+	C9-OV	Low purity c2	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-29-2427	1900	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Left	TCGA-29-2427-F27470	Stage IIIC	-21940			0	1900		1582	0			2010-2-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3	Recurrence				TCGA-29-2427.b53536ca-770c-4482-b2f7-4284d804db2e.pdf					5	5			0	0	15	15	80	80	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.5			29	>20 mm	Ovary		A	LIVING	2004		TCGA-29-2427-01		TCGA-29-2427-01A-01W-0799-08	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	596d6d8e-d15c-442b-bcd4-ed2dec59aef2		TCGA-29-2427-01A-01R-1569-13	TCGA-29-2427-01A-01D-0708-05	TCGA-29-2427-01	TCGA-29-2427-01	TCGA-29-2427-01A-01D-0704-01	TCGA-29-2427-01	TCGA-29-2427-01A-01D-0704-01	6bdeb0dd-6cac-446a-9bb8-e9946ea0342c	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	6bdeb0dd-6cac-446a-9bb8-e9946ea0342c	TCGA-29-2427-01A-21-1560-20	TCGA-29-2427-01A-01R-1569-13	TCGA-29-2427-01A-01R-0711-07		68e99d72-4df2-4d2d-9e24-b8fc81942a46	f1579d6e-6efd-47b5-b2b4-a97e1480ce0a	TCGA-29-2427-01A-01R-1569-13	TCGA-29-2427-01A-01W-0799-08	
TCGA-29-2428-01	0	TCGA-29-2428-01	1372	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-29-2428	1372	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Left	TCGA-29-2428-F27478	Stage IIIC	-21392			0	1372			0			2010-2-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.7		YES	G3					TCGA-29-2428.45a6c74c-045b-4fdd-a93d-9e1a8d36e4cb.pdf					0	5			0	0	20	5	80	90	90	95	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response			NO	R1	Primary Tumor	01	0.4			29	>20 mm	Ovary		A	LIVING	2005		TCGA-29-2428-01			9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	364ced0b-2737-4f70-a7bb-a5a9171e4ef8		TCGA-29-2428-01A-01R-1569-13	TCGA-29-2428-01A-01D-0708-05	TCGA-29-2428-01	TCGA-29-2428-01	TCGA-29-2428-01A-01D-0704-01	TCGA-29-2428-01	TCGA-29-2428-01A-01D-0704-01	fcfc7f2d-e53d-43e1-9838-fcc8c6525a6a	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	fcfc7f2d-e53d-43e1-9838-fcc8c6525a6a	TCGA-29-2428-01A-21-1560-20	TCGA-29-2428-01A-01R-1569-13	TCGA-29-2428-01A-01R-0711-07		b7c8f2a5-de96-4a38-bfa4-2a6c1b8ea1e2	9e4a4bc1-39cf-46dc-b7d3-c7d852cc033b	TCGA-29-2428-01A-01R-1569-13		
TCGA-29-2429-01	1	TCGA-29-2429-01	421	1	High		OV-like c1	OV-like c4					TCGA-29-2429	421	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			79	Right		Stage IIIC	-29156		421	0	149						2010-6-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1			G3					TCGA-29-2429.09804c6e-b6f3-482f-a23e-a4efa84f2ab7.pdf					5	10			0	0	10	10	85	80	95	90		WITH TUMOR						R1	Primary Tumor	01	0.3			29	>20 mm	Ovary		A	DECEASED	2005		TCGA-29-2429-01				3ba731e2-2840-44c0-aa48-541f8f9e4d29			TCGA-29-2429-01A-01D-1047-05			TCGA-29-2429-01A-01D-1043-01	TCGA-29-2429-01	TCGA-29-2429-01A-01D-1043-01	bfd6404a-1c99-45ca-b16b-4cf449308043			bfd6404a-1c99-45ca-b16b-4cf449308043	TCGA-29-2429-01A-21-1560-20		TCGA-29-2429-01A-01R-1050-07		1142b276-1e85-4021-8fa7-85e562b6c747				TCGA-29-2429-01A-01D-1526-09
TCGA-29-2431-01	0	TCGA-29-2431-01	1285	0	High		OV-like c1	OV-like c4					TCGA-29-2431	1285	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-29-2431-F27485	Stage IIIC	-21833			0	1285		960	0			2010-6-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G2	Recurrence				TCGA-29-2431.cbd3ddd8-b431-4852-b4db-b4be535115d6.pdf					0	0			0	0	7	20	93	80	95	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R0	Primary Tumor	01	0.3			29	1-10 mm	Ovary		A	LIVING	2006		TCGA-29-2431-01				f02341bc-10e3-4bbf-98c8-0604616796ea			TCGA-29-2431-01A-01D-1047-05			TCGA-29-2431-01A-01D-1043-01	TCGA-29-2431-01	TCGA-29-2431-01A-01D-1043-01	49faae6b-279a-4dec-af44-25fd7e00a8e9			49faae6b-279a-4dec-af44-25fd7e00a8e9	TCGA-29-2431-01A-21-1560-20		TCGA-29-2431-01A-01R-1050-07		88be95fd-3aa9-4279-91ff-e705db3e187c				TCGA-29-2431-01A-01D-1526-09
TCGA-29-2432-01	1	TCGA-29-2432-01	653	1	High		OV-like c1	OV-like c4					TCGA-29-2432	653	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-29-2432-F27492	Stage IIIC	-22605		653	0	360		174				2010-6-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.3			G3	Recurrence				TCGA-29-2432.9de0ca7f-0603-46a9-9c69-7e2196cbfb6f.pdf					0	0			0	0	15	10	85	90	94	95		WITH TUMOR	YES	Progressive Disease			NO	R1	Primary Tumor	01	0.5			29	11-20 mm	Ovary		A	DECEASED	2008		TCGA-29-2432-01				a835eb6a-c37b-49de-bea5-9f9251f817a5			TCGA-29-2432-01A-01D-1047-05			TCGA-29-2432-01A-01D-1043-01	TCGA-29-2432-01	TCGA-29-2432-01A-01D-1043-01	7092999f-069f-439e-a1fb-dcfaff2b8292			7092999f-069f-439e-a1fb-dcfaff2b8292	TCGA-29-2432-01A-21-1560-20		TCGA-29-2432-01A-01R-1050-07		6fcda1cc-9224-452c-8fda-369e73f2f05e				TCGA-29-2432-01A-01D-1526-09
TCGA-29-2434-01	0	TCGA-29-2434-01	349	0	High		OV-like c1	OV-like c4					TCGA-29-2434	349	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Left	TCGA-29-2434-F27505	Stage IIIC	-18997			0	349						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G3					TCGA-29-2434.0891ac31-d9ed-4cb3-82ae-8499fb4c29ea.pdf					5	0			0	0	10	5	85	95	90	95		TUMOR FREE	YES	Complete Remission/Response			NO	R0	Primary Tumor	01	0.4			29	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-29-2434-01				9eb175cd-3311-4f57-a37a-7a2463bc58fb			TCGA-29-2434-01A-01D-1047-05			TCGA-29-2434-01A-01D-1043-01	TCGA-29-2434-01	TCGA-29-2434-01A-01D-1043-01	05b48ec8-6422-490b-b587-c376cb7d0475			05b48ec8-6422-490b-b587-c376cb7d0475	TCGA-29-2434-01A-21-1560-20		TCGA-29-2434-01A-01R-1050-07		7b45cfcd-a37c-4f92-b35f-e75ac6b1d000				TCGA-29-2434-01A-01D-1526-09
TCGA-29-2435-01	0	TCGA-29-2435-01	34	0				OV-like c4					TCGA-29-2435	34	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Left	TCGA-29-2435-F27510	Stage IV	-28779			0	34						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5			G3										0	0			0	0	5	1	95	99	95	99			YES					R1	Primary Tumor	01	0.3			29	11-20 mm	Ovary		A	LIVING	2009						84e1540d-c756-414e-92c9-3e0d5f45cd48													TCGA-29-2435-01A-21-1560-20								
TCGA-29-2436-01	0	TCGA-29-2436-01	297	0	COAD-READ		Low purity c2	OV-like c4					TCGA-29-2436	297	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			36	Bilateral	TCGA-29-2436-F27514	Stage IIIC	-13346			0	297						2010-6-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.3			G2					TCGA-29-2436.0caa891b-3d47-44c1-bc75-0468afc11495.pdf					0	0			0	0	10	5	90	95	95	99		TUMOR FREE	YES	Complete Remission/Response			NO	R0	Primary Tumor	01	0.4			29	1-10 mm	Ovary	YES	A	LIVING	2009		TCGA-29-2436-01				851a2dc8-da35-4a80-bcd1-1ed74ee459c7			TCGA-29-2436-01A-01D-1047-05			TCGA-29-2436-01A-01D-1043-01	TCGA-29-2436-01	TCGA-29-2436-01A-01D-1043-01	0631dead-bc69-486f-a288-dc1eb1d382f1			0631dead-bc69-486f-a288-dc1eb1d382f1	TCGA-29-2436-01A-21-1560-20		TCGA-29-2436-01A-01R-1050-07		e467e3e0-9311-48ff-8da8-f3b9118011e7				TCGA-29-2436-01A-01D-1526-09
TCGA-29-A5NZ-01	0	TCGA-29-A5NZ-01	640	0									TCGA-29-A5NZ	640	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			66			Stage IIIC	-24161	515		0	640						2013-8-20	FEMALE	Serous Cystadenocarcinoma	No	C48.1	8460/3	C48.1	YES		1040		NO					G3				true	TCGA-29-A5NZ.B7F69EE0-E844-434B-A76B-390590C85864.pdf		0		0		10		5		0		10		80		80					No				Primary Tumor	01				29		Ovary		A	LIVING	2011								TCGA-29-A5NZ-01A-11R-A407-13				TCGA-29-A5NZ-01A-11D-A402-01		TCGA-29-A5NZ-01A-11D-A402-01	e93181c8-807e-41c7-99a1-93c3eead37f7			e93181c8-807e-41c7-99a1-93c3eead37f7				TCGA-29-A5NZ-01A-11D-A409-05					
TCGA-30-1714-01	1	TCGA-30-1714-01	1158	1	High		OV-like c1			miRNA cluster 1	cluster 3		TCGA-30-1714	1158	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	68	Bilateral	TCGA-30-1714-F27518	Stage IV	-25032		1158	0	1158		241				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3	Recurrence				TCGA-30-1714.7bec7160-e40c-4b47-b0d6-93652c5e27f2.pdf					2	2			0	0	23	38	75	60	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary	NO	A	DECEASED	2001		TCGA-30-1714-01						TCGA-30-1714-01A-02R-1567-13	TCGA-30-1714-01A-02D-0563-05			TCGA-30-1714-01A-02D-0559-01	TCGA-30-1714-01	TCGA-30-1714-01A-02D-0559-01	3a5d57c7-62f9-48cc-9b9e-b8d437d7c86d			3a5d57c7-62f9-48cc-9b9e-b8d437d7c86d		TCGA-30-1714-01A-02R-1567-13	TCGA-30-1714-01A-02R-0566-07		9b91d688-3f05-43a9-8900-57027113b885		TCGA-30-1714-01A-02R-1567-13		TCGA-30-1714-01A-02W-0633-09
TCGA-30-1718-01	1	TCGA-30-1718-01	1579	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-30-1718	1579	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	44	Bilateral	TCGA-30-1718-F27534	Stage IIIC	-16400		1579	0	1579		896				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3		NO	G3	Recurrence				TCGA-30-1718.078da76a-b9f5-40d0-9a57-04c306ade36a.pdf					2	0			0	0	18	40	80	60	90	90		WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2002		TCGA-30-1718-01			5abce979-686d-40c4-acd7-ef9cc5acf26f	bd7cf7cb-3d3f-44ff-a0ad-f559a3d26370		TCGA-30-1718-01A-01R-1567-13	TCGA-30-1718-01A-01D-0563-05	TCGA-30-1718-01	TCGA-30-1718-01	TCGA-30-1718-01A-01D-0559-01	TCGA-30-1718-01	TCGA-30-1718-01A-01D-0559-01	eb5ed8b0-d282-45c0-b673-c2822ddff885	5abce979-686d-40c4-acd7-ef9cc5acf26f	5abce979-686d-40c4-acd7-ef9cc5acf26f	eb5ed8b0-d282-45c0-b673-c2822ddff885	TCGA-30-1718-01A-21-1559-20	TCGA-30-1718-01A-01R-1567-13	TCGA-30-1718-01A-01R-0566-07		f9ba9bc4-5591-4a79-b8ad-fee2f83ea724	5abce979-686d-40c4-acd7-ef9cc5acf26f	TCGA-30-1718-01A-01R-1567-13		TCGA-30-1718-01A-01W-0633-09
TCGA-30-1853-01	1	TCGA-30-1853-01	1103	1	High		OV-like c1			miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1853	1103	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-30-1853-F27542	Stage IIIC	-21404		1103	0	1103		634				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence				TCGA-30-1853.ded9ba4c-8d3d-450b-a345-772a3e3ae288.pdf					1	1			0	0	1	1	98	98	99	99		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary		A	DECEASED	2000		TCGA-30-1853-01		TCGA-30-1853-01A-02W-0699-08				TCGA-30-1853-01A-02R-1567-13	TCGA-30-1853-01A-02D-0652-05			TCGA-30-1853-01A-02D-0648-01	TCGA-30-1853-01	TCGA-30-1853-01A-02D-0648-01	d27694d2-11bd-4504-9546-564c20cb6832			d27694d2-11bd-4504-9546-564c20cb6832		TCGA-30-1853-01A-02R-1567-13	TCGA-30-1853-01A-02R-0655-07		549e923d-4430-4b66-8378-af96f66646b7		TCGA-30-1853-01A-02R-1567-13	TCGA-30-1853-01A-02W-0699-08	
TCGA-30-1855-01	1	TCGA-30-1855-01	75	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-30-1855	75	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			61		TCGA-30-1855-F27550	Stage IIIC	-22394		75	0	75						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3					TCGA-30-1855.cba111de-b005-4460-b4d1-d8b24126d1d3.pdf					0	0			0	0	10	40	90	60	95	70		WITH TUMOR	NO				NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2001		TCGA-30-1855-01			732d0664-c343-4a63-9dc3-40985e540a59	6b1438ab-2904-4d21-865d-f14c76777f62		TCGA-30-1855-01A-01R-1567-13	TCGA-30-1855-01A-01D-0581-05	TCGA-30-1855-01	TCGA-30-1855-01	TCGA-30-1855-01A-01D-0577-01	TCGA-30-1855-01	TCGA-30-1855-01A-01D-0577-01	de79be76-863b-4c72-ad38-06d081b65984	732d0664-c343-4a63-9dc3-40985e540a59	732d0664-c343-4a63-9dc3-40985e540a59	de79be76-863b-4c72-ad38-06d081b65984	TCGA-30-1855-01A-21-1559-20	TCGA-30-1855-01A-01R-1567-13	TCGA-30-1855-01A-01R-0584-07		b47399a9-31a2-4721-8da0-63bf21c6fcae	732d0664-c343-4a63-9dc3-40985e540a59	TCGA-30-1855-01A-01R-1567-13		TCGA-30-1855-01A-01W-0639-09
TCGA-30-1856-01	1	TCGA-30-1856-01	477	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-30-1856	477	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-30-1856-F27552	Stage IIIC	-20626		477	0	477		220				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence				TCGA-30-1856.281005d7-4231-467c-9c6c-43f536fcebe1.pdf					0	0			0	0	5	10	95	90	99	95		WITH TUMOR	YES	Partial Remission/Response		First Seen At Further Surgery	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2001		TCGA-30-1856-01				60d477e5-467d-4be3-b495-ed511519e4fa		TCGA-30-1856-01A-01R-1567-13	TCGA-30-1856-01A-01D-0581-05			TCGA-30-1856-01A-01D-0577-01	TCGA-30-1856-01	TCGA-30-1856-01A-01D-0577-01	d5d2efba-1f54-4de0-b6f0-69ae40f257f6			d5d2efba-1f54-4de0-b6f0-69ae40f257f6	TCGA-30-1856-01A-21-1559-20		TCGA-30-1856-01A-01R-0584-07		73874ff9-38f8-4a31-9ac1-923793b88b91				TCGA-30-1856-01A-01W-0639-09
TCGA-30-1857-01	1	TCGA-30-1857-01	8	1	Squamous		OV-like c1			miRNA cluster 3	cluster 6		TCGA-30-1857	8	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Right	TCGA-30-1857-F27564	Stage IV	-23689		8	0	8						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3																							WITH TUMOR	NO				NO		Primary Tumor	01				30		Ovary			DECEASED	2001		TCGA-30-1857-01						TCGA-30-1857-01A-02R-1569-13	TCGA-30-1857-01A-02D-0581-05			TCGA-30-1857-01A-02D-0577-01	TCGA-30-1857-01	TCGA-30-1857-01A-02D-0577-01	f729e6d0-2adf-4c44-b25e-99b5aff0b85f			f729e6d0-2adf-4c44-b25e-99b5aff0b85f			TCGA-30-1857-01A-02R-0584-07		bffff720-6d86-4661-9ae9-85605520064f				TCGA-30-1857-01A-02W-0639-09
TCGA-30-1859-01	1	TCGA-30-1859-01	1463	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 3		TCGA-30-1859	1463	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-30-1859-F27566		-20498		1463	0	1463	210		0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.3	NO		1			G3	Locoregional Disease	YES			TCGA-30-1859.6c4d66bc-361f-465f-b18a-7bb1a0fc7752.pdf					0	0			0	0	20	20	80	80	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary		A	DECEASED	2002		TCGA-30-1859-01				063c9971-7f3f-45f5-8f42-11b3eca461fa		TCGA-30-1859-01A-01R-1567-13	TCGA-30-1859-01A-01D-0652-05			TCGA-30-1859-01A-01D-0648-01	TCGA-30-1859-01	TCGA-30-1859-01A-01D-0648-01	c0cc1915-31e9-4ed6-bfc9-405b6a8d2f10			c0cc1915-31e9-4ed6-bfc9-405b6a8d2f10	TCGA-30-1859-01A-21-1559-20		TCGA-30-1859-01A-01R-0655-07		4618e0b6-9a8d-4843-a67f-a0b0de96b4ec				
TCGA-30-1860-01	1	TCGA-30-1860-01	1366	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6		TCGA-30-1860	1366	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	58	Bilateral	TCGA-30-1860-F27580	Stage IIIC	-21406		1366	0	1366		397				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.5		NO	G3	Recurrence				TCGA-30-1860.d5b8e59f-1ae5-4e22-b933-48e48a364788.pdf					10	0			0	0	5	10	85	90	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			30	>20 mm	Ovary	NO	A	DECEASED	2002		TCGA-30-1860-01			1b8eed7b-173e-4e38-80a4-a3a0aea469a1	5c4486d9-1d91-4f42-83fd-85526c4f0836		TCGA-30-1860-01A-01R-1568-13	TCGA-30-1860-01A-01D-0652-05	TCGA-30-1860-01	TCGA-30-1860-01	TCGA-30-1860-01A-01D-0648-01	TCGA-30-1860-01	TCGA-30-1860-01A-01D-0648-01	e6d4da43-aa9e-4f0c-9cfd-c281e41ac0ea	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	e6d4da43-aa9e-4f0c-9cfd-c281e41ac0ea	TCGA-30-1860-01A-21-1559-20	TCGA-30-1860-01A-01R-1568-13	TCGA-30-1860-01A-01R-0655-07		713acb94-3fd4-444d-ae04-e79c1ee73b3a	1b8eed7b-173e-4e38-80a4-a3a0aea469a1	TCGA-30-1860-01A-01R-1568-13		
TCGA-30-1861-01	1	TCGA-30-1861-01	1058	1	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-30-1861	1058	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Bilateral		Stage IIIC	-27103		1058	0	1058						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.8			G3					TCGA-30-1861.446be880-d1d8-4b63-b4d5-5aa0468ccafe.pdf					0	0			0	0	25	25	75	75	80	80									Primary Tumor	01	0.4			30	1-10 mm	Ovary		A	DECEASED	2002		TCGA-30-1861-01				7e253248-d889-4b00-a098-55cfcb18758b		TCGA-30-1861-01A-01R-1568-13	TCGA-30-1861-01A-01D-0652-05			TCGA-30-1861-01A-01D-0648-01	TCGA-30-1861-01	TCGA-30-1861-01A-01D-0648-01	4ae6e2e6-c949-4bd2-8258-156075a41920			4ae6e2e6-c949-4bd2-8258-156075a41920	TCGA-30-1861-01A-21-1559-20	TCGA-30-1861-01A-01R-1568-13	TCGA-30-1861-01A-01R-0655-07		617ac2af-9b70-4c2b-b659-02436e604267		TCGA-30-1861-01A-01R-1568-13		
TCGA-30-1862-01	1	TCGA-30-1862-01	186	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-30-1862	186	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			65		TCGA-30-1862-F27593	Stage IV	-23895		186	0	186						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO				NO	G2					TCGA-30-1862.a6b7b0c1-5954-487b-b27d-73850a08a194.pdf					0	0			0	0	30	40	70	60	80	70		WITH TUMOR	NO				NO		Primary Tumor	01				30	>20 mm	Ovary		A	DECEASED	2003		TCGA-30-1862-01		TCGA-30-1862-01A-02W-0699-08	ab0701bc-0bc5-4008-a75b-5f665ef9c14a			TCGA-30-1862-01A-02R-1568-13	TCGA-30-1862-01A-02D-0652-05	TCGA-30-1862-01	TCGA-30-1862-01	TCGA-30-1862-01A-02D-0648-01	TCGA-30-1862-01	TCGA-30-1862-01A-02D-0648-01	8e98ecf8-ef07-43bf-8dc3-9410eca8ab79	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	8e98ecf8-ef07-43bf-8dc3-9410eca8ab79		TCGA-30-1862-01A-02R-1568-13	TCGA-30-1862-01A-02R-0655-07		b1c27950-57b3-4a9e-96f6-5c7232951f1c	ab0701bc-0bc5-4008-a75b-5f665ef9c14a	TCGA-30-1862-01A-02R-1568-13		
TCGA-30-1866-01	1	TCGA-30-1866-01	1114	1	High		OV-like c1			miRNA cluster 2	cluster 1		TCGA-30-1866	1114	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-30-1866-F27595	Stage IV	-22562		1114	0	1114		285				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G2	Recurrence																						WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				30	1-10 mm	Ovary			DECEASED	2003		TCGA-30-1866-01						TCGA-30-1866-01A-02R-1568-13	TCGA-30-1866-01A-02D-0652-05			TCGA-30-1866-01A-02D-0648-01	TCGA-30-1866-01	TCGA-30-1866-01A-02D-0648-01	ba4acff6-1f39-4b71-9016-1138025e3165			ba4acff6-1f39-4b71-9016-1138025e3165		TCGA-30-1866-01A-02R-1568-13	TCGA-30-1866-01A-02R-0655-07		a334b0fd-05cc-4aa3-bbff-4439e2807085		TCGA-30-1866-01A-02R-1568-13		
TCGA-30-1867-01	1	TCGA-30-1867-01	37	1	High		OV-like c1			miRNA cluster 1	cluster 6		TCGA-30-1867	37	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46		TCGA-30-1867-F27605	Stage IV	-17159		37	0	37						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.1	YES	Tumor resection		0.3	NO		0.3			GX					TCGA-30-1867.420a6b8c-33b8-4b1e-8bba-e299c20611c7.pdf					0	0			0	0	30	25	70	75	80	80		WITH TUMOR	NO				NO		Primary Tumor	01	0.3			30		Ovary		A	DECEASED	2004		TCGA-30-1867-01						TCGA-30-1867-01A-01R-1568-13	TCGA-30-1867-01A-01D-0652-05			TCGA-30-1867-01A-01D-0648-01	TCGA-30-1867-01	TCGA-30-1867-01A-01D-0648-01	54dedb5e-643b-49fc-8225-4bd46bd46c82			54dedb5e-643b-49fc-8225-4bd46bd46c82			TCGA-30-1867-01A-01R-0655-07		105890a2-5198-4ecf-af7f-6538542dc162				
TCGA-30-1869-01	1	TCGA-30-1869-01	1563	1			OV-like c1	OV-like c4					TCGA-30-1869	1563	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	50	Bilateral	TCGA-30-1869-F27607	Stage IV	-18398		1563	0	1563		767				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection			NO				NO	G3	Recurrence				TCGA-30-1869.8d42d1a4-dff9-47a9-b95b-2eb27747308c.pdf					0	0			0		40		60		70	0		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				30	1-10 mm	Ovary		A	DECEASED	2004						014cbeef-19c7-4ac9-b9a0-5f95e07c5d45			TCGA-30-1869-01A-01D-0652-05										TCGA-30-1869-01A-21-1559-20								
TCGA-30-1880-01	1	TCGA-30-1880-01	1751	1	Squamous		Low purity c2			miRNA cluster 1	cluster 3		TCGA-30-1880	1751	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Bilateral	TCGA-30-1880-F27620	Stage IIIC	-20525		1751	0	1751		348				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1		NO	G3	Recurrence				TCGA-30-1880.D23622FE-9648-422D-AE92-B21F9B6E5A51.pdf					1	0			0	0	10	1	89	99	90	99		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			30	No Macroscopic disease	Ovary		A	DECEASED	2001		TCGA-30-1880-01						TCGA-30-1880-01A-01R-1568-13	TCGA-30-1880-01A-01D-0652-05			TCGA-30-1880-01A-01D-0648-01	TCGA-30-1880-01	TCGA-30-1880-01A-01D-0648-01	aa5c6912-345d-432f-a1a7-caf8d6237b9a			aa5c6912-345d-432f-a1a7-caf8d6237b9a			TCGA-30-1880-01A-01R-0655-07		2d39ca81-8c8c-43ab-b065-38627152d132				
TCGA-30-1887-01	1	TCGA-30-1887-01	738	1	High		OV-like c1	OV-like c4		miRNA cluster 2	cluster 6		TCGA-30-1887	738	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-30-1887-F27633	Stage IIIC	-24495		738	0	738						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1		YES	G2					TCGA-30-1887.a074363f-dd94-4193-b583-70885400ff2f.pdf					5	0			0	0	15	10	80	90	80	90		WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.5			30	1-10 mm	Ovary	YES	A	DECEASED	2005		TCGA-30-1887-01				e26411ea-dc83-4441-a0f4-84fd52798fdd		TCGA-30-1887-01A-01R-1568-13	TCGA-30-1887-01A-01D-0652-05			TCGA-30-1887-01A-01D-0648-01	TCGA-30-1887-01	TCGA-30-1887-01A-01D-0648-01	c7553a24-4cdc-42d7-9af7-8c4e1dc88e3b			c7553a24-4cdc-42d7-9af7-8c4e1dc88e3b	TCGA-30-1887-01A-21-1559-20		TCGA-30-1887-01A-01R-0655-07		1065d480-5815-40a4-93c6-faa8712a1e94				
TCGA-30-1891-01	1	TCGA-30-1891-01	914	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-30-1891	914	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-30-1891-F27640	Stage IIIC	-22344		914	0	914		181				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2		NO	G2	Recurrence				TCGA-30-1891.F2E0C289-3ED3-4876-8BFA-A447AB1DBB2B.pdf					15	10			0	0	20	20	65	70	80	80		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			30	1-10 mm	Ovary	NO	A	DECEASED	2004		TCGA-30-1891-01		TCGA-30-1891-01A-01W-0699-08	690d1437-2a05-4263-8fa7-8f4481893b83	7f8386ef-cf19-4207-86ae-13029c49d944		TCGA-30-1891-01A-01R-1568-13	TCGA-30-1891-01A-01D-0652-05	TCGA-30-1891-01	TCGA-30-1891-01	TCGA-30-1891-01A-01D-0648-01	TCGA-30-1891-01	TCGA-30-1891-01A-01D-0648-01	3d12d22b-4400-4141-9ee8-111bd81681ab	690d1437-2a05-4263-8fa7-8f4481893b83	690d1437-2a05-4263-8fa7-8f4481893b83	3d12d22b-4400-4141-9ee8-111bd81681ab	TCGA-30-1891-01A-21-1559-20	TCGA-30-1891-01A-01R-1568-13	TCGA-30-1891-01A-01R-0655-07		d97a0c15-2c1d-4af3-9e62-ff67cbf7b700	690d1437-2a05-4263-8fa7-8f4481893b83	TCGA-30-1891-01A-01R-1568-13		
TCGA-30-1892-01	1	TCGA-30-1892-01	1484	1	Squamous		OV-like c1	OV-like c4		miRNA cluster 3	cluster 6		TCGA-30-1892	1484	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	52	Left	TCGA-30-1892-F27654	Stage IIIC	-19256		1484	0	1484		253				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2			G3	Recurrence				TCGA-30-1892.fb7c966c-9b16-4781-9c01-2db480c88d63.pdf					10	10			0	0	20	10	70	80	80	90		WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO		Primary Tumor	01	0.3			30	1-10 mm	Ovary		A	DECEASED	2004		TCGA-30-1892-01				3c68d944-a329-44c2-8697-2f8c50a8b38c		TCGA-30-1892-01A-01R-1568-13	TCGA-30-1892-01A-01D-0652-05			TCGA-30-1892-01A-01D-0648-01	TCGA-30-1892-01	TCGA-30-1892-01A-01D-0648-01	e4d8afcf-21af-4406-bc25-ff15f9c85107			e4d8afcf-21af-4406-bc25-ff15f9c85107	TCGA-30-1892-01A-21-1559-20	TCGA-30-1892-01A-01R-1568-13	TCGA-30-1892-01A-01R-0655-07		e969eb72-cef5-4c16-b1fd-8a97324ce3e4		TCGA-30-1892-01A-01R-1568-13		
TCGA-31-1944-01	0	TCGA-31-1944-01	1386	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-31-1944	1386	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-31-1944-F27668	Stage IIIC	-17207			0	1386		678				2009-10-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence				TCGA-31-1944.bd7361f7-07c1-4be8-92c6-4f0a3dea99b2.pdf					3	5			0	0	27	20	70	70	95	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2005		TCGA-31-1944-01			c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	332735d2-c077-400a-b011-1f0984b07339		TCGA-31-1944-01A-01R-1568-13	TCGA-31-1944-01A-01D-0652-05	TCGA-31-1944-01	TCGA-31-1944-01	TCGA-31-1944-01A-01D-0648-01	TCGA-31-1944-01	TCGA-31-1944-01A-01D-0648-01	26cb4901-7bc2-4f43-8c4e-fb2d1f3b48ff	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	26cb4901-7bc2-4f43-8c4e-fb2d1f3b48ff	TCGA-31-1944-01A-21-1559-20	TCGA-31-1944-01A-01R-1568-13	TCGA-31-1944-01A-01R-0655-07		b9b5c6a5-cbc8-4645-9ce1-131c26e36683	c8a1ec95-a4b3-4fb2-b135-1c7616db9ab2	TCGA-31-1944-01A-01R-1568-13		
TCGA-31-1946-01	0	TCGA-31-1946-01	918	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-31-1946	918	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	30	Bilateral	TCGA-31-1946-F27679	Stage IIIC	-11146			0	918		664				2009-10-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1		NO	G3	Recurrence				TCGA-31-1946.5ef31a8f-38e7-486b-8efc-99cd8c1ec06d.pdf					5	2			0	0	40	13	55	85	85	85		WITH TUMOR	YES			Physical Examination	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2006		TCGA-31-1946-01				fb44d557-9e0a-40d5-83c3-3b9431e72d9d		TCGA-31-1946-01A-01R-1568-13	TCGA-31-1946-01A-01D-0652-05			TCGA-31-1946-01A-01D-0648-01	TCGA-31-1946-01	TCGA-31-1946-01A-01D-0648-01	877c9240-32e0-43f3-9dfd-b4466e054bc7			877c9240-32e0-43f3-9dfd-b4466e054bc7	TCGA-31-1946-01A-21-1559-20	TCGA-31-1946-01A-01R-1568-13	TCGA-31-1946-01A-01R-0655-07		fb4cc131-9ac0-4615-b8c1-802273c4c6cf		TCGA-31-1946-01A-01R-1568-13		
TCGA-31-1950-01	0	TCGA-31-1950-01	571	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1950	571	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76	Bilateral	TCGA-31-1950-F27688	Stage IIIC	-28100			0	571		349	1			2009-10-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2		NO	G2	Recurrence				TCGA-31-1950.4ed80cbd-e56d-4d09-b8ac-2b6535346b73.pdf					2	5			0	0	85	15	13	80	85	85	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			31	1-10 mm	Ovary	NO	A	LIVING	2007		TCGA-31-1950-01		TCGA-31-1950-01A-01W-0699-08	a32eba80-dbe9-464e-8102-5f77a3c7e177	6f927c4d-19b8-4bc9-92eb-da2402ed6e31		TCGA-31-1950-01A-01R-1568-13	TCGA-31-1950-01A-01D-0652-05			TCGA-31-1950-01A-01D-0648-01	TCGA-31-1950-01	TCGA-31-1950-01A-01D-0648-01	cccc4e19-6828-4a2a-bc10-5458f4221229	a32eba80-dbe9-464e-8102-5f77a3c7e177	a32eba80-dbe9-464e-8102-5f77a3c7e177	cccc4e19-6828-4a2a-bc10-5458f4221229	TCGA-31-1950-01A-21-1559-20	TCGA-31-1950-01A-01R-1568-13	TCGA-31-1950-01A-01R-0655-07		72689370-cb7a-4e3b-8964-2dcde6633902	a32eba80-dbe9-464e-8102-5f77a3c7e177	TCGA-31-1950-01A-01R-1568-13	TCGA-31-1950-01A-01W-0699-08	
TCGA-31-1951-01	0	TCGA-31-1951-01	684	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-31-1951	684	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Left	TCGA-31-1951-F27692	Stage IIIC	-21352			0	684		659				2010-1-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.7		YES	G3	Recurrence				TCGA-31-1951.b10efe75-1420-47d2-9c5b-202b09099357.pdf					2	1			0	0	18	19	90	80	90	95		WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.3			31	No Macroscopic disease	Ovary	YES	A	LIVING	2007		TCGA-31-1951-01			197ea6b5-5716-4e5c-9c7f-92ed4521682a	a6bb52ad-58cf-4ee0-ae89-9615811f4de6		TCGA-31-1951-01A-01R-1568-13	TCGA-31-1951-01A-01D-0652-05	TCGA-31-1951-01	TCGA-31-1951-01	TCGA-31-1951-01A-01D-0648-01	TCGA-31-1951-01	TCGA-31-1951-01A-01D-0648-01	32f2ebdc-08fd-4130-a2b2-8a3b054846c4	197ea6b5-5716-4e5c-9c7f-92ed4521682a	197ea6b5-5716-4e5c-9c7f-92ed4521682a	32f2ebdc-08fd-4130-a2b2-8a3b054846c4	TCGA-31-1951-01A-21-1559-20	TCGA-31-1951-01A-01R-1568-13	TCGA-31-1951-01A-01R-0655-07		c9806ee2-6323-4078-bfc0-6fc773a7f66e	197ea6b5-5716-4e5c-9c7f-92ed4521682a	TCGA-31-1951-01A-01R-1568-13		
TCGA-31-1953-01	0	TCGA-31-1953-01	204	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-31-1953	204	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	52	Bilateral	TCGA-31-1953-F27698	Stage IIIC	-19064			0	204		70	1			2009-10-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		NO	G3	Recurrence				TCGA-31-1953.c824400d-b062-4a04-b805-f717426d688e.pdf	3	1			0	2			0	0	10	8	90	90	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.1			31		Ovary	NO	A	LIVING	2008		TCGA-31-1953-01		TCGA-31-1953-01A-01W-0699-08	7b31fc47-0299-4449-aa5b-622ba549371f			TCGA-31-1953-01A-01R-1568-13	TCGA-31-1953-01A-01D-0652-05	TCGA-31-1953-01	TCGA-31-1953-01	TCGA-31-1953-01A-01D-0648-01	TCGA-31-1953-01	TCGA-31-1953-01A-01D-0648-01	ac9b9cbc-04ee-47e8-aaf3-9166bb74b52a	7b31fc47-0299-4449-aa5b-622ba549371f	7b31fc47-0299-4449-aa5b-622ba549371f	ac9b9cbc-04ee-47e8-aaf3-9166bb74b52a		TCGA-31-1953-01A-01R-1568-13	TCGA-31-1953-01A-01R-0655-07		b3f75e69-3519-46eb-821c-773c2506d7fd	7b31fc47-0299-4449-aa5b-622ba549371f	TCGA-31-1953-01A-01R-1568-13		
TCGA-31-1955-01	0	TCGA-31-1955-01	1293	0	Squamous		OV-like c1	OV-like c4					TCGA-31-1955	1293	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	43	Bilateral	TCGA-31-1955-F27704	Stage IIIC	-15926			0	1293		918				2009-10-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.4		NO	G3	Recurrence				TCGA-31-1955.16f5a24e-2c57-42fe-bd79-ef174d44b8b1.pdf	3	1			2	5			0	0	15	10	83	85	90	90		WITH TUMOR	YES			Physical Examination	YES		Primary Tumor	01	0.4			31	No Macroscopic disease	Ovary	YES	A	LIVING	2005		TCGA-31-1955-01				47461ed4-1491-4f27-bd9c-cbd1ee184f5a			TCGA-31-1955-01A-01D-0652-05			TCGA-31-1955-01A-01D-0648-01	TCGA-31-1955-01	TCGA-31-1955-01A-01D-0648-01	149d892e-9687-4e7b-a825-7375f6c1704d			149d892e-9687-4e7b-a825-7375f6c1704d	TCGA-31-1955-01A-21-1559-20		TCGA-31-1955-01A-01R-0655-07						
TCGA-31-1956-01	0	TCGA-31-1956-01	1342	0	Squamous		OV-like c1		OV-like c16	miRNA cluster 3	cluster 6		TCGA-31-1956	1342	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Left	TCGA-31-1956-F27711	Stage IIIB	-22100			0	1342	119					2009-10-19	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G3	Locoregional Disease	YES			TCGA-31-1956.3646c24b-c4b7-400b-bc93-7ef485c6892c.pdf		5		3	2	5			0	0	18	45	80	50	90	85		WITH TUMOR	YES				NO		Primary Tumor	01	0.2			31		Ovary	NO	A	LIVING	2005		TCGA-31-1956-01			24cfcfd9-ce30-4e24-9470-60265efd6721			TCGA-31-1956-01A-01R-1568-13	TCGA-31-1956-01A-01D-0652-05	TCGA-31-1956-01	TCGA-31-1956-01	TCGA-31-1956-01A-01D-0648-01	TCGA-31-1956-01	TCGA-31-1956-01A-01D-0648-01	e36080ab-77a2-4c42-91c4-64e38c7a5c49	24cfcfd9-ce30-4e24-9470-60265efd6721	24cfcfd9-ce30-4e24-9470-60265efd6721	e36080ab-77a2-4c42-91c4-64e38c7a5c49		TCGA-31-1956-01A-01R-1568-13	TCGA-31-1956-01A-01R-0655-07		c6dcadc5-be05-4d61-b82a-bc5111fb2634	24cfcfd9-ce30-4e24-9470-60265efd6721	TCGA-31-1956-01A-01R-1568-13		
TCGA-31-1959-01	0	TCGA-31-1959-01	67	0	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-31-1959	67	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Bilateral	TCGA-31-1959-F27715	Stage IV	-18247			0	67						2009-10-20	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Excisional Biopsy		0.7	NO		1.1		YES	G2					TCGA-31-1959.c78c6998-1f86-4dd2-bf41-78f12d43c33a.pdf	2	2			0	3			0	0	40	37	60	60	70	75		WITH TUMOR	YES				NO		Primary Tumor	01	0.2			31		Ovary	YES	A	LIVING	2009		TCGA-31-1959-01		TCGA-31-1959-01A-01W-0699-08				TCGA-31-1959-01A-01R-1568-13	TCGA-31-1959-01A-01D-0652-05			TCGA-31-1959-01A-01D-0648-01	TCGA-31-1959-01	TCGA-31-1959-01A-01D-0648-01	71d66a83-6c0b-4d65-bfc1-39c00b4d09cf			71d66a83-6c0b-4d65-bfc1-39c00b4d09cf		TCGA-31-1959-01A-01R-1568-13	TCGA-31-1959-01A-01R-0655-07		427e1629-b22d-4421-b6f5-ffbd672fd164		TCGA-31-1959-01A-01R-1568-13		
TCGA-36-1568-01	0	TCGA-36-1568-01	875	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1568	875	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	52	Bilateral	TCGA-36-1568-F27850	Stage IIIC	-19311			0	875		548				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.6		NO	G3	Recurrence				TCGA-36-1568.dad4bbdc-0156-48c2-a975-27ccfb9152a3.pdf					0	0			0	0	5	5	95	95	95	95		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			36		Ovary		A	LIVING	2007	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01	TCGA-36-1568-01A-01W-0615-10	TCGA-36-1568-01A-01W-0615-10	4e539c62-454a-4b1c-bde1-6951ee12d109	b9598717-cdb9-49e1-a8d5-49ec5189cb31		TCGA-36-1568-01A-01R-1566-13	TCGA-36-1568-01A-01D-0536-05	TCGA-36-1568-01	TCGA-36-1568-01	TCGA-36-1568-01A-01D-0533-01	TCGA-36-1568-01	TCGA-36-1568-01A-01D-0533-01	d99f3cec-5a1f-451a-b6e2-2de44f57a4ae	4e539c62-454a-4b1c-bde1-6951ee12d109	4e539c62-454a-4b1c-bde1-6951ee12d109	d99f3cec-5a1f-451a-b6e2-2de44f57a4ae	TCGA-36-1568-01A-21-1558-20	TCGA-36-1568-01A-01R-1566-13	TCGA-36-1568-01A-01R-0540-07		cde7f1d6-c4c9-4fc3-a6cf-696addee91d6	4e539c62-454a-4b1c-bde1-6951ee12d109	TCGA-36-1568-01A-01R-1566-13		
TCGA-36-1569-01	0	TCGA-36-1569-01	885	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1569	885	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-36-1569-F27855	Stage IIIC	-19151			0	885			0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.6		YES	G3										0	0			0	0	10	10	90	90	90	90	Pre-Operative		YES	Partial Remission/Response			NO		Primary Tumor	01	0.4			36	1-10 mm	Ovary		A	LIVING	2007	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01	TCGA-36-1569-01A-01W-0615-10	TCGA-36-1569-01A-01W-0615-10		44783ce8-15cb-45b3-9a4f-e45925356334		TCGA-36-1569-01A-01R-1566-13	TCGA-36-1569-01A-01D-0536-05			TCGA-36-1569-01A-01D-0533-01	TCGA-36-1569-01	TCGA-36-1569-01A-01D-0533-01	03d26103-3b2a-41e4-a9bb-1d34807b1c1f			03d26103-3b2a-41e4-a9bb-1d34807b1c1f	TCGA-36-1569-01A-21-1558-20	TCGA-36-1569-01A-01R-1566-13	TCGA-36-1569-01A-01R-0540-07		3ae2deaa-bc6d-4b38-b9ea-56e91c83b53a		TCGA-36-1569-01A-01R-1566-13		
TCGA-36-1570-01	0	TCGA-36-1570-01	655	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-36-1570	655	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-36-1570-F27857	Stage IIIC	-17956			0	655		375	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.3		YES	G3	Recurrence				TCGA-36-1570.f83833f4-a820-4fb9-a040-c238084976c3.pdf					1	1			0	0	5	5	94	94	95	95	Pre-Operative	WITH TUMOR	YES	Partial Remission/Response		Physical Examination	NO		Primary Tumor	01	0.7			36	>20 mm	Ovary	YES	A	LIVING	2007	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01	TCGA-36-1570-01A-01W-0615-10	TCGA-36-1570-01A-01W-0615-10	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	0bd6d1dc-2f53-479b-bbaa-ef70250341a2		TCGA-36-1570-01A-01R-1566-13	TCGA-36-1570-01A-01D-0536-05	TCGA-36-1570-01	TCGA-36-1570-01	TCGA-36-1570-01A-01D-0533-01	TCGA-36-1570-01	TCGA-36-1570-01A-01D-0533-01	e55ec846-0a70-46ec-94c1-8be4a58f82f8	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	e55ec846-0a70-46ec-94c1-8be4a58f82f8	TCGA-36-1570-01A-21-1558-20	TCGA-36-1570-01A-01R-1566-13	TCGA-36-1570-01A-01R-0540-07		2893bba4-3d68-4a21-97d6-51342437a657	cd799c12-6a2b-4f7a-af72-f4bd7f69f6c7	TCGA-36-1570-01A-01R-1566-13		
TCGA-36-1571-01	1	TCGA-36-1571-01	695	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-36-1571	695	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-36-1571-F27862	Stage IIIB	-19608		695	0	695		375				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		NO	G3	Recurrence				TCGA-36-1571.cee6fb75-8fcc-4347-824e-b00b96e6e481.pdf					0	1			0	0	5	5	95	94	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.9			36	No Macroscopic disease	Ovary	NO	A	DECEASED	2007	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01	TCGA-36-1571-01A-01W-0615-10	TCGA-36-1571-01A-01W-0615-10	55c68aef-938c-4f68-a74d-f408673fff9c	8add1736-9ac5-4d0e-9969-7ea6ffaf635c		TCGA-36-1571-01A-01R-1566-13	TCGA-36-1571-01A-01D-0536-05	TCGA-36-1571-01	TCGA-36-1571-01	TCGA-36-1571-01A-01D-0533-01	TCGA-36-1571-01	TCGA-36-1571-01A-01D-0533-01	63eb62f1-969d-49a9-963a-af10e9e878cf	55c68aef-938c-4f68-a74d-f408673fff9c	55c68aef-938c-4f68-a74d-f408673fff9c	63eb62f1-969d-49a9-963a-af10e9e878cf	TCGA-36-1571-01A-21-1558-20	TCGA-36-1571-01A-01R-1566-13	TCGA-36-1571-01A-01R-0540-07		62f86b95-1bfe-4123-8f09-311c9c826de0	55c68aef-938c-4f68-a74d-f408673fff9c	TCGA-36-1571-01A-01R-1566-13		
TCGA-36-1574-01	0	TCGA-36-1574-01	686	0	Squamous	C9-OV	Low purity c2		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 5	TCGA-36-1574	686	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	48	Bilateral	TCGA-36-1574-F27868	Stage IIIC	-17847			0	686		648	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Recurrence																					Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				36	>20 mm	Ovary			LIVING	2007	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01	TCGA-36-1574-01A-01W-0615-10	TCGA-36-1574-01A-01W-0615-10	ff781a4f-7281-4195-880f-3df099a401cc			TCGA-36-1574-01A-01R-1566-13	TCGA-36-1574-01A-01D-0536-05	TCGA-36-1574-01	TCGA-36-1574-01	TCGA-36-1574-01A-01D-0533-01	TCGA-36-1574-01	TCGA-36-1574-01A-01D-0533-01	a42c583f-320d-4082-bd9f-c1961aef2127	ff781a4f-7281-4195-880f-3df099a401cc	ff781a4f-7281-4195-880f-3df099a401cc	a42c583f-320d-4082-bd9f-c1961aef2127		TCGA-36-1574-01A-01R-1566-13	TCGA-36-1574-01A-01R-0540-07		d83bcf90-4a10-4318-ac80-4ae41ea88894	ff781a4f-7281-4195-880f-3df099a401cc	TCGA-36-1574-01A-01R-1566-13		
TCGA-36-1575-01	0	TCGA-36-1575-01	260	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1575	260	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			83		TCGA-36-1575-F27872	Stage IIIB	-30592			0	260						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6		NO	G3					TCGA-36-1575.44cf8eee-71b1-4499-815a-7d1c3092dbe3.pdf					5	5			15	0	5	10	80	85	95	95		TUMOR FREE	YES				NO		Primary Tumor	01	0.4			36	No Macroscopic disease	Ovary	NO	A	LIVING	2006	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01	TCGA-36-1575-01A-01W-0615-10	TCGA-36-1575-01A-01W-0615-10	a28ef775-c78b-416f-afeb-89ba265440f0	ba2a2d99-a0a6-4d8d-a207-d1a82501f18d		TCGA-36-1575-01A-01R-1566-13	TCGA-36-1575-01A-01D-0536-05	TCGA-36-1575-01	TCGA-36-1575-01	TCGA-36-1575-01A-01D-0533-01	TCGA-36-1575-01	TCGA-36-1575-01A-01D-0533-01	087e0085-480e-4f55-afa6-d48b2b42a960	a28ef775-c78b-416f-afeb-89ba265440f0	a28ef775-c78b-416f-afeb-89ba265440f0	087e0085-480e-4f55-afa6-d48b2b42a960	TCGA-36-1575-01A-21-1558-20	TCGA-36-1575-01A-01R-1566-13	TCGA-36-1575-01A-01R-0540-07		fb275fb0-6793-4401-99a0-5d3bdf2a7ac0	a28ef775-c78b-416f-afeb-89ba265440f0	TCGA-36-1575-01A-01R-1566-13		
TCGA-36-1576-01	0	TCGA-36-1576-01	915	0	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-36-1576	915	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76		TCGA-36-1576-F27874	Stage IIIC	-27778			0	915		817	2			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2.6		YES	G3	Recurrence				TCGA-36-1576.2eb0b46a-ecd3-43b4-bfc2-e1c5e6101d1f.pdf					2	2			0	0	10	10	88	88	95	95	Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			36	>20 mm	Ovary	YES	A	LIVING	2006	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01	TCGA-36-1576-01A-01W-0615-10	TCGA-36-1576-01A-01W-0615-10		e1158086-b305-4b38-8ebe-43bd33c73952		TCGA-36-1576-01A-01R-1566-13	TCGA-36-1576-01A-01D-0536-05			TCGA-36-1576-01A-01D-0533-01	TCGA-36-1576-01	TCGA-36-1576-01A-01D-0533-01	18f46108-26bb-42a2-802f-2205ae194d39			18f46108-26bb-42a2-802f-2205ae194d39	TCGA-36-1576-01A-21-1558-20	TCGA-36-1576-01A-01R-1566-13	TCGA-36-1576-01A-01R-0540-07		15528051-b343-4e7d-9433-b9fc052e7d77		TCGA-36-1576-01A-01R-1566-13		
TCGA-36-1577-01	0	TCGA-36-1577-01	783	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-36-1577	783	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			43	Bilateral	TCGA-36-1577-F27878	Stage IIC	-15804			0	783						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		1.7			G2					TCGA-36-1577.0c55b26c-ccf8-4223-9f5e-157bbdf6e5dc.pdf					10	5			0	0	40	50	50	45	70	70		TUMOR FREE	YES	Complete Remission/Response			YES		Primary Tumor	01	0.6			36	No Macroscopic disease	Ovary		A	LIVING	2007	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01	TCGA-36-1577-01A-01W-0615-10	TCGA-36-1577-01A-01W-0615-10	9ec93bbd-5c62-4974-984f-f86301f0d27e	ec733c30-ab8b-454e-88f9-8ee34bcf0416		TCGA-36-1577-01A-01R-1566-13	TCGA-36-1577-01A-01D-0536-05	TCGA-36-1577-01	TCGA-36-1577-01	TCGA-36-1577-01A-01D-0533-01	TCGA-36-1577-01	TCGA-36-1577-01A-01D-0533-01	15fec2b6-ee7a-4675-b551-fd523a5612c6	9ec93bbd-5c62-4974-984f-f86301f0d27e	9ec93bbd-5c62-4974-984f-f86301f0d27e	15fec2b6-ee7a-4675-b551-fd523a5612c6	TCGA-36-1577-01A-21-1558-20	TCGA-36-1577-01A-01R-1566-13	TCGA-36-1577-01A-01R-0540-07		ea44120c-4ba1-426a-a989-11ce1ca54e15	9ec93bbd-5c62-4974-984f-f86301f0d27e	TCGA-36-1577-01A-01R-1566-13		
TCGA-36-1578-01	0	TCGA-36-1578-01	847	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-36-1578	847	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63		TCGA-36-1578-F27884	Stage IV	-23329			0	847		310	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.6			G3	Recurrence									2	2			0	0	8	8	90	90	95	95	Pre-Operative	WITH TUMOR	YES			Imaging Study	NO		Primary Tumor	01	0.5			36	>20 mm	Ovary	NO	A	LIVING	2007	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01	TCGA-36-1578-01A-01W-0615-10	TCGA-36-1578-01A-01W-0615-10	7ecb58fe-e2fe-4dc8-996b-2b959da43566	cb41005f-cf76-417e-9ce8-8b5d3047609c		TCGA-36-1578-01A-01R-1566-13	TCGA-36-1578-01A-01D-0536-05	TCGA-36-1578-01	TCGA-36-1578-01	TCGA-36-1578-01A-01D-0533-01	TCGA-36-1578-01	TCGA-36-1578-01A-01D-0533-01	236d5b82-7332-40a1-aadc-158e8302b923	7ecb58fe-e2fe-4dc8-996b-2b959da43566	7ecb58fe-e2fe-4dc8-996b-2b959da43566	236d5b82-7332-40a1-aadc-158e8302b923	TCGA-36-1578-01A-21-1558-20	TCGA-36-1578-01A-01R-1566-13	TCGA-36-1578-01A-01R-0540-07		644de2b8-bb23-4161-b6dc-dbb926d573f0	7ecb58fe-e2fe-4dc8-996b-2b959da43566	TCGA-36-1578-01A-01R-1566-13		
TCGA-36-1580-01	1	TCGA-36-1580-01	737	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-36-1580	737	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	82		TCGA-36-1580-F27889	Stage IIIC	-29992		737	0	737		440	1			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C48.1	YES	Cytology (e.g. Peritoneal or pleural fluid)		1	NO		2			G3	Recurrence				TCGA-36-1580.a647e4da-8579-4848-b545-bc857db85d98.pdf					10	5			0	0	45	40	45	55	70	70	Pre-Operative	WITH TUMOR	YES			Physical Examination	NO		Primary Tumor	01	0.4			36	>20 mm	Ovary		A	DECEASED	2007	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01	TCGA-36-1580-01A-01W-0615-10	TCGA-36-1580-01A-01W-0615-10	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	1d325272-4508-4a42-97ba-9e59edf59993		TCGA-36-1580-01A-01R-1566-13	TCGA-36-1580-01A-01D-0536-05	TCGA-36-1580-01	TCGA-36-1580-01	TCGA-36-1580-01A-01D-0533-01	TCGA-36-1580-01	TCGA-36-1580-01A-01D-0533-01	f14c674a-b25b-4929-b28b-4ba9ff78eb17	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	f14c674a-b25b-4929-b28b-4ba9ff78eb17	TCGA-36-1580-01A-21-1558-20	TCGA-36-1580-01A-01R-1566-13	TCGA-36-1580-01A-01R-0540-07		2b7461a0-84ad-4a91-b136-395c33f059fc	6a101b07-3cc5-4da3-90ab-0e45fa5b9cd3	TCGA-36-1580-01A-01R-1566-13		
TCGA-36-1581-01	0	TCGA-36-1581-01	751	0	High	C1-LUAD-enriched	Cluster 5	BRCA basal-like c6	OV-like c16	miRNA cluster 2	cluster 6		TCGA-36-1581	751	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Left	TCGA-36-1581-F27893	Stage IIC	-23272			0	751		702	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G3	Recurrence																					Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01				36	No Macroscopic disease	Ovary			LIVING	2007		TCGA-36-1581-01			d84c76a9-dbee-4720-8639-91382101b27a	c3ce568b-8558-45db-97b4-23882e482cbf		TCGA-36-1581-01A-01R-1566-13	TCGA-36-1581-01A-01D-0536-05	TCGA-36-1581-01	TCGA-36-1581-01	TCGA-36-1581-01A-01D-0533-01	TCGA-36-1581-01	TCGA-36-1581-01A-01D-0533-01	c59f2d68-22fb-496c-831a-17d42785f815	d84c76a9-dbee-4720-8639-91382101b27a	d84c76a9-dbee-4720-8639-91382101b27a	c59f2d68-22fb-496c-831a-17d42785f815	TCGA-36-1581-01A-03-1563-20	TCGA-36-1581-01A-01R-1566-13	TCGA-36-1581-01A-01R-0540-07		ba4c8ab9-f8ee-48ab-a513-ab43f71b8723	d84c76a9-dbee-4720-8639-91382101b27a	TCGA-36-1581-01A-01R-1566-13		
TCGA-36-2529-01	0	TCGA-36-2529-01	1066	0	High		OV-like c1	OV-like c4					TCGA-36-2529	1066	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-36-2529-F27897	Stage IIIC	-26092			0	1066		567	0			2010-8-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8441/3	C56.9	YES	Tumor resection								G3	Recurrence																					Pre-Adjuvant Therapy	WITH TUMOR	YES	Complete Remission/Response		Physical Examination	NO	R1	Primary Tumor	01				36	>20 mm	Peritoneum ovary			LIVING	2007		TCGA-36-2529-01				a954f069-3088-49e6-839f-d823017cfa40			TCGA-36-2529-01A-01D-1047-05			TCGA-36-2529-01A-01D-1043-01	TCGA-36-2529-01	TCGA-36-2529-01A-01D-1043-01	f043caa4-0483-42a6-8627-e161e1941695			f043caa4-0483-42a6-8627-e161e1941695	TCGA-36-2529-01A-21-1560-20		TCGA-36-2529-01A-01R-1050-07		d63b58d4-56b8-4879-b103-74cb3f92c242				
TCGA-36-2530-01	0	TCGA-36-2530-01	1004	0	Squamous			OV-like c4					TCGA-36-2530	1004	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	38	Bilateral	TCGA-36-2530-F27906	Stage IIIC	-13885			0	1004		630				2010-8-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		2.5		NO	G3	Recurrence				TCGA-36-2530.41402b2e-81d6-4914-b655-c97c3538e3f7.pdf					5	5			0	0	5	7	90	88	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.7			36	11-20 mm	Ovary		A	LIVING	2007		TCGA-36-2530-01				ae583504-181e-4199-a79c-8fd11d3c99af						TCGA-36-2530-01A-01D-1043-01	TCGA-36-2530-01	TCGA-36-2530-01A-01D-1043-01	5f315a27-e7d5-4c73-86d6-f377d6debab6			5f315a27-e7d5-4c73-86d6-f377d6debab6	TCGA-36-2530-01A-21-1560-20		TCGA-36-2530-01A-01R-1050-07		f4fa786b-3eaf-45ab-9d3e-4cf7ec61de3c				TCGA-36-2530-01A-01D-1526-09
TCGA-36-2532-01	0	TCGA-36-2532-01	897	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2532	897	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			61	Bilateral	TCGA-36-2532-F27913	Stage IIIC	-22333			0	897						2010-8-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		2.7		YES	G3					TCGA-36-2532.d99b756c-2a3c-48cd-844e-ce61f811c3a0.pdf					3	5			0	0	5	10	92	85	90	90		WITH TUMOR	YES				NO	R0	Primary Tumor	01	0.7			36	No Macroscopic disease	Ovary	YES	A	LIVING	2007		TCGA-36-2532-01				0ee5a901-a30a-493d-895a-6e674967a5eb			TCGA-36-2532-01A-01D-1047-05			TCGA-36-2532-01A-01D-1043-01	TCGA-36-2532-01	TCGA-36-2532-01A-01D-1043-01	e610d760-7a91-41f9-aac6-4981ce6e54eb			e610d760-7a91-41f9-aac6-4981ce6e54eb	TCGA-36-2532-01A-21-1560-20		TCGA-36-2532-01A-01R-1050-07		0830b9f6-0220-4c58-9c8b-58478ac2f49e				TCGA-36-2532-01A-01D-1526-09
TCGA-36-2533-01		TCGA-36-2533-01			Squamous		OV-like c1	OV-like c4					TCGA-36-2533		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Right		Stage IIIC	-20187			0	0						2010-9-14	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1		YES	G3					TCGA-36-2533.ebe9dfc0-28ac-4d22-a18b-b910aa2814e0.pdf					5	10			0	0	25	20	70	70	80	80									Primary Tumor	01	0.4			36		Ovary		A		2007		TCGA-36-2533-01				6b83e35e-5d42-43db-a0cc-a5979af12af3			TCGA-36-2533-01A-01D-1047-05			TCGA-36-2533-01A-01D-1043-01	TCGA-36-2533-01	TCGA-36-2533-01A-01D-1043-01	572d0ef3-8c5d-48c8-9129-a2397790f0e5			572d0ef3-8c5d-48c8-9129-a2397790f0e5	TCGA-36-2533-01A-21-1560-20		TCGA-36-2533-01A-01R-1050-07		06bf48f2-1c9a-42eb-bf68-505501a4c354				TCGA-36-2533-01A-01D-1526-09
TCGA-36-2534-01	0	TCGA-36-2534-01	907	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2534	907	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	72	Right	TCGA-36-2534-F27918	Stage IIIC	-26621			0	907		383	1			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.5			G3	Progression of Disease				TCGA-36-2534.b62a4922-ad09-4422-8cb2-bea80a0fe533.pdf					3	2			0	0	8	15	89	83	90	85	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.5			36	>20 mm	Ovary		A	LIVING	2007		TCGA-36-2534-01				d32b063f-7dc4-4081-8ba5-301ea0f98089			TCGA-36-2534-01A-01D-1047-05			TCGA-36-2534-01A-01D-1043-01	TCGA-36-2534-01	TCGA-36-2534-01A-01D-1043-01	fc832eea-a988-4f59-bf1c-3df2b37f3e32			fc832eea-a988-4f59-bf1c-3df2b37f3e32	TCGA-36-2534-01A-21-1560-20		TCGA-36-2534-01A-01R-1050-07		39d1a308-db4f-4161-ad51-7cb9ccb4d059				TCGA-36-2534-01A-01D-1526-09
TCGA-36-2537-01	0	TCGA-36-2537-01	788	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2537	788	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	39	Bilateral	TCGA-36-2537-F27923	Stage IIIC	-14595			0	788		431	2			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.2			G3	Progression of Disease				TCGA-36-2537.9b122691-9140-439e-9ef6-16701081b905.pdf					8	0			0	0	10	25	82	75	90	70	Pre-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.8			36	>20 mm	Ovary		A	LIVING	2008		TCGA-36-2537-01				dab8df2a-7a8a-4735-9548-ebac64341b3a			TCGA-36-2537-01A-01D-1047-05			TCGA-36-2537-01A-01D-1043-01	TCGA-36-2537-01	TCGA-36-2537-01A-01D-1043-01	194452cf-0dd6-42a4-91c6-117d476501d0			194452cf-0dd6-42a4-91c6-117d476501d0	TCGA-36-2537-01A-21-1560-20		TCGA-36-2537-01A-01R-1050-07		74f16c9d-4f75-4307-a243-35a387eb20db				TCGA-36-2537-01A-01D-1526-09
TCGA-36-2538-01	0	TCGA-36-2538-01	763	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2538	763	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	37	Right	TCGA-36-2538-F27930	Stage IIIB	-13681			0	763		523				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1		NO	G3	Recurrence				TCGA-36-2538.e78dd67e-58f2-4b75-b3a5-1ca9ee6e01e5.pdf					5	12			0	0	25	20	75	68	70	75		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.3			36	11-20 mm	Ovary	NO	A	LIVING	2008		TCGA-36-2538-01				da67724e-5273-48f5-8545-56c9a944c0a8			TCGA-36-2538-01A-01D-1047-05			TCGA-36-2538-01A-01D-1043-01	TCGA-36-2538-01	TCGA-36-2538-01A-01D-1043-01	aeaf1a10-0085-4701-b3b5-e22f0ee578e3			aeaf1a10-0085-4701-b3b5-e22f0ee578e3	TCGA-36-2538-01A-21-20		TCGA-36-2538-01A-01R-1050-07		8e5e1961-d950-4ae8-9f07-1c5a10c82ad4				TCGA-36-2538-01A-01D-1526-09
TCGA-36-2539-01		TCGA-36-2539-01			Squamous		OV-like c1	OV-like c4					TCGA-36-2539		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.6	NO		1.3								TCGA-36-2539.c388f1d4-53dd-4e8b-bc68-ded38c816530.pdf					3	3			0	8	40	10	57	79	65	85									Primary Tumor	01	0.4							A								22ebbb58-a3c5-4473-82e6-4c4e0a5995e5			TCGA-36-2539-01A-01D-1047-05			TCGA-36-2539-01A-01D-1043-01		TCGA-36-2539-01A-01D-1043-01	e8242e31-e8eb-4cf6-81db-27f5be5294e4			e8242e31-e8eb-4cf6-81db-27f5be5294e4	TCGA-36-2539-01A-21-20		TCGA-36-2539-01A-01R-1050-07		f335ca72-d387-445f-a46c-542b608b2646				TCGA-36-2539-01A-01D-1526-09
TCGA-36-2540-01	0	TCGA-36-2540-01	724	0	Kirc+		Low purity c2	OV-like c4					TCGA-36-2540	724	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	26	Bilateral	TCGA-36-2540-F27936	Stage IIIC	-9760			0	724		665	0			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.3		YES	G1	Recurrence				TCGA-36-2540.d66d4750-20f9-4e75-bdb7-b48de6dbc449.pdf					0	0			0	20	8	8	92	82	85	80	Pre-Operative	WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.2			36	>20 mm	Ovary	YES	A	LIVING	2008		TCGA-36-2540-01				72b43e39-cb64-4610-b39e-02cc4b39c541			TCGA-36-2540-01A-01D-1047-05			TCGA-36-2540-01A-01D-1043-01	TCGA-36-2540-01	TCGA-36-2540-01A-01D-1043-01	410b0b1c-c115-4cb6-b896-d1846a8384de			410b0b1c-c115-4cb6-b896-d1846a8384de	TCGA-36-2540-01A-21-20		TCGA-36-2540-01A-01R-1050-07		75cee431-5541-49ea-a935-5e3b287f367b				TCGA-36-2540-01A-01D-1526-09
TCGA-36-2542-01	0	TCGA-36-2542-01	657	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2542	657	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-36-2542-F27942	Stage IIIB	-21902			0	657						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.5			G3					TCGA-36-2542.f901accb-a3be-461f-b145-39b83c201293.pdf					3	3			0	0	10	20	87	77	85	90		TUMOR FREE	YES	Complete Remission/Response			NO	R1	Primary Tumor	01	0.6			36	1-10 mm	Ovary		A	LIVING	2008		TCGA-36-2542-01				e58dd1a4-afb0-40c4-a0b2-aad520bcd0c9			TCGA-36-2542-01A-01D-1047-05			TCGA-36-2542-01A-01D-1043-01	TCGA-36-2542-01	TCGA-36-2542-01A-01D-1043-01	51555091-fa54-411f-9492-216557340bac			51555091-fa54-411f-9492-216557340bac	TCGA-36-2542-01A-21-20		TCGA-36-2542-01A-01R-1050-07		e4d9b54f-bf90-484f-9f85-06cd87712fd7				TCGA-36-2542-01A-01D-1526-09
TCGA-36-2543-01	1	TCGA-36-2543-01	68	1	High		OV-like c1	OV-like c4					TCGA-36-2543	68	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	85	Bilateral	TCGA-36-2543-F27946	Stage IIIC	-31211		68	0	68		27	3			2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.5	NO		1.6			G3	Progression of Disease				TCGA-36-2543.ec25ac8e-1a07-459b-a986-c78edfff88c0.pdf					5	3			10	8	8	8	77	81	85	90	Other	WITH TUMOR	NO	Progressive Disease			NO	R1	Primary Tumor	01	0.4			36	>20 mm	Ovary		A	DECEASED	2008		TCGA-36-2543-01				2146a3b5-3eb9-47be-9143-3a5de8c4a0d5			TCGA-36-2543-01A-01D-1047-05			TCGA-36-2543-01A-01D-1043-01	TCGA-36-2543-01	TCGA-36-2543-01A-01D-1043-01	da6176df-e670-4160-885f-d7a5dd04d852			da6176df-e670-4160-885f-d7a5dd04d852	TCGA-36-2543-01A-21-20		TCGA-36-2543-01A-01R-1050-07		c25023f6-f376-41b0-8346-3f898a11fd1f				TCGA-36-2543-01A-01D-1526-09
TCGA-36-2544-01	0	TCGA-36-2544-01	638	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2544	638	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-36-2544-F27948	Stage IIIC	-21384			0	638		325				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		2.3			G3	Progression of Disease				TCGA-36-2544.87f69148-d6fb-4b70-8404-c24b106b6195.pdf					5	8			0	0	8	12	87	80	90	90		WITH TUMOR	YES	Partial Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.7			36	>20 mm	Ovary		A	LIVING	2008		TCGA-36-2544-01				5ef7b46e-b379-4137-a5ab-91c9d6de74a3			TCGA-36-2544-01A-01D-1047-05			TCGA-36-2544-01A-01D-1043-01	TCGA-36-2544-01	TCGA-36-2544-01A-01D-1043-01	2f63f98f-8eb2-4bce-89c5-b5a7e9b6218c			2f63f98f-8eb2-4bce-89c5-b5a7e9b6218c	TCGA-36-2544-01A-21-20		TCGA-36-2544-01A-01R-1050-07		7f53f5f6-c900-4ebb-87d8-9e1edcbe1de5				TCGA-36-2544-01A-01D-1526-09
TCGA-36-2545-01	0	TCGA-36-2545-01	557	0	Squamous		OV-like c1	OV-like c4					TCGA-36-2545	557	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			42	Bilateral	TCGA-36-2545-F27954	Stage IIIA	-15444			0	557						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		2			G3					TCGA-36-2545.e8e6f050-7372-41f3-b198-72ddb241fb08.pdf					10	5			0	0	18	10	72	85	85	85		TUMOR FREE	YES				NO	R0	Primary Tumor	01	0.8			36	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-36-2545-01				ecfb4f91-8c7a-465b-86f0-054855f71fe5			TCGA-36-2545-01A-01D-1047-05			TCGA-36-2545-01A-01D-1043-01	TCGA-36-2545-01	TCGA-36-2545-01A-01D-1043-01	1f85cffd-00d3-4063-90c5-ccf48b0bb014			1f85cffd-00d3-4063-90c5-ccf48b0bb014	TCGA-36-2545-01A-21-20		TCGA-36-2545-01A-01R-1050-07		625f1165-c70d-4a7f-be3b-ff55aca5ca12				TCGA-36-2545-01A-01D-1526-09
TCGA-36-2547-01	0	TCGA-36-2547-01	624	0	High		OV-like c1	OV-like c4					TCGA-36-2547	624	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Left	TCGA-36-2547-F27958	Stage IIIC	-23706			0	624						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.7			G3					TCGA-36-2547.f615f400-96c3-42f3-bee9-c273b1a16b63.pdf					5	5			0	0	25	20	70	75	75	75			YES				NO	R0	Primary Tumor	01	0.7			36	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-36-2547-01				48b9af43-88a1-46c9-b6c7-ec1d1ac9e5f9			TCGA-36-2547-01A-01D-1047-05			TCGA-36-2547-01A-01D-1043-01	TCGA-36-2547-01	TCGA-36-2547-01A-01D-1043-01	7de81bd9-018a-46cc-9ca5-e1726b2ce951			7de81bd9-018a-46cc-9ca5-e1726b2ce951	TCGA-36-2547-01A-21-20		TCGA-36-2547-01A-01R-1050-07		40ca7354-e907-4a61-853e-c1d66651f9a3				TCGA-36-2547-01A-01D-1526-09
TCGA-36-2548-01	0	TCGA-36-2548-01	431	0	High		OV-like c1	OV-like c4					TCGA-36-2548	431	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Right	TCGA-36-2548-F27962	Stage IIIC	-20897			0	431		395				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Other method, specify:		0.7	NO		1.3			G3	Recurrence				TCGA-36-2548.68bf291c-3320-46f9-8e5f-7de81f0c6964.pdf					5	8			0	0	25	15	70	77	75	85		WITH TUMOR	YES			Imaging Study	NO	R1	Primary Tumor	01	0.7			36	>20 mm	Ovary		A	LIVING	2008		TCGA-36-2548-01				4794aace-89fb-4e9e-b117-3234ef1fc792			TCGA-36-2548-01A-01D-1047-05			TCGA-36-2548-01A-01D-1043-01	TCGA-36-2548-01	TCGA-36-2548-01A-01D-1043-01	86294b03-0b4e-432d-8fd1-7529422f0e7e			86294b03-0b4e-432d-8fd1-7529422f0e7e	TCGA-36-2548-01A-21-20		TCGA-36-2548-01A-01R-1050-07		abe78829-2661-4c6e-ba83-03e06963d9aa				TCGA-36-2548-01A-01D-1526-09
TCGA-36-2549-01	0	TCGA-36-2549-01	184	0	BRCA-LUAD+		OV-like c1	OV-like c4					TCGA-36-2549	184	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			54	Bilateral	TCGA-36-2549-F27966	Stage IIC	-20076			0	184						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.4			G3					TCGA-36-2549.42b18428-81f6-48d0-8a5f-fd08926128b1.pdf					8	5			8	0	12	12	80	83	85	85		TUMOR FREE	YES				NO	R0	Primary Tumor	01	0.6			36	No Macroscopic disease	Ovary		A	LIVING	2008		TCGA-36-2549-01				0b81fd60-103b-484a-a954-839f7941bf98			TCGA-36-2549-01A-01D-1047-05			TCGA-36-2549-01A-01D-1043-01	TCGA-36-2549-01	TCGA-36-2549-01A-01D-1043-01	ad6d5939-7ddd-41e6-b5a5-f45e8e2f94ea			ad6d5939-7ddd-41e6-b5a5-f45e8e2f94ea	TCGA-36-2549-01A-21-20		TCGA-36-2549-01A-01R-1050-07		3dac49f4-f485-4050-93d1-cbc22eef91d9				
TCGA-36-2551-01	0	TCGA-36-2551-01	492	0	High		OV-like c1	OV-like c4					TCGA-36-2551	492	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-36-2551-F27970	Stage IIIC	-21045			0	492		338				2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		1		NO	G3	Recurrence				TCGA-36-2551.c3e022a3-b58d-437b-a990-691730e9daf1.pdf					0	3			0	15	15	10	85	75	85	75		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO	R1	Primary Tumor	01	0.3			36	>20 mm	Ovary		A	LIVING	2009		TCGA-36-2551-01				ceb02af7-9228-4bfa-812b-f1d88482c383			TCGA-36-2551-01A-01D-1047-05			TCGA-36-2551-01A-01D-1043-01	TCGA-36-2551-01	TCGA-36-2551-01A-01D-1043-01	80c88442-c0dc-4d36-aa98-5d44ed2ca8c0			80c88442-c0dc-4d36-aa98-5d44ed2ca8c0	TCGA-36-2551-01A-21-20		TCGA-36-2551-01A-01R-1050-07		543cc9e3-5fb6-4229-aedb-a55273230b98				TCGA-36-2551-01A-01D-1526-09
TCGA-36-2552-01	0	TCGA-36-2552-01	349	0	High		OV-like c1	OV-like c4					TCGA-36-2552	349	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			64	Bilateral	TCGA-36-2552-F27976	Stage IIC	-23379			0	349						2010-8-18	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3					TCGA-36-2552.9504a356-0742-44f1-a218-62b769e64a33.pdf					8	3			0	0	20	30	72	67	80	70		TUMOR FREE	YES				NO	R0	Primary Tumor	01	0.8			36	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-36-2552-01				984b6351-1d3e-4ef1-99c4-d99895a3a49b			TCGA-36-2552-01A-01D-1047-05			TCGA-36-2552-01A-01D-1043-01	TCGA-36-2552-01	TCGA-36-2552-01A-01D-1043-01	386c8c8b-eba1-4840-b292-1b923029a5d5			386c8c8b-eba1-4840-b292-1b923029a5d5	TCGA-36-2552-01A-21-20		TCGA-36-2552-01A-01R-1050-07		4f0b1c4b-e033-4679-a32a-9bf80ff6d42d				TCGA-36-2552-01A-01D-1526-09
TCGA-3P-A9WA-01	0	TCGA-3P-A9WA-01	420	0									TCGA-3P-A9WA	420	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Left	TCGA-3P-A9WA-F67273	Stage IIB	-20211	126		0	420				Scheduled Follow-up Submission	Complete Remission/Response	2014-11-4	FEMALE	Serous Cystadenocarcinoma	No		8440/3	C56.9	YES	Other method, specify:	660		NO	100		NO		G3			NO	false	TCGA-3P-A9WA.4B2E4D3D-128A-49DD-AE0B-ACFC78615B16.pdf		5		0		0		0		5		15		80		80	Pre-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Yes, History of Synchronous/Bilateral Malignancy		NO	RX	Primary Tumor	01		YES	NO	3P		Ovary		A	LIVING	2013								TCGA-3P-A9WA-01A-11R-A407-13				TCGA-3P-A9WA-01A-11D-A402-01		TCGA-3P-A9WA-01A-11D-A402-01	997c7fe1-5f90-4aeb-983d-6d36bac3b03b			997c7fe1-5f90-4aeb-983d-6d36bac3b03b				TCGA-3P-A9WA-01A-11D-A409-05					
TCGA-42-2582-01	0	TCGA-42-2582-01	435	0	High		OV-like c1	OV-like c4					TCGA-42-2582	435	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	49	Bilateral	TCGA-42-2582-F28812	Stage IIIC	-17961			0	435		616	1			2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.3		YES	G3	Recurrence									0	0			0	0	0	0	100	100	80	60		WITH TUMOR	YES	Stable Disease		Imaging Study	NO	R0	Primary Tumor	01	0.2			42	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-42-2582-01				61f8ad02-1fe9-48ca-b317-c573aba61c08			TCGA-42-2582-01A-01D-1047-05			TCGA-42-2582-01A-01D-1043-01	TCGA-42-2582-01	TCGA-42-2582-01A-01D-1043-01	299a7405-40f7-467c-9b5b-acb728df2859			299a7405-40f7-467c-9b5b-acb728df2859	TCGA-42-2582-01A-21-20		TCGA-42-2582-01A-01R-1231-07		7f63006e-7016-483d-9a09-7d535a342d3a				TCGA-42-2582-01A-01D-1526-09
TCGA-42-2587-01	0	TCGA-42-2587-01	276	0	Squamous		OV-like c1	OV-like c4					TCGA-42-2587	276	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			75	Bilateral	TCGA-42-2587-F28033	Stage IIIC	-27510			0	276						2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.4		YES	G3					TCGA-42-2587.dc4896ef-1797-4796-8869-e9f5d19456d2.pdf					0	5			0	0	0	0	100	95	60	90		TUMOR FREE	YES	Complete Remission/Response			NO	R1	Primary Tumor	01	0.6			42	>20 mm	Ovary	YES	A	LIVING	2009		TCGA-42-2587-01				934207be-d750-48bc-a51a-c6740d415d56			TCGA-42-2587-01A-01D-1047-05			TCGA-42-2587-01A-01D-1043-01	TCGA-42-2587-01	TCGA-42-2587-01A-01D-1043-01	978e5657-d510-4704-971e-7f5241638216			978e5657-d510-4704-971e-7f5241638216	TCGA-42-2587-01A-21-1563-20		TCGA-42-2587-01A-01R-1050-07		e8013ca8-18e0-42ee-aa94-b7171902da03				TCGA-42-2587-01A-01D-1526-09
TCGA-42-2588-01	0	TCGA-42-2588-01	287	0	High		OV-like c1	OV-like c4					TCGA-42-2588	287	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Bilateral	TCGA-42-2588-F28039	Stage IV	-22377			0	287		112	2			2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.7	NO		0.9		YES	G3	Progression of Disease				TCGA-42-2588.0a11a32d-bc41-4322-bc00-357ecdd593af.pdf					0	0			0	15	0	0	100	85	60	80	Pre-Operative	WITH TUMOR	YES	Progressive Disease			NO	R2	Primary Tumor	01	0.4			42	>20 mm	Ovary		A	LIVING	2009		TCGA-42-2588-01				ba162045-6055-466e-bf4d-ff04006919db			TCGA-42-2588-01A-01D-1047-05			TCGA-42-2588-01A-01D-1043-01	TCGA-42-2588-01	TCGA-42-2588-01A-01D-1043-01	54c64bfb-98e2-4161-bb35-d03295584bd3			54c64bfb-98e2-4161-bb35-d03295584bd3	TCGA-42-2588-01A-21-20		TCGA-42-2588-01A-01R-1050-07		fd52301b-6882-4868-95e8-501ec794f7a8				TCGA-42-2588-01A-01D-1526-09
TCGA-42-2589-01	0	TCGA-42-2589-01	230	0	High		OV-like c1	OV-like c4					TCGA-42-2589	230	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-42-2589-F28800	Stage IIIC	-19852			0	230		364				2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Fine needle aspiration biopsy		1	NO		1		YES	G3	Recurrence				TCGA-42-2589.07cceb21-4aca-4343-965e-81960a40cff2.pdf					3	1			0	0	25	25	72	74	85	90		TUMOR FREE	YES	Complete Remission/Response		Imaging Study	NO	R0	Primary Tumor	01	0.5			42	1-10 mm	Ovary		A	LIVING	2009		TCGA-42-2589-01				77d0cab8-5a58-4fed-ac41-68dff4f946cd			TCGA-42-2589-01A-01D-1047-05			TCGA-42-2589-01A-01D-1043-01	TCGA-42-2589-01	TCGA-42-2589-01A-01D-1043-01	5528ed94-763e-4543-acda-16194c6172cd			5528ed94-763e-4543-acda-16194c6172cd	TCGA-42-2589-01A-21-20		TCGA-42-2589-01A-01R-1050-07		9add86b7-a9d7-41ea-8536-41a204c97ae1				TCGA-42-2589-01A-01D-1526-09
TCGA-42-2590-01	0	TCGA-42-2590-01	227	0	High		OV-like c1	OV-like c4					TCGA-42-2590	227	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	57	Bilateral	TCGA-42-2590-F28050	Stage IV	-20965			0	227		226	1			2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		2.2			G2	Progression of Disease				TCGA-42-2590.9c7c0209-b1d6-4174-b57e-e8bcd3e5d766.pdf					20	0			0	0	5	20	75	80	85	90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease			NO	R1	Primary Tumor	01	0.4			42	>20 mm	Ovary		A	LIVING	2009		TCGA-42-2590-01				043ea617-6eec-43ae-a45c-b5cffacc7695			TCGA-42-2590-01A-01D-1047-05			TCGA-42-2590-01A-01D-1043-01	TCGA-42-2590-01	TCGA-42-2590-01A-01D-1043-01	72e32531-8d78-4b26-8d89-8a431c4ac509			72e32531-8d78-4b26-8d89-8a431c4ac509	TCGA-42-2590-01A-21-20		TCGA-42-2590-01A-01R-1050-07		919946b9-3135-45fd-9fdd-b2d40c8bc3ba				TCGA-42-2590-01A-01D-1526-09
TCGA-42-2591-01	0	TCGA-42-2591-01	232	0	Squamous		OV-like c1	OV-like c4					TCGA-42-2591	232	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-42-2591-F28054	Stage IIIC	-18654			0	232						2010-6-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		YES	GX					TCGA-42-2591.f4c9e6c0-c6bf-4793-a5de-c85c347b4097.pdf					15	5			0	0	15	15	70	80	90	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			42	No Macroscopic disease	Ovary		A	LIVING	2009		TCGA-42-2591-01				0a1bb74b-fa00-4320-b966-ea146e76c9fa			TCGA-42-2591-01A-01D-1047-05			TCGA-42-2591-01A-01D-1043-01	TCGA-42-2591-01	TCGA-42-2591-01A-01D-1043-01	66d09ec6-b2a5-49ae-ad0c-ebf8a7e61112			66d09ec6-b2a5-49ae-ad0c-ebf8a7e61112	TCGA-42-2591-01A-21-20		TCGA-42-2591-01A-01R-1050-07		5c6e2798-32a6-4fb9-b246-c6267f7dfc51				TCGA-42-2591-01A-01D-1526-09
TCGA-42-2593-01	1	TCGA-42-2593-01	45	1	High		OV-like c1	OV-like c4					TCGA-42-2593	45	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			67	Bilateral	TCGA-42-2593-F39341	Stage IIIC	-24823		45	0				4	Scheduled Follow-up Submission		2013-1-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.9	NO	YES	G3			NO		TCGA-42-2593.302c2898-9b19-494b-86a5-f0ff3cab7163.pdf					5	0			0	0	60	30	35	70	70	90	Other	WITH TUMOR	NO				NO	R2	Primary Tumor	01	0.4	YES	NO	42	>20 mm	Ovary	YES	A	DECEASED	2009						8ae9695c-082b-4011-b078-f55aa285fa11			TCGA-42-2593-01A-01D-1047-05			TCGA-42-2593-01A-01D-1043-01		TCGA-42-2593-01A-01D-1043-01	ae9f95e1-e3d0-4752-86b1-ca9fe03bbdd8			ae9f95e1-e3d0-4752-86b1-ca9fe03bbdd8	TCGA-42-2593-01A-21-20		TCGA-42-2593-01A-01R-1050-07		f5e8a865-c4eb-4043-9a8f-7979d3fe6532				
TCGA-57-1582-01	1	TCGA-57-1582-01	731	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-57-1582	731	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Left	TCGA-57-1582-F28059	Stage IIIC			731	0	731						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		2		YES	G3					TCGA-57-1582.0ed35510-c6ad-416b-8b57-e97005471dc1.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.6			57	1-10 mm	Ovary	YES	A	DECEASED	2006	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01	TCGA-57-1582-01A-01W-0615-10	TCGA-57-1582-01A-01W-0615-10	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90			TCGA-57-1582-01A-01R-1566-13	TCGA-57-1582-01A-01D-0536-05	TCGA-57-1582-01	TCGA-57-1582-01	TCGA-57-1582-01A-01D-0533-01	TCGA-57-1582-01	TCGA-57-1582-01A-01D-0533-01	e9a6932d-2457-47a1-92ef-db2d0c3638e4	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	e9a6932d-2457-47a1-92ef-db2d0c3638e4		TCGA-57-1582-01A-01R-1566-13	TCGA-57-1582-01A-01R-0540-07		18e8fac4-913e-4c0f-bb6e-3d19b58518cc	cb7a4405-b9a5-4e1a-825f-c3ee205c8a90	TCGA-57-1582-01A-01R-1566-13		
TCGA-57-1583-01	1	TCGA-57-1583-01	346	1	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-57-1583	346	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Left	TCGA-57-1583-F28068	Stage IIIC	-21167		346	0	346						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3					TCGA-57-1583.b899b485-621f-46df-8bda-97b0fbe10b6d.pdf					1	1			0	0	10	10	94	94	95	95		WITH TUMOR	YES				NO		Primary Tumor	01	0.4			57	No Macroscopic disease	Ovary	NO	A	DECEASED	2006	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01	TCGA-57-1583-01A-01W-0615-10	TCGA-57-1583-01A-01W-0615-10	3a37e320-0301-4f2b-bf09-f102c12502b1			TCGA-57-1583-01A-01R-1566-13	TCGA-57-1583-01A-01D-0536-05	TCGA-57-1583-01	TCGA-57-1583-01	TCGA-57-1583-01A-01D-0533-01	TCGA-57-1583-01	TCGA-57-1583-01A-01D-0533-01	f9fc5722-4216-43f8-b7bb-95752acc78f6	3a37e320-0301-4f2b-bf09-f102c12502b1	3a37e320-0301-4f2b-bf09-f102c12502b1	f9fc5722-4216-43f8-b7bb-95752acc78f6		TCGA-57-1583-01A-01R-1566-13	TCGA-57-1583-01A-01R-0540-07		bb6bfbc9-0379-4f74-8720-186fa0a165b9	3a37e320-0301-4f2b-bf09-f102c12502b1	TCGA-57-1583-01A-01R-1566-13		
TCGA-57-1584-01	0	TCGA-57-1584-01	643	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 3	cluster 6	mutation cluster 3	TCGA-57-1584	643	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-57-1584-F28072	Stage IIIC	-17263			0	643		530	0			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2.3		YES	G3	Recurrence				TCGA-57-1584.3e4b484e-4727-444f-b2bc-c32d5d1ad815.pdf					0	0			0	0	10	10	90	90	90	90	Pre-Adjuvant Therapy	WITH TUMOR	NO			Imaging Study	NO		Primary Tumor	01	0.8			57	1-10 mm	Ovary	YES	A	LIVING	2007	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01	TCGA-57-1584-01A-01W-0615-10	TCGA-57-1584-01A-01W-0615-10	e92b95df-bacb-4083-b2de-78e540ec0e68			TCGA-57-1584-01A-01R-1566-13	TCGA-57-1584-01A-01D-0536-05	TCGA-57-1584-01	TCGA-57-1584-01	TCGA-57-1584-01A-01D-0533-01	TCGA-57-1584-01	TCGA-57-1584-01A-01D-0533-01	716c8389-daf4-4b23-9069-4e0862a0db5d	e92b95df-bacb-4083-b2de-78e540ec0e68	e92b95df-bacb-4083-b2de-78e540ec0e68	716c8389-daf4-4b23-9069-4e0862a0db5d		TCGA-57-1584-01A-01R-1566-13	TCGA-57-1584-01A-01R-0540-07		e10d4b1f-cba8-4e34-af2e-331949b18dba	e92b95df-bacb-4083-b2de-78e540ec0e68	TCGA-57-1584-01A-01R-1566-13		
TCGA-57-1585-01	1	TCGA-57-1585-01	53	1	Squamous		OV-like c1			miRNA cluster 3	cluster 6		TCGA-57-1585	53	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Bilateral	TCGA-57-1585-F28076	Stage IIIC	-20862		53	0	53						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		0.8		YES	G3					TCGA-57-1585.2c748aca-e5b2-4418-9820-1343293d379f.pdf					5	5			0	0	15	10	80	85	85	90		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.3			57	11-20 mm	Ovary	YES	A	DECEASED	2007		TCGA-57-1585-01						TCGA-57-1585-01A-01R-1566-13	TCGA-57-1585-01A-01D-0536-05			TCGA-57-1585-01A-01D-0533-01	TCGA-57-1585-01	TCGA-57-1585-01A-01D-0533-01	33185003-e0a6-4c8e-bf25-4623b5c7ef82			33185003-e0a6-4c8e-bf25-4623b5c7ef82		TCGA-57-1585-01A-01R-1566-13	TCGA-57-1585-01A-01R-0540-07		9485c5c9-3fa8-48a3-bb75-a152f1547ae3		TCGA-57-1585-01A-01R-1566-13		
TCGA-57-1586-01	0	TCGA-57-1586-01	679	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-57-1586	679	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	66	Bilateral	TCGA-57-1586-F28080	Stage IIIC	-24304			0	679		259				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G3	Recurrence				TCGA-57-1586.1245d63d-8859-496a-828e-4ccad717c114.pdf					0	1			0	0	5	5	95	94	90	95		WITH TUMOR	YES			Molecular Marker(S)	NO		Primary Tumor	01	0.2			57	11-20 mm	Ovary	YES	A	LIVING	2007		TCGA-57-1586-01				a93a15b9-aef1-403b-85c4-1d5203e6d9dc		TCGA-57-1586-01A-02R-1567-13	TCGA-57-1586-01A-02D-0563-05			TCGA-57-1586-01A-02D-0559-01	TCGA-57-1586-01	TCGA-57-1586-01A-02D-0559-01	8071cdd3-94c7-4863-945d-0977eab87107			8071cdd3-94c7-4863-945d-0977eab87107	TCGA-57-1586-01A-03-1563-20	TCGA-57-1586-01A-02R-1567-13	TCGA-57-1586-01A-02R-0566-07		ec771953-9297-4d7d-aa29-531499b3e2eb		TCGA-57-1586-01A-02R-1567-13		TCGA-57-1586-01A-02W-0633-09
TCGA-57-1992-01	0	TCGA-57-1992-01	882	0	High		OV-like c1						TCGA-57-1992	882	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Left	TCGA-57-1992-F28090	Stage IC				0	882						2009-12-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.3		YES	G3					TCGA-57-1992.77c742d8-bb0b-4ea9-9f61-9606c78c438e.pdf					0	0			0	0	40	25	60	75	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			57	No Macroscopic disease	Ovary	YES	A	LIVING	2006		TCGA-57-1992-01							TCGA-57-1992-01A-01D-0652-05			TCGA-57-1992-01A-01D-0648-01	TCGA-57-1992-01	TCGA-57-1992-01A-01D-0648-01	8b66a23d-b6c1-46bc-9ac2-eee368762059			8b66a23d-b6c1-46bc-9ac2-eee368762059			TCGA-57-1992-01A-01R-0655-07		6fcb27b1-5f0d-4c30-b9a4-205f60bc880b				
TCGA-57-1993-01	0	TCGA-57-1993-01	763	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-57-1993	763	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			56	Bilateral	TCGA-57-1993-F28092	Stage IIIC	-20498			0	763						2010-1-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.5		YES	G3					TCGA-57-1993.55495e3a-6052-4fb1-b8a9-10b54dcdfbea.pdf					0	0			0	0	30	10	70	90	95	95		TUMOR FREE	YES				NO	R0	Primary Tumor	01	0.5			57	No Macroscopic disease	Ovary	YES	A	LIVING	2007		TCGA-57-1993-01		TCGA-57-1993-01A-01W-0699-08	55f9061c-54e7-465c-af61-21d8bc8ecbe0			TCGA-57-1993-01A-01R-1568-13	TCGA-57-1993-01A-01D-0652-05	TCGA-57-1993-01	TCGA-57-1993-01	TCGA-57-1993-01A-01D-0648-01	TCGA-57-1993-01	TCGA-57-1993-01A-01D-0648-01	bb7d6126-2bf6-41ab-b657-da66ba7abd8c	55f9061c-54e7-465c-af61-21d8bc8ecbe0	55f9061c-54e7-465c-af61-21d8bc8ecbe0	bb7d6126-2bf6-41ab-b657-da66ba7abd8c		TCGA-57-1993-01A-01R-1568-13	TCGA-57-1993-01A-01R-0655-07		f8c91078-d156-4ee9-96c9-7ec6937c40b3	55f9061c-54e7-465c-af61-21d8bc8ecbe0	TCGA-57-1993-01A-01R-1568-13	TCGA-57-1993-01A-01W-0699-08	
TCGA-57-1994-01	0	TCGA-57-1994-01	761	0	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-57-1994	761	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63		TCGA-57-1994-F28096		-23062			0	761						2011-6-10	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.5								TCGA-57-1994.54c3dd01-b473-424f-987a-c5d6e972e9bb.pdf	1				5	10			0	0	5	10	90	80	95	90			NO				NO		Primary Tumor	01	0.4			57		Ovary		A	LIVING	2004		TCGA-57-1994-01			2cf309ea-0c2e-4f28-a94b-342dc9a1aae8			TCGA-57-1994-01A-01R-1568-13	TCGA-57-1994-01A-01D-0652-05	TCGA-57-1994-01	TCGA-57-1994-01	TCGA-57-1994-01A-01D-0648-01	TCGA-57-1994-01	TCGA-57-1994-01A-01D-0648-01	61e9dfe5-0e48-498b-ab8d-075ed75a8bdc	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	61e9dfe5-0e48-498b-ab8d-075ed75a8bdc		TCGA-57-1994-01A-01R-1568-13	TCGA-57-1994-01A-01R-0655-07		24fbfb49-2a8c-40af-b607-577cc3001b2d	2cf309ea-0c2e-4f28-a94b-342dc9a1aae8	TCGA-57-1994-01A-01R-1568-13		
TCGA-59-2348-01	0	TCGA-59-2348-01	5481	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2348	5481	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			59	Bilateral	TCGA-59-2348-F28098	Stage IIIC				0	5481						2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2			G3					TCGA-59-2348.ffb300e9-cb06-4162-a751-f079fec57153.pdf					5	5			0	0	10	10	85	85	90	90		TUMOR FREE		Complete Remission/Response					Primary Tumor	01	0.4			59		Ovary		A	LIVING	1994		TCGA-59-2348-01		TCGA-59-2348-01A-01W-0799-08	7162d809-ff1a-4346-bb00-c8086386ec46	c37d3098-f79e-4ce7-9ed5-884d82725dff		TCGA-59-2348-01A-01R-1569-13	TCGA-59-2348-01A-01D-0708-05	TCGA-59-2348-01	TCGA-59-2348-01	TCGA-59-2348-01A-01D-0704-01	TCGA-59-2348-01	TCGA-59-2348-01A-01D-0704-01	abf2071b-b577-4dce-9e96-8ee1dcc83236	7162d809-ff1a-4346-bb00-c8086386ec46	7162d809-ff1a-4346-bb00-c8086386ec46	abf2071b-b577-4dce-9e96-8ee1dcc83236	TCGA-59-2348-01A-21-1560-20	TCGA-59-2348-01A-01R-1569-13	TCGA-59-2348-01A-01R-0711-07		139d2d19-f3e9-46fc-bd88-b57709af9ec5	7162d809-ff1a-4346-bb00-c8086386ec46	TCGA-59-2348-01A-01R-1569-13	TCGA-59-2348-01A-01W-0799-08	
TCGA-59-2349-01	1	TCGA-59-2349-01	2437	1	Kirc+		Cluster 5	BRCA basal-like c6					TCGA-59-2349	2437	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Left	TCGA-59-2349-F28100	Stage IA			2437	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.3			G3					TCGA-59-2349.a56064eb-651a-4a7d-b32c-5c890821e338.pdf					0	0			1	1	4	4	95	95	95	95				Complete Remission/Response					Primary Tumor	01	0.3	NO	YES	59	No Macroscopic disease	Ovary		A	DECEASED	1994		TCGA-59-2349-01				96c57593-695a-4b64-997b-b465ed28917c			TCGA-59-2349-01A-01D-0708-05			TCGA-59-2349-01A-01D-0704-01	TCGA-59-2349-01	TCGA-59-2349-01A-01D-0704-01	d5526f65-7d4a-4182-aa70-f18074413a20			d5526f65-7d4a-4182-aa70-f18074413a20	TCGA-59-2349-01A-21-1560-20		TCGA-59-2349-01A-01R-0711-07		7557f686-ae87-4ab8-b7df-b1f1b0850e51				
TCGA-59-2350-01	1	TCGA-59-2350-01	679	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-59-2350	679	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			44	Bilateral	TCGA-59-2350-F28102	Stage IV			679	0			211				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection								G3	Progression of Disease																						WITH TUMOR		Partial Remission/Response					Primary Tumor	01		NO	YES	59	1-10 mm	Ovary			DECEASED	1995		TCGA-59-2350-01		TCGA-59-2350-01A-01W-0799-08	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0			TCGA-59-2350-01A-01R-1569-13	TCGA-59-2350-01A-01D-0708-05	TCGA-59-2350-01	TCGA-59-2350-01	TCGA-59-2350-01A-01D-0704-01	TCGA-59-2350-01	TCGA-59-2350-01A-01D-0704-01	a3747731-86b6-4f6d-8044-d677000432cd	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	a3747731-86b6-4f6d-8044-d677000432cd		TCGA-59-2350-01A-01R-1569-13	TCGA-59-2350-01A-01R-0711-07		e5b094fc-335d-4a9e-9ead-d0bda9695e33	e05f2e2a-77d2-4f86-8e21-27cdd93b88b0	TCGA-59-2350-01A-01R-1569-13	TCGA-59-2350-01A-01W-0799-08	
TCGA-59-2351-01	0	TCGA-59-2351-01	3532	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 6	mutation cluster 5	TCGA-59-2351	3532	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	51	Bilateral	TCGA-59-2351-F28104	Stage IIIC				0	3532		2139				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		2			G3	Progression of Disease				TCGA-59-2351.6cec74e9-4ad7-4c6d-abdd-36ba1573d6ad.pdf					1	1			1	1	19	19	79	79	80	80		TUMOR FREE		Complete Remission/Response		Imaging Study			Primary Tumor	01	0.4	NO	YES	59	1-10 mm	Ovary		A	LIVING	1999		TCGA-59-2351-01		TCGA-59-2351-01A-01W-0799-08	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	2cdeaf4d-f2c6-44fd-872e-965ef80e505b		TCGA-59-2351-01A-01R-1569-13	TCGA-59-2351-01A-01D-0708-05	TCGA-59-2351-01	TCGA-59-2351-01	TCGA-59-2351-01A-01D-0704-01	TCGA-59-2351-01	TCGA-59-2351-01A-01D-0704-01	d17bcbde-2313-4553-9017-297ef7900b81	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	d17bcbde-2313-4553-9017-297ef7900b81	TCGA-59-2351-01A-21-1560-20	TCGA-59-2351-01A-01R-1569-13	TCGA-59-2351-01A-01R-0711-07		2c72e167-d9b6-47e2-ae10-3183a6d13e7a	7e58cfd1-07eb-44e2-a563-fa7a00b338a3	TCGA-59-2351-01A-01R-1569-13	TCGA-59-2351-01A-01W-0799-08	
TCGA-59-2352-01	1	TCGA-59-2352-01	286	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2352	286	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Right		Stage IIIC			286	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.2	NO		2			G3					TCGA-59-2352.15f65643-b84c-4239-bc14-0ddacdfe0425.pdf					5	1			0	0	10	10	85	89	90	90		WITH TUMOR							Primary Tumor	01	0.4	NO	YES	59		Ovary		A	DECEASED	2002		TCGA-59-2352-01		TCGA-59-2352-01A-01W-0799-08	a209a8f4-9462-4ade-be57-caaec54999cb	d9066d98-0039-4956-9e7e-9931b8c28379		TCGA-59-2352-01A-01R-1569-13	TCGA-59-2352-01A-01D-0708-05	TCGA-59-2352-01	TCGA-59-2352-01	TCGA-59-2352-01A-01D-0704-01	TCGA-59-2352-01	TCGA-59-2352-01A-01D-0704-01	a8594369-1e61-444b-a8f9-d47ca065010d	a209a8f4-9462-4ade-be57-caaec54999cb	a209a8f4-9462-4ade-be57-caaec54999cb	a8594369-1e61-444b-a8f9-d47ca065010d	TCGA-59-2352-01A-21-1560-20	TCGA-59-2352-01A-01R-1569-13	TCGA-59-2352-01A-01R-0711-07		87ec1cd8-27d3-4cde-a59b-58c82ab8cbbe	a209a8f4-9462-4ade-be57-caaec54999cb	TCGA-59-2352-01A-01R-1569-13	TCGA-59-2352-01A-01W-0799-08	
TCGA-59-2354-01	1	TCGA-59-2354-01	1046	1	Squamous	C9-OV	OV-like c1	OV-like c4		miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2354	1046	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Left	TCGA-59-2354-F28107	Stage IIIC			1046	0			462				2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		2.4		YES	G3	Progression of Disease				TCGA-59-2354.cbdd4d6e-0df4-4abd-af75-b3a66bdba9cc.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Stable Disease		Imaging Study			Primary Tumor	01	0.3			59	1-10 mm	Ovary		A	DECEASED	2005		TCGA-59-2354-01		TCGA-59-2354-01A-01W-0799-08		d80db939-9815-4d8b-8d3d-927a54355003		TCGA-59-2354-01A-01R-1569-13	TCGA-59-2354-01A-01D-0708-05			TCGA-59-2354-01A-01D-0704-01	TCGA-59-2354-01	TCGA-59-2354-01A-01D-0704-01	786c5533-6c42-469a-a7eb-9a3feefdfdcb			786c5533-6c42-469a-a7eb-9a3feefdfdcb	TCGA-59-2354-01A-21-1560-20	TCGA-59-2354-01A-01R-1569-13	TCGA-59-2354-01A-01R-0711-07		e0e3aedf-ace3-4525-83c2-887b517837c0		TCGA-59-2354-01A-01R-1569-13	TCGA-59-2354-01A-01W-0799-08	
TCGA-59-2355-01	1	TCGA-59-2355-01	65	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-59-2355	65	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			58	Right	TCGA-59-2355-F28111	Stage IV			65	0							2010-1-29	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3					TCGA-59-2355.322bedf6-e6b5-4275-a186-0075a2ec271e.pdf					20	0			0	0	20	15	60	85	80	85		WITH TUMOR	YES						Primary Tumor	01	0.2			59	>20 mm	Ovary		A	DECEASED	2006		TCGA-59-2355-01		TCGA-59-2355-01A-01W-0799-08	866c7355-e2ec-4816-953f-7bf791033283			TCGA-59-2355-01A-01R-1569-13	TCGA-59-2355-01A-01D-0708-05	TCGA-59-2355-01	TCGA-59-2355-01	TCGA-59-2355-01A-01D-0704-01	TCGA-59-2355-01	TCGA-59-2355-01A-01D-0704-01	f3bf0766-203a-4cef-9b0f-d9e84bfcfb38	866c7355-e2ec-4816-953f-7bf791033283	866c7355-e2ec-4816-953f-7bf791033283	f3bf0766-203a-4cef-9b0f-d9e84bfcfb38		TCGA-59-2355-01A-01R-1569-13	TCGA-59-2355-01A-01R-0711-07		9c18086a-f203-48f5-af4c-d756fe1b266b	866c7355-e2ec-4816-953f-7bf791033283	TCGA-59-2355-01A-01R-1569-13	TCGA-59-2355-01A-01W-0799-08	
TCGA-59-2363-01	0	TCGA-59-2363-01	165	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1	mutation cluster 5	TCGA-59-2363	165	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			40	Bilateral	TCGA-59-2363-F28115	Stage IIIA				0	165						2010-2-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		NO	G3					TCGA-59-2363.9b047485-eb2b-4fc1-a22a-d96046b63bf2.pdf					5	0			1	0	10	10	84	90	90	90		TUMOR FREE	YES	Complete Remission/Response			NO	R0	Primary Tumor	01	0.4			59	No Macroscopic disease	Ovary	NO	A	LIVING	2007		TCGA-59-2363-01		TCGA-59-2363-01A-01W-0799-08	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	abdc5a45-9e20-4c0e-b854-9a2ec535245a		TCGA-59-2363-01A-01R-1569-13	TCGA-59-2363-01A-01D-0708-05	TCGA-59-2363-01	TCGA-59-2363-01	TCGA-59-2363-01A-01D-0704-01	TCGA-59-2363-01	TCGA-59-2363-01A-01D-0704-01	eb5241b3-941e-499b-8753-6a0e2eb474e8	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	eb5241b3-941e-499b-8753-6a0e2eb474e8	TCGA-59-2363-01A-21-1560-20	TCGA-59-2363-01A-01R-1569-13	TCGA-59-2363-01A-01R-0711-07		0ef0c1bf-9885-4be9-85b1-ed400a1a940f	1d3f29ac-5f19-452d-99b6-72c0abf1ce32	TCGA-59-2363-01A-01R-1569-13	TCGA-59-2363-01A-01W-0799-08	
TCGA-59-2372-01	1	TCGA-59-2372-01	1363	1	High		OV-like c1	OV-like c4					TCGA-59-2372	1363	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			73	Bilateral	TCGA-59-2372-F28119	Stage IIIC			1363	0							2010-2-12	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1		NO	G2					TCGA-59-2372.4411c3e9-2751-45eb-bc8f-e64ca2940a09.pdf	0	0	0	0	2	0	0	0	0	0	0	0	98	100	90	85			YES				NO	R0	Primary Tumor	01	0.5			59	No Macroscopic disease	Ovary	NO	A	DECEASED	2005		TCGA-59-2372-01				7d66df01-e224-4584-8c36-f54735a2fc53			TCGA-59-2372-01A-01D-1047-05			TCGA-59-2372-01A-01D-1043-01	TCGA-59-2372-01	TCGA-59-2372-01A-01D-1043-01	f20b8655-d80d-4b0a-9df6-c8e1e534a710			f20b8655-d80d-4b0a-9df6-c8e1e534a710	TCGA-59-2372-01A-21-1560-20		TCGA-59-2372-01A-01R-1050-07		b368a37f-fa86-47ae-9a1c-d1038f19a663				TCGA-59-2372-01A-01D-1526-09
TCGA-59-A5PD-01	1	TCGA-59-A5PD-01	624	1									TCGA-59-A5PD	624	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Right		Stage IC	-20263	730	624	0				0			2013-6-25	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection	130		NO	100			YES	G3			YES	false	TCGA-59-A5PD.9A3CB382-654F-4DFD-BF41-7615710D2825.pdf		40		20		10		20		0		30		60		60	Pre-Operative	WITH TUMOR	NO	Complete Remission/Response	Yes, History of Synchronous/Bilateral Malignancy		NO		Primary Tumor	01		NO	YES	59		Ovary	YES	A	DECEASED	2011								TCGA-59-A5PD-01A-11R-A407-13				TCGA-59-A5PD-01A-11D-A402-01		TCGA-59-A5PD-01A-11D-A402-01	2612e023-e918-4aac-9ca0-422c52efe0bc			2612e023-e918-4aac-9ca0-422c52efe0bc				TCGA-59-A5PD-01A-11D-A409-05					
TCGA-5X-AA5U-01	0	TCGA-5X-AA5U-01	361	0									TCGA-5X-AA5U	361	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			61	Right	TCGA-5X-AA5U-F69358	Stage IIC	-22438	11		0	361			0	Scheduled Follow-up Submission	Complete Remission/Response	2015-1-7	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	230		NO	100		NO	NO	GX			NO	true	TCGA-5X-AA5U.28F20F49-20C6-4B93-957D-8DAEF04657AE.pdf		2		0		0		0		5		20		75		75	Post-Adjuvant Therapy	TUMOR FREE	YES	Complete Remission/Response	Yes, History of Synchronous/Bilateral Malignancy		NO	R0	Primary Tumor	01		YES	NO	5X		Ovary	NO	A	LIVING	2013								TCGA-5X-AA5U-01A-11R-A407-13				TCGA-5X-AA5U-01A-11D-A402-01		TCGA-5X-AA5U-01A-11D-A402-01	e1aceff8-11e2-404b-ba6d-bdad05a7116b			e1aceff8-11e2-404b-ba6d-bdad05a7116b				TCGA-5X-AA5U-01A-11D-A409-05					
TCGA-61-1721-01	0	TCGA-61-1721-01	338	0	Quiet	C5-KIRC	Low purity c2	OV-like c4	GBM-like c6	miRNA cluster 3	cluster 6		TCGA-61-1721	338	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			38	Bilateral	TCGA-61-1721-F28123	Stage IV	-13894			0	338						2009-6-2	FEMALE	Serous Cystadenocarcinoma	Yes		8441/3	C56.9	YES	Excisional Biopsy		0.9	NO		1		YES	G1					TCGA-61-1721.f44d906c-f069-45e6-9cc4-49eb0da74226.pdf					15	15			0	0	0	0	85	85	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61		Ovary	YES	A	LIVING	2008		TCGA-61-1721-01			226f9774-e22b-4b8b-8259-934edb649fc3	0479fc63-879d-4b50-b014-20d276a2d13d		TCGA-61-1721-01A-01R-1569-13	TCGA-61-1721-01A-01D-0652-05	TCGA-61-1721-01	TCGA-61-1721-01	TCGA-61-1721-01A-01D-0648-01	TCGA-61-1721-01	TCGA-61-1721-01A-01D-0648-01	20c43493-7383-4650-a5f2-4a24759b53cb	226f9774-e22b-4b8b-8259-934edb649fc3	226f9774-e22b-4b8b-8259-934edb649fc3	20c43493-7383-4650-a5f2-4a24759b53cb	TCGA-61-1721-01A-21-1559-20	TCGA-61-1721-01A-01R-1569-13	TCGA-61-1721-01A-01R-0655-07		13cc06b1-0e57-4cfe-bfe1-b6ec96321199	226f9774-e22b-4b8b-8259-934edb649fc3	TCGA-61-1721-01A-01R-1569-13		
TCGA-61-1722-01	0	TCGA-61-1722-01	246	0	High		OV-like c1	OV-like c4					TCGA-61-1722	246	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			89	Bilateral	TCGA-61-1722-F28129	Stage IB	-32853			0	246						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3					TCGA-61-1722.059421f4-442e-4e81-a726-7a8486c74cdc.pdf					10	0			0	0	25	20	65	80	95	95		WITH TUMOR	NO	Stable Disease			NO		Primary Tumor	01	0.2			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008		TCGA-61-1722-01				b17eace3-8ff6-4e2c-abd1-81f67343d8d1			TCGA-61-1722-01A-01D-0581-05			TCGA-61-1722-01A-01D-0577-01	TCGA-61-1722-01	TCGA-61-1722-01A-01D-0577-01	b37b89ba-4a07-4bc7-85ae-932db8485ef0			b37b89ba-4a07-4bc7-85ae-932db8485ef0	TCGA-61-1722-01A-21-1559-20		TCGA-61-1722-01A-01R-0584-07		79b7ffda-716b-4253-a580-4b1372a8f152				TCGA-61-1722-01A-01D-1556-09
TCGA-61-1724-01	1	TCGA-61-1724-01	637	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 3	cluster 5		TCGA-61-1724	637	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	47	Bilateral	TCGA-61-1724-F28135	Stage IIIC	-17168		637	0	637	187					2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.2		YES	G3	Locoregional Disease	YES			TCGA-61-1724.ec0d70e7-672b-425b-a558-d233e0ef1779.pdf					5	10			0	0	0	5	95	85	90	90		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.3			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2007		TCGA-61-1724-01			faab5b85-3c69-4c64-bba0-a8d5404939a2	eb6edbbc-bc05-4627-b5af-6f91d7b6c5dd		TCGA-61-1724-01A-01R-1568-13	TCGA-61-1724-01A-01D-0652-05	TCGA-61-1724-01	TCGA-61-1724-01	TCGA-61-1724-01A-01D-0648-01	TCGA-61-1724-01	TCGA-61-1724-01A-01D-0648-01	400e0133-bdd9-42b7-85cb-e486303ab5b2	faab5b85-3c69-4c64-bba0-a8d5404939a2	faab5b85-3c69-4c64-bba0-a8d5404939a2	400e0133-bdd9-42b7-85cb-e486303ab5b2	TCGA-61-1724-01A-21-1559-20	TCGA-61-1724-01A-01R-1568-13	TCGA-61-1724-01A-01R-0655-07		af7c2e4b-c7c1-46d1-854e-c75365f3c967	faab5b85-3c69-4c64-bba0-a8d5404939a2	TCGA-61-1724-01A-01R-1568-13		
TCGA-61-1725-01	0	TCGA-61-1725-01	956	0	Squamous		OV-like c1		OV-like c16	miRNA cluster 1	cluster 2		TCGA-61-1725	956	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-61-1725-F28143	Stage IIIC	-14782			0	956		844				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1		YES	G3	Recurrence				TCGA-61-1725.8bcf7f73-abe7-43d0-a7da-ede3f5c2bb04.pdf					10	20			0	0	0	0	90	80	95	90		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary	YES	A	LIVING	2007		TCGA-61-1725-01			748ff969-cb49-4f22-994f-6debe734c38f			TCGA-61-1725-01A-01R-1567-13	TCGA-61-1725-01A-01D-0581-05	TCGA-61-1725-01	TCGA-61-1725-01	TCGA-61-1725-01A-01D-0577-01	TCGA-61-1725-01	TCGA-61-1725-01A-01D-0577-01	93d96010-3670-4f45-97dc-90437772e893	748ff969-cb49-4f22-994f-6debe734c38f	748ff969-cb49-4f22-994f-6debe734c38f	93d96010-3670-4f45-97dc-90437772e893		TCGA-61-1725-01A-01R-1567-13	TCGA-61-1725-01A-01R-0584-07		be16e66f-a839-44c7-b700-4a95d366435f	748ff969-cb49-4f22-994f-6debe734c38f	TCGA-61-1725-01A-01R-1567-13		TCGA-61-1725-01A-01W-0639-09
TCGA-61-1727-01	0	TCGA-61-1727-01	564	0	Squamous		OV-like c1	OV-like c4					TCGA-61-1727	564	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Right	TCGA-61-1727-F28152	Stage IC	-27203			0	564						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.1			G3					TCGA-61-1727.f8e2cbf2-911a-48a7-ad80-c23124af44fe.pdf	15	10			2	5			0	0	0	0	98	95	75	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2007		TCGA-61-1727-01				3d14831f-1ab6-43e9-bd15-0c6e930304e8			TCGA-61-1727-01A-01D-0581-05			TCGA-61-1727-01A-01D-0577-01	TCGA-61-1727-01	TCGA-61-1727-01A-01D-0577-01	1945210f-1564-43d1-9590-2ff9f0700e82			1945210f-1564-43d1-9590-2ff9f0700e82	TCGA-61-1727-01A-21-1559-20		TCGA-61-1727-01A-01R-0584-07		ea305cbb-1171-49bd-be79-debefe08023f				TCGA-61-1727-01A-01W-0639-09
TCGA-61-1728-01	0	TCGA-61-1728-01	848	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1728	848	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	59	Bilateral	TCGA-61-1728-F28156	Stage IV	-21582			0	848		533				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.1		NO	G3	Recurrence				TCGA-61-1728.7611c4d4-f58b-404e-93f1-949c865c9e12.pdf					15	10			0	0	0	0	85	90	90	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	NO	A	LIVING	2007		TCGA-61-1728-01		TCGA-61-1728-01A-01W-0699-08	bf909020-d6a1-49f1-8007-4192d39abd04			TCGA-61-1728-01A-01R-1568-13	TCGA-61-1728-01A-01D-0652-05	TCGA-61-1728-01	TCGA-61-1728-01	TCGA-61-1728-01A-01D-0648-01	TCGA-61-1728-01	TCGA-61-1728-01A-01D-0648-01	aea4673c-80e9-4ef8-a833-cf71ace574a7	bf909020-d6a1-49f1-8007-4192d39abd04	bf909020-d6a1-49f1-8007-4192d39abd04	aea4673c-80e9-4ef8-a833-cf71ace574a7		TCGA-61-1728-01A-01R-1568-13	TCGA-61-1728-01A-01R-0655-07		54635249-84d5-466b-b956-e125a7113132	bf909020-d6a1-49f1-8007-4192d39abd04	TCGA-61-1728-01A-01R-1568-13	TCGA-61-1728-01A-01W-0699-08	
TCGA-61-1730-01	1	TCGA-61-1730-01	132	1	High		OV-like c1	OV-like c4					TCGA-61-1730	132	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Left	TCGA-61-1730-F28161	Stage IC	-28508		132	0	132						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.2		NO	G3					TCGA-61-1730.4624968a-27c1-4f4f-b9f1-3e6997c15a21.pdf					5	15			0	0	0	0	95	85	90	90		WITH TUMOR	NO				NO		Primary Tumor	01	0.4			61	1-10 mm	Ovary	NO	A	DECEASED	2007		TCGA-61-1730-01				1a49f3dd-f92d-4206-bce7-05a2ff6df71e			TCGA-61-1730-01A-01D-0581-05			TCGA-61-1730-01A-01D-0577-01	TCGA-61-1730-01	TCGA-61-1730-01A-01D-0577-01	234848ba-4be8-4507-8ec0-462398e50a26			234848ba-4be8-4507-8ec0-462398e50a26	TCGA-61-1730-01A-21-1559-20		TCGA-61-1730-01A-01R-0584-07		59246787-027e-4aea-8a7e-04521b0f96a6				TCGA-61-1730-01A-01W-0639-09
TCGA-61-1733-01	0	TCGA-61-1733-01	967	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-61-1733	967	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-61-1733-F28163	Stage IIIC	-26180			0	967		175				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G3	Recurrence				TCGA-61-1733.bc4e6e92-d716-4ab3-8459-4f339caecffd.pdf		5			5	2			0	0	0	0	95	98	85	85		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.2			61	No Macroscopic disease	Ovary	YES	A	LIVING	2006		TCGA-61-1733-01			e6f856bf-0694-4c21-aecc-0d8dd54761f1	1b2390f5-f59e-4c94-8586-35b620e0dc4d		TCGA-61-1733-01A-01R-1567-13	TCGA-61-1733-01A-01D-0581-05	TCGA-61-1733-01	TCGA-61-1733-01	TCGA-61-1733-01A-01D-0577-01	TCGA-61-1733-01	TCGA-61-1733-01A-01D-0577-01	825d3945-c096-414d-9671-1525b08e6107	e6f856bf-0694-4c21-aecc-0d8dd54761f1	e6f856bf-0694-4c21-aecc-0d8dd54761f1	825d3945-c096-414d-9671-1525b08e6107	TCGA-61-1733-01A-21-1559-20	TCGA-61-1733-01A-01R-1567-13	TCGA-61-1733-01A-01R-0584-07		dd206c0f-dd03-40ee-ad76-e6b3bf84ffc8	e6f856bf-0694-4c21-aecc-0d8dd54761f1	TCGA-61-1733-01A-01R-1567-13		TCGA-61-1733-01A-01W-0639-09
TCGA-61-1734-01	0	TCGA-61-1734-01	866	0	Squamous		OV-like c1	OV-like c4					TCGA-61-1734	866	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-61-1734-F28171	Stage IC	-19026			0	866						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2		YES	G3										0	0			0	0	5	10	95	90	99	99		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61		Ovary	YES	B	LIVING	2006		TCGA-61-1734-01				8d84c559-ee21-4b79-a879-99d3bc6a624e			TCGA-61-1734-01B-01D-0667-05			TCGA-61-1734-01B-01D-0663-01	TCGA-61-1734-01	TCGA-61-1734-01B-01D-0663-01	c5dc8961-d6a6-495f-a6c3-51b5ca3ff874			c5dc8961-d6a6-495f-a6c3-51b5ca3ff874	TCGA-61-1734-01B-21-1559-20		TCGA-61-1734-01B-01R-0670-07		b3b6480c-a96b-44c5-9590-e0659b2fc9ad				
TCGA-61-1736-01	1	TCGA-61-1736-01	1484	1	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-1736	1484	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Bilateral	TCGA-61-1736-F28175	Stage IIIC	-16613		1484	0	1484		764				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Excisional Biopsy		0.8	NO		1		YES	G3	Recurrence									1	0			0	0	39	30	60	70	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61		Ovary	YES	B	DECEASED	2005		TCGA-61-1736-01		TCGA-61-1736-01B-01W-0722-08	89f1ae39-c387-4dff-be38-e3b7265222bb	de7da1bd-3d13-495a-a931-5ae952aa5ea3		TCGA-61-1736-01B-01R-1568-13	TCGA-61-1736-01B-01D-0667-05	TCGA-61-1736-01	TCGA-61-1736-01	TCGA-61-1736-01B-01D-0663-01	TCGA-61-1736-01	TCGA-61-1736-01B-01D-0663-01	f2a87dfd-48e3-4ca8-be68-808d869dbfec	89f1ae39-c387-4dff-be38-e3b7265222bb	89f1ae39-c387-4dff-be38-e3b7265222bb	f2a87dfd-48e3-4ca8-be68-808d869dbfec	TCGA-61-1736-01B-21-1559-20	TCGA-61-1736-01B-01R-1568-13	TCGA-61-1736-01B-01R-0670-07		4f3d65e1-2001-48dc-bded-b8dd0a949c2c	89f1ae39-c387-4dff-be38-e3b7265222bb	TCGA-61-1736-01B-01R-1568-13	TCGA-61-1736-01B-01W-0722-08	
TCGA-61-1737-01	0	TCGA-61-1737-01	1364	0	High		OV-like c1			miRNA cluster 1	cluster 5		TCGA-61-1737	1364	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			42	Bilateral	TCGA-61-1737-F28182	Stage IV	-15515			0	1364						2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.3	NO		0.7		YES	G3					TCGA-61-1737.2fa09bf8-8be5-411c-a9cf-16c12ed1390f.pdf	5				5	10			0	0	0	0	95	90	85	90		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2005		TCGA-61-1737-01						TCGA-61-1737-01A-01R-1567-13	TCGA-61-1737-01A-01D-0581-05			TCGA-61-1737-01A-01D-0577-01	TCGA-61-1737-01	TCGA-61-1737-01A-01D-0577-01	d71d3446-dc5c-491c-a2a8-930aeb4c256e			d71d3446-dc5c-491c-a2a8-930aeb4c256e		TCGA-61-1737-01A-01R-1567-13	TCGA-61-1737-01A-01R-0584-07		478e4825-4983-4315-aeda-12145a87f92b		TCGA-61-1737-01A-01R-1567-13		TCGA-61-1737-01A-01W-0639-09
TCGA-61-1738-01	1	TCGA-61-1738-01	1089	1	High	C9-OV	UCEC Serous c4	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-1738	1089	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	60	Right	TCGA-61-1738-F28190	Stage IIIC	-21965		1089	0	1089		276				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.2		YES	G3	Recurrence				TCGA-61-1738.05898c76-9832-4724-ada5-ff47eb3838b5.pdf	3		2		5	2			0	0	0	0	95	98	90	95		WITH TUMOR	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	DECEASED	2005		TCGA-61-1738-01			1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	3fed489e-8243-43c5-8ca2-37979d540d22		TCGA-61-1738-01A-01R-1567-13	TCGA-61-1738-01A-01D-0581-05	TCGA-61-1738-01	TCGA-61-1738-01	TCGA-61-1738-01A-01D-0577-01	TCGA-61-1738-01	TCGA-61-1738-01A-01D-0577-01	217579ca-cc7a-4c54-a669-1b511735f20e	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	217579ca-cc7a-4c54-a669-1b511735f20e	TCGA-61-1738-01A-21-1559-20	TCGA-61-1738-01A-01R-1567-13	TCGA-61-1738-01A-01R-0584-07		4c4af8bd-a614-4875-bdb5-4e8c64c4d134	1ca9af90-a8db-4f7e-b17a-0bf32fed98c7	TCGA-61-1738-01A-01R-1567-13		TCGA-61-1738-01A-01W-0639-09
TCGA-61-1740-01	1	TCGA-61-1740-01	74	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 2		TCGA-61-1740	74	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Right	TCGA-61-1740-F28198	Stage IIIC	-26169		74	0	74			3			2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.6		YES	G3					TCGA-61-1740.b87690ba-0cd2-458e-938f-553cd5ab6d84.pdf	5	10			2	2			0	0	0	0	98	98	90	85	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.3			61	>20 mm	Ovary	YES	A	DECEASED	2005		TCGA-61-1740-01			e7825482-380d-4323-a4fb-d11b365c7073	3349b819-24fe-404f-a480-0e94ed56a1cd		TCGA-61-1740-01A-01R-1567-13	TCGA-61-1740-01A-01D-0581-05	TCGA-61-1740-01	TCGA-61-1740-01	TCGA-61-1740-01A-01D-0577-01	TCGA-61-1740-01	TCGA-61-1740-01A-01D-0577-01	dbcc180d-1916-4914-8ca8-44ba79083add	e7825482-380d-4323-a4fb-d11b365c7073	e7825482-380d-4323-a4fb-d11b365c7073	dbcc180d-1916-4914-8ca8-44ba79083add	TCGA-61-1740-01A-21-1559-20	TCGA-61-1740-01A-01R-1567-13	TCGA-61-1740-01A-01R-0584-07		7e650317-6bd3-4ad9-b4ad-47178983707c	e7825482-380d-4323-a4fb-d11b365c7073	TCGA-61-1740-01A-01R-1567-13		TCGA-61-1740-01A-01W-0639-09
TCGA-61-1741-01	1	TCGA-61-1741-01	1024	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 3		TCGA-61-1741	1024	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	76	Bilateral	TCGA-61-1741-F28201	Stage IIIB	-27762		1024	0	1024		488				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G3	Recurrence				TCGA-61-1741.e2d0ec41-559c-48d4-8c4d-59e0f9d48823.pdf	5	3		2	5	15			0	0	0	0	95	85	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	>20 mm	Ovary	NO	A	DECEASED	2004		TCGA-61-1741-01			92d5764e-c576-47cd-a6bd-68ed0365c213	4da87c92-0d8f-4475-b5c8-332329e3d7b2		TCGA-61-1741-01A-02R-1567-13	TCGA-61-1741-01A-02D-0581-05	TCGA-61-1741-01	TCGA-61-1741-01	TCGA-61-1741-01A-02D-0577-01	TCGA-61-1741-01	TCGA-61-1741-01A-02D-0577-01	ecf278dc-02fe-48ca-82ac-14f7a013aba1	92d5764e-c576-47cd-a6bd-68ed0365c213	92d5764e-c576-47cd-a6bd-68ed0365c213	ecf278dc-02fe-48ca-82ac-14f7a013aba1	TCGA-61-1741-01A-11-1563-20	TCGA-61-1741-01A-02R-1567-13	TCGA-61-1741-01A-02R-0584-07		fba783f9-28fc-41c2-b82a-1fcc55d19941	92d5764e-c576-47cd-a6bd-68ed0365c213	TCGA-61-1741-01A-02R-1567-13		TCGA-61-1741-01A-02W-0639-09
TCGA-61-1743-01	1	TCGA-61-1743-01	1329	1	High	C9-OV	OV-like c1	BRCA basal-like c6	OV-like c16	miRNA cluster 1	cluster 1		TCGA-61-1743	1329	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma		NO	53	Bilateral	TCGA-61-1743-F28209	Stage IIC	-19365		1329	0	1329		809				2009-6-2	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G2	Recurrence				TCGA-61-1743.190b258b-d756-4872-b5f4-53c2d10e86b1.pdf	10				5	5			0	0	0	0	95	95	80	90		WITH TUMOR	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61	No Macroscopic disease	Ovary		A	DECEASED	2004		TCGA-61-1743-01			f3277084-b0a8-43df-946e-dc792bbb8cdb	a6fffcf6-69f4-4c40-b183-a0345dacff1a		TCGA-61-1743-01A-01R-1568-13	TCGA-61-1743-01A-01D-0652-05	TCGA-61-1743-01	TCGA-61-1743-01	TCGA-61-1743-01A-01D-0648-01	TCGA-61-1743-01	TCGA-61-1743-01A-01D-0648-01	fb06147a-5892-4f9f-9698-4d71896fa8e7	f3277084-b0a8-43df-946e-dc792bbb8cdb	f3277084-b0a8-43df-946e-dc792bbb8cdb	fb06147a-5892-4f9f-9698-4d71896fa8e7	TCGA-61-1743-01A-21-1559-20	TCGA-61-1743-01A-01R-1568-13	TCGA-61-1743-01A-01R-0655-07		5e99b999-2c02-4a1b-97b6-176afa3edfb3	f3277084-b0a8-43df-946e-dc792bbb8cdb	TCGA-61-1743-01A-01R-1568-13		
TCGA-61-1895-01	0	TCGA-61-1895-01	44	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1895	44	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			52	Bilateral	TCGA-61-1895-F28213	Stage IIIB	-19060			0	44						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.1		YES	G3					TCGA-61-1895.b33d3a26-d864-4669-b06e-1335be4e9e3a.pdf					5	5			2	2	8	8	85	85	90	90		TUMOR FREE	YES	Stable Disease			NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2009		TCGA-61-1895-01				9525c377-b25f-422f-8da7-60319fc43d79		TCGA-61-1895-01A-01R-1567-13	TCGA-61-1895-01A-01D-0581-05			TCGA-61-1895-01A-01D-0577-01	TCGA-61-1895-01	TCGA-61-1895-01A-01D-0577-01	e5916941-3135-4a54-a047-35f554a226e7			e5916941-3135-4a54-a047-35f554a226e7	TCGA-61-1895-01A-21-1559-20		TCGA-61-1895-01A-01R-0584-07		7ca1db65-98e8-471a-81d5-063d6c3c3a0c				TCGA-61-1895-01A-01W-0639-09
TCGA-61-1899-01	0	TCGA-61-1899-01	256	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1899	256	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			81	Left	TCGA-61-1899-F28217	Stage IIIC	-29692			0	256						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5			G3					TCGA-61-1899.0b416e24-55c4-4235-b56b-9dc1507ee5ef.pdf					0	1			0	0	5	5	95	94	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008		TCGA-61-1899-01				fdb5929a-eedd-48b3-9938-5d08ac8ba4fc		TCGA-61-1899-01A-01R-1567-13	TCGA-61-1899-01A-01D-0581-05			TCGA-61-1899-01A-01D-0577-01	TCGA-61-1899-01	TCGA-61-1899-01A-01D-0577-01	0056b0fa-8cd7-4e78-a76b-9c616246f9c2			0056b0fa-8cd7-4e78-a76b-9c616246f9c2	TCGA-61-1899-01A-21-1559-20		TCGA-61-1899-01A-01R-0584-07		06aa647b-fe58-4a63-976b-9bd171297b87				TCGA-61-1899-01A-01W-0639-09
TCGA-61-1900-01	0	TCGA-61-1900-01	176	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-1900	176	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-61-1900-F28221	Stage IIIB	-18963			0	176						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.5		NO	G3					TCGA-61-1900.b0dd202d-16dc-42ec-ad83-6f02b37b919f.pdf					10	0			0	0	10	5	80	95	90	95		TUMOR FREE	YES	Stable Disease			NO		Primary Tumor	01	0.6			61	No Macroscopic disease	Ovary	NO	A	LIVING	2008		TCGA-61-1900-01			92adf6a1-4880-4ee4-8ebe-09a943dbfe04	c3a92cba-410a-4853-8bae-4bec74b693d7		TCGA-61-1900-01A-01R-1567-13	TCGA-61-1900-01A-01D-0581-05	TCGA-61-1900-01	TCGA-61-1900-01	TCGA-61-1900-01A-01D-0577-01	TCGA-61-1900-01	TCGA-61-1900-01A-01D-0577-01	a1cff263-34f4-4b99-b038-3089c69c120f	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	a1cff263-34f4-4b99-b038-3089c69c120f	TCGA-61-1900-01A-21-1559-20	TCGA-61-1900-01A-01R-1567-13	TCGA-61-1900-01A-01R-0584-07		c5d1eb0e-d7a4-49e1-9a07-1abe99e33881	92adf6a1-4880-4ee4-8ebe-09a943dbfe04	TCGA-61-1900-01A-01R-1567-13		TCGA-61-1900-01A-01W-0639-09
TCGA-61-1901-01	1	TCGA-61-1901-01	347	1	Squamous		OV-like c1			miRNA cluster 1	cluster 6		TCGA-61-1901	347	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	65	Bilateral	TCGA-61-1901-F28226	Stage IV	-24042		347	0	347		329				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.9	NO		1.3		YES	G3	Progression of Disease				TCGA-61-1901.bf0681ba-341e-4c73-8081-7400740ffcb3.pdf					0	0			0	0	20	20	80	80	80	80		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.3			61		Ovary	YES	A	DECEASED	2008		TCGA-61-1901-01						TCGA-61-1901-01A-01R-1567-13	TCGA-61-1901-01A-01D-0581-05			TCGA-61-1901-01A-01D-0577-01	TCGA-61-1901-01	TCGA-61-1901-01A-01D-0577-01	87ae7c63-445c-420a-9fc0-f9e4e03d131e			87ae7c63-445c-420a-9fc0-f9e4e03d131e			TCGA-61-1901-01A-01R-0584-07		e34c17f8-b6a2-4c24-bba7-d9548a0cca89				TCGA-61-1901-01A-01W-0639-09
TCGA-61-1903-01	0	TCGA-61-1903-01	396	0	High		OV-like c1	OV-like c4					TCGA-61-1903	396	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Bilateral	TCGA-61-1903-F28231	Stage IB	-20381			0	396						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2		NO	G3					TCGA-61-1903.879ac4e3-cb0d-4fcb-a51d-8cbc6ad0c4a0.pdf					1	1			0	0	5	5	94	94	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61		Ovary	NO	A	LIVING	2007		TCGA-61-1903-01				57c3b3e8-b200-43e1-9f63-f7e0f872ca8c			TCGA-61-1903-01A-01D-0581-05			TCGA-61-1903-01A-01D-0577-01	TCGA-61-1903-01	TCGA-61-1903-01A-01D-0577-01	f9ef779b-0228-4ef1-a6c4-824dff5460d2			f9ef779b-0228-4ef1-a6c4-824dff5460d2	TCGA-61-1903-01A-21-1559-20		TCGA-61-1903-01A-01R-0584-07		9bcc6171-29ca-40b3-880a-2e3e95a95f94				TCGA-61-1903-01A-01W-0639-09
TCGA-61-1904-01	0	TCGA-61-1904-01	276	0	High		OV-like c1						TCGA-61-1904	276	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Bilateral	TCGA-61-1904-F28236	Stage IIIC	-22009			0	276						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection							NO	G3																							TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01				61	1-10 mm	Ovary	NO		LIVING	2007		TCGA-61-1904-01							TCGA-61-1904-01A-01D-0581-05			TCGA-61-1904-01A-01D-0577-01	TCGA-61-1904-01	TCGA-61-1904-01A-01D-0577-01	d51d1aba-7551-440d-b917-0ed23c8224dd			d51d1aba-7551-440d-b917-0ed23c8224dd			TCGA-61-1904-01A-01R-0584-07		ac3f73b4-4953-4836-8834-43729c647ac3				TCGA-61-1904-01A-01W-0639-09
TCGA-61-1906-01	1	TCGA-61-1906-01	1038	1	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 6		TCGA-61-1906	1038	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Bilateral	TCGA-61-1906-F28240	Stage IIIC	-20378		1038	0	1038		236				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3	Recurrence				TCGA-61-1906.a540b6e3-4a34-4546-a91a-a6bcd09921bd.pdf					0	0			0	0	20	5	80	95	80	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			61	11-20 mm	Ovary	YES	A	DECEASED	2006		TCGA-61-1906-01				f3b04ec3-bd80-437b-be87-aa7b75249821		TCGA-61-1906-01A-01R-1567-13	TCGA-61-1906-01A-01D-0581-05			TCGA-61-1906-01A-01D-0577-01	TCGA-61-1906-01	TCGA-61-1906-01A-01D-0577-01	a8f002eb-8a8f-4d7f-a93e-5b7b6fdeb975			a8f002eb-8a8f-4d7f-a93e-5b7b6fdeb975	TCGA-61-1906-01A-21-1559-20		TCGA-61-1906-01A-01R-0584-07		9e164e07-0887-4e9d-8e54-92e2b9621257				TCGA-61-1906-01A-01W-0639-09
TCGA-61-1907-01	0	TCGA-61-1907-01	952	0	Squamous	C9-OV	OV-like c1	UCEC-like c5	OV-like c16	miRNA cluster 1	cluster 4		TCGA-61-1907	952	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Bilateral	TCGA-61-1907-F28250	Stage IIIC	-23204			0	952		743				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.9	NO		1.6			G3	Recurrence				TCGA-61-1907.ae7e4795-496e-47d0-ad60-cec04e5876b0.pdf					0	1			0	0	5	5	95	94	95	95		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary	YES	A	LIVING	2006		TCGA-61-1907-01			6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	2356261e-fe60-47da-9f8e-c06bfe510a03		TCGA-61-1907-01A-01R-1567-13	TCGA-61-1907-01A-01D-0581-05	TCGA-61-1907-01	TCGA-61-1907-01	TCGA-61-1907-01A-01D-0577-01	TCGA-61-1907-01	TCGA-61-1907-01A-01D-0577-01	ca3115ed-9f4b-4831-aa71-7321a71295d2	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	ca3115ed-9f4b-4831-aa71-7321a71295d2	TCGA-61-1907-01A-21-1559-20	TCGA-61-1907-01A-01R-1567-13	TCGA-61-1907-01A-01R-0584-07		429e7e1a-3ded-46a3-9eee-aa048cbfade2	6d9a1fe4-7131-487c-a7ff-0cf8a53919ed	TCGA-61-1907-01A-01R-1567-13		TCGA-61-1907-01A-01W-0639-09
TCGA-61-1910-01	0	TCGA-61-1910-01	1127	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 6		TCGA-61-1910	1127	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			56	Bilateral	TCGA-61-1910-F28256	Stage IIC	-20779			0	1127						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.5		YES	G3					TCGA-61-1910.32905714-6e41-4df8-91dd-6d3068475b40.pdf					1	1			0	0	5	5	94	94	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61	1-10 mm	Ovary	YES	A	LIVING	2006		TCGA-61-1910-01			65e4e40b-f27f-4b84-9979-af659564363d	18b958a6-f51e-4fb3-a240-cfe22c05d967		TCGA-61-1910-01A-01R-1567-13	TCGA-61-1910-01A-01D-0581-05	TCGA-61-1910-01	TCGA-61-1910-01	TCGA-61-1910-01A-01D-0577-01	TCGA-61-1910-01	TCGA-61-1910-01A-01D-0577-01	5cfffde5-d299-47e2-8016-f4959d6c88f2	65e4e40b-f27f-4b84-9979-af659564363d	65e4e40b-f27f-4b84-9979-af659564363d	5cfffde5-d299-47e2-8016-f4959d6c88f2	TCGA-61-1910-01A-21-1559-20	TCGA-61-1910-01A-01R-1567-13	TCGA-61-1910-01A-01R-0584-07		e61d1b4c-7a8a-431c-bef5-1be42deda0c1	65e4e40b-f27f-4b84-9979-af659564363d	TCGA-61-1910-01A-01R-1567-13		TCGA-61-1910-01A-01W-0639-09
TCGA-61-1911-01	0	TCGA-61-1911-01	1293	0	High		OV-like c1	OV-like c4		miRNA cluster 1	cluster 2		TCGA-61-1911	1293	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	55	Left	TCGA-61-1911-F28260	Stage IIA	-20144			0	1293		844				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		2		YES	G3	Recurrence				TCGA-61-1911.ba6325b4-af61-42cc-b84c-aacee9d7ecc8.pdf					1	0			0	0	5	5	94	95	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2005		TCGA-61-1911-01				18959b13-60ff-43b5-8f53-acee023d775a		TCGA-61-1911-01A-01R-1567-13	TCGA-61-1911-01A-01D-0581-05			TCGA-61-1911-01A-01D-0577-01	TCGA-61-1911-01	TCGA-61-1911-01A-01D-0577-01	47a40c55-6066-499f-a0ab-127555f66481			47a40c55-6066-499f-a0ab-127555f66481	TCGA-61-1911-01A-21-1559-20	TCGA-61-1911-01A-01R-1567-13	TCGA-61-1911-01A-01R-0584-07		70685d12-f206-43bd-bc6d-1954ffa1b600		TCGA-61-1911-01A-01R-1567-13		TCGA-61-1911-01A-01W-0639-09
TCGA-61-1913-01	0	TCGA-61-1913-01	1488	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1913	1488	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Right	TCGA-61-1913-F28269	Stage IIIB	-17575			0	1488						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1			G3					TCGA-61-1913.b789ee6d-d1e2-4836-8bdc-3c59b0729ee1.pdf					1	0			0	0	10	5	89	95	90	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61	1-10 mm	Ovary	YES	A	LIVING	2005		TCGA-61-1913-01				a97ee569-979a-4d19-bf30-61dd734ed78d		TCGA-61-1913-01A-01R-1567-13	TCGA-61-1913-01A-01D-0581-05			TCGA-61-1913-01A-01D-0577-01	TCGA-61-1913-01	TCGA-61-1913-01A-01D-0577-01	b3877e46-6cd0-4123-9909-2698a8f627ce			b3877e46-6cd0-4123-9909-2698a8f627ce	TCGA-61-1913-01A-21-1559-20		TCGA-61-1913-01A-01R-0584-07		7b569b43-ae4c-4611-8852-1e8213c1d7ae				TCGA-61-1913-01A-01W-0639-09
TCGA-61-1914-01	0	TCGA-61-1914-01	1722	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 1		TCGA-61-1914	1722	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-61-1914-F28273	Stage IIIC	-23850			0	1722		1674				2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2		YES	G3	Recurrence				TCGA-61-1914.b634b2cf-9e8d-4dd4-8442-337c22522a43.pdf					5	1			0	0	10	10	85	89	90	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	>20 mm	Ovary	YES	A	LIVING	2003		TCGA-61-1914-01			0d75483f-eab3-41c8-b2cc-453af29b6f44	7497a274-7ee4-423f-a0bd-59afb02a305e		TCGA-61-1914-01A-01R-1567-13	TCGA-61-1914-01A-01D-0581-05	TCGA-61-1914-01	TCGA-61-1914-01	TCGA-61-1914-01A-01D-0577-01	TCGA-61-1914-01	TCGA-61-1914-01A-01D-0577-01	841485f0-4b77-4204-b84a-315f8c1fb560	0d75483f-eab3-41c8-b2cc-453af29b6f44	0d75483f-eab3-41c8-b2cc-453af29b6f44	841485f0-4b77-4204-b84a-315f8c1fb560	TCGA-61-1914-01A-21-1559-20	TCGA-61-1914-01A-01R-1567-13	TCGA-61-1914-01A-01R-0584-07		32a0bd09-8cc4-46e6-a36d-67478fab51fc	0d75483f-eab3-41c8-b2cc-453af29b6f44	TCGA-61-1914-01A-01R-1567-13		TCGA-61-1914-01A-01W-0639-09
TCGA-61-1915-01	0	TCGA-61-1915-01	2061	0	Squamous		OV-like c1	OV-like c4		miRNA cluster 1	cluster 4		TCGA-61-1915	2061	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			50	Bilateral	TCGA-61-1915-F28280	Stage IIC	-18424			0	2061						2009-10-1	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1			G3					TCGA-61-1915.1c305700-d86f-449a-a556-02f32484dda1.pdf					1	1			0	0	5	5	94	94	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2003		TCGA-61-1915-01				407fd5a4-3e13-42c6-9f10-424562adfee5		TCGA-61-1915-01A-01R-1567-13	TCGA-61-1915-01A-01D-0581-05			TCGA-61-1915-01A-01D-0577-01	TCGA-61-1915-01	TCGA-61-1915-01A-01D-0577-01	4d1b7d5b-3060-48ed-8a7c-1b51741719b1			4d1b7d5b-3060-48ed-8a7c-1b51741719b1	TCGA-61-1915-01A-21-1559-20		TCGA-61-1915-01A-01R-0584-07		4c9b5377-7e2c-4a97-9663-3ff18822053c				TCGA-61-1915-01A-01W-0639-09
TCGA-61-1916-01	1	TCGA-61-1916-01	475	1	Quiet		OV-like c1	OV-like c4					TCGA-61-1916	475	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			53	Bilateral	TCGA-61-1916-F28284	Stage IIIC	-19463		475	0	475		326				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)								G2	Recurrence																							YES				NO	R1	Primary Tumor	01				61	1-10 mm	Ovary	YES		DECEASED	2002						e7b8ce5d-a28b-44c9-8b3a-d52882fce319			TCGA-61-1916-01A-01D-0807-05				TCGA-61-1916-01						TCGA-61-1916-01A-21-1559-20		TCGA-61-1916-01A-01R-0810-07		aab4f5cd-7169-41e6-ae24-2bddbd752f62				
TCGA-61-1916-02	1	TCGA-61-1916-02	475	1			OV-like c1						TCGA-61-1916	475	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			53	Bilateral	TCGA-61-1916-F28284	Stage IIIC	-19463		475	0	475		326				2010-2-26	FEMALE	Serous Cystadenocarcinoma	No		8461/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.3	NO		1.8			G2	Recurrence									0	0	0	0	0	0	5	5	95	95	90	90			YES				NO	R1	Recurrent Tumor	02	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2002									TCGA-61-1916-02A-01D-0807-05						355408fe-aef5-4207-964d-34ec652840f5			355408fe-aef5-4207-964d-34ec652840f5			TCGA-61-1916-02A-01R-0810-07		6490d8bc-620c-45d2-9314-97ec1b52e4d0				
TCGA-61-1917-01	1	TCGA-61-1917-01	1321	1	High		OV-like c1		OV-like c16	miRNA cluster 1	cluster 4		TCGA-61-1917	1321	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			60	Bilateral	TCGA-61-1917-F28290	Stage IIIB	-21972		1321	0	1321						2009-11-30	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		2			G3					TCGA-61-1917.ebb81051-f181-4878-85ac-7e00ad6aca85.pdf					5	10			0	0	10	10	85	80	90	90			YES	Complete Remission/Response			NO		Primary Tumor	01	0.1			61		Ovary	NO	A	DECEASED	2002		TCGA-61-1917-01			519aea8b-5e08-47b2-bb98-b311f2dba540			TCGA-61-1917-01A-01R-1568-13	TCGA-61-1917-01A-01D-0652-05	TCGA-61-1917-01	TCGA-61-1917-01	TCGA-61-1917-01A-01D-0648-01	TCGA-61-1917-01	TCGA-61-1917-01A-01D-0648-01	570200ec-cb6e-48a2-8c86-612593ce4c76	519aea8b-5e08-47b2-bb98-b311f2dba540	519aea8b-5e08-47b2-bb98-b311f2dba540	570200ec-cb6e-48a2-8c86-612593ce4c76		TCGA-61-1917-01A-01R-1568-13	TCGA-61-1917-01A-01R-0655-07		5005b439-42ac-4dc7-aa13-3817d6091536	519aea8b-5e08-47b2-bb98-b311f2dba540	TCGA-61-1917-01A-01R-1568-13		
TCGA-61-1918-01	1	TCGA-61-1918-01	479	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2		TCGA-61-1918	479	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	45	Bilateral	TCGA-61-1918-F28295	Stage IV	-16689		479	0	479		413				2009-11-30	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1			G3	Recurrence				TCGA-61-1918.6c95bd12-e871-4e4e-961f-09a64c1fe2de.pdf					15	10			0	0	15	10	70	80	85	90		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2002		TCGA-61-1918-01			62f75d97-ea9e-4694-8c83-1a0e6d137a02	8c7cf533-1039-4e1a-9a0a-83c8d8c2e597		TCGA-61-1918-01A-01R-1568-13	TCGA-61-1918-01A-01D-0652-05	TCGA-61-1918-01	TCGA-61-1918-01	TCGA-61-1918-01A-01D-0648-01	TCGA-61-1918-01	TCGA-61-1918-01A-01D-0648-01	eaa038ef-a98e-4cae-a8b2-11d6afd9991c	62f75d97-ea9e-4694-8c83-1a0e6d137a02	62f75d97-ea9e-4694-8c83-1a0e6d137a02	eaa038ef-a98e-4cae-a8b2-11d6afd9991c	TCGA-61-1918-01A-21-1559-20	TCGA-61-1918-01A-01R-1568-13	TCGA-61-1918-01A-01R-0655-07		5f2955fc-dc80-4ce8-93d6-6db708af6ea4	62f75d97-ea9e-4694-8c83-1a0e6d137a02	TCGA-61-1918-01A-01R-1568-13		
TCGA-61-1919-01	1	TCGA-61-1919-01	1161	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-1919	1161	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	58	Bilateral	TCGA-61-1919-F28300	Stage IIIC	-21199		1161	0	1161		439				2009-11-30	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.5			G2	Recurrence				TCGA-61-1919.240a49a3-b611-4949-b3b9-3799d8c0dc46.pdf					5	10			0	0	20	20	75	70	80	80			YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61		Ovary		A	DECEASED	2001		TCGA-61-1919-01		TCGA-61-1919-01A-01W-0699-08	056cca38-92df-42ff-b064-b0c243f8a82f	278e1675-c8e6-4578-b83d-4cd82de93d4b		TCGA-61-1919-01A-01R-1568-13	TCGA-61-1919-01A-01D-0652-05	TCGA-61-1919-01	TCGA-61-1919-01	TCGA-61-1919-01A-01D-0648-01	TCGA-61-1919-01	TCGA-61-1919-01A-01D-0648-01	098abc3c-1001-415f-847a-53bfee74ab79	056cca38-92df-42ff-b064-b0c243f8a82f	056cca38-92df-42ff-b064-b0c243f8a82f	098abc3c-1001-415f-847a-53bfee74ab79	TCGA-61-1919-01A-21-1559-20	TCGA-61-1919-01A-01R-1568-13	TCGA-61-1919-01A-01R-0655-07		e2935fb6-7c83-4691-b144-029cd17eadac	056cca38-92df-42ff-b064-b0c243f8a82f	TCGA-61-1919-01A-01R-1568-13		
TCGA-61-1995-01	0	TCGA-61-1995-01	61	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 13	TCGA-61-1995	61	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			43	Bilateral	TCGA-61-1995-F28302	Stage IIIC	-16016			0	61						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		1.1		YES	G3					TCGA-61-1995.5ea6d43b-376d-43cb-873f-c33ec814a95d.pdf					10	12			8	10	8	10	74	68	75	75		WITH TUMOR	YES	Stable Disease			NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2009		TCGA-61-1995-01		TCGA-61-1995-01A-01W-0722-08	13b2c972-c6ef-4d1f-8ada-f831d2606023	1bdc5555-06ec-496c-ac44-b8847ca95fb5		TCGA-61-1995-01A-01R-1568-13	TCGA-61-1995-01A-01D-0667-05	TCGA-61-1995-01	TCGA-61-1995-01	TCGA-61-1995-01A-01D-0663-01	TCGA-61-1995-01	TCGA-61-1995-01A-01D-0663-01	41b84231-a3ed-464c-8dbf-e8164042de6a	13b2c972-c6ef-4d1f-8ada-f831d2606023	13b2c972-c6ef-4d1f-8ada-f831d2606023	41b84231-a3ed-464c-8dbf-e8164042de6a	TCGA-61-1995-01A-21-1559-20	TCGA-61-1995-01A-01R-1568-13	TCGA-61-1995-01A-01R-0670-07		180584fa-7aa6-4182-b57b-4e02365663e1	13b2c972-c6ef-4d1f-8ada-f831d2606023	TCGA-61-1995-01A-01R-1568-13	TCGA-61-1995-01A-01W-0722-08	
TCGA-61-1998-01	0	TCGA-61-1998-01	168	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-1998	168	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Bilateral	TCGA-61-1998-F28306	Stage IIIC	-17855			0	168						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1		YES	G3					TCGA-61-1998.788d25c6-75c4-4c85-be93-98dec021219a.pdf					5	15			15	15	72	40	8	30	90	90		WITH TUMOR	YES				NO		Primary Tumor	01	0.1			61	1-10 mm	Ovary	YES	A	LIVING	2009		TCGA-61-1998-01		TCGA-61-1998-01A-01W-0722-08	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d			TCGA-61-1998-01A-01R-1568-13	TCGA-61-1998-01A-01D-0667-05	TCGA-61-1998-01	TCGA-61-1998-01	TCGA-61-1998-01A-01D-0663-01	TCGA-61-1998-01	TCGA-61-1998-01A-01D-0663-01	81bfda42-19a0-4b57-9373-556b084db6c4	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	81bfda42-19a0-4b57-9373-556b084db6c4		TCGA-61-1998-01A-01R-1568-13	TCGA-61-1998-01A-01R-0670-07		03f33fd8-fd9b-46b0-8291-ba92d1d32102	0814c20e-fe77-4ff9-ab5e-a8ae2f74069d	TCGA-61-1998-01A-01R-1568-13	TCGA-61-1998-01A-01W-0722-08	
TCGA-61-2000-01	0	TCGA-61-2000-01	441	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2000	441	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	67	Bilateral	TCGA-61-2000-F28311	Stage IIIC	-24723			0	441		339				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1		YES	G3	Recurrence				TCGA-61-2000.4e13b897-c34a-4422-9c66-7ca8b2734ef2.pdf					8	15			8	10	5	10	79	65	90	90		WITH TUMOR	YES	Stable Disease		Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2008		TCGA-61-2000-01		TCGA-61-2000-01A-01W-0722-08	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	c7083eed-998f-456d-b294-5fbcf50eff88		TCGA-61-2000-01A-01R-1568-13	TCGA-61-2000-01A-01D-0667-05	TCGA-61-2000-01	TCGA-61-2000-01	TCGA-61-2000-01A-01D-0663-01	TCGA-61-2000-01	TCGA-61-2000-01A-01D-0663-01	7117504b-bdff-41de-8ca0-581fa89ee376	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	7117504b-bdff-41de-8ca0-581fa89ee376	TCGA-61-2000-01A-21-1559-20	TCGA-61-2000-01A-01R-1568-13	TCGA-61-2000-01A-01R-0670-07		4150fb96-e722-40db-a6d0-d55e60cc30f6	f4fccaa6-cd8c-4e5a-a7a8-beb63cf7b109	TCGA-61-2000-01A-01R-1568-13	TCGA-61-2000-01A-01W-0722-08	
TCGA-61-2002-01	0	TCGA-61-2002-01	547	0	High		OV-like c1			miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2002	547	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			46	Bilateral	TCGA-61-2002-F28321	Stage IIIC	-17115			0	547						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1.2		YES	G3					TCGA-61-2002.8030b8aa-9686-45b3-bf39-1889a6b8b36f.pdf					8	5			8	10	8	5	76	80	90	95		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.2			61	11-20 mm	Ovary	YES	A	LIVING	2008		TCGA-61-2002-01		TCGA-61-2002-01A-01W-0722-08				TCGA-61-2002-01A-01R-1568-13	TCGA-61-2002-01A-01D-0667-05			TCGA-61-2002-01A-01D-0663-01	TCGA-61-2002-01	TCGA-61-2002-01A-01D-0663-01	8ce1744c-f0ff-4e20-8cfd-098a79a9bc7b			8ce1744c-f0ff-4e20-8cfd-098a79a9bc7b		TCGA-61-2002-01A-01R-1568-13	TCGA-61-2002-01A-01R-0670-07		a31ab004-2dce-4cd6-a015-88c43ca44086		TCGA-61-2002-01A-01R-1568-13	TCGA-61-2002-01A-01W-0722-08	
TCGA-61-2003-01	0	TCGA-61-2003-01	122	0	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2003	122	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			53	Bilateral	TCGA-61-2003-F28327	Stage IIIC	-19605			0	122						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		1.4	NO		1.5		YES	G2					TCGA-61-2003.79c66510-6e38-470f-9e91-d774665d39a6.pdf					3	3			7	7	5	5	85	85	95	95		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.2			61	1-10 mm	Ovary	YES	A	LIVING	2008		TCGA-61-2003-01		TCGA-61-2003-01A-01W-0722-08		379f3f36-fb28-4eb4-8c56-24c0382bf38f		TCGA-61-2003-01A-01R-1568-13	TCGA-61-2003-01A-01D-0667-05			TCGA-61-2003-01A-01D-0663-01	TCGA-61-2003-01	TCGA-61-2003-01A-01D-0663-01	f7c3b854-9d24-4afd-9bae-a24d86227610			f7c3b854-9d24-4afd-9bae-a24d86227610	TCGA-61-2003-01A-21-1559-20	TCGA-61-2003-01A-01R-1568-13	TCGA-61-2003-01A-01R-0670-07		a878c841-59fa-4ef2-af20-dc8937f92b9b		TCGA-61-2003-01A-01R-1568-13	TCGA-61-2003-01A-01W-0722-08	
TCGA-61-2008-01	0	TCGA-61-2008-01	932	0	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 6	mutation cluster 5	TCGA-61-2008	932	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-61-2008-F28334	Stage IIC	-14791			0	932		818				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.2		YES	G2	Recurrence				TCGA-61-2008.25448427-9a2c-4c36-bc9d-40a82d6e3710.pdf					1	1			0	1	30	29	69	69	70	70		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	LIVING	2007		TCGA-61-2008-01		TCGA-61-2008-01A-02W-0722-08	10271f7f-cce6-44fd-8754-7a4beabfb394			TCGA-61-2008-01A-02R-1568-13	TCGA-61-2008-01A-02D-0667-05	TCGA-61-2008-01	TCGA-61-2008-01	TCGA-61-2008-01A-02D-0663-01	TCGA-61-2008-01	TCGA-61-2008-01A-02D-0663-01	715a71ed-ca25-4124-8273-0bf88e69d5cb	10271f7f-cce6-44fd-8754-7a4beabfb394	10271f7f-cce6-44fd-8754-7a4beabfb394	715a71ed-ca25-4124-8273-0bf88e69d5cb		TCGA-61-2008-01A-02R-1568-13	TCGA-61-2008-01A-02R-0670-07		5df0fa21-8263-4992-a797-44e2a1981b93	10271f7f-cce6-44fd-8754-7a4beabfb394	TCGA-61-2008-01A-02R-1568-13	TCGA-61-2008-01A-02W-0722-08	
TCGA-61-2008-02	0	TCGA-61-2008-02	932	0		C9-OV	OV-like c1		OV-like c16	miRNA cluster 1		mutation cluster 5	TCGA-61-2008	932	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-61-2008-F28334	Stage IIC	-14791			0	932		818				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.5	NO		2		YES	G2	Recurrence									10	5			0	0	5	5	75	80	85	85		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			61	No Macroscopic disease	Ovary	YES	A	LIVING	2007					b90a4b33-cb6f-4c75-bc26-ff316ea81cce			TCGA-61-2008-02A-01R-1568-13	TCGA-61-2008-02A-01D-0807-05						ac13ba9d-e8f3-44f1-9a72-cf4bbb9aa1a7	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	ac13ba9d-e8f3-44f1-9a72-cf4bbb9aa1a7		TCGA-61-2008-02A-01R-1568-13	TCGA-61-2008-02A-01R-0810-07		0d478984-a92d-491d-88e6-4a7621463012	b90a4b33-cb6f-4c75-bc26-ff316ea81cce	TCGA-61-2008-02A-01R-1568-13		
TCGA-61-2009-01	0	TCGA-61-2009-01	1212	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 2	TCGA-61-2009	1212	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	65	Bilateral	TCGA-61-2009-F28341	Stage IIIC	-23772			0	1212		101				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2		YES	G3	Recurrence				TCGA-61-2009.39de8c59-e593-47d3-932d-575a4537b4dc.pdf					5	1			0	0	10	5	85	94	90	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.2			61	11-20 mm	Ovary	YES	A	LIVING	2006		TCGA-61-2009-01		TCGA-61-2009-01A-01W-0722-08	b6ed2184-0885-49ba-8b00-a3e57e4e5500	8e12e5af-19de-4c90-a0b6-da67eeb438f4		TCGA-61-2009-01A-01R-1568-13	TCGA-61-2009-01A-01D-0667-05	TCGA-61-2009-01	TCGA-61-2009-01	TCGA-61-2009-01A-01D-0663-01	TCGA-61-2009-01	TCGA-61-2009-01A-01D-0663-01	0e1c9ec4-1b65-4dd9-ab99-2abc8fdea3ba	b6ed2184-0885-49ba-8b00-a3e57e4e5500	b6ed2184-0885-49ba-8b00-a3e57e4e5500	0e1c9ec4-1b65-4dd9-ab99-2abc8fdea3ba	TCGA-61-2009-01A-21-1559-20	TCGA-61-2009-01A-01R-1568-13	TCGA-61-2009-01A-01R-0670-07		c8e01e3b-9789-4216-b771-18ac3b062a4c	b6ed2184-0885-49ba-8b00-a3e57e4e5500	TCGA-61-2009-01A-01R-1568-13	TCGA-61-2009-01A-01W-0722-08	
TCGA-61-2012-01	0	TCGA-61-2012-01	932	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 8	TCGA-61-2012	932	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			81	Left	TCGA-61-2012-F28352	Stage IIC	-29830			0	932						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.6		YES	G2					TCGA-61-2012.534e3236-b9e7-4b0b-a2a3-2fc3a96fac81.pdf					10	10			0	0	10	10	80	80	90	90			YES				YES		Primary Tumor	01	0.4			61		Ovary	YES	A	LIVING	2006		TCGA-61-2012-01		TCGA-61-2012-01A-01W-0722-08	929c2bc4-4cee-4f82-b336-918fe041a588	6eb6997b-a982-44b0-ab5a-5faaa1b0c2be		TCGA-61-2012-01A-01R-1568-13	TCGA-61-2012-01A-01D-0667-05	TCGA-61-2012-01	TCGA-61-2012-01	TCGA-61-2012-01A-01D-0663-01	TCGA-61-2012-01	TCGA-61-2012-01A-01D-0663-01	4b634cdf-e7d6-4ac5-8128-d29baeb34bf8	929c2bc4-4cee-4f82-b336-918fe041a588	929c2bc4-4cee-4f82-b336-918fe041a588	4b634cdf-e7d6-4ac5-8128-d29baeb34bf8	TCGA-61-2012-01A-21-1559-20	TCGA-61-2012-01A-01R-1568-13	TCGA-61-2012-01A-01R-0670-07		12b5e477-31d5-4ec1-ac90-989ce781c36a	929c2bc4-4cee-4f82-b336-918fe041a588	TCGA-61-2012-01A-01R-1568-13	TCGA-61-2012-01A-01W-0722-08	
TCGA-61-2016-01	1	TCGA-61-2016-01	36	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2016	36	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-61-2016-F28357	Stage IIIC	-18788		36	0	36						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5		YES	G3					TCGA-61-2016.1bb87fde-9ff0-4c33-a388-b655f9647407.pdf					0	0			0	0	10	10	90	90	90	90		WITH TUMOR	YES	Progressive Disease			NO		Primary Tumor	01	0.1			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2006		TCGA-61-2016-01		TCGA-61-2016-01A-01W-0722-08	a391b870-b6fb-4ca8-b425-2331fceae442			TCGA-61-2016-01A-01R-1568-13	TCGA-61-2016-01A-01D-0667-05	TCGA-61-2016-01	TCGA-61-2016-01	TCGA-61-2016-01A-01D-0663-01	TCGA-61-2016-01	TCGA-61-2016-01A-01D-0663-01	a936f935-1d08-4408-a115-beaa5313f7c7	a391b870-b6fb-4ca8-b425-2331fceae442	a391b870-b6fb-4ca8-b425-2331fceae442	a936f935-1d08-4408-a115-beaa5313f7c7		TCGA-61-2016-01A-01R-1568-13	TCGA-61-2016-01A-01R-0670-07		4e470958-8a7a-4a48-a609-2d7f49b49bbf	a391b870-b6fb-4ca8-b425-2331fceae442	TCGA-61-2016-01A-01R-1568-13	TCGA-61-2016-01A-01W-0722-08	
TCGA-61-2017-01	0	TCGA-61-2017-01	1398	0	Squamous		OV-like c1	OV-like c4					TCGA-61-2017	1398	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	64	Bilateral	TCGA-61-2017-F28359	Stage IIIC	-23509			0	1398		1006				2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		0.8		NO	G1	Recurrence				TCGA-61-2017.b24757fc-4585-496e-b89e-f3dafac36b8b.pdf					1	0			0	0	5	5	94	95	95	95		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.3			61	1-10 mm	Ovary	NO	A	LIVING	2005		TCGA-61-2017-01				62d181c0-c0fb-44b3-9837-040f5780c2ff			TCGA-61-2017-01A-01D-0667-05			TCGA-61-2017-01A-01D-0663-01	TCGA-61-2017-01	TCGA-61-2017-01A-01D-0663-01	edb2fee4-9451-49ea-b330-f11eb396a51e			edb2fee4-9451-49ea-b330-f11eb396a51e	TCGA-61-2017-01A-21-1559-20		TCGA-61-2017-01A-01R-0670-07		7cfe4d7d-392d-4612-a29a-80ddafdfcbd0				
TCGA-61-2018-01	0	TCGA-61-2018-01	1381	0	High		OV-like c1	OV-like c4					TCGA-61-2018	1381	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Bilateral	TCGA-61-2018-F28366	Stage IC	-22929			0	1381						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.9		NO	G3					TCGA-61-2018.2aec8abd-7bdc-4ca3-a404-7dce57aea7c7.pdf					0	0			0	0	10	5	90	95	90	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61	No Macroscopic disease	Ovary	NO	A	LIVING	2005		TCGA-61-2018-01				99bf9379-737b-4b8c-9196-2c1fa0148eae			TCGA-61-2018-01A-01D-0667-05			TCGA-61-2018-01A-01D-0663-01	TCGA-61-2018-01	TCGA-61-2018-01A-01D-0663-01	1f1208d3-3643-4854-96c4-987e0d1068fd			1f1208d3-3643-4854-96c4-987e0d1068fd	TCGA-61-2018-01A-21-1559-20		TCGA-61-2018-01A-01R-0670-07		a13bb1ee-868f-4891-921f-d0005ebe1ab8				
TCGA-61-2087-01	0	TCGA-61-2087-01	146	0	High		OV-like c1	OV-like c4					TCGA-61-2087	146	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			49	Left	TCGA-61-2087-F28372	Stage IC	-18182			0	146						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		1.5		NO	G3					TCGA-61-2087.fadb191f-2726-4afe-a146-1d912ff4b5b8.pdf					1	1			0	0	5	5	94	94	95	95		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.6			61	No Macroscopic disease	Ovary	NO	A	LIVING	2009		TCGA-61-2087-01				b59fdd2e-4ec7-4e64-95fd-f5777ecdc89b			TCGA-61-2087-01A-01D-0667-05			TCGA-61-2087-01A-01D-0663-01	TCGA-61-2087-01	TCGA-61-2087-01A-01D-0663-01	5d9486c6-7129-4a67-9e77-cf33b58252f0			5d9486c6-7129-4a67-9e77-cf33b58252f0	TCGA-61-2087-01A-21-1560-20		TCGA-61-2087-01A-01R-0670-07		a60b189b-6316-4098-adc7-fefca69b803b				
TCGA-61-2088-01	0	TCGA-61-2088-01	145	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 12	cluster 5	mutation cluster 5	TCGA-61-2088	145	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			51	Bilateral	TCGA-61-2088-F28377	Stage IIIC	-18770			0	145						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.4		NO	G3					TCGA-61-2088.62624308-45b6-46f3-85a0-5a4639b44bf3.pdf					1	1			0	0	5	5	94	94	95	95		TUMOR FREE	YES				NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2009		TCGA-61-2088-01		TCGA-61-2088-01A-01W-0722-08	62fdea50-f152-4f43-9130-a93079b5e61f	2b716c21-1692-4b95-9363-0c6a23de28d6		TCGA-61-2088-01A-01R-1568-13	TCGA-61-2088-01A-01D-0667-05	TCGA-61-2088-01	TCGA-61-2088-01	TCGA-61-2088-01A-01D-0663-01	TCGA-61-2088-01	TCGA-61-2088-01A-01D-0663-01	666293a2-e6f7-4c1e-b299-de0fb8776c1b	62fdea50-f152-4f43-9130-a93079b5e61f	62fdea50-f152-4f43-9130-a93079b5e61f	666293a2-e6f7-4c1e-b299-de0fb8776c1b	TCGA-61-2088-01A-21-1560-20	TCGA-61-2088-01A-01R-1568-13	TCGA-61-2088-01A-01R-0670-07		9959458a-de14-4d2d-b13f-9ab2f0c88bf1	62fdea50-f152-4f43-9130-a93079b5e61f	TCGA-61-2088-01A-01R-1568-13		
TCGA-61-2092-01	0	TCGA-61-2092-01	1573	0	BRCA-LUAD+	C9-OV	UCEC non-CIMP c3	OV-like c4	COADREAD-like c15	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2092	1573	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			57	Bilateral	TCGA-61-2092-F28381	Stage IIIC	-21072			0	1573						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.2	NO		1.3		NO	G3					TCGA-61-2092.35b4bfa3-e6a5-4b55-a7f1-bc39953422c0.pdf					0	0			0	0	5	10	95	90	99	99		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2004		TCGA-61-2092-01		TCGA-61-2092-01A-01W-0722-08	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	94487130-5cc1-4f68-beab-57c211204449		TCGA-61-2092-01A-01R-1568-13	TCGA-61-2092-01A-01D-0667-05	TCGA-61-2092-01	TCGA-61-2092-01	TCGA-61-2092-01A-01D-0663-01	TCGA-61-2092-01	TCGA-61-2092-01A-01D-0663-01	8c29ee0e-c6d1-412a-93c3-9bc90c22b16d	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	8c29ee0e-c6d1-412a-93c3-9bc90c22b16d	TCGA-61-2092-01A-21-1560-20	TCGA-61-2092-01A-01R-1568-13	TCGA-61-2092-01A-01R-0670-07		cf1288eb-e5c8-4c90-9f83-f3bdcbd94a96	0ed6e7a9-cdaa-48dc-962f-219f1eb39c1a	TCGA-61-2092-01A-01R-1568-13	TCGA-61-2092-01A-01W-0722-08	
TCGA-61-2094-01	0	TCGA-61-2094-01	2182	0	Squamous	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 2	mutation cluster 5	TCGA-61-2094	2182	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			63	Bilateral	TCGA-61-2094-F28385	Stage IIIC	-23273			0	2182						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.1	NO		2			G3					TCGA-61-2094.205b0520-854c-480e-881d-89bc8cbcff75.pdf					2	5			0	0	18	5	80	90	99	99		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.3			61		Ovary		A	LIVING	2003		TCGA-61-2094-01		TCGA-61-2094-01A-01W-0722-08	c6e1c591-3225-482a-8350-112b664a37e6	1ac0ed16-0e91-4c45-9b9d-b68ceb9940da		TCGA-61-2094-01A-01R-1568-13	TCGA-61-2094-01A-01D-0667-05	TCGA-61-2094-01	TCGA-61-2094-01	TCGA-61-2094-01A-01D-0663-01	TCGA-61-2094-01	TCGA-61-2094-01A-01D-0663-01	83e7fa41-7dc6-4b03-a8c0-ad6dcb166a2c	c6e1c591-3225-482a-8350-112b664a37e6	c6e1c591-3225-482a-8350-112b664a37e6	83e7fa41-7dc6-4b03-a8c0-ad6dcb166a2c	TCGA-61-2094-01A-21-1560-20	TCGA-61-2094-01A-01R-1568-13	TCGA-61-2094-01A-01R-0670-07		1429ef11-964e-4e8b-afbb-8f38b75ad39f	c6e1c591-3225-482a-8350-112b664a37e6	TCGA-61-2094-01A-01R-1568-13	TCGA-61-2094-01A-01W-0722-08	
TCGA-61-2095-01	1	TCGA-61-2095-01	1875	1	Kirc+	C9-OV	OV-like c1	OV-like c4		miRNA cluster 3	cluster 6	mutation c1uster 9	TCGA-61-2095	1875	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-61-2095-F28389	Stage IIIC	-19797		1875	0	1875		445				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1.2			G2	Recurrence				TCGA-61-2095.3e08408b-b76a-4a32-b3f1-4590459f4af8.pdf					1	2			0	0	39	38	60	60	80	80		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003		TCGA-61-2095-01		TCGA-61-2095-01A-01W-0722-08		74a1f15a-05c4-4d85-a731-9a4e5281f644		TCGA-61-2095-01A-01R-1568-13	TCGA-61-2095-01A-01D-0667-05			TCGA-61-2095-01A-01D-0663-01	TCGA-61-2095-01	TCGA-61-2095-01A-01D-0663-01	0f90bddb-ac68-44ad-a48a-6293e7529aa1			0f90bddb-ac68-44ad-a48a-6293e7529aa1	TCGA-61-2095-01A-21-1560-20	TCGA-61-2095-01A-01R-1568-13	TCGA-61-2095-01A-01R-0670-07		5229ff68-9cae-49dc-aba8-757026e6e452		TCGA-61-2095-01A-01R-1568-13	TCGA-61-2095-01A-01W-0722-08	
TCGA-61-2095-02	1	TCGA-61-2095-02	1875	1		C9-OV	OV-like c1					mutation c1uster 9	TCGA-61-2095	1875	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	54	Bilateral	TCGA-61-2095-F28389	Stage IIIC	-19797		1875	0	1875		445				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G2	Recurrence					1	1	0	0	0	0	0	0	0	0	25	25	75	75	75	75		WITH TUMOR	YES	Complete Remission/Response		Imaging Study	NO		Recurrent Tumor	02	0.3			61	No Macroscopic disease	Ovary	YES	A	DECEASED	2003									TCGA-61-2095-02A-01D-0807-05						e49f394f-9548-4187-9ecd-04cb3fb5d238			e49f394f-9548-4187-9ecd-04cb3fb5d238			TCGA-61-2095-02A-01R-0810-07		9105d49a-b3ca-4453-95c7-3bb78b3e9e80				
TCGA-61-2096-01	0	TCGA-61-2096-01	1776	0	Squamous		OV-like c1	OV-like c4					TCGA-61-2096	1776	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	56	Right	TCGA-61-2096-F28398	Stage IC	-20663			0	1776		421				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence				TCGA-61-2096.9f95fe7d-4865-4ca5-bb57-9d47c388a7ed.pdf					0	1			0	0	70	29	30	70	80	95		TUMOR FREE	YES	Progressive Disease		Imaging Study	NO		Primary Tumor	01	0.5			61	No Macroscopic disease	Ovary		A	LIVING	2003		TCGA-61-2096-01				91b0b079-17b3-4c29-9ebd-1781ae28c86a			TCGA-61-2096-01A-01D-0667-05			TCGA-61-2096-01A-01D-0663-01	TCGA-61-2096-01	TCGA-61-2096-01A-01D-0663-01	b4f7c70b-4262-4fa7-8a9d-8239ed3f8363			b4f7c70b-4262-4fa7-8a9d-8239ed3f8363	TCGA-61-2096-01A-21-1560-20		TCGA-61-2096-01A-01R-0670-07		9497f7ac-b177-401b-a063-6297f90f009c				
TCGA-61-2097-01	0	TCGA-61-2097-01	1844	0	High	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2097	1844	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			71	Bilateral	TCGA-61-2097-F28413	Stage IIC	-25961			0	1844						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2		YES	G2					TCGA-61-2097.6d23149d-a9b0-422f-a560-bc1b4a3b99d6.pdf	0	0	0	0	0	0	0	0	0	0	20	20	80	80	80	80		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			61	1-10 mm	Ovary	YES	A	LIVING	2003		TCGA-61-2097-01		TCGA-61-2097-01A-02W-0722-08	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1			TCGA-61-2097-01A-02R-1568-13	TCGA-61-2097-01A-02D-0667-05	TCGA-61-2097-01	TCGA-61-2097-01	TCGA-61-2097-01A-02D-0663-01	TCGA-61-2097-01	TCGA-61-2097-01A-02D-0663-01	1cddea11-beb7-443f-9faa-f13824cc3e35	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	1cddea11-beb7-443f-9faa-f13824cc3e35		TCGA-61-2097-01A-02R-1568-13	TCGA-61-2097-01A-02R-0670-07		c1da73c7-9f61-41b6-90a1-fdc7bbf4ecd3	d76a99a6-18cd-4a50-9945-ebf5c5ccbfd1	TCGA-61-2097-01A-02R-1568-13	TCGA-61-2097-01A-02W-0722-08	
TCGA-61-2098-01	0	TCGA-61-2098-01	1993	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5		TCGA-61-2098	1993	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			62	Bilateral	TCGA-61-2098-F28418	Stage IIIC	-22876			0	1993						2009-12-8	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.7	NO		2			G2					TCGA-61-2098.d1c8ab49-5ba0-46c3-8205-53b4e39808b3.pdf					0	0			0	0	20	30	80	70	80	70		TUMOR FREE	YES	Complete Remission/Response			NO		Primary Tumor	01	0.5			61	11-20 mm	Ovary	NO	A	LIVING	2003		TCGA-61-2098-01			d855f86a-f302-47fb-aa9f-5977632c695a	f69ce3d8-2a32-4048-a786-50d7e153c051		TCGA-61-2098-01A-01R-1568-13	TCGA-61-2098-01A-01D-0667-05	TCGA-61-2098-01	TCGA-61-2098-01	TCGA-61-2098-01A-01D-0663-01	TCGA-61-2098-01	TCGA-61-2098-01A-01D-0663-01	89f4b51d-2c3d-4a66-8580-cb1edb8bb072	d855f86a-f302-47fb-aa9f-5977632c695a	d855f86a-f302-47fb-aa9f-5977632c695a	89f4b51d-2c3d-4a66-8580-cb1edb8bb072	TCGA-61-2098-01A-21-1560-20	TCGA-61-2098-01A-01R-1568-13	TCGA-61-2098-01A-01R-0670-07		0a007e29-e769-44ca-b0a8-465df5d46f4e	d855f86a-f302-47fb-aa9f-5977632c695a	TCGA-61-2098-01A-01R-1568-13		
TCGA-61-2101-01	1	TCGA-61-2101-01	1688	1	High	C9-OV	OV-like c1	OV-like c4		miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2101	1688	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Bilateral	TCGA-61-2101-F28422	Stage IIIC	-20287		1688	0	1688			0			2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO	100	1.5			G2					TCGA-61-2101.b9d85995-85dd-4b00-b93f-3387cd018475.pdf					0	0			0	0	10	10	90	90	90	90	Post-Adjuvant Therapy	WITH TUMOR	YES	Partial Remission/Response			NO		Primary Tumor	01	0.4			61	11-20 mm	Ovary		A	DECEASED	1999		TCGA-61-2101-01		TCGA-61-2101-01A-01W-0722-08		c33bc4d6-607a-425b-bffd-e818b69949f8		TCGA-61-2101-01A-01R-1568-13	TCGA-61-2101-01A-01D-0667-05			TCGA-61-2101-01A-01D-0663-01	TCGA-61-2101-01	TCGA-61-2101-01A-01D-0663-01	604f0e46-eff5-4389-9197-27b7399b2ad9			604f0e46-eff5-4389-9197-27b7399b2ad9	TCGA-61-2101-01A-21-1560-20	TCGA-61-2101-01A-01R-1568-13	TCGA-61-2101-01A-01R-0670-07		504e1539-a518-4ef6-90b0-4ec6cd2ffbe8		TCGA-61-2101-01A-01R-1568-13	TCGA-61-2101-01A-01W-0722-08	
TCGA-61-2102-01	1	TCGA-61-2102-01	197	1	High	C9-OV	OV-like c1	KIRC-like c1	OV-like c16	miRNA cluster 2	cluster 3	mutation cluster 5	TCGA-61-2102	197	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			74	Right	TCGA-61-2102-F28438	Stage IIIC	-27256		197	0	197						2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.5			G3					TCGA-61-2102.f0521e47-1cc3-4f72-9efd-3d128f57e614.pdf					15	10			25	85	0	85	60	5	85	85		WITH TUMOR	YES				NO		Primary Tumor	01	0.3			61		Ovary		A	DECEASED	1999		TCGA-61-2102-01		TCGA-61-2102-01A-01W-0722-08	7ac6af79-c14a-4026-84aa-a288afcb96da	0f492d79-0174-4e9f-8693-2827ba83fd7c		TCGA-61-2102-01A-01R-1568-13	TCGA-61-2102-01A-01D-0667-05	TCGA-61-2102-01	TCGA-61-2102-01	TCGA-61-2102-01A-01D-0663-01	TCGA-61-2102-01	TCGA-61-2102-01A-01D-0663-01	7d0cc9f7-b9ad-4338-a6ea-2d815502dbfe	7ac6af79-c14a-4026-84aa-a288afcb96da	7ac6af79-c14a-4026-84aa-a288afcb96da	7d0cc9f7-b9ad-4338-a6ea-2d815502dbfe	TCGA-61-2102-01A-21-1560-20	TCGA-61-2102-01A-01R-1568-13	TCGA-61-2102-01A-01R-0670-07		5b4f1e0c-f04d-4aa1-a794-5936189506d7	7ac6af79-c14a-4026-84aa-a288afcb96da	TCGA-61-2102-01A-01R-1568-13	TCGA-61-2102-01A-01W-0722-08	
TCGA-61-2104-01	0	TCGA-61-2104-01	2338	0	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 4	mutation cluster 5	TCGA-61-2104	2338	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Bilateral	TCGA-61-2104-F28442	Stage IIC	-19432			0	2338		1680				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.6	NO		1.5			G2	Recurrence				TCGA-61-2104.38d2e115-ec9a-40e5-bfa0-30fb1db60691.pdf					5	8			15	12	5	10	75	70	77	85			YES	Complete Remission/Response		Imaging Study	NO		Primary Tumor	01	0.4			61	No Macroscopic disease	Ovary	NO	A	LIVING	2003		TCGA-61-2104-01		TCGA-61-2104-01A-01W-0722-08	721a8fc8-bb54-4ec3-a19c-340c35f05280	14d97fdf-fcf4-4471-8595-4b6b5401caf6		TCGA-61-2104-01A-01R-1568-13	TCGA-61-2104-01A-01D-0667-05	TCGA-61-2104-01	TCGA-61-2104-01	TCGA-61-2104-01A-01D-0663-01	TCGA-61-2104-01	TCGA-61-2104-01A-01D-0663-01	7cbdfccd-ff2d-4410-bc82-7ed2e1f7b1d0	721a8fc8-bb54-4ec3-a19c-340c35f05280	721a8fc8-bb54-4ec3-a19c-340c35f05280	7cbdfccd-ff2d-4410-bc82-7ed2e1f7b1d0	TCGA-61-2104-01A-21-1560-20	TCGA-61-2104-01A-01R-1568-13	TCGA-61-2104-01A-01R-0670-07		28510e09-fb60-4595-802a-48b0aafc09b9	721a8fc8-bb54-4ec3-a19c-340c35f05280	TCGA-61-2104-01A-01R-1568-13	TCGA-61-2104-01A-01W-0722-08	
TCGA-61-2109-01	1	TCGA-61-2109-01	629	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 1	cluster 5	mutation cluster 5	TCGA-61-2109	629	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-61-2109-F28450	Stage IIIC	-14900		629	0	629		465				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.8	NO		1.7		NO	G3	Recurrence				TCGA-61-2109.c16bfe93-016f-49d4-8895-05b9055344c9.pdf					5	7			5	13	0	5	90	75	97	95		WITH TUMOR	YES			Molecular Marker(S)	NO		Primary Tumor	01	0.2			61	>20 mm	Ovary	NO	A	DECEASED	1999		TCGA-61-2109-01		TCGA-61-2109-01A-01W-0722-08	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	d3e2505d-0838-4a9c-a626-ad04f9254dd1		TCGA-61-2109-01A-01R-1568-13	TCGA-61-2109-01A-01D-0667-05	TCGA-61-2109-01	TCGA-61-2109-01	TCGA-61-2109-01A-01D-0663-01	TCGA-61-2109-01	TCGA-61-2109-01A-01D-0663-01	1987530a-49d4-4e7a-aaef-fa30a1aac2d7	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	1987530a-49d4-4e7a-aaef-fa30a1aac2d7	TCGA-61-2109-01A-21-1560-20	TCGA-61-2109-01A-01R-1568-13	TCGA-61-2109-01A-01R-0670-07		37fc46df-f46d-462f-8761-d82c66b8a3a1	c87ddfc3-d7a4-4704-b3cc-a19edfb63452	TCGA-61-2109-01A-01R-1568-13	TCGA-61-2109-01A-01W-0722-08	
TCGA-61-2110-01	1	TCGA-61-2110-01	1354	1	Squamous	C9-OV	OV-like c1		OV-like c16	miRNA cluster 1	cluster 3	mutation cluster 5	TCGA-61-2110	1354	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	56	Bilateral	TCGA-61-2110-F28456	Stage IIIC	-20718		1354	0	1354		213				2009-12-4	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		0.4				Recurrence				TCGA-61-2110.d7a597dc-d607-4e20-90a9-a181d6c11d17.pdf					7	5			45	25	3	5	45	65	70	75		WITH TUMOR	YES	Progressive Disease		First Seen At Further Surgery	NO		Primary Tumor	01	0.1			61	No Macroscopic disease	Ovary		A	DECEASED	1998		TCGA-61-2110-01		TCGA-61-2110-01A-01W-0722-08	6561cdb8-8499-41a6-8a79-ef0119e34c66			TCGA-61-2110-01A-01R-1568-13	TCGA-61-2110-01A-01D-0667-05	TCGA-61-2110-01	TCGA-61-2110-01	TCGA-61-2110-01A-01D-0663-01	TCGA-61-2110-01	TCGA-61-2110-01A-01D-0663-01	6f43196c-f5bd-473e-8212-acbdd3a7f02d	6561cdb8-8499-41a6-8a79-ef0119e34c66	6561cdb8-8499-41a6-8a79-ef0119e34c66	6f43196c-f5bd-473e-8212-acbdd3a7f02d		TCGA-61-2110-01A-01R-1568-13	TCGA-61-2110-01A-01R-0670-07		8f17192c-1ecb-4f31-8df0-a6dde0b8ce96	6561cdb8-8499-41a6-8a79-ef0119e34c66	TCGA-61-2110-01A-01R-1568-13	TCGA-61-2110-01A-01W-0722-08	
TCGA-61-2111-01	0	TCGA-61-2111-01	3825	0	Squamous	C9-OV	UCEC Serous c4	OV-like c4	OV-like c16	miRNA c1uster 10	cluster 5	mutation cluster 5	TCGA-61-2111	3825	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	61	Left	TCGA-61-2111-F28467	Stage IV	-22517			0	3825		2205				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1.4	NO		1.5			G3	Recurrence				TCGA-61-2111.351930bc-ac4d-468e-9fe2-ba6f16c01444.pdf					10	14			0	3	5	3	85	80	80	75		WITH TUMOR	YES	Complete Remission/Response		Other Method: Specify In Notes	NO		Primary Tumor	01	0.3			61		Ovary		A	LIVING	1998		TCGA-61-2111-01		TCGA-61-2111-01A-01W-0722-08	25c0888a-25b9-4cc0-a02f-6d363a341e8f	975fb889-32f1-46e2-a558-b32d8a1b353f		TCGA-61-2111-01A-01R-1568-13	TCGA-61-2111-01A-01D-0667-05	TCGA-61-2111-01	TCGA-61-2111-01	TCGA-61-2111-01A-01D-0663-01	TCGA-61-2111-01	TCGA-61-2111-01A-01D-0663-01	18d87466-bae2-4006-bed7-2657e9f070d3	25c0888a-25b9-4cc0-a02f-6d363a341e8f	25c0888a-25b9-4cc0-a02f-6d363a341e8f	18d87466-bae2-4006-bed7-2657e9f070d3	TCGA-61-2111-01A-21-1560-20	TCGA-61-2111-01A-01R-1568-13	TCGA-61-2111-01A-01R-0670-07		3ee05aa8-a556-4d87-8aab-a76491d30640	25c0888a-25b9-4cc0-a02f-6d363a341e8f	TCGA-61-2111-01A-01R-1568-13	TCGA-61-2111-01A-01W-0722-08	
TCGA-61-2113-01	1	TCGA-61-2113-01	676	1	High	C9-OV	OV-like c1	OV-like c4	OV-like c16	miRNA cluster 2	cluster 5	mutation cluster 5	TCGA-61-2113	676	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	53	Right	TCGA-61-2113-F28479	Stage IIC	-19722		676	0	676		291				2009-12-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.8	NO		1.6		YES	G3	Recurrence				TCGA-61-2113.d10e1b61-73c4-4ab7-bc4b-8c7827856602.pdf					0	0			0	0	30	30	70	70	70	70			YES				NO		Primary Tumor	01	0.4			61		Ovary	YES	A	DECEASED	1999		TCGA-61-2113-01		TCGA-61-2113-01A-01W-0722-08	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	a8827db2-9eab-4285-bf50-ab2b9e19be57		TCGA-61-2113-01A-01R-1568-13	TCGA-61-2113-01A-01D-0667-05	TCGA-61-2113-01	TCGA-61-2113-01	TCGA-61-2113-01A-01D-0663-01	TCGA-61-2113-01	TCGA-61-2113-01A-01D-0663-01	3746895b-2ff1-4dcb-9001-6023ebe66a34	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	3746895b-2ff1-4dcb-9001-6023ebe66a34	TCGA-61-2113-01A-21-1562-20	TCGA-61-2113-01A-01R-1568-13	TCGA-61-2113-01A-01R-0670-07		9467c678-f573-4a50-83d9-ae3a0880354b	d5752594-1a2c-47c8-a40b-bffd5b6b7e71	TCGA-61-2113-01A-01R-1568-13	TCGA-61-2113-01A-01W-0722-08	
TCGA-61-2610-01	1	TCGA-61-2610-01	1579	1				OV-like c4					TCGA-61-2610	1579	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	61	Left	TCGA-61-2610-F28484	Stage IIIC	-22481		1579	0	1579		524				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		1	NO		1			G3	Recurrence				TCGA-61-2610.a5914371-94ab-4079-a6ea-11c79e9db4a1.pdf																		WITH TUMOR	YES	Stable Disease		Imaging Study	NO	R1	Primary Tumor	01	0.4			61	11-20 mm	Ovary		A	DECEASED	1998						a3cbaeb1-63e7-4818-aa6b-ce817827231b													TCGA-61-2610-01A-21-20								
TCGA-61-2610-02	1	TCGA-61-2610-02	1579	1			OV-like c1						TCGA-61-2610	1579	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	YES	61	Left	TCGA-61-2610-F28484	Stage IIIC	-22481		1579	0	1579		524				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		0.6			G3	Recurrence									5	0			0	0	5	5	90	95	90	90		WITH TUMOR	YES	Stable Disease		Imaging Study	NO	R1	Recurrent Tumor	02	0.3			61	11-20 mm	Ovary		A	DECEASED	1998									TCGA-61-2610-02A-01D-1138-05						a9ad6ed4-b513-48c6-ac3c-334d60dfaf34			a9ad6ed4-b513-48c6-ac3c-334d60dfaf34			TCGA-61-2610-02A-01R-1141-07		30ed8178-1e57-4d4e-af54-ea8097a33bbe				TCGA-61-2610-02A-01W-1092-09
TCGA-61-2611-02	1	TCGA-61-2611-02	483	1			Low purity c2						TCGA-61-2611	483	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	40	Bilateral	TCGA-61-2611-F28491	Stage IIIC	-14782		483	0	483		383				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Cytology (e.g. Peritoneal or pleural fluid)		0.6	NO		0.7			G3	Recurrence									0	0			20	0	20	80	60	20	80	70		WITH TUMOR	YES	Complete Remission/Response		First Seen At Further Surgery	NO	R1	Recurrent Tumor	02	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2008									TCGA-61-2611-02A-01D-1138-05						7e9a894d-11d2-49b6-af84-e8d9723942e8			7e9a894d-11d2-49b6-af84-e8d9723942e8			TCGA-61-2611-02A-01R-1141-07		2983d372-ea74-4ceb-a26e-7b4e6a8acf8f				TCGA-61-2611-02A-01W-1092-09
TCGA-61-2612-01	1	TCGA-61-2612-01	193	1	High		OV-like c1	OV-like c4					TCGA-61-2612	193	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	63	Bilateral	TCGA-61-2612-F28496	Stage IIIC	-23074		193	0	193		179				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		2	NO		2.5		YES	G3	Recurrence				TCGA-61-2612.48d32d40-9eef-43d2-beb6-75fcc071c52b.pdf					10	10			0	0	35	30	55	60	80	80		WITH TUMOR	YES	Stable Disease		First Seen At Further Surgery	NO	R1	Primary Tumor	01	0.4			61	1-10 mm	Ovary	YES	A	DECEASED	2002		TCGA-61-2612-01				7055e7b7-38bb-4fe4-841b-1419a6273bad			TCGA-61-2612-01A-01D-1138-05			TCGA-61-2612-01A-01D-1134-01	TCGA-61-2612-01	TCGA-61-2612-01A-01D-1134-01	84ee91f1-d11b-4c5b-abee-47cd61945bc4			84ee91f1-d11b-4c5b-abee-47cd61945bc4	TCGA-61-2612-01A-21-20		TCGA-61-2612-01A-01R-1141-07		9b739900-7aff-4e27-aa8b-5feaaaa77247				TCGA-61-2612-01A-01W-1092-09
TCGA-61-2613-01	1	TCGA-61-2613-01	945	1	Squamous		OV-like c1	OV-like c4					TCGA-61-2613	945	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	73	Bilateral	TCGA-61-2613-F28500	Stage IIIC	-26779		945	0	945		358				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.5	NO		1.1			G3	Recurrence				TCGA-61-2613.6d7a40b1-02f0-4d7e-b3e2-e467e404a241.pdf					5	5			0	0	55	45	40	50	70	70		WITH TUMOR	YES	Stable Disease		Imaging Study	NO	R1	Primary Tumor	01	0.3			61	11-20 mm	Ovary		A	DECEASED	1998		TCGA-61-2613-01				fce6b5fb-7b97-4af7-a919-0215363156f0			TCGA-61-2613-01A-01D-1138-05			TCGA-61-2613-01A-01D-1134-01	TCGA-61-2613-01	TCGA-61-2613-01A-01D-1134-01	cf6b6185-cf35-43b2-a7f2-8544fadccedf			cf6b6185-cf35-43b2-a7f2-8544fadccedf	TCGA-61-2613-01A-21-20		TCGA-61-2613-01A-01R-1141-07		4f3e6b8b-2c5b-4c59-aca0-d3a6b7ee46b5				TCGA-61-2613-01A-01W-1092-09
TCGA-61-2614-01	1	TCGA-61-2614-01	262	1	High		OV-like c1	OV-like c4					TCGA-61-2614	262	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma	YES	NO	71	Bilateral	TCGA-61-2614-F28505	Stage IIIC	-26142		262	0	262		38				2010-9-7	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection		0.4	NO		1.6		YES	G3	Recurrence				TCGA-61-2614.d0ffe1e5-5b41-4dfb-b82d-da937b5b345b.pdf					5	5			0	0	40	40	55	55	75	75		WITH TUMOR	NO	Stable Disease		Imaging Study	NO	R1	Primary Tumor	01	0.3			61	1-10 mm	Ovary	YES	A	DECEASED	2007		TCGA-61-2614-01				81ab2618-ccb2-4a64-bab2-83e69633defe			TCGA-61-2614-01A-01D-1138-05			TCGA-61-2614-01A-01D-1134-01	TCGA-61-2614-01	TCGA-61-2614-01A-01D-1134-01	4613360f-cf63-4836-a12b-c48cb8602417			4613360f-cf63-4836-a12b-c48cb8602417	TCGA-61-2614-01A-21-20		TCGA-61-2614-01A-01R-1141-07		59193352-8a67-49d4-9ca0-430c36fe0d12				TCGA-61-2614-01A-01W-1092-09
TCGA-72-4231-01		TCGA-72-4231-01					OV-like c1						TCGA-72-4231		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.3	NO		0.5																																	Primary Tumor	01	0.1							A											TCGA-72-4231-01A-01D-1011-05			TCGA-72-4231-01A-01D-1017-01		TCGA-72-4231-01A-01D-1017-01	423aa111-bbe6-4589-8f72-a12c81726e15,71877e6e-572f-43f8-bb76-38af46c69e17			423aa111-bbe6-4589-8f72-a12c81726e15,71877e6e-572f-43f8-bb76-38af46c69e17									
TCGA-72-4232-01		TCGA-72-4232-01					OV-like c1						TCGA-72-4232		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.5	NO		0.6																																	Primary Tumor	01	0.1							A											TCGA-72-4232-01A-01D-1011-05			TCGA-72-4232-01A-01D-1017-01		TCGA-72-4232-01A-01D-1017-01	aa5555df-0e37-4b48-aa7b-e1f9970ae160,f248f5f6-324e-472b-92ae-a1d960be5152			aa5555df-0e37-4b48-aa7b-e1f9970ae160,f248f5f6-324e-472b-92ae-a1d960be5152									
TCGA-72-4233-01		TCGA-72-4233-01					OV-like c1						TCGA-72-4233		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.3	NO		0.5																																	Primary Tumor	01	0.1							A											TCGA-72-4233-01A-01D-1011-05			TCGA-72-4233-01A-01D-1017-01		TCGA-72-4233-01A-01D-1017-01	2273c426-9ab7-442f-b232-96e192f5d1b0,c5ae2cf0-f7b7-48cf-854c-3ad774091de0			2273c426-9ab7-442f-b232-96e192f5d1b0,c5ae2cf0-f7b7-48cf-854c-3ad774091de0									
TCGA-72-4234-01		TCGA-72-4234-01					OV-like c1						TCGA-72-4234		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.2	NO		1.2																																	Primary Tumor	01	0.1							A											TCGA-72-4234-01A-01D-1011-05			TCGA-72-4234-01A-01D-1017-01		TCGA-72-4234-01A-01D-1017-01	b37800d7-c8cb-4197-a178-f2a2787f70cb,cf2d64ed-2967-40b1-aea9-18764d69e183			b37800d7-c8cb-4197-a178-f2a2787f70cb,cf2d64ed-2967-40b1-aea9-18764d69e183									
TCGA-72-4235-01		TCGA-72-4235-01					OV-like c1						TCGA-72-4235		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.6	NO		1																																	Primary Tumor	01	0.1							A											TCGA-72-4235-01A-01D-1011-05			TCGA-72-4235-01A-01D-1017-01		TCGA-72-4235-01A-01D-1017-01	5eae71b2-2c59-4367-99a0-d867a899cf05,eb9229d9-1a7a-4504-9724-2538177f9053			5eae71b2-2c59-4367-99a0-d867a899cf05,eb9229d9-1a7a-4504-9724-2538177f9053									
TCGA-72-4236-01		TCGA-72-4236-01					OV-like c1						TCGA-72-4236		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.2	NO		0.4																																	Primary Tumor	01	0.1							A											TCGA-72-4236-01A-01D-1011-05			TCGA-72-4236-01A-01D-1017-01		TCGA-72-4236-01A-01D-1017-01	8df8f3e7-6894-4270-be51-d0848f65c1db,8e490868-41d8-489c-8afb-23f97bba13f4			8df8f3e7-6894-4270-be51-d0848f65c1db,8e490868-41d8-489c-8afb-23f97bba13f4									
TCGA-72-4237-01		TCGA-72-4237-01					OV-like c1						TCGA-72-4237		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.3	NO		1.5																																	Primary Tumor	01	0.1							A											TCGA-72-4237-01A-01D-1011-05			TCGA-72-4237-01A-01D-1017-01		TCGA-72-4237-01A-01D-1017-01	1bf31b9e-d86a-47f9-b26e-3f3d6eaf59a8,fa4f901d-5a82-4111-a822-41778606cad9			1bf31b9e-d86a-47f9-b26e-3f3d6eaf59a8,fa4f901d-5a82-4111-a822-41778606cad9									
TCGA-72-4238-01		TCGA-72-4238-01					OV-like c1						TCGA-72-4238		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.4	NO		1.5																																	Primary Tumor	01	0.1							A											TCGA-72-4238-01A-01D-1011-05			TCGA-72-4238-01A-01D-1017-01		TCGA-72-4238-01A-01D-1017-01	61aa26da-944e-48b4-ab65-e6e26e34b07a,af0c4826-0291-4831-a9e2-2799bc3dc7c9			61aa26da-944e-48b4-ab65-e6e26e34b07a,af0c4826-0291-4831-a9e2-2799bc3dc7c9									
TCGA-72-4240-01		TCGA-72-4240-01					OV-like c1						TCGA-72-4240		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											1	NO		1																																	Primary Tumor	01	0.1							A											TCGA-72-4240-01A-01D-1011-05			TCGA-72-4240-01A-01D-1017-01		TCGA-72-4240-01A-01D-1017-01	1e36f528-71e0-488d-ba73-1a8017e45d86,45cefcc7-52bc-4a47-9cf3-c8efacb38f51			1e36f528-71e0-488d-ba73-1a8017e45d86,45cefcc7-52bc-4a47-9cf3-c8efacb38f51									
TCGA-72-4241-01		TCGA-72-4241-01					OV-like c1						TCGA-72-4241		Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma																											0.3	NO		2																																	Primary Tumor	01	0.1							A											TCGA-72-4241-01A-01D-1011-05			TCGA-72-4241-01A-01D-1017-01		TCGA-72-4241-01A-01D-1017-01	831c7676-6772-413d-9417-a993393cdfa6,ee1fde23-4077-44dd-b91a-3bc22b0fd04e			831c7676-6772-413d-9417-a993393cdfa6,ee1fde23-4077-44dd-b91a-3bc22b0fd04e									
TCGA-OY-A56P-01	0	TCGA-OY-A56P-01	1207	0									TCGA-OY-A56P	1207	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			48	Right	TCGA-OY-A56P-F56664	Stage IIIB	-17580	796		0	1207				Scheduled Follow-up Submission	Stable Disease	2014-2-17	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Tumor resection	390		NO			NO	NO	G3				false	TCGA-OY-A56P.D916ED58-54D5-43FC-A5B0-6E4844A7F677.pdf		2		1		5		0		0		0		95		80		WITH TUMOR	YES	Complete Remission/Response	No		NO	R2	Primary Tumor	01		YES	NO	OY	1-10 mm	Ovary	NO	A	LIVING	2010								TCGA-OY-A56P-01A-12R-A407-13				TCGA-OY-A56P-01A-12D-A402-01		TCGA-OY-A56P-01A-12D-A402-01	efb6506d-f0d6-49e8-8e5f-35780806bc66			efb6506d-f0d6-49e8-8e5f-35780806bc66				TCGA-OY-A56P-01A-12D-A409-05					
TCGA-OY-A56Q-01	0	TCGA-OY-A56Q-01	576	0									TCGA-OY-A56Q	576	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			78	Left	TCGA-OY-A56Q-F57585	Stage IIA	-28623	120		0	576				Scheduled Follow-up Submission	Complete Remission/Response	2014-3-17	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection	370		NO			NO	NO	G3			NO	false	TCGA-OY-A56Q.3EF6F66B-8B6E-48E6-9CF4-F8A6B236856D.pdf		1		0		0		0		0		0		100		85		TUMOR FREE	YES	Complete Remission/Response	No		NO	RX	Primary Tumor	01		YES	NO	OY	No Macroscopic disease	Ovary	NO	A	LIVING	2012								TCGA-OY-A56Q-01A-11R-A407-13				TCGA-OY-A56Q-01A-11D-A402-01		TCGA-OY-A56Q-01A-11D-A402-01	5e52d425-00fa-4cd2-a278-8e298d333ce1			5e52d425-00fa-4cd2-a278-8e298d333ce1				TCGA-OY-A56Q-01A-11D-A409-05					
TCGA-VG-A8LO-01	1	TCGA-VG-A8LO-01	24	1									TCGA-VG-A8LO	24	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			55	Right		Stage IV	-20274	122	24	0				4			2014-3-25	FEMALE	Serous Cystadenocarcinoma	No	C56.9	8460/3	C56.9	YES	Excisional Biopsy	260		NO	50				GB			NO	false	TCGA-VG-A8LO.6FF4C359-F127-44E6-A1A2-641D60A3665F.pdf		0		0		0		0		0		10		90		90	Other	WITH TUMOR	YES		No		NO	R2	Primary Tumor	01		YES	NO	VG	>20 mm	Ovary		A	DECEASED	2013								TCGA-VG-A8LO-01A-11R-A407-13				TCGA-VG-A8LO-01A-11D-A402-01		TCGA-VG-A8LO-01A-11D-A402-01	254728bc-a38b-4133-8995-663648738957			254728bc-a38b-4133-8995-663648738957				TCGA-VG-A8LO-01A-11D-A409-05					
TCGA-WR-A838-01	1	TCGA-WR-A838-01	304	1									TCGA-WR-A838	304	Ovary	TCGA Ovarian Cancer	ovarian serous cystadenocarcinoma			72	Right	TCGA-WR-A838-F66184	Stage IIIC	-26418	110	304	0	245		245	1	Scheduled Follow-up Submission	Progressive Disease	2014-10-3	FEMALE	Serous Cystadenocarcinoma	No		8441/3	C56.9	YES	Tumor resection	200		NO			NO	YES	G3	Progression of Disease		NO	false	TCGA-WR-A838.8F364931-727D-4099-A1D2-E96C61461479.pdf		0		0		5		0		0		10		85		90	Pre-Adjuvant Therapy	WITH TUMOR	YES	Progressive Disease	No		NO		Primary Tumor	01		NO	YES	WR		Ovary	YES	A	DECEASED	2013								TCGA-WR-A838-01A-12R-A407-13				TCGA-WR-A838-01A-12D-A402-01		TCGA-WR-A838-01A-12D-A402-01	19411d88-5575-4dbb-bdf2-1d0018c6a964			19411d88-5575-4dbb-bdf2-1d0018c6a964				TCGA-WR-A838-01A-12D-A409-05					
